STUDYID,DOMAIN,USUBJID,PCSEQ,PCGRPID,PCTESTCD,PCTEST,PCORRES,PCORRESU,PCSTRESC,PCSTRESN,PCSTRESU,PCSTAT,PCREASND,PCNAM,PCSPEC,PCLLOQ,VISITNUM,VISIT,EPOCH,PCDTC,PCDY,PCTPT,PCTPTNUM,PCTPTREF,PCRFTDTC
3110-103-002,PC,3110-103-002.103001005,1.0,1345449,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T09:18:00,1.0,Predose,0.0,Period 1 Dose,2018-03-23T09:48:00
3110-103-002,PC,3110-103-002.103001005,2.0,1345455,UBRO,Ubrogepant,74.46,ng/mL,74.46,74.46,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:18:00,1.0,0.5 h,0.5,Period 1 Dose,2018-03-23T09:48:00
3110-103-002,PC,3110-103-002.103001005,3.0,1345461,UBRO,Ubrogepant,255.88,ng/mL,255.88,255.88,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:48:00,1.0,1 h,1.0,Period 1 Dose,2018-03-23T09:48:00
3110-103-002,PC,3110-103-002.103001005,4.0,1345466,UBRO,Ubrogepant,167.78,ng/mL,167.78,167.78,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:18:00,1.0,1.5 h,1.5,Period 1 Dose,2018-03-23T09:48:00
3110-103-002,PC,3110-103-002.103001005,5.0,1345477,UBRO,Ubrogepant,174.34,ng/mL,174.34,174.34,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:48:00,1.0,2 h,2.0,Period 1 Dose,2018-03-23T09:48:00
3110-103-002,PC,3110-103-002.103001005,6.0,1345480,UBRO,Ubrogepant,116.00,ng/mL,116.00,116.0,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T12:48:00,1.0,3 h,3.0,Period 1 Dose,2018-03-23T09:48:00
3110-103-002,PC,3110-103-002.103001005,7.0,1345483,UBRO,Ubrogepant,92.91,ng/mL,92.91,92.91,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T13:48:00,1.0,4 h,4.0,Period 1 Dose,2018-03-23T09:48:00
3110-103-002,PC,3110-103-002.103001005,8.0,1345494,UBRO,Ubrogepant,55.31,ng/mL,55.31,55.31,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T14:48:00,1.0,5 h,5.0,Period 1 Dose,2018-03-23T09:48:00
3110-103-002,PC,3110-103-002.103001005,9.0,1345496,UBRO,Ubrogepant,45.15,ng/mL,45.15,45.15,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T15:49:05,1.0,6 h,6.0,Period 1 Dose,2018-03-23T09:48:00
3110-103-002,PC,3110-103-002.103001005,10.0,1345498,UBRO,Ubrogepant,25.50,ng/mL,25.50,25.5,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T17:48:00,1.0,8 h,8.0,Period 1 Dose,2018-03-23T09:48:00
3110-103-002,PC,3110-103-002.103001005,11.0,1345504,UBRO,Ubrogepant,9.44,ng/mL,9.44,9.44,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T21:48:00,1.0,12 h,12.0,Period 1 Dose,2018-03-23T09:48:00
3110-103-002,PC,3110-103-002.103001005,12.0,1345510,UBRO,Ubrogepant,7.13,ng/mL,7.13,7.13,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T23:51:01,1.0,14 h,14.0,Period 1 Dose,2018-03-23T09:48:00
3110-103-002,PC,3110-103-002.103001005,13.0,1345523,UBRO,Ubrogepant,2.31,ng/mL,2.31,2.31,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-03-24T09:48:00,2.0,24 h,24.0,Period 1 Dose,2018-03-23T09:48:00
3110-103-002,PC,3110-103-002.103001005,14.0,1345567,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T09:18:00,8.0,Predose,0.0,Period 2 Dose,2018-03-30T09:48:00
3110-103-002,PC,3110-103-002.103001005,15.0,1345573,UBRO,Ubrogepant,68.91,ng/mL,68.91,68.91,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:18:00,8.0,0.5 h,0.5,Period 2 Dose,2018-03-30T09:48:00
3110-103-002,PC,3110-103-002.103001005,16.0,1345576,UBRO,Ubrogepant,241.67,ng/mL,241.67,241.67,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:48:00,8.0,1 h,1.0,Period 2 Dose,2018-03-30T09:48:00
3110-103-002,PC,3110-103-002.103001005,17.0,1345579,UBRO,Ubrogepant,241.95,ng/mL,241.95,241.95,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:18:00,8.0,1.5 h,1.5,Period 2 Dose,2018-03-30T09:48:00
3110-103-002,PC,3110-103-002.103001005,18.0,1345586,UBRO,Ubrogepant,213.53,ng/mL,213.53,213.53,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:48:00,8.0,2 h,2.0,Period 2 Dose,2018-03-30T09:48:00
3110-103-002,PC,3110-103-002.103001005,19.0,1345587,UBRO,Ubrogepant,165.06,ng/mL,165.06,165.06,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T12:48:00,8.0,3 h,3.0,Period 2 Dose,2018-03-30T09:48:00
3110-103-002,PC,3110-103-002.103001005,20.0,1345588,UBRO,Ubrogepant,134.60,ng/mL,134.60,134.6,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T13:48:00,8.0,4 h,4.0,Period 2 Dose,2018-03-30T09:48:00
3110-103-002,PC,3110-103-002.103001005,21.0,1345593,UBRO,Ubrogepant,96.95,ng/mL,96.95,96.95,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T14:48:00,8.0,5 h,5.0,Period 2 Dose,2018-03-30T09:48:00
3110-103-002,PC,3110-103-002.103001005,22.0,1345594,UBRO,Ubrogepant,74.45,ng/mL,74.45,74.45,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T15:48:00,8.0,6 h,6.0,Period 2 Dose,2018-03-30T09:48:00
3110-103-002,PC,3110-103-002.103001005,23.0,1345595,UBRO,Ubrogepant,41.25,ng/mL,41.25,41.25,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T17:48:00,8.0,8 h,8.0,Period 2 Dose,2018-03-30T09:48:00
3110-103-002,PC,3110-103-002.103001005,24.0,1345598,UBRO,Ubrogepant,15.65,ng/mL,15.65,15.65,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T21:48:00,8.0,12 h,12.0,Period 2 Dose,2018-03-30T09:48:00
3110-103-002,PC,3110-103-002.103001005,25.0,1345601,UBRO,Ubrogepant,10.60,ng/mL,10.60,10.6,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T23:48:00,8.0,14 h,14.0,Period 2 Dose,2018-03-30T09:48:00
3110-103-002,PC,3110-103-002.103001005,26.0,1345607,UBRO,Ubrogepant,2.46,ng/mL,2.46,2.46,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-03-31T09:48:00,9.0,24 h,24.0,Period 2 Dose,2018-03-30T09:48:00
3110-103-002,PC,3110-103-002.103001005,27.0,1345632,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T09:18:00,15.0,Predose,0.0,Period 3 Dose,2018-04-06T09:48:00
3110-103-002,PC,3110-103-002.103001005,28.0,1345634,UBRO,Ubrogepant,163.87,ng/mL,163.87,163.87,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:18:00,15.0,0.5 h,0.5,Period 3 Dose,2018-04-06T09:48:00
3110-103-002,PC,3110-103-002.103001005,29.0,1345637,UBRO,Ubrogepant,209.00,ng/mL,209.00,209.0,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:48:00,15.0,1 h,1.0,Period 3 Dose,2018-04-06T09:48:00
3110-103-002,PC,3110-103-002.103001005,30.0,1345640,UBRO,Ubrogepant,142.47,ng/mL,142.47,142.47,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:18:00,15.0,1.5 h,1.5,Period 3 Dose,2018-04-06T09:48:00
3110-103-002,PC,3110-103-002.103001005,31.0,1345644,UBRO,Ubrogepant,160.65,ng/mL,160.65,160.65,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:48:00,15.0,2 h,2.0,Period 3 Dose,2018-04-06T09:48:00
3110-103-002,PC,3110-103-002.103001005,32.0,1345645,UBRO,Ubrogepant,118.79,ng/mL,118.79,118.79,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T12:48:00,15.0,3 h,3.0,Period 3 Dose,2018-04-06T09:48:00
3110-103-002,PC,3110-103-002.103001005,33.0,1345646,UBRO,Ubrogepant,71.18,ng/mL,71.18,71.18,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T13:48:00,15.0,4 h,4.0,Period 3 Dose,2018-04-06T09:48:00
3110-103-002,PC,3110-103-002.103001005,34.0,1345651,UBRO,Ubrogepant,53.99,ng/mL,53.99,53.99,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T14:48:00,15.0,5 h,5.0,Period 3 Dose,2018-04-06T09:48:00
3110-103-002,PC,3110-103-002.103001005,35.0,1345652,UBRO,Ubrogepant,56.00,ng/mL,56.00,56.0,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T15:48:00,15.0,6 h,6.0,Period 3 Dose,2018-04-06T09:48:00
3110-103-002,PC,3110-103-002.103001005,36.0,1345653,UBRO,Ubrogepant,34.44,ng/mL,34.44,34.44,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T17:48:00,15.0,8 h,8.0,Period 3 Dose,2018-04-06T09:48:00
3110-103-002,PC,3110-103-002.103001005,37.0,1345656,UBRO,Ubrogepant,14.88,ng/mL,14.88,14.88,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T21:48:00,15.0,12 h,12.0,Period 3 Dose,2018-04-06T09:48:00
3110-103-002,PC,3110-103-002.103001005,38.0,1345659,UBRO,Ubrogepant,10.30,ng/mL,10.30,10.3,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T23:48:00,15.0,14 h,14.0,Period 3 Dose,2018-04-06T09:48:00
3110-103-002,PC,3110-103-002.103001005,39.0,1345665,UBRO,Ubrogepant,2.95,ng/mL,2.95,2.95,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,26.0,Period 3 Day 16,TREATMENT,2018-04-07T09:48:00,16.0,24 h,24.0,Period 3 Dose,2018-04-06T09:48:00
3110-103-002,PC,3110-103-002.103001007,1.0,1343371,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T09:11:00,1.0,Predose,0.0,Period 1 Dose,2018-03-23T09:41:00
3110-103-002,PC,3110-103-002.103001007,2.0,1343373,UBRO,Ubrogepant,56.97,ng/mL,56.97,56.97,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:11:00,1.0,0.5 h,0.5,Period 1 Dose,2018-03-23T09:41:00
3110-103-002,PC,3110-103-002.103001007,3.0,1343376,UBRO,Ubrogepant,309.24,ng/mL,309.24,309.24,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:41:00,1.0,1 h,1.0,Period 1 Dose,2018-03-23T09:41:00
3110-103-002,PC,3110-103-002.103001007,4.0,1343379,UBRO,Ubrogepant,401.28,ng/mL,401.28,401.28,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:11:00,1.0,1.5 h,1.5,Period 1 Dose,2018-03-23T09:41:00
3110-103-002,PC,3110-103-002.103001007,5.0,1343383,UBRO,Ubrogepant,406.84,ng/mL,406.84,406.84,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:41:00,1.0,2 h,2.0,Period 1 Dose,2018-03-23T09:41:00
3110-103-002,PC,3110-103-002.103001007,6.0,1343384,UBRO,Ubrogepant,226.57,ng/mL,226.57,226.57,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T12:41:00,1.0,3 h,3.0,Period 1 Dose,2018-03-23T09:41:00
3110-103-002,PC,3110-103-002.103001007,7.0,1343385,UBRO,Ubrogepant,139.46,ng/mL,139.46,139.46,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T13:41:00,1.0,4 h,4.0,Period 1 Dose,2018-03-23T09:41:00
3110-103-002,PC,3110-103-002.103001007,8.0,1343390,UBRO,Ubrogepant,111.84,ng/mL,111.84,111.84,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T14:41:00,1.0,5 h,5.0,Period 1 Dose,2018-03-23T09:41:00
3110-103-002,PC,3110-103-002.103001007,9.0,1343391,UBRO,Ubrogepant,84.90,ng/mL,84.90,84.9,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T15:41:00,1.0,6 h,6.0,Period 1 Dose,2018-03-23T09:41:00
3110-103-002,PC,3110-103-002.103001007,10.0,1343392,UBRO,Ubrogepant,55.20,ng/mL,55.20,55.2,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T17:41:00,1.0,8 h,8.0,Period 1 Dose,2018-03-23T09:41:00
3110-103-002,PC,3110-103-002.103001007,11.0,1343395,UBRO,Ubrogepant,17.78,ng/mL,17.78,17.78,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T21:41:00,1.0,12 h,12.0,Period 1 Dose,2018-03-23T09:41:00
3110-103-002,PC,3110-103-002.103001007,12.0,1343398,UBRO,Ubrogepant,11.07,ng/mL,11.07,11.07,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T23:41:00,1.0,14 h,14.0,Period 1 Dose,2018-03-23T09:41:00
3110-103-002,PC,3110-103-002.103001007,13.0,1343404,UBRO,Ubrogepant,2.21,ng/mL,2.21,2.21,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-03-24T09:41:00,2.0,24 h,24.0,Period 1 Dose,2018-03-23T09:41:00
3110-103-002,PC,3110-103-002.103001008,1.0,1345126,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T09:19:00,1.0,Predose,0.0,Period 1 Dose,2018-03-23T09:49:00
3110-103-002,PC,3110-103-002.103001008,2.0,1345128,UBRO,Ubrogepant,240.45,ng/mL,240.45,240.45,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:22:02,1.0,0.5 h,0.5,Period 1 Dose,2018-03-23T09:49:00
3110-103-002,PC,3110-103-002.103001008,3.0,1345131,UBRO,Ubrogepant,525.64,ng/mL,525.64,525.64,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:49:00,1.0,1 h,1.0,Period 1 Dose,2018-03-23T09:49:00
3110-103-002,PC,3110-103-002.103001008,4.0,1345134,UBRO,Ubrogepant,262.53,ng/mL,262.53,262.53,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:19:00,1.0,1.5 h,1.5,Period 1 Dose,2018-03-23T09:49:00
3110-103-002,PC,3110-103-002.103001008,5.0,1345138,UBRO,Ubrogepant,187.02,ng/mL,187.02,187.02,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:55:20,1.0,2 h,2.0,Period 1 Dose,2018-03-23T09:49:00
3110-103-002,PC,3110-103-002.103001008,6.0,1345139,UBRO,Ubrogepant,125.33,ng/mL,125.33,125.33,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T12:49:00,1.0,3 h,3.0,Period 1 Dose,2018-03-23T09:49:00
3110-103-002,PC,3110-103-002.103001008,7.0,1345140,UBRO,Ubrogepant,99.59,ng/mL,99.59,99.59,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T13:49:00,1.0,4 h,4.0,Period 1 Dose,2018-03-23T09:49:00
3110-103-002,PC,3110-103-002.103001008,8.0,1345145,UBRO,Ubrogepant,75.52,ng/mL,75.52,75.52,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T14:49:00,1.0,5 h,5.0,Period 1 Dose,2018-03-23T09:49:00
3110-103-002,PC,3110-103-002.103001008,9.0,1345146,UBRO,Ubrogepant,58.51,ng/mL,58.51,58.51,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T15:49:00,1.0,6 h,6.0,Period 1 Dose,2018-03-23T09:49:00
3110-103-002,PC,3110-103-002.103001008,10.0,1345147,UBRO,Ubrogepant,30.36,ng/mL,30.36,30.36,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T17:53:21,1.0,8 h,8.0,Period 1 Dose,2018-03-23T09:49:00
3110-103-002,PC,3110-103-002.103001008,11.0,1345150,UBRO,Ubrogepant,10.95,ng/mL,10.95,10.95,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T21:49:00,1.0,12 h,12.0,Period 1 Dose,2018-03-23T09:49:00
3110-103-002,PC,3110-103-002.103001008,12.0,1345153,UBRO,Ubrogepant,6.51,ng/mL,6.51,6.51,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T23:49:00,1.0,14 h,14.0,Period 1 Dose,2018-03-23T09:49:00
3110-103-002,PC,3110-103-002.103001008,13.0,1345159,UBRO,Ubrogepant,2.50,ng/mL,2.50,2.5,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-03-24T09:49:00,2.0,24 h,24.0,Period 1 Dose,2018-03-23T09:49:00
3110-103-002,PC,3110-103-002.103001008,14.0,1345184,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T09:19:00,8.0,Predose,0.0,Period 2 Dose,2018-03-30T09:49:00
3110-103-002,PC,3110-103-002.103001008,15.0,1345186,UBRO,Ubrogepant,235.15,ng/mL,235.15,235.15,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:22:41,8.0,0.5 h,0.5,Period 2 Dose,2018-03-30T09:49:00
3110-103-002,PC,3110-103-002.103001008,16.0,1345189,UBRO,Ubrogepant,478.33,ng/mL,478.33,478.33,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:49:00,8.0,1 h,1.0,Period 2 Dose,2018-03-30T09:49:00
3110-103-002,PC,3110-103-002.103001008,17.0,1345192,UBRO,Ubrogepant,273.63,ng/mL,273.63,273.63,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:19:00,8.0,1.5 h,1.5,Period 2 Dose,2018-03-30T09:49:00
3110-103-002,PC,3110-103-002.103001008,18.0,1345196,UBRO,Ubrogepant,204.45,ng/mL,204.45,204.45,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:52:49,8.0,2 h,2.0,Period 2 Dose,2018-03-30T09:49:00
3110-103-002,PC,3110-103-002.103001008,19.0,1345197,UBRO,Ubrogepant,131.78,ng/mL,131.78,131.78,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T12:50:05,8.0,3 h,3.0,Period 2 Dose,2018-03-30T09:49:00
3110-103-002,PC,3110-103-002.103001008,20.0,1345198,UBRO,Ubrogepant,103.98,ng/mL,103.98,103.98,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T13:50:23,8.0,4 h,4.0,Period 2 Dose,2018-03-30T09:49:00
3110-103-002,PC,3110-103-002.103001008,21.0,1345203,UBRO,Ubrogepant,72.33,ng/mL,72.33,72.33,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T14:49:00,8.0,5 h,5.0,Period 2 Dose,2018-03-30T09:49:00
3110-103-002,PC,3110-103-002.103001008,22.0,1345204,UBRO,Ubrogepant,61.31,ng/mL,61.31,61.31,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T15:49:00,8.0,6 h,6.0,Period 2 Dose,2018-03-30T09:49:00
3110-103-002,PC,3110-103-002.103001008,23.0,1345205,UBRO,Ubrogepant,31.02,ng/mL,31.02,31.02,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T17:49:00,8.0,8 h,8.0,Period 2 Dose,2018-03-30T09:49:00
3110-103-002,PC,3110-103-002.103001008,24.0,1345208,UBRO,Ubrogepant,11.20,ng/mL,11.20,11.2,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T21:53:07,8.0,12 h,12.0,Period 2 Dose,2018-03-30T09:49:00
3110-103-002,PC,3110-103-002.103001008,25.0,1345211,UBRO,Ubrogepant,7.16,ng/mL,7.16,7.16,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T23:49:00,8.0,14 h,14.0,Period 2 Dose,2018-03-30T09:49:00
3110-103-002,PC,3110-103-002.103001008,26.0,1345217,UBRO,Ubrogepant,1.86,ng/mL,1.86,1.86,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-03-31T09:49:00,9.0,24 h,24.0,Period 2 Dose,2018-03-30T09:49:00
3110-103-002,PC,3110-103-002.103001008,27.0,1345242,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T09:19:00,15.0,Predose,0.0,Period 3 Dose,2018-04-06T09:49:00
3110-103-002,PC,3110-103-002.103001008,28.0,1345244,UBRO,Ubrogepant,182.78,ng/mL,182.78,182.78,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:19:00,15.0,0.5 h,0.5,Period 3 Dose,2018-04-06T09:49:00
3110-103-002,PC,3110-103-002.103001008,29.0,1345247,UBRO,Ubrogepant,565.24,ng/mL,565.24,565.24,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:49:00,15.0,1 h,1.0,Period 3 Dose,2018-04-06T09:49:00
3110-103-002,PC,3110-103-002.103001008,30.0,1345250,UBRO,Ubrogepant,292.67,ng/mL,292.67,292.67,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:19:00,15.0,1.5 h,1.5,Period 3 Dose,2018-04-06T09:49:00
3110-103-002,PC,3110-103-002.103001008,31.0,1345254,UBRO,Ubrogepant,210.78,ng/mL,210.78,210.78,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:49:00,15.0,2 h,2.0,Period 3 Dose,2018-04-06T09:49:00
3110-103-002,PC,3110-103-002.103001008,32.0,1345255,UBRO,Ubrogepant,136.62,ng/mL,136.62,136.62,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T12:49:00,15.0,3 h,3.0,Period 3 Dose,2018-04-06T09:49:00
3110-103-002,PC,3110-103-002.103001008,33.0,1345256,UBRO,Ubrogepant,97.49,ng/mL,97.49,97.49,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T13:49:00,15.0,4 h,4.0,Period 3 Dose,2018-04-06T09:49:00
3110-103-002,PC,3110-103-002.103001008,34.0,1345261,UBRO,Ubrogepant,77.25,ng/mL,77.25,77.25,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T14:49:00,15.0,5 h,5.0,Period 3 Dose,2018-04-06T09:49:00
3110-103-002,PC,3110-103-002.103001008,35.0,1345262,UBRO,Ubrogepant,55.42,ng/mL,55.42,55.42,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T15:49:00,15.0,6 h,6.0,Period 3 Dose,2018-04-06T09:49:00
3110-103-002,PC,3110-103-002.103001008,36.0,1345263,UBRO,Ubrogepant,33.46,ng/mL,33.46,33.46,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T17:49:00,15.0,8 h,8.0,Period 3 Dose,2018-04-06T09:49:00
3110-103-002,PC,3110-103-002.103001008,37.0,1345266,UBRO,Ubrogepant,9.81,ng/mL,9.81,9.81,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T21:49:00,15.0,12 h,12.0,Period 3 Dose,2018-04-06T09:49:00
3110-103-002,PC,3110-103-002.103001008,38.0,1345269,UBRO,Ubrogepant,7.07,ng/mL,7.07,7.07,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T23:49:00,15.0,14 h,14.0,Period 3 Dose,2018-04-06T09:49:00
3110-103-002,PC,3110-103-002.103001008,39.0,1345275,UBRO,Ubrogepant,1.82,ng/mL,1.82,1.82,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,26.0,Period 3 Day 16,TREATMENT,2018-04-07T09:49:00,16.0,24 h,24.0,Period 3 Dose,2018-04-06T09:49:00
3110-103-002,PC,3110-103-002.103001009,1.0,1341226,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T09:36:00,1.0,Predose,0.0,Period 1 Dose,2018-03-23T10:06:00
3110-103-002,PC,3110-103-002.103001009,2.0,1341228,UBRO,Ubrogepant,140.14,ng/mL,140.14,140.14,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:36:00,1.0,0.5 h,0.5,Period 1 Dose,2018-03-23T10:06:00
3110-103-002,PC,3110-103-002.103001009,3.0,1341231,UBRO,Ubrogepant,259.24,ng/mL,259.24,259.24,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:06:00,1.0,1 h,1.0,Period 1 Dose,2018-03-23T10:06:00
3110-103-002,PC,3110-103-002.103001009,4.0,1341234,UBRO,Ubrogepant,188.52,ng/mL,188.52,188.52,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:36:00,1.0,1.5 h,1.5,Period 1 Dose,2018-03-23T10:06:00
3110-103-002,PC,3110-103-002.103001009,5.0,1341238,UBRO,Ubrogepant,120.66,ng/mL,120.66,120.66,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T12:06:00,1.0,2 h,2.0,Period 1 Dose,2018-03-23T10:06:00
3110-103-002,PC,3110-103-002.103001009,6.0,1341239,UBRO,Ubrogepant,81.38,ng/mL,81.38,81.38,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T13:06:00,1.0,3 h,3.0,Period 1 Dose,2018-03-23T10:06:00
3110-103-002,PC,3110-103-002.103001009,7.0,1341240,UBRO,Ubrogepant,65.08,ng/mL,65.08,65.08,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T14:06:00,1.0,4 h,4.0,Period 1 Dose,2018-03-23T10:06:00
3110-103-002,PC,3110-103-002.103001009,8.0,1341245,UBRO,Ubrogepant,56.59,ng/mL,56.59,56.59,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T15:06:00,1.0,5 h,5.0,Period 1 Dose,2018-03-23T10:06:00
3110-103-002,PC,3110-103-002.103001009,9.0,1341246,UBRO,Ubrogepant,43.97,ng/mL,43.97,43.97,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T16:06:00,1.0,6 h,6.0,Period 1 Dose,2018-03-23T10:06:00
3110-103-002,PC,3110-103-002.103001009,10.0,1341247,UBRO,Ubrogepant,22.27,ng/mL,22.27,22.27,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T18:06:00,1.0,8 h,8.0,Period 1 Dose,2018-03-23T10:06:00
3110-103-002,PC,3110-103-002.103001009,11.0,1341250,UBRO,Ubrogepant,7.73,ng/mL,7.73,7.73,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T22:06:00,1.0,12 h,12.0,Period 1 Dose,2018-03-23T10:06:00
3110-103-002,PC,3110-103-002.103001009,12.0,1341253,UBRO,Ubrogepant,4.33,ng/mL,4.33,4.33,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-24T00:06:00,2.0,14 h,14.0,Period 1 Dose,2018-03-23T10:06:00
3110-103-002,PC,3110-103-002.103001009,13.0,1341259,UBRO,Ubrogepant,1.14,ng/mL,1.14,1.14,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-03-24T10:06:00,2.0,24 h,24.0,Period 1 Dose,2018-03-23T10:06:00
3110-103-002,PC,3110-103-002.103001009,14.0,1341284,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T09:36:00,8.0,Predose,0.0,Period 2 Dose,2018-03-30T10:06:00
3110-103-002,PC,3110-103-002.103001009,15.0,1341286,UBRO,Ubrogepant,14.25,ng/mL,14.25,14.25,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:36:00,8.0,0.5 h,0.5,Period 2 Dose,2018-03-30T10:06:00
3110-103-002,PC,3110-103-002.103001009,16.0,1341289,UBRO,Ubrogepant,68.67,ng/mL,68.67,68.67,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:06:00,8.0,1 h,1.0,Period 2 Dose,2018-03-30T10:06:00
3110-103-002,PC,3110-103-002.103001009,17.0,1341292,UBRO,Ubrogepant,286.37,ng/mL,286.37,286.37,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:36:00,8.0,1.5 h,1.5,Period 2 Dose,2018-03-30T10:06:00
3110-103-002,PC,3110-103-002.103001009,18.0,1341296,UBRO,Ubrogepant,331.25,ng/mL,331.25,331.25,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T12:06:00,8.0,2 h,2.0,Period 2 Dose,2018-03-30T10:06:00
3110-103-002,PC,3110-103-002.103001009,19.0,1341297,UBRO,Ubrogepant,175.78,ng/mL,175.78,175.78,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T13:06:00,8.0,3 h,3.0,Period 2 Dose,2018-03-30T10:06:00
3110-103-002,PC,3110-103-002.103001009,20.0,1341298,UBRO,Ubrogepant,100.52,ng/mL,100.52,100.52,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T14:06:00,8.0,4 h,4.0,Period 2 Dose,2018-03-30T10:06:00
3110-103-002,PC,3110-103-002.103001009,21.0,1341303,UBRO,Ubrogepant,80.15,ng/mL,80.15,80.15,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T15:06:00,8.0,5 h,5.0,Period 2 Dose,2018-03-30T10:06:00
3110-103-002,PC,3110-103-002.103001009,22.0,1341304,UBRO,Ubrogepant,47.22,ng/mL,47.22,47.22,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T16:06:00,8.0,6 h,6.0,Period 2 Dose,2018-03-30T10:06:00
3110-103-002,PC,3110-103-002.103001009,23.0,1341305,UBRO,Ubrogepant,27.41,ng/mL,27.41,27.41,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T18:06:00,8.0,8 h,8.0,Period 2 Dose,2018-03-30T10:06:00
3110-103-002,PC,3110-103-002.103001009,24.0,1341308,UBRO,Ubrogepant,7.00,ng/mL,7.00,7.0,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T22:06:00,8.0,12 h,12.0,Period 2 Dose,2018-03-30T10:06:00
3110-103-002,PC,3110-103-002.103001009,25.0,1341311,UBRO,Ubrogepant,5.03,ng/mL,5.03,5.03,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-31T00:06:00,9.0,14 h,14.0,Period 2 Dose,2018-03-30T10:06:00
3110-103-002,PC,3110-103-002.103001009,26.0,1341317,UBRO,Ubrogepant,1.34,ng/mL,1.34,1.34,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-03-31T10:06:00,9.0,24 h,24.0,Period 2 Dose,2018-03-30T10:06:00
3110-103-002,PC,3110-103-002.103001009,27.0,1341342,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T09:36:00,15.0,Predose,0.0,Period 3 Dose,2018-04-06T10:06:00
3110-103-002,PC,3110-103-002.103001009,28.0,1341344,UBRO,Ubrogepant,130.51,ng/mL,130.51,130.51,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:36:00,15.0,0.5 h,0.5,Period 3 Dose,2018-04-06T10:06:00
3110-103-002,PC,3110-103-002.103001009,29.0,1341347,UBRO,Ubrogepant,378.04,ng/mL,378.04,378.04,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:06:00,15.0,1 h,1.0,Period 3 Dose,2018-04-06T10:06:00
3110-103-002,PC,3110-103-002.103001009,30.0,1341350,UBRO,Ubrogepant,241.75,ng/mL,241.75,241.75,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:36:00,15.0,1.5 h,1.5,Period 3 Dose,2018-04-06T10:06:00
3110-103-002,PC,3110-103-002.103001009,31.0,1341354,UBRO,Ubrogepant,170.82,ng/mL,170.82,170.82,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T12:06:00,15.0,2 h,2.0,Period 3 Dose,2018-04-06T10:06:00
3110-103-002,PC,3110-103-002.103001009,32.0,1341355,UBRO,Ubrogepant,114.43,ng/mL,114.43,114.43,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T13:06:00,15.0,3 h,3.0,Period 3 Dose,2018-04-06T10:06:00
3110-103-002,PC,3110-103-002.103001009,33.0,1341356,UBRO,Ubrogepant,73.66,ng/mL,73.66,73.66,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T14:06:00,15.0,4 h,4.0,Period 3 Dose,2018-04-06T10:06:00
3110-103-002,PC,3110-103-002.103001009,34.0,1341361,UBRO,Ubrogepant,53.47,ng/mL,53.47,53.47,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T15:06:00,15.0,5 h,5.0,Period 3 Dose,2018-04-06T10:06:00
3110-103-002,PC,3110-103-002.103001009,35.0,1341362,UBRO,Ubrogepant,41.85,ng/mL,41.85,41.85,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T16:06:00,15.0,6 h,6.0,Period 3 Dose,2018-04-06T10:06:00
3110-103-002,PC,3110-103-002.103001009,36.0,1341363,UBRO,Ubrogepant,21.35,ng/mL,21.35,21.35,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T18:06:00,15.0,8 h,8.0,Period 3 Dose,2018-04-06T10:06:00
3110-103-002,PC,3110-103-002.103001009,37.0,1341366,UBRO,Ubrogepant,6.08,ng/mL,6.08,6.08,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T22:06:00,15.0,12 h,12.0,Period 3 Dose,2018-04-06T10:06:00
3110-103-002,PC,3110-103-002.103001009,38.0,1341369,UBRO,Ubrogepant,3.59,ng/mL,3.59,3.59,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-07T00:06:00,16.0,14 h,14.0,Period 3 Dose,2018-04-06T10:06:00
3110-103-002,PC,3110-103-002.103001009,39.0,1341375,UBRO,Ubrogepant,1.76,ng/mL,1.76,1.76,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,26.0,Period 3 Day 16,TREATMENT,2018-04-07T10:06:00,16.0,24 h,24.0,Period 3 Dose,2018-04-06T10:06:00
3110-103-002,PC,3110-103-002.103001010,1.0,1338886,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T09:02:00,1.0,Predose,0.0,Period 1 Dose,2018-03-23T09:32:00
3110-103-002,PC,3110-103-002.103001010,2.0,1338888,UBRO,Ubrogepant,159.85,ng/mL,159.85,159.85,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:02:00,1.0,0.5 h,0.5,Period 1 Dose,2018-03-23T09:32:00
3110-103-002,PC,3110-103-002.103001010,3.0,1338891,UBRO,Ubrogepant,209.38,ng/mL,209.38,209.38,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:32:00,1.0,1 h,1.0,Period 1 Dose,2018-03-23T09:32:00
3110-103-002,PC,3110-103-002.103001010,4.0,1338894,UBRO,Ubrogepant,168.45,ng/mL,168.45,168.45,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:02:00,1.0,1.5 h,1.5,Period 1 Dose,2018-03-23T09:32:00
3110-103-002,PC,3110-103-002.103001010,5.0,1338898,UBRO,Ubrogepant,171.82,ng/mL,171.82,171.82,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:32:00,1.0,2 h,2.0,Period 1 Dose,2018-03-23T09:32:00
3110-103-002,PC,3110-103-002.103001010,6.0,1338899,UBRO,Ubrogepant,144.41,ng/mL,144.41,144.41,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T12:32:00,1.0,3 h,3.0,Period 1 Dose,2018-03-23T09:32:00
3110-103-002,PC,3110-103-002.103001010,7.0,1338900,UBRO,Ubrogepant,109.35,ng/mL,109.35,109.35,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T13:32:00,1.0,4 h,4.0,Period 1 Dose,2018-03-23T09:32:00
3110-103-002,PC,3110-103-002.103001010,8.0,1338905,UBRO,Ubrogepant,73.80,ng/mL,73.80,73.8,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T14:32:00,1.0,5 h,5.0,Period 1 Dose,2018-03-23T09:32:00
3110-103-002,PC,3110-103-002.103001010,9.0,1338906,UBRO,Ubrogepant,58.83,ng/mL,58.83,58.83,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T15:32:00,1.0,6 h,6.0,Period 1 Dose,2018-03-23T09:32:00
3110-103-002,PC,3110-103-002.103001010,10.0,1338907,UBRO,Ubrogepant,31.56,ng/mL,31.56,31.56,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T17:32:00,1.0,8 h,8.0,Period 1 Dose,2018-03-23T09:32:00
3110-103-002,PC,3110-103-002.103001010,11.0,1338910,UBRO,Ubrogepant,15.81,ng/mL,15.81,15.81,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T21:32:00,1.0,12 h,12.0,Period 1 Dose,2018-03-23T09:32:00
3110-103-002,PC,3110-103-002.103001010,12.0,1338913,UBRO,Ubrogepant,10.95,ng/mL,10.95,10.95,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T23:32:00,1.0,14 h,14.0,Period 1 Dose,2018-03-23T09:32:00
3110-103-002,PC,3110-103-002.103001010,13.0,1338919,UBRO,Ubrogepant,3.66,ng/mL,3.66,3.66,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-03-24T09:32:00,2.0,24 h,24.0,Period 1 Dose,2018-03-23T09:32:00
3110-103-002,PC,3110-103-002.103001010,14.0,1338944,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T09:02:00,8.0,Predose,0.0,Period 2 Dose,2018-03-30T09:32:00
3110-103-002,PC,3110-103-002.103001010,15.0,1338946,UBRO,Ubrogepant,132.93,ng/mL,132.93,132.93,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:02:00,8.0,0.5 h,0.5,Period 2 Dose,2018-03-30T09:32:00
3110-103-002,PC,3110-103-002.103001010,16.0,1338949,UBRO,Ubrogepant,432.34,ng/mL,432.34,432.34,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:32:00,8.0,1 h,1.0,Period 2 Dose,2018-03-30T09:32:00
3110-103-002,PC,3110-103-002.103001010,17.0,1338952,UBRO,Ubrogepant,298.00,ng/mL,298.00,298.0,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:02:00,8.0,1.5 h,1.5,Period 2 Dose,2018-03-30T09:32:00
3110-103-002,PC,3110-103-002.103001010,18.0,1338956,UBRO,Ubrogepant,199.68,ng/mL,199.68,199.68,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:32:00,8.0,2 h,2.0,Period 2 Dose,2018-03-30T09:32:00
3110-103-002,PC,3110-103-002.103001010,19.0,1338957,UBRO,Ubrogepant,141.54,ng/mL,141.54,141.54,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T12:32:00,8.0,3 h,3.0,Period 2 Dose,2018-03-30T09:32:00
3110-103-002,PC,3110-103-002.103001010,20.0,1338958,UBRO,Ubrogepant,106.48,ng/mL,106.48,106.48,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T13:32:00,8.0,4 h,4.0,Period 2 Dose,2018-03-30T09:32:00
3110-103-002,PC,3110-103-002.103001010,21.0,1338963,UBRO,Ubrogepant,86.49,ng/mL,86.49,86.49,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T14:32:00,8.0,5 h,5.0,Period 2 Dose,2018-03-30T09:32:00
3110-103-002,PC,3110-103-002.103001010,22.0,1338964,UBRO,Ubrogepant,66.24,ng/mL,66.24,66.24,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T15:32:00,8.0,6 h,6.0,Period 2 Dose,2018-03-30T09:32:00
3110-103-002,PC,3110-103-002.103001010,23.0,1338965,UBRO,Ubrogepant,32.13,ng/mL,32.13,32.13,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T17:32:00,8.0,8 h,8.0,Period 2 Dose,2018-03-30T09:32:00
3110-103-002,PC,3110-103-002.103001010,24.0,1338968,UBRO,Ubrogepant,12.97,ng/mL,12.97,12.97,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T21:32:00,8.0,12 h,12.0,Period 2 Dose,2018-03-30T09:32:00
3110-103-002,PC,3110-103-002.103001010,25.0,1338971,UBRO,Ubrogepant,8.68,ng/mL,8.68,8.68,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T23:33:23,8.0,14 h,14.0,Period 2 Dose,2018-03-30T09:32:00
3110-103-002,PC,3110-103-002.103001010,26.0,1338977,UBRO,Ubrogepant,1.97,ng/mL,1.97,1.97,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-03-31T09:32:00,9.0,24 h,24.0,Period 2 Dose,2018-03-30T09:32:00
3110-103-002,PC,3110-103-002.103001010,27.0,1339002,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T09:02:00,15.0,Predose,0.0,Period 3 Dose,2018-04-06T09:32:00
3110-103-002,PC,3110-103-002.103001010,28.0,1339004,UBRO,Ubrogepant,119.67,ng/mL,119.67,119.67,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:02:00,15.0,0.5 h,0.5,Period 3 Dose,2018-04-06T09:32:00
3110-103-002,PC,3110-103-002.103001010,29.0,1339007,UBRO,Ubrogepant,138.31,ng/mL,138.31,138.31,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:32:00,15.0,1 h,1.0,Period 3 Dose,2018-04-06T09:32:00
3110-103-002,PC,3110-103-002.103001010,30.0,1339010,UBRO,Ubrogepant,120.37,ng/mL,120.37,120.37,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:02:00,15.0,1.5 h,1.5,Period 3 Dose,2018-04-06T09:32:00
3110-103-002,PC,3110-103-002.103001010,31.0,1339014,UBRO,Ubrogepant,135.59,ng/mL,135.59,135.59,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:32:00,15.0,2 h,2.0,Period 3 Dose,2018-04-06T09:32:00
3110-103-002,PC,3110-103-002.103001010,32.0,1339015,UBRO,Ubrogepant,126.93,ng/mL,126.93,126.93,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T12:32:00,15.0,3 h,3.0,Period 3 Dose,2018-04-06T09:32:00
3110-103-002,PC,3110-103-002.103001010,33.0,1339016,UBRO,Ubrogepant,89.31,ng/mL,89.31,89.31,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T13:32:00,15.0,4 h,4.0,Period 3 Dose,2018-04-06T09:32:00
3110-103-002,PC,3110-103-002.103001010,34.0,1339021,UBRO,Ubrogepant,68.16,ng/mL,68.16,68.16,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T14:32:00,15.0,5 h,5.0,Period 3 Dose,2018-04-06T09:32:00
3110-103-002,PC,3110-103-002.103001010,35.0,1339022,UBRO,Ubrogepant,52.50,ng/mL,52.50,52.5,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T15:32:00,15.0,6 h,6.0,Period 3 Dose,2018-04-06T09:32:00
3110-103-002,PC,3110-103-002.103001010,36.0,1339023,UBRO,Ubrogepant,28.18,ng/mL,28.18,28.18,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T17:32:00,15.0,8 h,8.0,Period 3 Dose,2018-04-06T09:32:00
3110-103-002,PC,3110-103-002.103001010,37.0,1339026,UBRO,Ubrogepant,16.17,ng/mL,16.17,16.17,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T21:32:00,15.0,12 h,12.0,Period 3 Dose,2018-04-06T09:32:00
3110-103-002,PC,3110-103-002.103001010,38.0,1339029,UBRO,Ubrogepant,10.79,ng/mL,10.79,10.79,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T23:32:00,15.0,14 h,14.0,Period 3 Dose,2018-04-06T09:32:00
3110-103-002,PC,3110-103-002.103001010,39.0,1339035,UBRO,Ubrogepant,3.99,ng/mL,3.99,3.99,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,26.0,Period 3 Day 16,TREATMENT,2018-04-07T09:32:00,16.0,24 h,24.0,Period 3 Dose,2018-04-06T09:32:00
3110-103-002,PC,3110-103-002.103001015,1.0,1339081,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T09:03:00,1.0,Predose,0.0,Period 1 Dose,2018-03-23T09:33:00
3110-103-002,PC,3110-103-002.103001015,2.0,1339083,UBRO,Ubrogepant,20.08,ng/mL,20.08,20.08,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:03:00,1.0,0.5 h,0.5,Period 1 Dose,2018-03-23T09:33:00
3110-103-002,PC,3110-103-002.103001015,3.0,1339086,UBRO,Ubrogepant,223.81,ng/mL,223.81,223.81,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:33:00,1.0,1 h,1.0,Period 1 Dose,2018-03-23T09:33:00
3110-103-002,PC,3110-103-002.103001015,4.0,1339089,UBRO,Ubrogepant,427.65,ng/mL,427.65,427.65,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:03:00,1.0,1.5 h,1.5,Period 1 Dose,2018-03-23T09:33:00
3110-103-002,PC,3110-103-002.103001015,5.0,1339093,UBRO,Ubrogepant,402.34,ng/mL,402.34,402.34,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:33:00,1.0,2 h,2.0,Period 1 Dose,2018-03-23T09:33:00
3110-103-002,PC,3110-103-002.103001015,6.0,1339094,UBRO,Ubrogepant,236.91,ng/mL,236.91,236.91,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T12:33:00,1.0,3 h,3.0,Period 1 Dose,2018-03-23T09:33:00
3110-103-002,PC,3110-103-002.103001015,7.0,1339095,UBRO,Ubrogepant,162.81,ng/mL,162.81,162.81,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T13:33:00,1.0,4 h,4.0,Period 1 Dose,2018-03-23T09:33:00
3110-103-002,PC,3110-103-002.103001015,8.0,1339100,UBRO,Ubrogepant,116.46,ng/mL,116.46,116.46,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T14:33:00,1.0,5 h,5.0,Period 1 Dose,2018-03-23T09:33:00
3110-103-002,PC,3110-103-002.103001015,9.0,1339101,UBRO,Ubrogepant,92.73,ng/mL,92.73,92.73,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T15:33:00,1.0,6 h,6.0,Period 1 Dose,2018-03-23T09:33:00
3110-103-002,PC,3110-103-002.103001015,10.0,1339102,UBRO,Ubrogepant,50.31,ng/mL,50.31,50.31,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T17:33:00,1.0,8 h,8.0,Period 1 Dose,2018-03-23T09:33:00
3110-103-002,PC,3110-103-002.103001015,11.0,1339105,UBRO,Ubrogepant,17.69,ng/mL,17.69,17.69,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T21:33:00,1.0,12 h,12.0,Period 1 Dose,2018-03-23T09:33:00
3110-103-002,PC,3110-103-002.103001015,12.0,1339108,UBRO,Ubrogepant,11.14,ng/mL,11.14,11.14,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T23:33:00,1.0,14 h,14.0,Period 1 Dose,2018-03-23T09:33:00
3110-103-002,PC,3110-103-002.103001015,13.0,1339114,UBRO,Ubrogepant,2.29,ng/mL,2.29,2.29,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-03-24T09:33:00,2.0,24 h,24.0,Period 1 Dose,2018-03-23T09:33:00
3110-103-002,PC,3110-103-002.103001015,14.0,1339139,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T09:03:00,8.0,Predose,0.0,Period 2 Dose,2018-03-30T09:33:00
3110-103-002,PC,3110-103-002.103001015,15.0,1339141,UBRO,Ubrogepant,105.12,ng/mL,105.12,105.12,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:03:00,8.0,0.5 h,0.5,Period 2 Dose,2018-03-30T09:33:00
3110-103-002,PC,3110-103-002.103001015,16.0,1339144,UBRO,Ubrogepant,256.02,ng/mL,256.02,256.02,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:33:00,8.0,1 h,1.0,Period 2 Dose,2018-03-30T09:33:00
3110-103-002,PC,3110-103-002.103001015,17.0,1339147,UBRO,Ubrogepant,263.42,ng/mL,263.42,263.42,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:03:00,8.0,1.5 h,1.5,Period 2 Dose,2018-03-30T09:33:00
3110-103-002,PC,3110-103-002.103001015,18.0,1339151,UBRO,Ubrogepant,229.52,ng/mL,229.52,229.52,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:33:00,8.0,2 h,2.0,Period 2 Dose,2018-03-30T09:33:00
3110-103-002,PC,3110-103-002.103001015,19.0,1339152,UBRO,Ubrogepant,204.50,ng/mL,204.50,204.5,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T12:33:00,8.0,3 h,3.0,Period 2 Dose,2018-03-30T09:33:00
3110-103-002,PC,3110-103-002.103001015,20.0,1339153,UBRO,Ubrogepant,173.94,ng/mL,173.94,173.94,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T13:33:00,8.0,4 h,4.0,Period 2 Dose,2018-03-30T09:33:00
3110-103-002,PC,3110-103-002.103001015,21.0,1339158,UBRO,Ubrogepant,128.04,ng/mL,128.04,128.04,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T14:33:00,8.0,5 h,5.0,Period 2 Dose,2018-03-30T09:33:00
3110-103-002,PC,3110-103-002.103001015,22.0,1339159,UBRO,Ubrogepant,91.39,ng/mL,91.39,91.39,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T15:33:00,8.0,6 h,6.0,Period 2 Dose,2018-03-30T09:33:00
3110-103-002,PC,3110-103-002.103001015,23.0,1339160,UBRO,Ubrogepant,57.69,ng/mL,57.69,57.69,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T17:33:00,8.0,8 h,8.0,Period 2 Dose,2018-03-30T09:33:00
3110-103-002,PC,3110-103-002.103001015,24.0,1339163,UBRO,Ubrogepant,19.49,ng/mL,19.49,19.49,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T21:33:00,8.0,12 h,12.0,Period 2 Dose,2018-03-30T09:33:00
3110-103-002,PC,3110-103-002.103001015,25.0,1339166,UBRO,Ubrogepant,11.58,ng/mL,11.58,11.58,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T23:33:00,8.0,14 h,14.0,Period 2 Dose,2018-03-30T09:33:00
3110-103-002,PC,3110-103-002.103001015,26.0,1339172,UBRO,Ubrogepant,2.61,ng/mL,2.61,2.61,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-03-31T09:33:00,9.0,24 h,24.0,Period 2 Dose,2018-03-30T09:33:00
3110-103-002,PC,3110-103-002.103001015,27.0,1339197,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T09:03:00,15.0,Predose,0.0,Period 3 Dose,2018-04-06T09:33:00
3110-103-002,PC,3110-103-002.103001015,28.0,1339199,UBRO,Ubrogepant,82.53,ng/mL,82.53,82.53,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:03:00,15.0,0.5 h,0.5,Period 3 Dose,2018-04-06T09:33:00
3110-103-002,PC,3110-103-002.103001015,29.0,1339202,UBRO,Ubrogepant,248.87,ng/mL,248.87,248.87,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:33:00,15.0,1 h,1.0,Period 3 Dose,2018-04-06T09:33:00
3110-103-002,PC,3110-103-002.103001015,30.0,1339205,UBRO,Ubrogepant,185.27,ng/mL,185.27,185.27,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:03:00,15.0,1.5 h,1.5,Period 3 Dose,2018-04-06T09:33:00
3110-103-002,PC,3110-103-002.103001015,31.0,1339209,UBRO,Ubrogepant,169.12,ng/mL,169.12,169.12,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:33:00,15.0,2 h,2.0,Period 3 Dose,2018-04-06T09:33:00
3110-103-002,PC,3110-103-002.103001015,32.0,1339210,UBRO,Ubrogepant,131.52,ng/mL,131.52,131.52,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T12:33:00,15.0,3 h,3.0,Period 3 Dose,2018-04-06T09:33:00
3110-103-002,PC,3110-103-002.103001015,33.0,1339211,UBRO,Ubrogepant,102.95,ng/mL,102.95,102.95,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T13:33:00,15.0,4 h,4.0,Period 3 Dose,2018-04-06T09:33:00
3110-103-002,PC,3110-103-002.103001015,34.0,1339216,UBRO,Ubrogepant,76.93,ng/mL,76.93,76.93,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T14:33:00,15.0,5 h,5.0,Period 3 Dose,2018-04-06T09:33:00
3110-103-002,PC,3110-103-002.103001015,35.0,1339217,UBRO,Ubrogepant,56.59,ng/mL,56.59,56.59,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T15:33:00,15.0,6 h,6.0,Period 3 Dose,2018-04-06T09:33:00
3110-103-002,PC,3110-103-002.103001015,36.0,1339218,UBRO,Ubrogepant,35.96,ng/mL,35.96,35.96,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T17:33:00,15.0,8 h,8.0,Period 3 Dose,2018-04-06T09:33:00
3110-103-002,PC,3110-103-002.103001015,37.0,1339221,UBRO,Ubrogepant,11.91,ng/mL,11.91,11.91,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T21:33:00,15.0,12 h,12.0,Period 3 Dose,2018-04-06T09:33:00
3110-103-002,PC,3110-103-002.103001015,38.0,1339224,UBRO,Ubrogepant,8.18,ng/mL,8.18,8.18,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T23:33:00,15.0,14 h,14.0,Period 3 Dose,2018-04-06T09:33:00
3110-103-002,PC,3110-103-002.103001015,39.0,1339230,UBRO,Ubrogepant,2.10,ng/mL,2.10,2.1,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,26.0,Period 3 Day 16,TREATMENT,2018-04-07T09:33:00,16.0,24 h,24.0,Period 3 Dose,2018-04-06T09:33:00
3110-103-002,PC,3110-103-002.103001022,1.0,1341031,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T09:37:00,1.0,Predose,0.0,Period 1 Dose,2018-03-23T10:07:00
3110-103-002,PC,3110-103-002.103001022,2.0,1341033,UBRO,Ubrogepant,155.80,ng/mL,155.80,155.8,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:37:00,1.0,0.5 h,0.5,Period 1 Dose,2018-03-23T10:07:00
3110-103-002,PC,3110-103-002.103001022,3.0,1341036,UBRO,Ubrogepant,357.43,ng/mL,357.43,357.43,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:07:00,1.0,1 h,1.0,Period 1 Dose,2018-03-23T10:07:00
3110-103-002,PC,3110-103-002.103001022,4.0,1341039,UBRO,Ubrogepant,242.05,ng/mL,242.05,242.05,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:37:00,1.0,1.5 h,1.5,Period 1 Dose,2018-03-23T10:07:00
3110-103-002,PC,3110-103-002.103001022,5.0,1341043,UBRO,Ubrogepant,194.17,ng/mL,194.17,194.17,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T12:07:00,1.0,2 h,2.0,Period 1 Dose,2018-03-23T10:07:00
3110-103-002,PC,3110-103-002.103001022,6.0,1341044,UBRO,Ubrogepant,119.68,ng/mL,119.68,119.68,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T13:07:00,1.0,3 h,3.0,Period 1 Dose,2018-03-23T10:07:00
3110-103-002,PC,3110-103-002.103001022,7.0,1341045,UBRO,Ubrogepant,77.59,ng/mL,77.59,77.59,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T14:07:00,1.0,4 h,4.0,Period 1 Dose,2018-03-23T10:07:00
3110-103-002,PC,3110-103-002.103001022,8.0,1341050,UBRO,Ubrogepant,59.05,ng/mL,59.05,59.05,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T15:07:00,1.0,5 h,5.0,Period 1 Dose,2018-03-23T10:07:00
3110-103-002,PC,3110-103-002.103001022,9.0,1341051,UBRO,Ubrogepant,48.98,ng/mL,48.98,48.98,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T16:07:00,1.0,6 h,6.0,Period 1 Dose,2018-03-23T10:07:00
3110-103-002,PC,3110-103-002.103001022,10.0,1341052,UBRO,Ubrogepant,21.05,ng/mL,21.05,21.05,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T18:07:00,1.0,8 h,8.0,Period 1 Dose,2018-03-23T10:07:00
3110-103-002,PC,3110-103-002.103001022,11.0,1341055,UBRO,Ubrogepant,8.25,ng/mL,8.25,8.25,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T22:08:40,1.0,12 h,12.0,Period 1 Dose,2018-03-23T10:07:00
3110-103-002,PC,3110-103-002.103001022,12.0,1341058,UBRO,Ubrogepant,6.36,ng/mL,6.36,6.36,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-24T00:07:00,2.0,14 h,14.0,Period 1 Dose,2018-03-23T10:07:00
3110-103-002,PC,3110-103-002.103001022,13.0,1341064,UBRO,Ubrogepant,2.47,ng/mL,2.47,2.47,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-03-24T10:07:00,2.0,24 h,24.0,Period 1 Dose,2018-03-23T10:07:00
3110-103-002,PC,3110-103-002.103001022,14.0,1341089,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T09:37:00,8.0,Predose,0.0,Period 2 Dose,2018-03-30T10:07:00
3110-103-002,PC,3110-103-002.103001022,15.0,1341091,UBRO,Ubrogepant,169.06,ng/mL,169.06,169.06,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:37:00,8.0,0.5 h,0.5,Period 2 Dose,2018-03-30T10:07:00
3110-103-002,PC,3110-103-002.103001022,16.0,1341094,UBRO,Ubrogepant,391.51,ng/mL,391.51,391.51,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:07:00,8.0,1 h,1.0,Period 2 Dose,2018-03-30T10:07:00
3110-103-002,PC,3110-103-002.103001022,17.0,1341097,UBRO,Ubrogepant,259.07,ng/mL,259.07,259.07,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:37:00,8.0,1.5 h,1.5,Period 2 Dose,2018-03-30T10:07:00
3110-103-002,PC,3110-103-002.103001022,18.0,1341101,UBRO,Ubrogepant,178.28,ng/mL,178.28,178.28,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T12:07:00,8.0,2 h,2.0,Period 2 Dose,2018-03-30T10:07:00
3110-103-002,PC,3110-103-002.103001022,19.0,1341102,UBRO,Ubrogepant,131.61,ng/mL,131.61,131.61,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T13:07:00,8.0,3 h,3.0,Period 2 Dose,2018-03-30T10:07:00
3110-103-002,PC,3110-103-002.103001022,20.0,1341103,UBRO,Ubrogepant,95.07,ng/mL,95.07,95.07,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T14:07:00,8.0,4 h,4.0,Period 2 Dose,2018-03-30T10:07:00
3110-103-002,PC,3110-103-002.103001022,21.0,1341108,UBRO,Ubrogepant,62.41,ng/mL,62.41,62.41,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T15:07:00,8.0,5 h,5.0,Period 2 Dose,2018-03-30T10:07:00
3110-103-002,PC,3110-103-002.103001022,22.0,1341109,UBRO,Ubrogepant,48.39,ng/mL,48.39,48.39,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T16:07:00,8.0,6 h,6.0,Period 2 Dose,2018-03-30T10:07:00
3110-103-002,PC,3110-103-002.103001022,23.0,1341110,UBRO,Ubrogepant,21.53,ng/mL,21.53,21.53,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T18:07:00,8.0,8 h,8.0,Period 2 Dose,2018-03-30T10:07:00
3110-103-002,PC,3110-103-002.103001022,24.0,1341113,UBRO,Ubrogepant,9.17,ng/mL,9.17,9.17,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T22:07:00,8.0,12 h,12.0,Period 2 Dose,2018-03-30T10:07:00
3110-103-002,PC,3110-103-002.103001022,25.0,1341116,UBRO,Ubrogepant,6.23,ng/mL,6.23,6.23,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-31T00:07:00,9.0,14 h,14.0,Period 2 Dose,2018-03-30T10:07:00
3110-103-002,PC,3110-103-002.103001022,26.0,1341122,UBRO,Ubrogepant,2.65,ng/mL,2.65,2.65,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-03-31T10:07:00,9.0,24 h,24.0,Period 2 Dose,2018-03-30T10:07:00
3110-103-002,PC,3110-103-002.103001022,27.0,1341147,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T09:37:00,15.0,Predose,0.0,Period 3 Dose,2018-04-06T10:07:00
3110-103-002,PC,3110-103-002.103001022,28.0,1341149,UBRO,Ubrogepant,132.09,ng/mL,132.09,132.09,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:37:00,15.0,0.5 h,0.5,Period 3 Dose,2018-04-06T10:07:00
3110-103-002,PC,3110-103-002.103001022,29.0,1341152,UBRO,Ubrogepant,375.46,ng/mL,375.46,375.46,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:07:00,15.0,1 h,1.0,Period 3 Dose,2018-04-06T10:07:00
3110-103-002,PC,3110-103-002.103001022,30.0,1341155,UBRO,Ubrogepant,283.95,ng/mL,283.95,283.95,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:37:00,15.0,1.5 h,1.5,Period 3 Dose,2018-04-06T10:07:00
3110-103-002,PC,3110-103-002.103001022,31.0,1341159,UBRO,Ubrogepant,212.38,ng/mL,212.38,212.38,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T12:07:00,15.0,2 h,2.0,Period 3 Dose,2018-04-06T10:07:00
3110-103-002,PC,3110-103-002.103001022,32.0,1341160,UBRO,Ubrogepant,141.28,ng/mL,141.28,141.28,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T13:07:00,15.0,3 h,3.0,Period 3 Dose,2018-04-06T10:07:00
3110-103-002,PC,3110-103-002.103001022,33.0,1341161,UBRO,Ubrogepant,80.78,ng/mL,80.78,80.78,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T14:07:00,15.0,4 h,4.0,Period 3 Dose,2018-04-06T10:07:00
3110-103-002,PC,3110-103-002.103001022,34.0,1341166,UBRO,Ubrogepant,70.08,ng/mL,70.08,70.08,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T15:07:00,15.0,5 h,5.0,Period 3 Dose,2018-04-06T10:07:00
3110-103-002,PC,3110-103-002.103001022,35.0,1341167,UBRO,Ubrogepant,47.24,ng/mL,47.24,47.24,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T16:07:00,15.0,6 h,6.0,Period 3 Dose,2018-04-06T10:07:00
3110-103-002,PC,3110-103-002.103001022,36.0,1341168,UBRO,Ubrogepant,23.23,ng/mL,23.23,23.23,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T18:07:00,15.0,8 h,8.0,Period 3 Dose,2018-04-06T10:07:00
3110-103-002,PC,3110-103-002.103001022,37.0,1341171,UBRO,Ubrogepant,11.24,ng/mL,11.24,11.24,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T22:07:00,15.0,12 h,12.0,Period 3 Dose,2018-04-06T10:07:00
3110-103-002,PC,3110-103-002.103001022,38.0,1341174,UBRO,Ubrogepant,6.39,ng/mL,6.39,6.39,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-07T00:07:00,16.0,14 h,14.0,Period 3 Dose,2018-04-06T10:07:00
3110-103-002,PC,3110-103-002.103001022,39.0,1341180,UBRO,Ubrogepant,2.21,ng/mL,2.21,2.21,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,26.0,Period 3 Day 16,TREATMENT,2018-04-07T10:07:00,16.0,24 h,24.0,Period 3 Dose,2018-04-06T10:07:00
3110-103-002,PC,3110-103-002.103001031,1.0,1344931,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T09:21:06,1.0,Predose,0.0,Period 1 Dose,2018-03-23T09:50:00
3110-103-002,PC,3110-103-002.103001031,2.0,1344933,UBRO,Ubrogepant,49.05,ng/mL,49.05,49.05,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:22:10,1.0,0.5 h,0.5,Period 1 Dose,2018-03-23T09:50:00
3110-103-002,PC,3110-103-002.103001031,3.0,1344936,UBRO,Ubrogepant,141.03,ng/mL,141.03,141.03,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:50:00,1.0,1 h,1.0,Period 1 Dose,2018-03-23T09:50:00
3110-103-002,PC,3110-103-002.103001031,4.0,1344939,UBRO,Ubrogepant,81.74,ng/mL,81.74,81.74,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:20:00,1.0,1.5 h,1.5,Period 1 Dose,2018-03-23T09:50:00
3110-103-002,PC,3110-103-002.103001031,5.0,1344943,UBRO,Ubrogepant,100.57,ng/mL,100.57,100.57,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:50:00,1.0,2 h,2.0,Period 1 Dose,2018-03-23T09:50:00
3110-103-002,PC,3110-103-002.103001031,6.0,1344944,UBRO,Ubrogepant,313.49,ng/mL,313.49,313.49,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T12:50:00,1.0,3 h,3.0,Period 1 Dose,2018-03-23T09:50:00
3110-103-002,PC,3110-103-002.103001031,7.0,1344945,UBRO,Ubrogepant,201.62,ng/mL,201.62,201.62,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T13:51:29,1.0,4 h,4.0,Period 1 Dose,2018-03-23T09:50:00
3110-103-002,PC,3110-103-002.103001031,8.0,1344950,UBRO,Ubrogepant,131.67,ng/mL,131.67,131.67,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T14:50:00,1.0,5 h,5.0,Period 1 Dose,2018-03-23T09:50:00
3110-103-002,PC,3110-103-002.103001031,9.0,1344951,UBRO,Ubrogepant,74.41,ng/mL,74.41,74.41,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T15:54:38,1.0,6 h,6.0,Period 1 Dose,2018-03-23T09:50:00
3110-103-002,PC,3110-103-002.103001031,10.0,1344952,UBRO,Ubrogepant,43.60,ng/mL,43.60,43.6,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T17:52:32,1.0,8 h,8.0,Period 1 Dose,2018-03-23T09:50:00
3110-103-002,PC,3110-103-002.103001031,11.0,1344955,UBRO,Ubrogepant,13.26,ng/mL,13.26,13.26,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T21:50:00,1.0,12 h,12.0,Period 1 Dose,2018-03-23T09:50:00
3110-103-002,PC,3110-103-002.103001031,12.0,1344958,UBRO,Ubrogepant,7.94,ng/mL,7.94,7.94,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T23:54:01,1.0,14 h,14.0,Period 1 Dose,2018-03-23T09:50:00
3110-103-002,PC,3110-103-002.103001031,13.0,1344964,UBRO,Ubrogepant,2.64,ng/mL,2.64,2.64,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-03-24T09:50:00,2.0,24 h,24.0,Period 1 Dose,2018-03-23T09:50:00
3110-103-002,PC,3110-103-002.103001031,14.0,1344989,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T09:20:00,8.0,Predose,0.0,Period 2 Dose,2018-03-30T09:50:00
3110-103-002,PC,3110-103-002.103001031,15.0,1344991,UBRO,Ubrogepant,51.96,ng/mL,51.96,51.96,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:20:00,8.0,0.5 h,0.5,Period 2 Dose,2018-03-30T09:50:00
3110-103-002,PC,3110-103-002.103001031,16.0,1344994,UBRO,Ubrogepant,152.95,ng/mL,152.95,152.95,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:50:00,8.0,1 h,1.0,Period 2 Dose,2018-03-30T09:50:00
3110-103-002,PC,3110-103-002.103001031,17.0,1344997,UBRO,Ubrogepant,138.85,ng/mL,138.85,138.85,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:20:00,8.0,1.5 h,1.5,Period 2 Dose,2018-03-30T09:50:00
3110-103-002,PC,3110-103-002.103001031,18.0,1345001,UBRO,Ubrogepant,205.82,ng/mL,205.82,205.82,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:50:00,8.0,2 h,2.0,Period 2 Dose,2018-03-30T09:50:00
3110-103-002,PC,3110-103-002.103001031,19.0,1345002,UBRO,Ubrogepant,216.91,ng/mL,216.91,216.91,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T12:51:27,8.0,3 h,3.0,Period 2 Dose,2018-03-30T09:50:00
3110-103-002,PC,3110-103-002.103001031,20.0,1345003,UBRO,Ubrogepant,135.82,ng/mL,135.82,135.82,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T13:50:00,8.0,4 h,4.0,Period 2 Dose,2018-03-30T09:50:00
3110-103-002,PC,3110-103-002.103001031,21.0,1345008,UBRO,Ubrogepant,87.54,ng/mL,87.54,87.54,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T14:50:00,8.0,5 h,5.0,Period 2 Dose,2018-03-30T09:50:00
3110-103-002,PC,3110-103-002.103001031,22.0,1345009,UBRO,Ubrogepant,67.75,ng/mL,67.75,67.75,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T15:50:00,8.0,6 h,6.0,Period 2 Dose,2018-03-30T09:50:00
3110-103-002,PC,3110-103-002.103001031,23.0,1345010,UBRO,Ubrogepant,37.27,ng/mL,37.27,37.27,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T17:50:00,8.0,8 h,8.0,Period 2 Dose,2018-03-30T09:50:00
3110-103-002,PC,3110-103-002.103001031,24.0,1345013,UBRO,Ubrogepant,14.90,ng/mL,14.90,14.9,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T21:50:00,8.0,12 h,12.0,Period 2 Dose,2018-03-30T09:50:00
3110-103-002,PC,3110-103-002.103001031,25.0,1345016,UBRO,Ubrogepant,7.98,ng/mL,7.98,7.98,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T23:50:00,8.0,14 h,14.0,Period 2 Dose,2018-03-30T09:50:00
3110-103-002,PC,3110-103-002.103001031,26.0,1345022,UBRO,Ubrogepant,2.73,ng/mL,2.73,2.73,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-03-31T09:52:00,9.0,24 h,24.0,Period 2 Dose,2018-03-30T09:50:00
3110-103-002,PC,3110-103-002.103001031,27.0,1345047,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T09:20:00,15.0,Predose,0.0,Period 3 Dose,2018-04-06T09:50:00
3110-103-002,PC,3110-103-002.103001031,28.0,1345049,UBRO,Ubrogepant,60.57,ng/mL,60.57,60.57,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:20:00,15.0,0.5 h,0.5,Period 3 Dose,2018-04-06T09:50:00
3110-103-002,PC,3110-103-002.103001031,29.0,1345052,UBRO,Ubrogepant,256.96,ng/mL,256.96,256.96,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:50:00,15.0,1 h,1.0,Period 3 Dose,2018-04-06T09:50:00
3110-103-002,PC,3110-103-002.103001031,30.0,1345055,UBRO,Ubrogepant,162.11,ng/mL,162.11,162.11,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:20:00,15.0,1.5 h,1.5,Period 3 Dose,2018-04-06T09:50:00
3110-103-002,PC,3110-103-002.103001031,31.0,1345059,UBRO,Ubrogepant,144.81,ng/mL,144.81,144.81,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:50:00,15.0,2 h,2.0,Period 3 Dose,2018-04-06T09:50:00
3110-103-002,PC,3110-103-002.103001031,32.0,1345060,UBRO,Ubrogepant,236.28,ng/mL,236.28,236.28,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T12:50:00,15.0,3 h,3.0,Period 3 Dose,2018-04-06T09:50:00
3110-103-002,PC,3110-103-002.103001031,33.0,1345061,UBRO,Ubrogepant,181.79,ng/mL,181.79,181.79,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T13:53:49,15.0,4 h,4.0,Period 3 Dose,2018-04-06T09:50:00
3110-103-002,PC,3110-103-002.103001031,34.0,1345066,UBRO,Ubrogepant,153.96,ng/mL,153.96,153.96,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T14:51:12,15.0,5 h,5.0,Period 3 Dose,2018-04-06T09:50:00
3110-103-002,PC,3110-103-002.103001031,35.0,1345067,UBRO,Ubrogepant,90.97,ng/mL,90.97,90.97,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T15:50:00,15.0,6 h,6.0,Period 3 Dose,2018-04-06T09:50:00
3110-103-002,PC,3110-103-002.103001031,36.0,1345068,UBRO,Ubrogepant,63.33,ng/mL,63.33,63.33,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T17:50:00,15.0,8 h,8.0,Period 3 Dose,2018-04-06T09:50:00
3110-103-002,PC,3110-103-002.103001031,37.0,1345071,UBRO,Ubrogepant,18.90,ng/mL,18.90,18.9,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T21:50:00,15.0,12 h,12.0,Period 3 Dose,2018-04-06T09:50:00
3110-103-002,PC,3110-103-002.103001031,38.0,1345074,UBRO,Ubrogepant,10.81,ng/mL,10.81,10.81,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T23:50:00,15.0,14 h,14.0,Period 3 Dose,2018-04-06T09:50:00
3110-103-002,PC,3110-103-002.103001031,39.0,1345080,UBRO,Ubrogepant,3.48,ng/mL,3.48,3.48,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,26.0,Period 3 Day 16,TREATMENT,2018-04-07T09:50:00,16.0,24 h,24.0,Period 3 Dose,2018-04-06T09:50:00
3110-103-002,PC,3110-103-002.103001032,1.0,1344736,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T09:21:00,1.0,Predose,0.0,Period 1 Dose,2018-03-23T09:51:00
3110-103-002,PC,3110-103-002.103001032,2.0,1344738,UBRO,Ubrogepant,241.06,ng/mL,241.06,241.06,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:21:00,1.0,0.5 h,0.5,Period 1 Dose,2018-03-23T09:51:00
3110-103-002,PC,3110-103-002.103001032,3.0,1344741,UBRO,Ubrogepant,201.93,ng/mL,201.93,201.93,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:51:00,1.0,1 h,1.0,Period 1 Dose,2018-03-23T09:51:00
3110-103-002,PC,3110-103-002.103001032,4.0,1344744,UBRO,Ubrogepant,136.96,ng/mL,136.96,136.96,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:21:00,1.0,1.5 h,1.5,Period 1 Dose,2018-03-23T09:51:00
3110-103-002,PC,3110-103-002.103001032,5.0,1344748,UBRO,Ubrogepant,136.92,ng/mL,136.92,136.92,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:51:00,1.0,2 h,2.0,Period 1 Dose,2018-03-23T09:51:00
3110-103-002,PC,3110-103-002.103001032,6.0,1344749,UBRO,Ubrogepant,104.12,ng/mL,104.12,104.12,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T12:51:00,1.0,3 h,3.0,Period 1 Dose,2018-03-23T09:51:00
3110-103-002,PC,3110-103-002.103001032,7.0,1344750,UBRO,Ubrogepant,78.81,ng/mL,78.81,78.81,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T13:51:00,1.0,4 h,4.0,Period 1 Dose,2018-03-23T09:51:00
3110-103-002,PC,3110-103-002.103001032,8.0,1344755,UBRO,Ubrogepant,61.77,ng/mL,61.77,61.77,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T14:51:00,1.0,5 h,5.0,Period 1 Dose,2018-03-23T09:51:00
3110-103-002,PC,3110-103-002.103001032,9.0,1344756,UBRO,Ubrogepant,61.07,ng/mL,61.07,61.07,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T15:51:00,1.0,6 h,6.0,Period 1 Dose,2018-03-23T09:51:00
3110-103-002,PC,3110-103-002.103001032,10.0,1344757,UBRO,Ubrogepant,39.42,ng/mL,39.42,39.42,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T17:51:00,1.0,8 h,8.0,Period 1 Dose,2018-03-23T09:51:00
3110-103-002,PC,3110-103-002.103001032,11.0,1344760,UBRO,Ubrogepant,20.78,ng/mL,20.78,20.78,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T21:51:00,1.0,12 h,12.0,Period 1 Dose,2018-03-23T09:51:00
3110-103-002,PC,3110-103-002.103001032,12.0,1344763,UBRO,Ubrogepant,16.05,ng/mL,16.05,16.05,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T23:52:31,1.0,14 h,14.0,Period 1 Dose,2018-03-23T09:51:00
3110-103-002,PC,3110-103-002.103001032,13.0,1344769,UBRO,Ubrogepant,6.06,ng/mL,6.06,6.06,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-03-24T09:51:00,2.0,24 h,24.0,Period 1 Dose,2018-03-23T09:51:00
3110-103-002,PC,3110-103-002.103001032,14.0,1344794,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T09:21:00,8.0,Predose,0.0,Period 2 Dose,2018-03-30T09:51:00
3110-103-002,PC,3110-103-002.103001032,15.0,1344796,UBRO,Ubrogepant,338.98,ng/mL,338.98,338.98,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:21:00,8.0,0.5 h,0.5,Period 2 Dose,2018-03-30T09:51:00
3110-103-002,PC,3110-103-002.103001032,16.0,1344799,UBRO,Ubrogepant,269.05,ng/mL,269.05,269.05,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:51:00,8.0,1 h,1.0,Period 2 Dose,2018-03-30T09:51:00
3110-103-002,PC,3110-103-002.103001032,17.0,1344802,UBRO,Ubrogepant,174.77,ng/mL,174.77,174.77,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:21:00,8.0,1.5 h,1.5,Period 2 Dose,2018-03-30T09:51:00
3110-103-002,PC,3110-103-002.103001032,18.0,1344806,UBRO,Ubrogepant,169.13,ng/mL,169.13,169.13,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:51:00,8.0,2 h,2.0,Period 2 Dose,2018-03-30T09:51:00
3110-103-002,PC,3110-103-002.103001032,19.0,1344807,UBRO,Ubrogepant,110.01,ng/mL,110.01,110.01,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T12:51:00,8.0,3 h,3.0,Period 2 Dose,2018-03-30T09:51:00
3110-103-002,PC,3110-103-002.103001032,20.0,1344808,UBRO,Ubrogepant,79.95,ng/mL,79.95,79.95,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T13:51:00,8.0,4 h,4.0,Period 2 Dose,2018-03-30T09:51:00
3110-103-002,PC,3110-103-002.103001032,21.0,1344813,UBRO,Ubrogepant,63.03,ng/mL,63.03,63.03,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T14:51:00,8.0,5 h,5.0,Period 2 Dose,2018-03-30T09:51:00
3110-103-002,PC,3110-103-002.103001032,22.0,1344814,UBRO,Ubrogepant,39.56,ng/mL,39.56,39.56,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T15:51:00,8.0,6 h,6.0,Period 2 Dose,2018-03-30T09:51:00
3110-103-002,PC,3110-103-002.103001032,23.0,1344815,UBRO,Ubrogepant,31.79,ng/mL,31.79,31.79,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T17:51:00,8.0,8 h,8.0,Period 2 Dose,2018-03-30T09:51:00
3110-103-002,PC,3110-103-002.103001032,24.0,1344818,UBRO,Ubrogepant,14.15,ng/mL,14.15,14.15,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T21:51:00,8.0,12 h,12.0,Period 2 Dose,2018-03-30T09:51:00
3110-103-002,PC,3110-103-002.103001032,25.0,1344821,UBRO,Ubrogepant,10.93,ng/mL,10.93,10.93,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T23:51:00,8.0,14 h,14.0,Period 2 Dose,2018-03-30T09:51:00
3110-103-002,PC,3110-103-002.103001032,26.0,1344827,UBRO,Ubrogepant,4.13,ng/mL,4.13,4.13,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-03-31T09:51:00,9.0,24 h,24.0,Period 2 Dose,2018-03-30T09:51:00
3110-103-002,PC,3110-103-002.103001032,27.0,1344852,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T09:21:00,15.0,Predose,0.0,Period 3 Dose,2018-04-06T09:51:00
3110-103-002,PC,3110-103-002.103001032,28.0,1344854,UBRO,Ubrogepant,318.98,ng/mL,318.98,318.98,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:21:00,15.0,0.5 h,0.5,Period 3 Dose,2018-04-06T09:51:00
3110-103-002,PC,3110-103-002.103001032,29.0,1344857,UBRO,Ubrogepant,495.75,ng/mL,495.75,495.75,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:51:00,15.0,1 h,1.0,Period 3 Dose,2018-04-06T09:51:00
3110-103-002,PC,3110-103-002.103001032,30.0,1344860,UBRO,Ubrogepant,286.57,ng/mL,286.57,286.57,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:21:00,15.0,1.5 h,1.5,Period 3 Dose,2018-04-06T09:51:00
3110-103-002,PC,3110-103-002.103001032,31.0,1344864,UBRO,Ubrogepant,220.43,ng/mL,220.43,220.43,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:51:00,15.0,2 h,2.0,Period 3 Dose,2018-04-06T09:51:00
3110-103-002,PC,3110-103-002.103001032,32.0,1344865,UBRO,Ubrogepant,153.12,ng/mL,153.12,153.12,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T12:51:00,15.0,3 h,3.0,Period 3 Dose,2018-04-06T09:51:00
3110-103-002,PC,3110-103-002.103001032,33.0,1344866,UBRO,Ubrogepant,104.84,ng/mL,104.84,104.84,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T13:51:00,15.0,4 h,4.0,Period 3 Dose,2018-04-06T09:51:00
3110-103-002,PC,3110-103-002.103001032,34.0,1344871,UBRO,Ubrogepant,86.12,ng/mL,86.12,86.12,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T14:51:00,15.0,5 h,5.0,Period 3 Dose,2018-04-06T09:51:00
3110-103-002,PC,3110-103-002.103001032,35.0,1344872,UBRO,Ubrogepant,60.15,ng/mL,60.15,60.15,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T15:51:00,15.0,6 h,6.0,Period 3 Dose,2018-04-06T09:51:00
3110-103-002,PC,3110-103-002.103001032,36.0,1344873,UBRO,Ubrogepant,38.47,ng/mL,38.47,38.47,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T17:51:00,15.0,8 h,8.0,Period 3 Dose,2018-04-06T09:51:00
3110-103-002,PC,3110-103-002.103001032,37.0,1344876,UBRO,Ubrogepant,15.71,ng/mL,15.71,15.71,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T21:51:00,15.0,12 h,12.0,Period 3 Dose,2018-04-06T09:51:00
3110-103-002,PC,3110-103-002.103001032,38.0,1344879,UBRO,Ubrogepant,12.08,ng/mL,12.08,12.08,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T23:51:00,15.0,14 h,14.0,Period 3 Dose,2018-04-06T09:51:00
3110-103-002,PC,3110-103-002.103001032,39.0,1344885,UBRO,Ubrogepant,3.93,ng/mL,3.93,3.93,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,26.0,Period 3 Day 16,TREATMENT,2018-04-07T09:51:00,16.0,24 h,24.0,Period 3 Dose,2018-04-06T09:51:00
3110-103-002,PC,3110-103-002.103001034,1.0,1339276,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T09:04:00,1.0,Predose,0.0,Period 1 Dose,2018-03-23T09:34:32
3110-103-002,PC,3110-103-002.103001034,2.0,1339278,UBRO,Ubrogepant,68.31,ng/mL,68.31,68.31,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:04:00,1.0,0.5 h,0.5,Period 1 Dose,2018-03-23T09:34:32
3110-103-002,PC,3110-103-002.103001034,3.0,1339281,UBRO,Ubrogepant,557.99,ng/mL,557.99,557.99,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:34:00,1.0,1 h,1.0,Period 1 Dose,2018-03-23T09:34:32
3110-103-002,PC,3110-103-002.103001034,4.0,1339284,UBRO,Ubrogepant,454.67,ng/mL,454.67,454.67,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:04:00,1.0,1.5 h,1.5,Period 1 Dose,2018-03-23T09:34:32
3110-103-002,PC,3110-103-002.103001034,5.0,1339288,UBRO,Ubrogepant,345.75,ng/mL,345.75,345.75,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:34:00,1.0,2 h,2.0,Period 1 Dose,2018-03-23T09:34:32
3110-103-002,PC,3110-103-002.103001034,6.0,1339289,UBRO,Ubrogepant,260.10,ng/mL,260.10,260.1,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T12:34:00,1.0,3 h,3.0,Period 1 Dose,2018-03-23T09:34:32
3110-103-002,PC,3110-103-002.103001034,7.0,1339290,UBRO,Ubrogepant,218.64,ng/mL,218.64,218.64,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T13:34:00,1.0,4 h,4.0,Period 1 Dose,2018-03-23T09:34:32
3110-103-002,PC,3110-103-002.103001034,8.0,1339295,UBRO,Ubrogepant,181.72,ng/mL,181.72,181.72,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T14:34:00,1.0,5 h,5.0,Period 1 Dose,2018-03-23T09:34:32
3110-103-002,PC,3110-103-002.103001034,9.0,1339296,UBRO,Ubrogepant,132.70,ng/mL,132.70,132.7,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T15:34:00,1.0,6 h,6.0,Period 1 Dose,2018-03-23T09:34:32
3110-103-002,PC,3110-103-002.103001034,10.0,1339297,UBRO,Ubrogepant,96.37,ng/mL,96.37,96.37,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T17:34:00,1.0,8 h,8.0,Period 1 Dose,2018-03-23T09:34:32
3110-103-002,PC,3110-103-002.103001034,11.0,1339300,UBRO,Ubrogepant,49.98,ng/mL,49.98,49.98,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T21:34:00,1.0,12 h,12.0,Period 1 Dose,2018-03-23T09:34:32
3110-103-002,PC,3110-103-002.103001034,12.0,1339303,UBRO,Ubrogepant,35.77,ng/mL,35.77,35.77,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T23:34:00,1.0,14 h,14.0,Period 1 Dose,2018-03-23T09:34:32
3110-103-002,PC,3110-103-002.103001034,13.0,1339309,UBRO,Ubrogepant,12.50,ng/mL,12.50,12.5,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-03-24T09:34:00,2.0,24 h,24.0,Period 1 Dose,2018-03-23T09:34:32
3110-103-002,PC,3110-103-002.103001034,14.0,1339334,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T09:04:00,8.0,Predose,0.0,Period 2 Dose,2018-03-30T09:34:00
3110-103-002,PC,3110-103-002.103001034,15.0,1339336,UBRO,Ubrogepant,137.36,ng/mL,137.36,137.36,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:04:00,8.0,0.5 h,0.5,Period 2 Dose,2018-03-30T09:34:00
3110-103-002,PC,3110-103-002.103001034,16.0,1339339,UBRO,Ubrogepant,543.34,ng/mL,543.34,543.34,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:34:00,8.0,1 h,1.0,Period 2 Dose,2018-03-30T09:34:00
3110-103-002,PC,3110-103-002.103001034,17.0,1339342,UBRO,Ubrogepant,358.42,ng/mL,358.42,358.42,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:04:00,8.0,1.5 h,1.5,Period 2 Dose,2018-03-30T09:34:00
3110-103-002,PC,3110-103-002.103001034,18.0,1339346,UBRO,Ubrogepant,314.03,ng/mL,314.03,314.03,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:34:00,8.0,2 h,2.0,Period 2 Dose,2018-03-30T09:34:00
3110-103-002,PC,3110-103-002.103001034,19.0,1339347,UBRO,Ubrogepant,252.58,ng/mL,252.58,252.58,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T12:34:00,8.0,3 h,3.0,Period 2 Dose,2018-03-30T09:34:00
3110-103-002,PC,3110-103-002.103001034,20.0,1339348,UBRO,Ubrogepant,200.21,ng/mL,200.21,200.21,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T13:34:00,8.0,4 h,4.0,Period 2 Dose,2018-03-30T09:34:00
3110-103-002,PC,3110-103-002.103001034,21.0,1339353,UBRO,Ubrogepant,139.97,ng/mL,139.97,139.97,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T14:34:00,8.0,5 h,5.0,Period 2 Dose,2018-03-30T09:34:00
3110-103-002,PC,3110-103-002.103001034,22.0,1339354,UBRO,Ubrogepant,114.20,ng/mL,114.20,114.2,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T15:34:00,8.0,6 h,6.0,Period 2 Dose,2018-03-30T09:34:00
3110-103-002,PC,3110-103-002.103001034,23.0,1339355,UBRO,Ubrogepant,64.91,ng/mL,64.91,64.91,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T17:34:00,8.0,8 h,8.0,Period 2 Dose,2018-03-30T09:34:00
3110-103-002,PC,3110-103-002.103001034,24.0,1339358,UBRO,Ubrogepant,27.46,ng/mL,27.46,27.46,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T21:34:00,8.0,12 h,12.0,Period 2 Dose,2018-03-30T09:34:00
3110-103-002,PC,3110-103-002.103001034,25.0,1339361,UBRO,Ubrogepant,20.59,ng/mL,20.59,20.59,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T23:34:00,8.0,14 h,14.0,Period 2 Dose,2018-03-30T09:34:00
3110-103-002,PC,3110-103-002.103001034,26.0,1339367,UBRO,Ubrogepant,6.32,ng/mL,6.32,6.32,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-03-31T09:34:00,9.0,24 h,24.0,Period 2 Dose,2018-03-30T09:34:00
3110-103-002,PC,3110-103-002.103001034,27.0,1339392,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T09:04:00,15.0,Predose,0.0,Period 3 Dose,2018-04-06T09:34:00
3110-103-002,PC,3110-103-002.103001034,28.0,1339394,UBRO,Ubrogepant,120.48,ng/mL,120.48,120.48,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:04:00,15.0,0.5 h,0.5,Period 3 Dose,2018-04-06T09:34:00
3110-103-002,PC,3110-103-002.103001034,29.0,1339397,UBRO,Ubrogepant,532.92,ng/mL,532.92,532.92,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:34:00,15.0,1 h,1.0,Period 3 Dose,2018-04-06T09:34:00
3110-103-002,PC,3110-103-002.103001034,30.0,1339400,UBRO,Ubrogepant,357.92,ng/mL,357.92,357.92,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:04:00,15.0,1.5 h,1.5,Period 3 Dose,2018-04-06T09:34:00
3110-103-002,PC,3110-103-002.103001034,31.0,1339404,UBRO,Ubrogepant,319.22,ng/mL,319.22,319.22,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:36:54,15.0,2 h,2.0,Period 3 Dose,2018-04-06T09:34:00
3110-103-002,PC,3110-103-002.103001034,32.0,1339405,UBRO,Ubrogepant,225.60,ng/mL,225.60,225.6,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T12:34:00,15.0,3 h,3.0,Period 3 Dose,2018-04-06T09:34:00
3110-103-002,PC,3110-103-002.103001034,33.0,1339406,UBRO,Ubrogepant,167.71,ng/mL,167.71,167.71,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T13:34:00,15.0,4 h,4.0,Period 3 Dose,2018-04-06T09:34:00
3110-103-002,PC,3110-103-002.103001034,34.0,1339411,UBRO,Ubrogepant,116.68,ng/mL,116.68,116.68,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T14:34:00,15.0,5 h,5.0,Period 3 Dose,2018-04-06T09:34:00
3110-103-002,PC,3110-103-002.103001034,35.0,1339412,UBRO,Ubrogepant,94.23,ng/mL,94.23,94.23,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T15:34:00,15.0,6 h,6.0,Period 3 Dose,2018-04-06T09:34:00
3110-103-002,PC,3110-103-002.103001034,36.0,1339413,UBRO,Ubrogepant,61.04,ng/mL,61.04,61.04,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T17:34:00,15.0,8 h,8.0,Period 3 Dose,2018-04-06T09:34:00
3110-103-002,PC,3110-103-002.103001034,37.0,1339416,UBRO,Ubrogepant,27.87,ng/mL,27.87,27.87,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T21:34:00,15.0,12 h,12.0,Period 3 Dose,2018-04-06T09:34:00
3110-103-002,PC,3110-103-002.103001034,38.0,1339419,UBRO,Ubrogepant,20.97,ng/mL,20.97,20.97,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T23:34:00,15.0,14 h,14.0,Period 3 Dose,2018-04-06T09:34:00
3110-103-002,PC,3110-103-002.103001034,39.0,1339425,UBRO,Ubrogepant,6.55,ng/mL,6.55,6.55,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,26.0,Period 3 Day 16,TREATMENT,2018-04-07T09:34:00,16.0,24 h,24.0,Period 3 Dose,2018-04-06T09:34:00
3110-103-002,PC,3110-103-002.103001035,1.0,1340836,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T09:38:00,1.0,Predose,0.0,Period 1 Dose,2018-03-23T10:08:00
3110-103-002,PC,3110-103-002.103001035,2.0,1340838,UBRO,Ubrogepant,303.92,ng/mL,303.92,303.92,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:38:00,1.0,0.5 h,0.5,Period 1 Dose,2018-03-23T10:08:00
3110-103-002,PC,3110-103-002.103001035,3.0,1340841,UBRO,Ubrogepant,355.97,ng/mL,355.97,355.97,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:08:00,1.0,1 h,1.0,Period 1 Dose,2018-03-23T10:08:00
3110-103-002,PC,3110-103-002.103001035,4.0,1340844,UBRO,Ubrogepant,314.69,ng/mL,314.69,314.69,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:39:07,1.0,1.5 h,1.5,Period 1 Dose,2018-03-23T10:08:00
3110-103-002,PC,3110-103-002.103001035,5.0,1340848,UBRO,Ubrogepant,273.10,ng/mL,273.10,273.1,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T12:08:00,1.0,2 h,2.0,Period 1 Dose,2018-03-23T10:08:00
3110-103-002,PC,3110-103-002.103001035,6.0,1340849,UBRO,Ubrogepant,150.04,ng/mL,150.04,150.04,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T13:08:00,1.0,3 h,3.0,Period 1 Dose,2018-03-23T10:08:00
3110-103-002,PC,3110-103-002.103001035,7.0,1340850,UBRO,Ubrogepant,108.80,ng/mL,108.80,108.8,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T14:08:00,1.0,4 h,4.0,Period 1 Dose,2018-03-23T10:08:00
3110-103-002,PC,3110-103-002.103001035,8.0,1340855,UBRO,Ubrogepant,74.62,ng/mL,74.62,74.62,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T15:08:00,1.0,5 h,5.0,Period 1 Dose,2018-03-23T10:08:00
3110-103-002,PC,3110-103-002.103001035,9.0,1340856,UBRO,Ubrogepant,50.73,ng/mL,50.73,50.73,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T16:08:00,1.0,6 h,6.0,Period 1 Dose,2018-03-23T10:08:00
3110-103-002,PC,3110-103-002.103001035,10.0,1340857,UBRO,Ubrogepant,27.25,ng/mL,27.25,27.25,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T18:08:00,1.0,8 h,8.0,Period 1 Dose,2018-03-23T10:08:00
3110-103-002,PC,3110-103-002.103001035,11.0,1340860,UBRO,Ubrogepant,7.32,ng/mL,7.32,7.32,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T22:08:00,1.0,12 h,12.0,Period 1 Dose,2018-03-23T10:08:00
3110-103-002,PC,3110-103-002.103001035,12.0,1340863,UBRO,Ubrogepant,5.00,ng/mL,5.00,5.0,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-24T00:08:00,2.0,14 h,14.0,Period 1 Dose,2018-03-23T10:08:00
3110-103-002,PC,3110-103-002.103001035,13.0,1340869,UBRO,Ubrogepant,1.77,ng/mL,1.77,1.77,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-03-24T10:08:00,2.0,24 h,24.0,Period 1 Dose,2018-03-23T10:08:00
3110-103-002,PC,3110-103-002.103001035,14.0,1340894,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T09:38:00,8.0,Predose,0.0,Period 2 Dose,2018-03-30T10:08:00
3110-103-002,PC,3110-103-002.103001035,15.0,1340896,UBRO,Ubrogepant,308.65,ng/mL,308.65,308.65,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:38:00,8.0,0.5 h,0.5,Period 2 Dose,2018-03-30T10:08:00
3110-103-002,PC,3110-103-002.103001035,16.0,1340899,UBRO,Ubrogepant,449.04,ng/mL,449.04,449.04,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:08:00,8.0,1 h,1.0,Period 2 Dose,2018-03-30T10:08:00
3110-103-002,PC,3110-103-002.103001035,17.0,1340902,UBRO,Ubrogepant,383.15,ng/mL,383.15,383.15,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:38:00,8.0,1.5 h,1.5,Period 2 Dose,2018-03-30T10:08:00
3110-103-002,PC,3110-103-002.103001035,18.0,1340906,UBRO,Ubrogepant,310.23,ng/mL,310.23,310.23,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T12:08:00,8.0,2 h,2.0,Period 2 Dose,2018-03-30T10:08:00
3110-103-002,PC,3110-103-002.103001035,19.0,1340907,UBRO,Ubrogepant,198.19,ng/mL,198.19,198.19,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T13:08:00,8.0,3 h,3.0,Period 2 Dose,2018-03-30T10:08:00
3110-103-002,PC,3110-103-002.103001035,20.0,1340908,UBRO,Ubrogepant,129.55,ng/mL,129.55,129.55,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T14:08:00,8.0,4 h,4.0,Period 2 Dose,2018-03-30T10:08:00
3110-103-002,PC,3110-103-002.103001035,21.0,1340913,UBRO,Ubrogepant,90.89,ng/mL,90.89,90.89,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T15:08:00,8.0,5 h,5.0,Period 2 Dose,2018-03-30T10:08:00
3110-103-002,PC,3110-103-002.103001035,22.0,1340914,UBRO,Ubrogepant,65.61,ng/mL,65.61,65.61,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T16:08:00,8.0,6 h,6.0,Period 2 Dose,2018-03-30T10:08:00
3110-103-002,PC,3110-103-002.103001035,23.0,1340915,UBRO,Ubrogepant,33.14,ng/mL,33.14,33.14,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T18:08:00,8.0,8 h,8.0,Period 2 Dose,2018-03-30T10:08:00
3110-103-002,PC,3110-103-002.103001035,24.0,1340918,UBRO,Ubrogepant,9.44,ng/mL,9.44,9.44,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T22:08:00,8.0,12 h,12.0,Period 2 Dose,2018-03-30T10:08:00
3110-103-002,PC,3110-103-002.103001035,25.0,1340921,UBRO,Ubrogepant,5.88,ng/mL,5.88,5.88,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-31T00:08:00,9.0,14 h,14.0,Period 2 Dose,2018-03-30T10:08:00
3110-103-002,PC,3110-103-002.103001035,26.0,1340927,UBRO,Ubrogepant,2.30,ng/mL,2.30,2.3,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-03-31T10:08:00,9.0,24 h,24.0,Period 2 Dose,2018-03-30T10:08:00
3110-103-002,PC,3110-103-002.103001035,27.0,1340952,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T09:38:00,15.0,Predose,0.0,Period 3 Dose,2018-04-06T10:08:00
3110-103-002,PC,3110-103-002.103001035,28.0,1340954,UBRO,Ubrogepant,112.27,ng/mL,112.27,112.27,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:38:00,15.0,0.5 h,0.5,Period 3 Dose,2018-04-06T10:08:00
3110-103-002,PC,3110-103-002.103001035,29.0,1340957,UBRO,Ubrogepant,364.59,ng/mL,364.59,364.59,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:08:00,15.0,1 h,1.0,Period 3 Dose,2018-04-06T10:08:00
3110-103-002,PC,3110-103-002.103001035,30.0,1340960,UBRO,Ubrogepant,453.57,ng/mL,453.57,453.57,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:38:00,15.0,1.5 h,1.5,Period 3 Dose,2018-04-06T10:08:00
3110-103-002,PC,3110-103-002.103001035,31.0,1340964,UBRO,Ubrogepant,381.34,ng/mL,381.34,381.34,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T12:08:00,15.0,2 h,2.0,Period 3 Dose,2018-04-06T10:08:00
3110-103-002,PC,3110-103-002.103001035,32.0,1340965,UBRO,Ubrogepant,204.63,ng/mL,204.63,204.63,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T13:08:00,15.0,3 h,3.0,Period 3 Dose,2018-04-06T10:08:00
3110-103-002,PC,3110-103-002.103001035,33.0,1340966,UBRO,Ubrogepant,132.29,ng/mL,132.29,132.29,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T14:08:00,15.0,4 h,4.0,Period 3 Dose,2018-04-06T10:08:00
3110-103-002,PC,3110-103-002.103001035,34.0,1340971,UBRO,Ubrogepant,83.67,ng/mL,83.67,83.67,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T15:08:00,15.0,5 h,5.0,Period 3 Dose,2018-04-06T10:08:00
3110-103-002,PC,3110-103-002.103001035,35.0,1340972,UBRO,Ubrogepant,58.53,ng/mL,58.53,58.53,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T16:08:00,15.0,6 h,6.0,Period 3 Dose,2018-04-06T10:08:00
3110-103-002,PC,3110-103-002.103001035,36.0,1340973,UBRO,Ubrogepant,25.58,ng/mL,25.58,25.58,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T18:08:00,15.0,8 h,8.0,Period 3 Dose,2018-04-06T10:08:00
3110-103-002,PC,3110-103-002.103001035,37.0,1340976,UBRO,Ubrogepant,7.26,ng/mL,7.26,7.26,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T22:08:00,15.0,12 h,12.0,Period 3 Dose,2018-04-06T10:08:00
3110-103-002,PC,3110-103-002.103001035,38.0,1340979,UBRO,Ubrogepant,5.30,ng/mL,5.30,5.3,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-07T00:08:00,16.0,14 h,14.0,Period 3 Dose,2018-04-06T10:08:00
3110-103-002,PC,3110-103-002.103001035,39.0,1340985,UBRO,Ubrogepant,2.05,ng/mL,2.05,2.05,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,26.0,Period 3 Day 16,TREATMENT,2018-04-07T10:08:00,16.0,24 h,24.0,Period 3 Dose,2018-04-06T10:08:00
3110-103-002,PC,3110-103-002.103001037,1.0,1345321,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T09:12:00,1.0,Predose,0.0,Period 1 Dose,2018-03-23T09:42:00
3110-103-002,PC,3110-103-002.103001037,2.0,1345323,UBRO,Ubrogepant,165.68,ng/mL,165.68,165.68,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:12:00,1.0,0.5 h,0.5,Period 1 Dose,2018-03-23T09:42:00
3110-103-002,PC,3110-103-002.103001037,3.0,1345326,UBRO,Ubrogepant,573.61,ng/mL,573.61,573.61,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:42:00,1.0,1 h,1.0,Period 1 Dose,2018-03-23T09:42:00
3110-103-002,PC,3110-103-002.103001037,4.0,1345329,UBRO,Ubrogepant,360.01,ng/mL,360.01,360.01,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:12:00,1.0,1.5 h,1.5,Period 1 Dose,2018-03-23T09:42:00
3110-103-002,PC,3110-103-002.103001037,5.0,1345333,UBRO,Ubrogepant,265.15,ng/mL,265.15,265.15,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:42:00,1.0,2 h,2.0,Period 1 Dose,2018-03-23T09:42:00
3110-103-002,PC,3110-103-002.103001037,6.0,1345334,UBRO,Ubrogepant,187.10,ng/mL,187.10,187.1,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T12:42:00,1.0,3 h,3.0,Period 1 Dose,2018-03-23T09:42:00
3110-103-002,PC,3110-103-002.103001037,7.0,1345335,UBRO,Ubrogepant,142.63,ng/mL,142.63,142.63,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T13:42:00,1.0,4 h,4.0,Period 1 Dose,2018-03-23T09:42:00
3110-103-002,PC,3110-103-002.103001037,8.0,1345340,UBRO,Ubrogepant,99.83,ng/mL,99.83,99.83,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T14:42:00,1.0,5 h,5.0,Period 1 Dose,2018-03-23T09:42:00
3110-103-002,PC,3110-103-002.103001037,9.0,1345341,UBRO,Ubrogepant,76.14,ng/mL,76.14,76.14,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T15:42:00,1.0,6 h,6.0,Period 1 Dose,2018-03-23T09:42:00
3110-103-002,PC,3110-103-002.103001037,10.0,1345342,UBRO,Ubrogepant,44.12,ng/mL,44.12,44.12,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T17:42:00,1.0,8 h,8.0,Period 1 Dose,2018-03-23T09:42:00
3110-103-002,PC,3110-103-002.103001037,11.0,1345345,UBRO,Ubrogepant,15.98,ng/mL,15.98,15.98,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T21:42:00,1.0,12 h,12.0,Period 1 Dose,2018-03-23T09:42:00
3110-103-002,PC,3110-103-002.103001037,12.0,1345348,UBRO,Ubrogepant,9.26,ng/mL,9.26,9.26,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T23:42:00,1.0,14 h,14.0,Period 1 Dose,2018-03-23T09:42:00
3110-103-002,PC,3110-103-002.103001037,13.0,1345354,UBRO,Ubrogepant,2.77,ng/mL,2.77,2.77,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-03-24T09:42:00,2.0,24 h,24.0,Period 1 Dose,2018-03-23T09:42:00
3110-103-002,PC,3110-103-002.103001037,14.0,1345379,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T09:12:00,8.0,Predose,0.0,Period 2 Dose,2018-03-30T09:42:00
3110-103-002,PC,3110-103-002.103001037,15.0,1345381,UBRO,Ubrogepant,59.37,ng/mL,59.37,59.37,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:12:00,8.0,0.5 h,0.5,Period 2 Dose,2018-03-30T09:42:00
3110-103-002,PC,3110-103-002.103001037,16.0,1345384,UBRO,Ubrogepant,453.39,ng/mL,453.39,453.39,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:42:00,8.0,1 h,1.0,Period 2 Dose,2018-03-30T09:42:00
3110-103-002,PC,3110-103-002.103001037,17.0,1345387,UBRO,Ubrogepant,391.45,ng/mL,391.45,391.45,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:12:00,8.0,1.5 h,1.5,Period 2 Dose,2018-03-30T09:42:00
3110-103-002,PC,3110-103-002.103001037,18.0,1345391,UBRO,Ubrogepant,339.05,ng/mL,339.05,339.05,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:42:00,8.0,2 h,2.0,Period 2 Dose,2018-03-30T09:42:00
3110-103-002,PC,3110-103-002.103001037,19.0,1345392,UBRO,Ubrogepant,187.35,ng/mL,187.35,187.35,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T12:42:00,8.0,3 h,3.0,Period 2 Dose,2018-03-30T09:42:00
3110-103-002,PC,3110-103-002.103001037,20.0,1345393,UBRO,Ubrogepant,133.77,ng/mL,133.77,133.77,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T13:42:00,8.0,4 h,4.0,Period 2 Dose,2018-03-30T09:42:00
3110-103-002,PC,3110-103-002.103001037,21.0,1345398,UBRO,Ubrogepant,88.97,ng/mL,88.97,88.97,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T14:42:00,8.0,5 h,5.0,Period 2 Dose,2018-03-30T09:42:00
3110-103-002,PC,3110-103-002.103001037,22.0,1345399,UBRO,Ubrogepant,65.21,ng/mL,65.21,65.21,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T15:42:00,8.0,6 h,6.0,Period 2 Dose,2018-03-30T09:42:00
3110-103-002,PC,3110-103-002.103001037,23.0,1345400,UBRO,Ubrogepant,39.81,ng/mL,39.81,39.81,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T17:42:00,8.0,8 h,8.0,Period 2 Dose,2018-03-30T09:42:00
3110-103-002,PC,3110-103-002.103001037,24.0,1345403,UBRO,Ubrogepant,13.62,ng/mL,13.62,13.62,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T21:42:00,8.0,12 h,12.0,Period 2 Dose,2018-03-30T09:42:00
3110-103-002,PC,3110-103-002.103001037,25.0,1345406,UBRO,Ubrogepant,8.65,ng/mL,8.65,8.65,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T23:42:00,8.0,14 h,14.0,Period 2 Dose,2018-03-30T09:42:00
3110-103-002,PC,3110-103-002.103001037,26.0,1345412,UBRO,Ubrogepant,2.38,ng/mL,2.38,2.38,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-03-31T09:42:00,9.0,24 h,24.0,Period 2 Dose,2018-03-30T09:42:00
3110-103-002,PC,3110-103-002.103001037,27.0,1345444,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T09:12:00,15.0,Predose,0.0,Period 3 Dose,2018-04-06T09:42:00
3110-103-002,PC,3110-103-002.103001037,28.0,1345450,UBRO,Ubrogepant,395.77,ng/mL,395.77,395.77,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:12:00,15.0,0.5 h,0.5,Period 3 Dose,2018-04-06T09:42:00
3110-103-002,PC,3110-103-002.103001037,29.0,1345454,UBRO,Ubrogepant,406.24,ng/mL,406.24,406.24,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:42:00,15.0,1 h,1.0,Period 3 Dose,2018-04-06T09:42:00
3110-103-002,PC,3110-103-002.103001037,30.0,1345460,UBRO,Ubrogepant,259.12,ng/mL,259.12,259.12,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:12:00,15.0,1.5 h,1.5,Period 3 Dose,2018-04-06T09:42:00
3110-103-002,PC,3110-103-002.103001037,31.0,1345468,UBRO,Ubrogepant,226.48,ng/mL,226.48,226.48,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:42:00,15.0,2 h,2.0,Period 3 Dose,2018-04-06T09:42:00
3110-103-002,PC,3110-103-002.103001037,32.0,1345471,UBRO,Ubrogepant,149.49,ng/mL,149.49,149.49,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T12:42:00,15.0,3 h,3.0,Period 3 Dose,2018-04-06T09:42:00
3110-103-002,PC,3110-103-002.103001037,33.0,1345472,UBRO,Ubrogepant,110.54,ng/mL,110.54,110.54,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T13:42:00,15.0,4 h,4.0,Period 3 Dose,2018-04-06T09:42:00
3110-103-002,PC,3110-103-002.103001037,34.0,1345479,UBRO,Ubrogepant,77.05,ng/mL,77.05,77.05,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T14:42:00,15.0,5 h,5.0,Period 3 Dose,2018-04-06T09:42:00
3110-103-002,PC,3110-103-002.103001037,35.0,1345481,UBRO,Ubrogepant,62.58,ng/mL,62.58,62.58,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T15:42:00,15.0,6 h,6.0,Period 3 Dose,2018-04-06T09:42:00
3110-103-002,PC,3110-103-002.103001037,36.0,1345482,UBRO,Ubrogepant,37.19,ng/mL,37.19,37.19,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T17:42:00,15.0,8 h,8.0,Period 3 Dose,2018-04-06T09:42:00
3110-103-002,PC,3110-103-002.103001037,37.0,1345487,UBRO,Ubrogepant,16.95,ng/mL,16.95,16.95,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T21:42:00,15.0,12 h,12.0,Period 3 Dose,2018-04-06T09:42:00
3110-103-002,PC,3110-103-002.103001037,38.0,1345493,UBRO,Ubrogepant,10.72,ng/mL,10.72,10.72,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T23:42:00,15.0,14 h,14.0,Period 3 Dose,2018-04-06T09:42:00
3110-103-002,PC,3110-103-002.103001037,39.0,1345505,UBRO,Ubrogepant,3.77,ng/mL,3.77,3.77,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,26.0,Period 3 Day 16,TREATMENT,2018-04-07T09:42:00,16.0,24 h,24.0,Period 3 Dose,2018-04-06T09:42:00
3110-103-002,PC,3110-103-002.103001038,1.0,1344541,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T09:26:42,1.0,Predose,0.0,Period 1 Dose,2018-03-23T09:52:00
3110-103-002,PC,3110-103-002.103001038,2.0,1344543,UBRO,Ubrogepant,379.26,ng/mL,379.26,379.26,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:23:01,1.0,0.5 h,0.5,Period 1 Dose,2018-03-23T09:52:00
3110-103-002,PC,3110-103-002.103001038,3.0,1344546,UBRO,Ubrogepant,902.08,ng/mL,902.08,902.08,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:52:00,1.0,1 h,1.0,Period 1 Dose,2018-03-23T09:52:00
3110-103-002,PC,3110-103-002.103001038,4.0,1344549,UBRO,Ubrogepant,466.69,ng/mL,466.69,466.69,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:22:00,1.0,1.5 h,1.5,Period 1 Dose,2018-03-23T09:52:00
3110-103-002,PC,3110-103-002.103001038,5.0,1344553,UBRO,Ubrogepant,369.72,ng/mL,369.72,369.72,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:52:00,1.0,2 h,2.0,Period 1 Dose,2018-03-23T09:52:00
3110-103-002,PC,3110-103-002.103001038,6.0,1344554,UBRO,Ubrogepant,225.52,ng/mL,225.52,225.52,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T12:52:00,1.0,3 h,3.0,Period 1 Dose,2018-03-23T09:52:00
3110-103-002,PC,3110-103-002.103001038,7.0,1344555,UBRO,Ubrogepant,170.32,ng/mL,170.32,170.32,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T13:52:00,1.0,4 h,4.0,Period 1 Dose,2018-03-23T09:52:00
3110-103-002,PC,3110-103-002.103001038,8.0,1344560,UBRO,Ubrogepant,120.17,ng/mL,120.17,120.17,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T14:55:45,1.0,5 h,5.0,Period 1 Dose,2018-03-23T09:52:00
3110-103-002,PC,3110-103-002.103001038,9.0,1344561,UBRO,Ubrogepant,83.74,ng/mL,83.74,83.74,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T15:52:00,1.0,6 h,6.0,Period 1 Dose,2018-03-23T09:52:00
3110-103-002,PC,3110-103-002.103001038,10.0,1344562,UBRO,Ubrogepant,37.69,ng/mL,37.69,37.69,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T18:05:07,1.0,8 h,8.0,Period 1 Dose,2018-03-23T09:52:00
3110-103-002,PC,3110-103-002.103001038,11.0,1344565,UBRO,Ubrogepant,18.09,ng/mL,18.09,18.09,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T21:52:00,1.0,12 h,12.0,Period 1 Dose,2018-03-23T09:52:00
3110-103-002,PC,3110-103-002.103001038,12.0,1344568,UBRO,Ubrogepant,10.24,ng/mL,10.24,10.24,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T23:58:32,1.0,14 h,14.0,Period 1 Dose,2018-03-23T09:52:00
3110-103-002,PC,3110-103-002.103001038,13.0,1344574,UBRO,Ubrogepant,3.97,ng/mL,3.97,3.97,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-03-24T09:52:00,2.0,24 h,24.0,Period 1 Dose,2018-03-23T09:52:00
3110-103-002,PC,3110-103-002.103001038,14.0,1344599,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T09:22:00,8.0,Predose,0.0,Period 2 Dose,2018-03-30T09:52:00
3110-103-002,PC,3110-103-002.103001038,15.0,1344601,UBRO,Ubrogepant,290.88,ng/mL,290.88,290.88,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:25:10,8.0,0.5 h,0.5,Period 2 Dose,2018-03-30T09:52:00
3110-103-002,PC,3110-103-002.103001038,16.0,1344604,UBRO,Ubrogepant,426.74,ng/mL,426.74,426.74,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:52:00,8.0,1 h,1.0,Period 2 Dose,2018-03-30T09:52:00
3110-103-002,PC,3110-103-002.103001038,17.0,1344607,UBRO,Ubrogepant,368.45,ng/mL,368.45,368.45,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:23:46,8.0,1.5 h,1.5,Period 2 Dose,2018-03-30T09:52:00
3110-103-002,PC,3110-103-002.103001038,18.0,1344611,UBRO,Ubrogepant,299.81,ng/mL,299.81,299.81,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:52:00,8.0,2 h,2.0,Period 2 Dose,2018-03-30T09:52:00
3110-103-002,PC,3110-103-002.103001038,19.0,1344612,UBRO,Ubrogepant,197.92,ng/mL,197.92,197.92,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T12:52:00,8.0,3 h,3.0,Period 2 Dose,2018-03-30T09:52:00
3110-103-002,PC,3110-103-002.103001038,20.0,1344613,UBRO,Ubrogepant,157.80,ng/mL,157.80,157.8,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T13:52:00,8.0,4 h,4.0,Period 2 Dose,2018-03-30T09:52:00
3110-103-002,PC,3110-103-002.103001038,21.0,1344618,UBRO,Ubrogepant,118.42,ng/mL,118.42,118.42,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T14:53:00,8.0,5 h,5.0,Period 2 Dose,2018-03-30T09:52:00
3110-103-002,PC,3110-103-002.103001038,22.0,1344619,UBRO,Ubrogepant,83.80,ng/mL,83.80,83.8,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T15:52:00,8.0,6 h,6.0,Period 2 Dose,2018-03-30T09:52:00
3110-103-002,PC,3110-103-002.103001038,23.0,1344620,UBRO,Ubrogepant,45.81,ng/mL,45.81,45.81,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T17:52:00,8.0,8 h,8.0,Period 2 Dose,2018-03-30T09:52:00
3110-103-002,PC,3110-103-002.103001038,24.0,1344623,UBRO,Ubrogepant,18.92,ng/mL,18.92,18.92,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T21:52:00,8.0,12 h,12.0,Period 2 Dose,2018-03-30T09:52:00
3110-103-002,PC,3110-103-002.103001038,25.0,1344626,UBRO,Ubrogepant,12.41,ng/mL,12.41,12.41,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T23:52:00,8.0,14 h,14.0,Period 2 Dose,2018-03-30T09:52:00
3110-103-002,PC,3110-103-002.103001038,26.0,1344632,UBRO,Ubrogepant,4.84,ng/mL,4.84,4.84,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-03-31T09:53:46,9.0,24 h,24.0,Period 2 Dose,2018-03-30T09:52:00
3110-103-002,PC,3110-103-002.103001038,27.0,1344657,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T09:22:00,15.0,Predose,0.0,Period 3 Dose,2018-04-06T09:52:00
3110-103-002,PC,3110-103-002.103001038,28.0,1344659,UBRO,Ubrogepant,190.46,ng/mL,190.46,190.46,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:24:25,15.0,0.5 h,0.5,Period 3 Dose,2018-04-06T09:52:00
3110-103-002,PC,3110-103-002.103001038,29.0,1344662,UBRO,Ubrogepant,475.21,ng/mL,475.21,475.21,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:52:00,15.0,1 h,1.0,Period 3 Dose,2018-04-06T09:52:00
3110-103-002,PC,3110-103-002.103001038,30.0,1344665,UBRO,Ubrogepant,370.78,ng/mL,370.78,370.78,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:22:00,15.0,1.5 h,1.5,Period 3 Dose,2018-04-06T09:52:00
3110-103-002,PC,3110-103-002.103001038,31.0,1344669,UBRO,Ubrogepant,328.33,ng/mL,328.33,328.33,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:52:00,15.0,2 h,2.0,Period 3 Dose,2018-04-06T09:52:00
3110-103-002,PC,3110-103-002.103001038,32.0,1344670,UBRO,Ubrogepant,238.92,ng/mL,238.92,238.92,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T12:53:14,15.0,3 h,3.0,Period 3 Dose,2018-04-06T09:52:00
3110-103-002,PC,3110-103-002.103001038,33.0,1344671,UBRO,Ubrogepant,156.94,ng/mL,156.94,156.94,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T13:52:00,15.0,4 h,4.0,Period 3 Dose,2018-04-06T09:52:00
3110-103-002,PC,3110-103-002.103001038,34.0,1344676,UBRO,Ubrogepant,126.73,ng/mL,126.73,126.73,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T14:52:00,15.0,5 h,5.0,Period 3 Dose,2018-04-06T09:52:00
3110-103-002,PC,3110-103-002.103001038,35.0,1344677,UBRO,Ubrogepant,96.79,ng/mL,96.79,96.79,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T15:52:00,15.0,6 h,6.0,Period 3 Dose,2018-04-06T09:52:00
3110-103-002,PC,3110-103-002.103001038,36.0,1344678,UBRO,Ubrogepant,50.66,ng/mL,50.66,50.66,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T17:52:00,15.0,8 h,8.0,Period 3 Dose,2018-04-06T09:52:00
3110-103-002,PC,3110-103-002.103001038,37.0,1344681,UBRO,Ubrogepant,18.99,ng/mL,18.99,18.99,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T21:52:00,15.0,12 h,12.0,Period 3 Dose,2018-04-06T09:52:00
3110-103-002,PC,3110-103-002.103001038,38.0,1344684,UBRO,Ubrogepant,11.43,ng/mL,11.43,11.43,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T23:52:00,15.0,14 h,14.0,Period 3 Dose,2018-04-06T09:52:00
3110-103-002,PC,3110-103-002.103001038,39.0,1344690,UBRO,Ubrogepant,3.52,ng/mL,3.52,3.52,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,26.0,Period 3 Day 16,TREATMENT,2018-04-07T09:52:00,16.0,24 h,24.0,Period 3 Dose,2018-04-06T09:52:00
3110-103-002,PC,3110-103-002.103001044,1.0,1342786,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T09:30:00,1.0,Predose,0.0,Period 1 Dose,2018-03-23T10:00:00
3110-103-002,PC,3110-103-002.103001044,2.0,1342788,UBRO,Ubrogepant,176.03,ng/mL,176.03,176.03,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:30:00,1.0,0.5 h,0.5,Period 1 Dose,2018-03-23T10:00:00
3110-103-002,PC,3110-103-002.103001044,3.0,1342791,UBRO,Ubrogepant,393.44,ng/mL,393.44,393.44,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:00:00,1.0,1 h,1.0,Period 1 Dose,2018-03-23T10:00:00
3110-103-002,PC,3110-103-002.103001044,4.0,1342794,UBRO,Ubrogepant,254.04,ng/mL,254.04,254.04,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:30:00,1.0,1.5 h,1.5,Period 1 Dose,2018-03-23T10:00:00
3110-103-002,PC,3110-103-002.103001044,5.0,1342798,UBRO,Ubrogepant,210.07,ng/mL,210.07,210.07,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T12:00:00,1.0,2 h,2.0,Period 1 Dose,2018-03-23T10:00:00
3110-103-002,PC,3110-103-002.103001044,6.0,1342799,UBRO,Ubrogepant,128.27,ng/mL,128.27,128.27,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T13:00:00,1.0,3 h,3.0,Period 1 Dose,2018-03-23T10:00:00
3110-103-002,PC,3110-103-002.103001044,7.0,1342800,UBRO,Ubrogepant,93.54,ng/mL,93.54,93.54,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T14:00:00,1.0,4 h,4.0,Period 1 Dose,2018-03-23T10:00:00
3110-103-002,PC,3110-103-002.103001044,8.0,1342805,UBRO,Ubrogepant,68.60,ng/mL,68.60,68.6,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T15:00:00,1.0,5 h,5.0,Period 1 Dose,2018-03-23T10:00:00
3110-103-002,PC,3110-103-002.103001044,9.0,1342806,UBRO,Ubrogepant,47.83,ng/mL,47.83,47.83,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T16:00:00,1.0,6 h,6.0,Period 1 Dose,2018-03-23T10:00:00
3110-103-002,PC,3110-103-002.103001044,10.0,1342807,UBRO,Ubrogepant,38.28,ng/mL,38.28,38.28,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T18:00:00,1.0,8 h,8.0,Period 1 Dose,2018-03-23T10:00:00
3110-103-002,PC,3110-103-002.103001044,11.0,1342810,UBRO,Ubrogepant,14.60,ng/mL,14.60,14.6,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T22:00:00,1.0,12 h,12.0,Period 1 Dose,2018-03-23T10:00:00
3110-103-002,PC,3110-103-002.103001044,12.0,1342813,UBRO,Ubrogepant,10.67,ng/mL,10.67,10.67,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-24T00:00:00,2.0,14 h,14.0,Period 1 Dose,2018-03-23T10:00:00
3110-103-002,PC,3110-103-002.103001044,13.0,1342819,UBRO,Ubrogepant,6.61,ng/mL,6.61,6.61,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-03-24T10:00:00,2.0,24 h,24.0,Period 1 Dose,2018-03-23T10:00:00
3110-103-002,PC,3110-103-002.103001044,14.0,1342844,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T09:30:00,8.0,Predose,0.0,Period 2 Dose,2018-03-30T10:00:00
3110-103-002,PC,3110-103-002.103001044,15.0,1342846,UBRO,Ubrogepant,73.24,ng/mL,73.24,73.24,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:30:00,8.0,0.5 h,0.5,Period 2 Dose,2018-03-30T10:00:00
3110-103-002,PC,3110-103-002.103001044,16.0,1342849,UBRO,Ubrogepant,262.07,ng/mL,262.07,262.07,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:00:00,8.0,1 h,1.0,Period 2 Dose,2018-03-30T10:00:00
3110-103-002,PC,3110-103-002.103001044,17.0,1342852,UBRO,Ubrogepant,407.23,ng/mL,407.23,407.23,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:30:00,8.0,1.5 h,1.5,Period 2 Dose,2018-03-30T10:00:00
3110-103-002,PC,3110-103-002.103001044,18.0,1342856,UBRO,Ubrogepant,381.70,ng/mL,381.70,381.7,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T12:00:00,8.0,2 h,2.0,Period 2 Dose,2018-03-30T10:00:00
3110-103-002,PC,3110-103-002.103001044,19.0,1342857,UBRO,Ubrogepant,200.52,ng/mL,200.52,200.52,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T13:00:00,8.0,3 h,3.0,Period 2 Dose,2018-03-30T10:00:00
3110-103-002,PC,3110-103-002.103001044,20.0,1342858,UBRO,Ubrogepant,136.02,ng/mL,136.02,136.02,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T14:00:00,8.0,4 h,4.0,Period 2 Dose,2018-03-30T10:00:00
3110-103-002,PC,3110-103-002.103001044,21.0,1342863,UBRO,Ubrogepant,116.89,ng/mL,116.89,116.89,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T15:00:00,8.0,5 h,5.0,Period 2 Dose,2018-03-30T10:00:00
3110-103-002,PC,3110-103-002.103001044,22.0,1342864,UBRO,Ubrogepant,89.75,ng/mL,89.75,89.75,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T16:00:00,8.0,6 h,6.0,Period 2 Dose,2018-03-30T10:00:00
3110-103-002,PC,3110-103-002.103001044,23.0,1342865,UBRO,Ubrogepant,51.80,ng/mL,51.80,51.8,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T18:00:00,8.0,8 h,8.0,Period 2 Dose,2018-03-30T10:00:00
3110-103-002,PC,3110-103-002.103001044,24.0,1342868,UBRO,Ubrogepant,21.64,ng/mL,21.64,21.64,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T22:00:00,8.0,12 h,12.0,Period 2 Dose,2018-03-30T10:00:00
3110-103-002,PC,3110-103-002.103001044,25.0,1342871,UBRO,Ubrogepant,14.05,ng/mL,14.05,14.05,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-31T00:00:00,9.0,14 h,14.0,Period 2 Dose,2018-03-30T10:00:00
3110-103-002,PC,3110-103-002.103001044,26.0,1342877,UBRO,Ubrogepant,4.28,ng/mL,4.28,4.28,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-03-31T10:00:00,9.0,24 h,24.0,Period 2 Dose,2018-03-30T10:00:00
3110-103-002,PC,3110-103-002.103001044,27.0,1342902,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T09:30:00,15.0,Predose,0.0,Period 3 Dose,2018-04-06T10:00:00
3110-103-002,PC,3110-103-002.103001044,28.0,1342904,UBRO,Ubrogepant,187.58,ng/mL,187.58,187.58,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:30:00,15.0,0.5 h,0.5,Period 3 Dose,2018-04-06T10:00:00
3110-103-002,PC,3110-103-002.103001044,29.0,1342907,UBRO,Ubrogepant,378.95,ng/mL,378.95,378.95,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:00:00,15.0,1 h,1.0,Period 3 Dose,2018-04-06T10:00:00
3110-103-002,PC,3110-103-002.103001044,30.0,1342910,UBRO,Ubrogepant,316.52,ng/mL,316.52,316.52,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:30:00,15.0,1.5 h,1.5,Period 3 Dose,2018-04-06T10:00:00
3110-103-002,PC,3110-103-002.103001044,31.0,1342914,UBRO,Ubrogepant,273.67,ng/mL,273.67,273.67,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T12:00:00,15.0,2 h,2.0,Period 3 Dose,2018-04-06T10:00:00
3110-103-002,PC,3110-103-002.103001044,32.0,1342915,UBRO,Ubrogepant,164.26,ng/mL,164.26,164.26,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T13:00:00,15.0,3 h,3.0,Period 3 Dose,2018-04-06T10:00:00
3110-103-002,PC,3110-103-002.103001044,33.0,1342916,UBRO,Ubrogepant,119.44,ng/mL,119.44,119.44,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T14:00:00,15.0,4 h,4.0,Period 3 Dose,2018-04-06T10:00:00
3110-103-002,PC,3110-103-002.103001044,34.0,1342921,UBRO,Ubrogepant,89.79,ng/mL,89.79,89.79,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T15:00:00,15.0,5 h,5.0,Period 3 Dose,2018-04-06T10:00:00
3110-103-002,PC,3110-103-002.103001044,35.0,1342922,UBRO,Ubrogepant,56.26,ng/mL,56.26,56.26,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T16:00:00,15.0,6 h,6.0,Period 3 Dose,2018-04-06T10:00:00
3110-103-002,PC,3110-103-002.103001044,36.0,1342923,UBRO,Ubrogepant,41.77,ng/mL,41.77,41.77,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T18:00:00,15.0,8 h,8.0,Period 3 Dose,2018-04-06T10:00:00
3110-103-002,PC,3110-103-002.103001044,37.0,1342926,UBRO,Ubrogepant,18.88,ng/mL,18.88,18.88,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T22:00:00,15.0,12 h,12.0,Period 3 Dose,2018-04-06T10:00:00
3110-103-002,PC,3110-103-002.103001044,38.0,1342929,UBRO,Ubrogepant,13.48,ng/mL,13.48,13.48,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-07T00:00:00,16.0,14 h,14.0,Period 3 Dose,2018-04-06T10:00:00
3110-103-002,PC,3110-103-002.103001044,39.0,1342935,UBRO,Ubrogepant,4.87,ng/mL,4.87,4.87,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,26.0,Period 3 Day 16,TREATMENT,2018-04-07T10:00:00,16.0,24 h,24.0,Period 3 Dose,2018-04-06T10:00:00
3110-103-002,PC,3110-103-002.103001048,1.0,1339471,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T09:05:00,1.0,Predose,0.0,Period 1 Dose,2018-03-23T09:35:00
3110-103-002,PC,3110-103-002.103001048,2.0,1339473,UBRO,Ubrogepant,88.18,ng/mL,88.18,88.18,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:05:00,1.0,0.5 h,0.5,Period 1 Dose,2018-03-23T09:35:00
3110-103-002,PC,3110-103-002.103001048,3.0,1339476,UBRO,Ubrogepant,322.68,ng/mL,322.68,322.68,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:35:00,1.0,1 h,1.0,Period 1 Dose,2018-03-23T09:35:00
3110-103-002,PC,3110-103-002.103001048,4.0,1339479,UBRO,Ubrogepant,283.35,ng/mL,283.35,283.35,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:05:00,1.0,1.5 h,1.5,Period 1 Dose,2018-03-23T09:35:00
3110-103-002,PC,3110-103-002.103001048,5.0,1339483,UBRO,Ubrogepant,186.18,ng/mL,186.18,186.18,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:35:00,1.0,2 h,2.0,Period 1 Dose,2018-03-23T09:35:00
3110-103-002,PC,3110-103-002.103001048,6.0,1339484,UBRO,Ubrogepant,111.15,ng/mL,111.15,111.15,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T12:35:00,1.0,3 h,3.0,Period 1 Dose,2018-03-23T09:35:00
3110-103-002,PC,3110-103-002.103001048,7.0,1339485,UBRO,Ubrogepant,94.66,ng/mL,94.66,94.66,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T13:35:00,1.0,4 h,4.0,Period 1 Dose,2018-03-23T09:35:00
3110-103-002,PC,3110-103-002.103001048,8.0,1339490,UBRO,Ubrogepant,61.80,ng/mL,61.80,61.8,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T14:35:00,1.0,5 h,5.0,Period 1 Dose,2018-03-23T09:35:00
3110-103-002,PC,3110-103-002.103001048,9.0,1339491,UBRO,Ubrogepant,38.23,ng/mL,38.23,38.23,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T15:35:00,1.0,6 h,6.0,Period 1 Dose,2018-03-23T09:35:00
3110-103-002,PC,3110-103-002.103001048,10.0,1339492,UBRO,Ubrogepant,28.47,ng/mL,28.47,28.47,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T17:35:00,1.0,8 h,8.0,Period 1 Dose,2018-03-23T09:35:00
3110-103-002,PC,3110-103-002.103001048,11.0,1339495,UBRO,Ubrogepant,10.15,ng/mL,10.15,10.15,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T21:35:00,1.0,12 h,12.0,Period 1 Dose,2018-03-23T09:35:00
3110-103-002,PC,3110-103-002.103001048,12.0,1339498,UBRO,Ubrogepant,6.03,ng/mL,6.03,6.03,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T23:35:00,1.0,14 h,14.0,Period 1 Dose,2018-03-23T09:35:00
3110-103-002,PC,3110-103-002.103001048,13.0,1339504,UBRO,Ubrogepant,1.25,ng/mL,1.25,1.25,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-03-24T09:35:00,2.0,24 h,24.0,Period 1 Dose,2018-03-23T09:35:00
3110-103-002,PC,3110-103-002.103001048,14.0,1339529,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T09:05:00,8.0,Predose,0.0,Period 2 Dose,2018-03-30T09:35:00
3110-103-002,PC,3110-103-002.103001048,15.0,1339531,UBRO,Ubrogepant,123.60,ng/mL,123.60,123.6,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:05:00,8.0,0.5 h,0.5,Period 2 Dose,2018-03-30T09:35:00
3110-103-002,PC,3110-103-002.103001048,16.0,1339534,UBRO,Ubrogepant,324.69,ng/mL,324.69,324.69,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:35:00,8.0,1 h,1.0,Period 2 Dose,2018-03-30T09:35:00
3110-103-002,PC,3110-103-002.103001048,17.0,1339537,UBRO,Ubrogepant,283.05,ng/mL,283.05,283.05,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:05:00,8.0,1.5 h,1.5,Period 2 Dose,2018-03-30T09:35:00
3110-103-002,PC,3110-103-002.103001048,18.0,1339541,UBRO,Ubrogepant,269.91,ng/mL,269.91,269.91,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:35:00,8.0,2 h,2.0,Period 2 Dose,2018-03-30T09:35:00
3110-103-002,PC,3110-103-002.103001048,19.0,1339542,UBRO,Ubrogepant,146.38,ng/mL,146.38,146.38,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T12:35:00,8.0,3 h,3.0,Period 2 Dose,2018-03-30T09:35:00
3110-103-002,PC,3110-103-002.103001048,20.0,1339543,UBRO,Ubrogepant,97.36,ng/mL,97.36,97.36,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T13:35:00,8.0,4 h,4.0,Period 2 Dose,2018-03-30T09:35:00
3110-103-002,PC,3110-103-002.103001048,21.0,1339548,UBRO,Ubrogepant,71.96,ng/mL,71.96,71.96,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T14:35:00,8.0,5 h,5.0,Period 2 Dose,2018-03-30T09:35:00
3110-103-002,PC,3110-103-002.103001048,22.0,1339549,UBRO,Ubrogepant,54.86,ng/mL,54.86,54.86,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T15:35:00,8.0,6 h,6.0,Period 2 Dose,2018-03-30T09:35:00
3110-103-002,PC,3110-103-002.103001048,23.0,1339550,UBRO,Ubrogepant,30.64,ng/mL,30.64,30.64,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T17:35:00,8.0,8 h,8.0,Period 2 Dose,2018-03-30T09:35:00
3110-103-002,PC,3110-103-002.103001048,24.0,1339553,UBRO,Ubrogepant,12.54,ng/mL,12.54,12.54,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T21:35:00,8.0,12 h,12.0,Period 2 Dose,2018-03-30T09:35:00
3110-103-002,PC,3110-103-002.103001048,25.0,1339556,UBRO,Ubrogepant,7.49,ng/mL,7.49,7.49,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T23:35:00,8.0,14 h,14.0,Period 2 Dose,2018-03-30T09:35:00
3110-103-002,PC,3110-103-002.103001048,26.0,1339562,UBRO,Ubrogepant,1.09,ng/mL,1.09,1.09,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-03-31T09:36:07,9.0,24 h,24.0,Period 2 Dose,2018-03-30T09:35:00
3110-103-002,PC,3110-103-002.103001048,27.0,1339587,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T09:05:00,15.0,Predose,0.0,Period 3 Dose,2018-04-06T09:35:00
3110-103-002,PC,3110-103-002.103001048,28.0,1339589,UBRO,Ubrogepant,114.85,ng/mL,114.85,114.85,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:05:00,15.0,0.5 h,0.5,Period 3 Dose,2018-04-06T09:35:00
3110-103-002,PC,3110-103-002.103001048,29.0,1339592,UBRO,Ubrogepant,314.69,ng/mL,314.69,314.69,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:35:00,15.0,1 h,1.0,Period 3 Dose,2018-04-06T09:35:00
3110-103-002,PC,3110-103-002.103001048,30.0,1339595,UBRO,Ubrogepant,255.35,ng/mL,255.35,255.35,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:05:00,15.0,1.5 h,1.5,Period 3 Dose,2018-04-06T09:35:00
3110-103-002,PC,3110-103-002.103001048,31.0,1339599,UBRO,Ubrogepant,184.71,ng/mL,184.71,184.71,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:35:00,15.0,2 h,2.0,Period 3 Dose,2018-04-06T09:35:00
3110-103-002,PC,3110-103-002.103001048,32.0,1339600,UBRO,Ubrogepant,109.16,ng/mL,109.16,109.16,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T12:35:00,15.0,3 h,3.0,Period 3 Dose,2018-04-06T09:35:00
3110-103-002,PC,3110-103-002.103001048,33.0,1339601,UBRO,Ubrogepant,91.55,ng/mL,91.55,91.55,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T13:35:00,15.0,4 h,4.0,Period 3 Dose,2018-04-06T09:35:00
3110-103-002,PC,3110-103-002.103001048,34.0,1339606,UBRO,Ubrogepant,57.77,ng/mL,57.77,57.77,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T14:35:00,15.0,5 h,5.0,Period 3 Dose,2018-04-06T09:35:00
3110-103-002,PC,3110-103-002.103001048,35.0,1339607,UBRO,Ubrogepant,49.26,ng/mL,49.26,49.26,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T15:35:00,15.0,6 h,6.0,Period 3 Dose,2018-04-06T09:35:00
3110-103-002,PC,3110-103-002.103001048,36.0,1339608,UBRO,Ubrogepant,28.22,ng/mL,28.22,28.22,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T17:35:00,15.0,8 h,8.0,Period 3 Dose,2018-04-06T09:35:00
3110-103-002,PC,3110-103-002.103001048,37.0,1339611,UBRO,Ubrogepant,9.40,ng/mL,9.40,9.4,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T21:35:00,15.0,12 h,12.0,Period 3 Dose,2018-04-06T09:35:00
3110-103-002,PC,3110-103-002.103001048,38.0,1339614,UBRO,Ubrogepant,5.79,ng/mL,5.79,5.79,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T23:35:00,15.0,14 h,14.0,Period 3 Dose,2018-04-06T09:35:00
3110-103-002,PC,3110-103-002.103001048,39.0,1339620,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,26.0,Period 3 Day 16,TREATMENT,2018-04-07T09:35:00,16.0,24 h,24.0,Period 3 Dose,2018-04-06T09:35:00
3110-103-002,PC,3110-103-002.103001052,1.0,1339666,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T09:06:00,1.0,Predose,0.0,Period 1 Dose,2018-03-23T09:36:00
3110-103-002,PC,3110-103-002.103001052,2.0,1339668,UBRO,Ubrogepant,122.72,ng/mL,122.72,122.72,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:06:00,1.0,0.5 h,0.5,Period 1 Dose,2018-03-23T09:36:00
3110-103-002,PC,3110-103-002.103001052,3.0,1339671,UBRO,Ubrogepant,275.25,ng/mL,275.25,275.25,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:36:00,1.0,1 h,1.0,Period 1 Dose,2018-03-23T09:36:00
3110-103-002,PC,3110-103-002.103001052,4.0,1339674,UBRO,Ubrogepant,174.20,ng/mL,174.20,174.2,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:06:00,1.0,1.5 h,1.5,Period 1 Dose,2018-03-23T09:36:00
3110-103-002,PC,3110-103-002.103001052,5.0,1339678,UBRO,Ubrogepant,143.93,ng/mL,143.93,143.93,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:36:00,1.0,2 h,2.0,Period 1 Dose,2018-03-23T09:36:00
3110-103-002,PC,3110-103-002.103001052,6.0,1339679,UBRO,Ubrogepant,124.62,ng/mL,124.62,124.62,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T12:36:00,1.0,3 h,3.0,Period 1 Dose,2018-03-23T09:36:00
3110-103-002,PC,3110-103-002.103001052,7.0,1339680,UBRO,Ubrogepant,104.64,ng/mL,104.64,104.64,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T13:36:00,1.0,4 h,4.0,Period 1 Dose,2018-03-23T09:36:00
3110-103-002,PC,3110-103-002.103001052,8.0,1339685,UBRO,Ubrogepant,83.35,ng/mL,83.35,83.35,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T14:36:00,1.0,5 h,5.0,Period 1 Dose,2018-03-23T09:36:00
3110-103-002,PC,3110-103-002.103001052,9.0,1339686,UBRO,Ubrogepant,61.51,ng/mL,61.51,61.51,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T15:36:00,1.0,6 h,6.0,Period 1 Dose,2018-03-23T09:36:00
3110-103-002,PC,3110-103-002.103001052,10.0,1339687,UBRO,Ubrogepant,35.24,ng/mL,35.24,35.24,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T17:36:00,1.0,8 h,8.0,Period 1 Dose,2018-03-23T09:36:00
3110-103-002,PC,3110-103-002.103001052,11.0,1339690,UBRO,Ubrogepant,16.03,ng/mL,16.03,16.03,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T21:36:00,1.0,12 h,12.0,Period 1 Dose,2018-03-23T09:36:00
3110-103-002,PC,3110-103-002.103001052,12.0,1339693,UBRO,Ubrogepant,8.97,ng/mL,8.97,8.97,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T23:36:00,1.0,14 h,14.0,Period 1 Dose,2018-03-23T09:36:00
3110-103-002,PC,3110-103-002.103001052,13.0,1339699,UBRO,Ubrogepant,2.29,ng/mL,2.29,2.29,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-03-24T09:36:00,2.0,24 h,24.0,Period 1 Dose,2018-03-23T09:36:00
3110-103-002,PC,3110-103-002.103001052,14.0,1339724,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T09:06:00,8.0,Predose,0.0,Period 2 Dose,2018-03-30T09:36:00
3110-103-002,PC,3110-103-002.103001052,15.0,1339726,UBRO,Ubrogepant,185.25,ng/mL,185.25,185.25,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:06:00,8.0,0.5 h,0.5,Period 2 Dose,2018-03-30T09:36:00
3110-103-002,PC,3110-103-002.103001052,16.0,1339729,UBRO,Ubrogepant,320.27,ng/mL,320.27,320.27,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:36:00,8.0,1 h,1.0,Period 2 Dose,2018-03-30T09:36:00
3110-103-002,PC,3110-103-002.103001052,17.0,1339732,UBRO,Ubrogepant,246.84,ng/mL,246.84,246.84,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:06:00,8.0,1.5 h,1.5,Period 2 Dose,2018-03-30T09:36:00
3110-103-002,PC,3110-103-002.103001052,18.0,1339736,UBRO,Ubrogepant,249.62,ng/mL,249.62,249.62,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:36:00,8.0,2 h,2.0,Period 2 Dose,2018-03-30T09:36:00
3110-103-002,PC,3110-103-002.103001052,19.0,1339737,UBRO,Ubrogepant,169.09,ng/mL,169.09,169.09,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T12:36:00,8.0,3 h,3.0,Period 2 Dose,2018-03-30T09:36:00
3110-103-002,PC,3110-103-002.103001052,20.0,1339738,UBRO,Ubrogepant,126.20,ng/mL,126.20,126.2,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T13:36:00,8.0,4 h,4.0,Period 2 Dose,2018-03-30T09:36:00
3110-103-002,PC,3110-103-002.103001052,21.0,1339743,UBRO,Ubrogepant,110.84,ng/mL,110.84,110.84,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T14:36:00,8.0,5 h,5.0,Period 2 Dose,2018-03-30T09:36:00
3110-103-002,PC,3110-103-002.103001052,22.0,1339744,UBRO,Ubrogepant,83.52,ng/mL,83.52,83.52,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T15:36:00,8.0,6 h,6.0,Period 2 Dose,2018-03-30T09:36:00
3110-103-002,PC,3110-103-002.103001052,23.0,1339745,UBRO,Ubrogepant,54.40,ng/mL,54.40,54.4,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T17:36:00,8.0,8 h,8.0,Period 2 Dose,2018-03-30T09:36:00
3110-103-002,PC,3110-103-002.103001052,24.0,1339748,UBRO,Ubrogepant,17.81,ng/mL,17.81,17.81,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T21:36:00,8.0,12 h,12.0,Period 2 Dose,2018-03-30T09:36:00
3110-103-002,PC,3110-103-002.103001052,25.0,1339751,UBRO,Ubrogepant,11.25,ng/mL,11.25,11.25,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T23:36:00,8.0,14 h,14.0,Period 2 Dose,2018-03-30T09:36:00
3110-103-002,PC,3110-103-002.103001052,26.0,1339757,UBRO,Ubrogepant,3.68,ng/mL,3.68,3.68,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-03-31T09:36:00,9.0,24 h,24.0,Period 2 Dose,2018-03-30T09:36:00
3110-103-002,PC,3110-103-002.103001052,27.0,1339782,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T09:06:00,15.0,Predose,0.0,Period 3 Dose,2018-04-06T09:36:00
3110-103-002,PC,3110-103-002.103001052,28.0,1339784,UBRO,Ubrogepant,155.25,ng/mL,155.25,155.25,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:06:00,15.0,0.5 h,0.5,Period 3 Dose,2018-04-06T09:36:00
3110-103-002,PC,3110-103-002.103001052,29.0,1339787,UBRO,Ubrogepant,317.72,ng/mL,317.72,317.72,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:36:00,15.0,1 h,1.0,Period 3 Dose,2018-04-06T09:36:00
3110-103-002,PC,3110-103-002.103001052,30.0,1339790,UBRO,Ubrogepant,241.77,ng/mL,241.77,241.77,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:06:00,15.0,1.5 h,1.5,Period 3 Dose,2018-04-06T09:36:00
3110-103-002,PC,3110-103-002.103001052,31.0,1339794,UBRO,Ubrogepant,197.68,ng/mL,197.68,197.68,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:36:00,15.0,2 h,2.0,Period 3 Dose,2018-04-06T09:36:00
3110-103-002,PC,3110-103-002.103001052,32.0,1339795,UBRO,Ubrogepant,236.79,ng/mL,236.79,236.79,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T12:36:00,15.0,3 h,3.0,Period 3 Dose,2018-04-06T09:36:00
3110-103-002,PC,3110-103-002.103001052,33.0,1339796,UBRO,Ubrogepant,158.13,ng/mL,158.13,158.13,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T13:36:00,15.0,4 h,4.0,Period 3 Dose,2018-04-06T09:36:00
3110-103-002,PC,3110-103-002.103001052,34.0,1339801,UBRO,Ubrogepant,144.32,ng/mL,144.32,144.32,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T14:36:00,15.0,5 h,5.0,Period 3 Dose,2018-04-06T09:36:00
3110-103-002,PC,3110-103-002.103001052,35.0,1339802,UBRO,Ubrogepant,100.12,ng/mL,100.12,100.12,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T15:36:00,15.0,6 h,6.0,Period 3 Dose,2018-04-06T09:36:00
3110-103-002,PC,3110-103-002.103001052,36.0,1339803,UBRO,Ubrogepant,60.20,ng/mL,60.20,60.2,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T17:36:00,15.0,8 h,8.0,Period 3 Dose,2018-04-06T09:36:00
3110-103-002,PC,3110-103-002.103001052,37.0,1339806,UBRO,Ubrogepant,22.06,ng/mL,22.06,22.06,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T21:36:00,15.0,12 h,12.0,Period 3 Dose,2018-04-06T09:36:00
3110-103-002,PC,3110-103-002.103001052,38.0,1339809,UBRO,Ubrogepant,14.08,ng/mL,14.08,14.08,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T23:36:00,15.0,14 h,14.0,Period 3 Dose,2018-04-06T09:36:00
3110-103-002,PC,3110-103-002.103001052,39.0,1339815,UBRO,Ubrogepant,3.64,ng/mL,3.64,3.64,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,26.0,Period 3 Day 16,TREATMENT,2018-04-07T09:36:00,16.0,24 h,24.0,Period 3 Dose,2018-04-06T09:36:00
3110-103-002,PC,3110-103-002.103001054,1.0,1339861,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T09:07:00,1.0,Predose,0.0,Period 1 Dose,2018-03-23T09:37:00
3110-103-002,PC,3110-103-002.103001054,2.0,1339863,UBRO,Ubrogepant,55.16,ng/mL,55.16,55.16,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:07:00,1.0,0.5 h,0.5,Period 1 Dose,2018-03-23T09:37:00
3110-103-002,PC,3110-103-002.103001054,3.0,1339866,UBRO,Ubrogepant,174.31,ng/mL,174.31,174.31,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:37:00,1.0,1 h,1.0,Period 1 Dose,2018-03-23T09:37:00
3110-103-002,PC,3110-103-002.103001054,4.0,1339869,UBRO,Ubrogepant,218.53,ng/mL,218.53,218.53,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:07:00,1.0,1.5 h,1.5,Period 1 Dose,2018-03-23T09:37:00
3110-103-002,PC,3110-103-002.103001054,5.0,1339873,UBRO,Ubrogepant,351.18,ng/mL,351.18,351.18,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:37:00,1.0,2 h,2.0,Period 1 Dose,2018-03-23T09:37:00
3110-103-002,PC,3110-103-002.103001054,6.0,1339874,UBRO,Ubrogepant,165.35,ng/mL,165.35,165.35,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T12:37:00,1.0,3 h,3.0,Period 1 Dose,2018-03-23T09:37:00
3110-103-002,PC,3110-103-002.103001054,7.0,1339875,UBRO,Ubrogepant,120.52,ng/mL,120.52,120.52,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T13:37:00,1.0,4 h,4.0,Period 1 Dose,2018-03-23T09:37:00
3110-103-002,PC,3110-103-002.103001054,8.0,1339880,UBRO,Ubrogepant,79.92,ng/mL,79.92,79.92,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T14:37:00,1.0,5 h,5.0,Period 1 Dose,2018-03-23T09:37:00
3110-103-002,PC,3110-103-002.103001054,9.0,1339881,UBRO,Ubrogepant,60.69,ng/mL,60.69,60.69,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T15:37:00,1.0,6 h,6.0,Period 1 Dose,2018-03-23T09:37:00
3110-103-002,PC,3110-103-002.103001054,10.0,1339882,UBRO,Ubrogepant,31.79,ng/mL,31.79,31.79,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T17:37:00,1.0,8 h,8.0,Period 1 Dose,2018-03-23T09:37:00
3110-103-002,PC,3110-103-002.103001054,11.0,1339885,UBRO,Ubrogepant,10.15,ng/mL,10.15,10.15,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T21:37:00,1.0,12 h,12.0,Period 1 Dose,2018-03-23T09:37:00
3110-103-002,PC,3110-103-002.103001054,12.0,1339888,UBRO,Ubrogepant,7.58,ng/mL,7.58,7.58,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T23:37:00,1.0,14 h,14.0,Period 1 Dose,2018-03-23T09:37:00
3110-103-002,PC,3110-103-002.103001054,13.0,1339894,UBRO,Ubrogepant,1.96,ng/mL,1.96,1.96,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-03-24T09:37:00,2.0,24 h,24.0,Period 1 Dose,2018-03-23T09:37:00
3110-103-002,PC,3110-103-002.103001054,14.0,1339919,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T09:07:00,8.0,Predose,0.0,Period 2 Dose,2018-03-30T09:37:00
3110-103-002,PC,3110-103-002.103001054,15.0,1339921,UBRO,Ubrogepant,168.34,ng/mL,168.34,168.34,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:07:00,8.0,0.5 h,0.5,Period 2 Dose,2018-03-30T09:37:00
3110-103-002,PC,3110-103-002.103001054,16.0,1339924,UBRO,Ubrogepant,299.49,ng/mL,299.49,299.49,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:37:00,8.0,1 h,1.0,Period 2 Dose,2018-03-30T09:37:00
3110-103-002,PC,3110-103-002.103001054,17.0,1339927,UBRO,Ubrogepant,218.90,ng/mL,218.90,218.9,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:07:00,8.0,1.5 h,1.5,Period 2 Dose,2018-03-30T09:37:00
3110-103-002,PC,3110-103-002.103001054,18.0,1339931,UBRO,Ubrogepant,189.41,ng/mL,189.41,189.41,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:37:00,8.0,2 h,2.0,Period 2 Dose,2018-03-30T09:37:00
3110-103-002,PC,3110-103-002.103001054,19.0,1339932,UBRO,Ubrogepant,126.28,ng/mL,126.28,126.28,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T12:37:00,8.0,3 h,3.0,Period 2 Dose,2018-03-30T09:37:00
3110-103-002,PC,3110-103-002.103001054,20.0,1339933,UBRO,Ubrogepant,86.88,ng/mL,86.88,86.88,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T13:37:00,8.0,4 h,4.0,Period 2 Dose,2018-03-30T09:37:00
3110-103-002,PC,3110-103-002.103001054,21.0,1339938,UBRO,Ubrogepant,67.53,ng/mL,67.53,67.53,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T14:37:00,8.0,5 h,5.0,Period 2 Dose,2018-03-30T09:37:00
3110-103-002,PC,3110-103-002.103001054,22.0,1339939,UBRO,Ubrogepant,51.28,ng/mL,51.28,51.28,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T15:37:00,8.0,6 h,6.0,Period 2 Dose,2018-03-30T09:37:00
3110-103-002,PC,3110-103-002.103001054,23.0,1339940,UBRO,Ubrogepant,34.56,ng/mL,34.56,34.56,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T17:37:00,8.0,8 h,8.0,Period 2 Dose,2018-03-30T09:37:00
3110-103-002,PC,3110-103-002.103001054,24.0,1339943,UBRO,Ubrogepant,11.20,ng/mL,11.20,11.2,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T21:37:00,8.0,12 h,12.0,Period 2 Dose,2018-03-30T09:37:00
3110-103-002,PC,3110-103-002.103001054,25.0,1339946,UBRO,Ubrogepant,7.21,ng/mL,7.21,7.21,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T23:37:00,8.0,14 h,14.0,Period 2 Dose,2018-03-30T09:37:00
3110-103-002,PC,3110-103-002.103001054,26.0,1339952,UBRO,Ubrogepant,2.81,ng/mL,2.81,2.81,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-03-31T09:37:00,9.0,24 h,24.0,Period 2 Dose,2018-03-30T09:37:00
3110-103-002,PC,3110-103-002.103001054,27.0,1339977,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T09:07:00,15.0,Predose,0.0,Period 3 Dose,2018-04-06T09:37:00
3110-103-002,PC,3110-103-002.103001054,28.0,1339979,UBRO,Ubrogepant,136.44,ng/mL,136.44,136.44,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:07:00,15.0,0.5 h,0.5,Period 3 Dose,2018-04-06T09:37:00
3110-103-002,PC,3110-103-002.103001054,29.0,1339982,UBRO,Ubrogepant,199.41,ng/mL,199.41,199.41,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:37:00,15.0,1 h,1.0,Period 3 Dose,2018-04-06T09:37:00
3110-103-002,PC,3110-103-002.103001054,30.0,1339985,UBRO,Ubrogepant,212.49,ng/mL,212.49,212.49,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:07:00,15.0,1.5 h,1.5,Period 3 Dose,2018-04-06T09:37:00
3110-103-002,PC,3110-103-002.103001054,31.0,1339989,UBRO,Ubrogepant,171.63,ng/mL,171.63,171.63,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:37:00,15.0,2 h,2.0,Period 3 Dose,2018-04-06T09:37:00
3110-103-002,PC,3110-103-002.103001054,32.0,1339990,UBRO,Ubrogepant,118.58,ng/mL,118.58,118.58,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T12:37:00,15.0,3 h,3.0,Period 3 Dose,2018-04-06T09:37:00
3110-103-002,PC,3110-103-002.103001054,33.0,1339991,UBRO,Ubrogepant,82.62,ng/mL,82.62,82.62,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T13:37:00,15.0,4 h,4.0,Period 3 Dose,2018-04-06T09:37:00
3110-103-002,PC,3110-103-002.103001054,34.0,1339996,UBRO,Ubrogepant,64.12,ng/mL,64.12,64.12,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T14:37:00,15.0,5 h,5.0,Period 3 Dose,2018-04-06T09:37:00
3110-103-002,PC,3110-103-002.103001054,35.0,1339997,UBRO,Ubrogepant,58.79,ng/mL,58.79,58.79,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T15:37:00,15.0,6 h,6.0,Period 3 Dose,2018-04-06T09:37:00
3110-103-002,PC,3110-103-002.103001054,36.0,1339998,UBRO,Ubrogepant,35.31,ng/mL,35.31,35.31,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T17:37:00,15.0,8 h,8.0,Period 3 Dose,2018-04-06T09:37:00
3110-103-002,PC,3110-103-002.103001054,37.0,1340001,UBRO,Ubrogepant,11.65,ng/mL,11.65,11.65,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T21:37:00,15.0,12 h,12.0,Period 3 Dose,2018-04-06T09:37:00
3110-103-002,PC,3110-103-002.103001054,38.0,1340004,UBRO,Ubrogepant,7.42,ng/mL,7.42,7.42,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T23:37:00,15.0,14 h,14.0,Period 3 Dose,2018-04-06T09:37:00
3110-103-002,PC,3110-103-002.103001054,39.0,1340010,UBRO,Ubrogepant,1.97,ng/mL,1.97,1.97,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,26.0,Period 3 Day 16,TREATMENT,2018-04-07T09:37:00,16.0,24 h,24.0,Period 3 Dose,2018-04-06T09:37:00
3110-103-002,PC,3110-103-002.103001057,1.0,1345711,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T09:17:00,1.0,Predose,0.0,Period 1 Dose,2018-03-23T09:47:00
3110-103-002,PC,3110-103-002.103001057,2.0,1345713,UBRO,Ubrogepant,107.56,ng/mL,107.56,107.56,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,,nan,0.5 h,0.5,Period 1 Dose,2018-03-23T09:47:00
3110-103-002,PC,3110-103-002.103001057,3.0,1345716,UBRO,Ubrogepant,123.22,ng/mL,123.22,123.22,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:47:00,1.0,1 h,1.0,Period 1 Dose,2018-03-23T09:47:00
3110-103-002,PC,3110-103-002.103001057,4.0,1345719,UBRO,Ubrogepant,141.01,ng/mL,141.01,141.01,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:17:00,1.0,1.5 h,1.5,Period 1 Dose,2018-03-23T09:47:00
3110-103-002,PC,3110-103-002.103001057,5.0,1345723,UBRO,Ubrogepant,135.01,ng/mL,135.01,135.01,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:47:00,1.0,2 h,2.0,Period 1 Dose,2018-03-23T09:47:00
3110-103-002,PC,3110-103-002.103001057,6.0,1345724,UBRO,Ubrogepant,86.13,ng/mL,86.13,86.13,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T12:47:00,1.0,3 h,3.0,Period 1 Dose,2018-03-23T09:47:00
3110-103-002,PC,3110-103-002.103001057,7.0,1345725,UBRO,Ubrogepant,61.74,ng/mL,61.74,61.74,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T13:47:00,1.0,4 h,4.0,Period 1 Dose,2018-03-23T09:47:00
3110-103-002,PC,3110-103-002.103001057,8.0,1345730,UBRO,Ubrogepant,42.16,ng/mL,42.16,42.16,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T14:47:00,1.0,5 h,5.0,Period 1 Dose,2018-03-23T09:47:00
3110-103-002,PC,3110-103-002.103001057,9.0,1345731,UBRO,Ubrogepant,29.92,ng/mL,29.92,29.92,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T15:47:00,1.0,6 h,6.0,Period 1 Dose,2018-03-23T09:47:00
3110-103-002,PC,3110-103-002.103001057,10.0,1345732,UBRO,Ubrogepant,17.15,ng/mL,17.15,17.15,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T17:47:00,1.0,8 h,8.0,Period 1 Dose,2018-03-23T09:47:00
3110-103-002,PC,3110-103-002.103001057,11.0,1345735,UBRO,Ubrogepant,7.61,ng/mL,7.61,7.61,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T21:47:00,1.0,12 h,12.0,Period 1 Dose,2018-03-23T09:47:00
3110-103-002,PC,3110-103-002.103001057,12.0,1345738,UBRO,Ubrogepant,4.74,ng/mL,4.74,4.74,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T23:47:00,1.0,14 h,14.0,Period 1 Dose,2018-03-23T09:47:00
3110-103-002,PC,3110-103-002.103001057,13.0,1345744,UBRO,Ubrogepant,1.90,ng/mL,1.90,1.9,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-03-24T09:47:00,2.0,24 h,24.0,Period 1 Dose,2018-03-23T09:47:00
3110-103-002,PC,3110-103-002.103001057,14.0,1345769,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T09:17:00,8.0,Predose,0.0,Period 2 Dose,2018-03-30T09:47:00
3110-103-002,PC,3110-103-002.103001057,15.0,1345771,UBRO,Ubrogepant,69.91,ng/mL,69.91,69.91,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:17:00,8.0,0.5 h,0.5,Period 2 Dose,2018-03-30T09:47:00
3110-103-002,PC,3110-103-002.103001057,16.0,1345774,UBRO,Ubrogepant,143.43,ng/mL,143.43,143.43,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:47:44,8.0,1 h,1.0,Period 2 Dose,2018-03-30T09:47:00
3110-103-002,PC,3110-103-002.103001057,17.0,1345777,UBRO,Ubrogepant,93.69,ng/mL,93.69,93.69,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:17:00,8.0,1.5 h,1.5,Period 2 Dose,2018-03-30T09:47:00
3110-103-002,PC,3110-103-002.103001057,18.0,1345781,UBRO,Ubrogepant,97.27,ng/mL,97.27,97.27,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:47:00,8.0,2 h,2.0,Period 2 Dose,2018-03-30T09:47:00
3110-103-002,PC,3110-103-002.103001057,19.0,1345782,UBRO,Ubrogepant,81.22,ng/mL,81.22,81.22,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T12:47:00,8.0,3 h,3.0,Period 2 Dose,2018-03-30T09:47:00
3110-103-002,PC,3110-103-002.103001057,20.0,1345783,UBRO,Ubrogepant,66.59,ng/mL,66.59,66.59,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T13:47:00,8.0,4 h,4.0,Period 2 Dose,2018-03-30T09:47:00
3110-103-002,PC,3110-103-002.103001057,21.0,1345788,UBRO,Ubrogepant,47.84,ng/mL,47.84,47.84,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T14:47:00,8.0,5 h,5.0,Period 2 Dose,2018-03-30T09:47:00
3110-103-002,PC,3110-103-002.103001057,22.0,1345789,UBRO,Ubrogepant,34.99,ng/mL,34.99,34.99,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T15:47:00,8.0,6 h,6.0,Period 2 Dose,2018-03-30T09:47:00
3110-103-002,PC,3110-103-002.103001057,23.0,1345790,UBRO,Ubrogepant,18.63,ng/mL,18.63,18.63,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T17:47:00,8.0,8 h,8.0,Period 2 Dose,2018-03-30T09:47:00
3110-103-002,PC,3110-103-002.103001057,24.0,1345793,UBRO,Ubrogepant,7.28,ng/mL,7.28,7.28,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T21:47:00,8.0,12 h,12.0,Period 2 Dose,2018-03-30T09:47:00
3110-103-002,PC,3110-103-002.103001057,25.0,1345796,UBRO,Ubrogepant,4.14,ng/mL,4.14,4.14,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T23:47:00,8.0,14 h,14.0,Period 2 Dose,2018-03-30T09:47:00
3110-103-002,PC,3110-103-002.103001057,26.0,1345802,UBRO,Ubrogepant,1.48,ng/mL,1.48,1.48,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-03-31T09:47:00,9.0,24 h,24.0,Period 2 Dose,2018-03-30T09:47:00
3110-103-002,PC,3110-103-002.103001057,27.0,1345827,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T09:17:00,15.0,Predose,0.0,Period 3 Dose,2018-04-06T09:47:00
3110-103-002,PC,3110-103-002.103001057,28.0,1345829,UBRO,Ubrogepant,95.65,ng/mL,95.65,95.65,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:17:00,15.0,0.5 h,0.5,Period 3 Dose,2018-04-06T09:47:00
3110-103-002,PC,3110-103-002.103001057,29.0,1345832,UBRO,Ubrogepant,112.44,ng/mL,112.44,112.44,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:47:00,15.0,1 h,1.0,Period 3 Dose,2018-04-06T09:47:00
3110-103-002,PC,3110-103-002.103001057,30.0,1345835,UBRO,Ubrogepant,85.40,ng/mL,85.40,85.4,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:17:00,15.0,1.5 h,1.5,Period 3 Dose,2018-04-06T09:47:00
3110-103-002,PC,3110-103-002.103001057,31.0,1345839,UBRO,Ubrogepant,111.31,ng/mL,111.31,111.31,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:47:00,15.0,2 h,2.0,Period 3 Dose,2018-04-06T09:47:00
3110-103-002,PC,3110-103-002.103001057,32.0,1345840,UBRO,Ubrogepant,85.58,ng/mL,85.58,85.58,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T12:47:00,15.0,3 h,3.0,Period 3 Dose,2018-04-06T09:47:00
3110-103-002,PC,3110-103-002.103001057,33.0,1345841,UBRO,Ubrogepant,61.30,ng/mL,61.30,61.3,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T13:47:00,15.0,4 h,4.0,Period 3 Dose,2018-04-06T09:47:00
3110-103-002,PC,3110-103-002.103001057,34.0,1345846,UBRO,Ubrogepant,47.09,ng/mL,47.09,47.09,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T14:47:00,15.0,5 h,5.0,Period 3 Dose,2018-04-06T09:47:00
3110-103-002,PC,3110-103-002.103001057,35.0,1345847,UBRO,Ubrogepant,37.06,ng/mL,37.06,37.06,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T15:47:00,15.0,6 h,6.0,Period 3 Dose,2018-04-06T09:47:00
3110-103-002,PC,3110-103-002.103001057,36.0,1345848,UBRO,Ubrogepant,23.62,ng/mL,23.62,23.62,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T17:47:00,15.0,8 h,8.0,Period 3 Dose,2018-04-06T09:47:00
3110-103-002,PC,3110-103-002.103001057,37.0,1345851,UBRO,Ubrogepant,7.78,ng/mL,7.78,7.78,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T21:47:00,15.0,12 h,12.0,Period 3 Dose,2018-04-06T09:47:00
3110-103-002,PC,3110-103-002.103001057,38.0,1345854,UBRO,Ubrogepant,5.37,ng/mL,5.37,5.37,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T23:49:12,15.0,14 h,14.0,Period 3 Dose,2018-04-06T09:47:00
3110-103-002,PC,3110-103-002.103001057,39.0,1345860,UBRO,Ubrogepant,1.45,ng/mL,1.45,1.45,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,26.0,Period 3 Day 16,TREATMENT,2018-04-07T09:47:00,16.0,24 h,24.0,Period 3 Dose,2018-04-06T09:47:00
3110-103-002,PC,3110-103-002.103001058,1.0,1345906,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T09:14:14,1.0,Predose,0.0,Period 1 Dose,2018-03-23T09:43:00
3110-103-002,PC,3110-103-002.103001058,2.0,1345908,UBRO,Ubrogepant,94.23,ng/mL,94.23,94.23,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:14:01,1.0,0.5 h,0.5,Period 1 Dose,2018-03-23T09:43:00
3110-103-002,PC,3110-103-002.103001058,3.0,1345911,UBRO,Ubrogepant,194.43,ng/mL,194.43,194.43,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:44:12,1.0,1 h,1.0,Period 1 Dose,2018-03-23T09:43:00
3110-103-002,PC,3110-103-002.103001058,4.0,1345914,UBRO,Ubrogepant,195.46,ng/mL,195.46,195.46,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:13:00,1.0,1.5 h,1.5,Period 1 Dose,2018-03-23T09:43:00
3110-103-002,PC,3110-103-002.103001058,5.0,1345918,UBRO,Ubrogepant,262.30,ng/mL,262.30,262.3,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:44:13,1.0,2 h,2.0,Period 1 Dose,2018-03-23T09:43:00
3110-103-002,PC,3110-103-002.103001058,6.0,1345919,UBRO,Ubrogepant,147.94,ng/mL,147.94,147.94,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T12:43:00,1.0,3 h,3.0,Period 1 Dose,2018-03-23T09:43:00
3110-103-002,PC,3110-103-002.103001058,7.0,1345920,UBRO,Ubrogepant,104.47,ng/mL,104.47,104.47,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T13:43:00,1.0,4 h,4.0,Period 1 Dose,2018-03-23T09:43:00
3110-103-002,PC,3110-103-002.103001058,8.0,1345925,UBRO,Ubrogepant,72.44,ng/mL,72.44,72.44,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T14:43:00,1.0,5 h,5.0,Period 1 Dose,2018-03-23T09:43:00
3110-103-002,PC,3110-103-002.103001058,9.0,1345926,UBRO,Ubrogepant,58.23,ng/mL,58.23,58.23,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T15:43:00,1.0,6 h,6.0,Period 1 Dose,2018-03-23T09:43:00
3110-103-002,PC,3110-103-002.103001058,10.0,1345927,UBRO,Ubrogepant,37.10,ng/mL,37.10,37.1,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T17:43:00,1.0,8 h,8.0,Period 1 Dose,2018-03-23T09:43:00
3110-103-002,PC,3110-103-002.103001058,11.0,1345930,UBRO,Ubrogepant,14.57,ng/mL,14.57,14.57,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T21:43:00,1.0,12 h,12.0,Period 1 Dose,2018-03-23T09:43:00
3110-103-002,PC,3110-103-002.103001058,12.0,1345933,UBRO,Ubrogepant,7.89,ng/mL,7.89,7.89,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T23:43:00,1.0,14 h,14.0,Period 1 Dose,2018-03-23T09:43:00
3110-103-002,PC,3110-103-002.103001058,13.0,1345939,UBRO,Ubrogepant,2.57,ng/mL,2.57,2.57,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-03-24T09:43:00,2.0,24 h,24.0,Period 1 Dose,2018-03-23T09:43:00
3110-103-002,PC,3110-103-002.103001059,1.0,1340641,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T09:39:00,1.0,Predose,0.0,Period 1 Dose,2018-03-23T10:09:00
3110-103-002,PC,3110-103-002.103001059,2.0,1340643,UBRO,Ubrogepant,211.83,ng/mL,211.83,211.83,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:39:00,1.0,0.5 h,0.5,Period 1 Dose,2018-03-23T10:09:00
3110-103-002,PC,3110-103-002.103001059,3.0,1340646,UBRO,Ubrogepant,309.11,ng/mL,309.11,309.11,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:09:00,1.0,1 h,1.0,Period 1 Dose,2018-03-23T10:09:00
3110-103-002,PC,3110-103-002.103001059,4.0,1340649,UBRO,Ubrogepant,407.55,ng/mL,407.55,407.55,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:39:00,1.0,1.5 h,1.5,Period 1 Dose,2018-03-23T10:09:00
3110-103-002,PC,3110-103-002.103001059,5.0,1340653,UBRO,Ubrogepant,313.42,ng/mL,313.42,313.42,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T12:09:00,1.0,2 h,2.0,Period 1 Dose,2018-03-23T10:09:00
3110-103-002,PC,3110-103-002.103001059,6.0,1340654,UBRO,Ubrogepant,145.37,ng/mL,145.37,145.37,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T13:09:05,1.0,3 h,3.0,Period 1 Dose,2018-03-23T10:09:00
3110-103-002,PC,3110-103-002.103001059,7.0,1340655,UBRO,Ubrogepant,97.15,ng/mL,97.15,97.15,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T14:09:00,1.0,4 h,4.0,Period 1 Dose,2018-03-23T10:09:00
3110-103-002,PC,3110-103-002.103001059,8.0,1340660,UBRO,Ubrogepant,60.21,ng/mL,60.21,60.21,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T15:09:00,1.0,5 h,5.0,Period 1 Dose,2018-03-23T10:09:00
3110-103-002,PC,3110-103-002.103001059,9.0,1340661,UBRO,Ubrogepant,44.73,ng/mL,44.73,44.73,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T16:09:00,1.0,6 h,6.0,Period 1 Dose,2018-03-23T10:09:00
3110-103-002,PC,3110-103-002.103001059,10.0,1340662,UBRO,Ubrogepant,,,,nan,,NOT DONE,Subject was an early term,Altasciences Company Inc.,,nan,1.0,Period 1 Day 1,TREATMENT,,nan,8 h,8.0,Period 1 Dose,2018-03-23T10:09:00
3110-103-002,PC,3110-103-002.103001066,1.0,1344346,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T09:23:00,1.0,Predose,0.0,Period 1 Dose,2018-03-23T09:53:00
3110-103-002,PC,3110-103-002.103001066,2.0,1344348,UBRO,Ubrogepant,6.81,ng/mL,6.81,6.81,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:23:00,1.0,0.5 h,0.5,Period 1 Dose,2018-03-23T09:53:00
3110-103-002,PC,3110-103-002.103001066,3.0,1344351,UBRO,Ubrogepant,95.14,ng/mL,95.14,95.14,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:53:00,1.0,1 h,1.0,Period 1 Dose,2018-03-23T09:53:00
3110-103-002,PC,3110-103-002.103001066,4.0,1344354,UBRO,Ubrogepant,193.57,ng/mL,193.57,193.57,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:23:00,1.0,1.5 h,1.5,Period 1 Dose,2018-03-23T09:53:00
3110-103-002,PC,3110-103-002.103001066,5.0,1344358,UBRO,Ubrogepant,279.30,ng/mL,279.30,279.3,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:53:00,1.0,2 h,2.0,Period 1 Dose,2018-03-23T09:53:00
3110-103-002,PC,3110-103-002.103001066,6.0,1344359,UBRO,Ubrogepant,472.93,ng/mL,472.93,472.93,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T12:53:00,1.0,3 h,3.0,Period 1 Dose,2018-03-23T09:53:00
3110-103-002,PC,3110-103-002.103001066,7.0,1344360,UBRO,Ubrogepant,237.54,ng/mL,237.54,237.54,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T13:53:00,1.0,4 h,4.0,Period 1 Dose,2018-03-23T09:53:00
3110-103-002,PC,3110-103-002.103001066,8.0,1344365,UBRO,Ubrogepant,142.00,ng/mL,142.00,142.0,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T14:53:00,1.0,5 h,5.0,Period 1 Dose,2018-03-23T09:53:00
3110-103-002,PC,3110-103-002.103001066,9.0,1344366,UBRO,Ubrogepant,119.38,ng/mL,119.38,119.38,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T15:53:00,1.0,6 h,6.0,Period 1 Dose,2018-03-23T09:53:00
3110-103-002,PC,3110-103-002.103001066,10.0,1344367,UBRO,Ubrogepant,61.57,ng/mL,61.57,61.57,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T17:53:00,1.0,8 h,8.0,Period 1 Dose,2018-03-23T09:53:00
3110-103-002,PC,3110-103-002.103001066,11.0,1344370,UBRO,Ubrogepant,23.31,ng/mL,23.31,23.31,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T21:54:16,1.0,12 h,12.0,Period 1 Dose,2018-03-23T09:53:00
3110-103-002,PC,3110-103-002.103001066,12.0,1344373,UBRO,Ubrogepant,15.18,ng/mL,15.18,15.18,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T23:53:00,1.0,14 h,14.0,Period 1 Dose,2018-03-23T09:53:00
3110-103-002,PC,3110-103-002.103001066,13.0,1344379,UBRO,Ubrogepant,5.09,ng/mL,5.09,5.09,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-03-24T09:53:00,2.0,24 h,24.0,Period 1 Dose,2018-03-23T09:53:00
3110-103-002,PC,3110-103-002.103001066,14.0,1344404,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T09:23:00,8.0,Predose,0.0,Period 2 Dose,2018-03-30T09:53:00
3110-103-002,PC,3110-103-002.103001066,15.0,1344406,UBRO,Ubrogepant,41.20,ng/mL,41.20,41.2,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:23:00,8.0,0.5 h,0.5,Period 2 Dose,2018-03-30T09:53:00
3110-103-002,PC,3110-103-002.103001066,16.0,1344409,UBRO,Ubrogepant,233.87,ng/mL,233.87,233.87,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:53:00,8.0,1 h,1.0,Period 2 Dose,2018-03-30T09:53:00
3110-103-002,PC,3110-103-002.103001066,17.0,1344412,UBRO,Ubrogepant,411.96,ng/mL,411.96,411.96,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:23:00,8.0,1.5 h,1.5,Period 2 Dose,2018-03-30T09:53:00
3110-103-002,PC,3110-103-002.103001066,18.0,1344416,UBRO,Ubrogepant,358.94,ng/mL,358.94,358.94,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:53:00,8.0,2 h,2.0,Period 2 Dose,2018-03-30T09:53:00
3110-103-002,PC,3110-103-002.103001066,19.0,1344417,UBRO,Ubrogepant,219.73,ng/mL,219.73,219.73,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T12:53:00,8.0,3 h,3.0,Period 2 Dose,2018-03-30T09:53:00
3110-103-002,PC,3110-103-002.103001066,20.0,1344418,UBRO,Ubrogepant,144.48,ng/mL,144.48,144.48,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T13:53:00,8.0,4 h,4.0,Period 2 Dose,2018-03-30T09:53:00
3110-103-002,PC,3110-103-002.103001066,21.0,1344423,UBRO,Ubrogepant,114.22,ng/mL,114.22,114.22,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T14:53:00,8.0,5 h,5.0,Period 2 Dose,2018-03-30T09:53:00
3110-103-002,PC,3110-103-002.103001066,22.0,1344424,UBRO,Ubrogepant,98.30,ng/mL,98.30,98.3,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T15:54:52,8.0,6 h,6.0,Period 2 Dose,2018-03-30T09:53:00
3110-103-002,PC,3110-103-002.103001066,23.0,1344425,UBRO,Ubrogepant,48.09,ng/mL,48.09,48.09,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T17:53:00,8.0,8 h,8.0,Period 2 Dose,2018-03-30T09:53:00
3110-103-002,PC,3110-103-002.103001066,24.0,1344428,UBRO,Ubrogepant,19.37,ng/mL,19.37,19.37,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T21:53:00,8.0,12 h,12.0,Period 2 Dose,2018-03-30T09:53:00
3110-103-002,PC,3110-103-002.103001066,25.0,1344431,UBRO,Ubrogepant,14.54,ng/mL,14.54,14.54,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T23:53:00,8.0,14 h,14.0,Period 2 Dose,2018-03-30T09:53:00
3110-103-002,PC,3110-103-002.103001066,26.0,1344437,UBRO,Ubrogepant,6.20,ng/mL,6.20,6.2,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-03-31T09:56:21,9.0,24 h,24.0,Period 2 Dose,2018-03-30T09:53:00
3110-103-002,PC,3110-103-002.103001066,27.0,1344462,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T09:23:00,15.0,Predose,0.0,Period 3 Dose,2018-04-06T09:53:00
3110-103-002,PC,3110-103-002.103001066,28.0,1344464,UBRO,Ubrogepant,4.53,ng/mL,4.53,4.53,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:23:00,15.0,0.5 h,0.5,Period 3 Dose,2018-04-06T09:53:00
3110-103-002,PC,3110-103-002.103001066,29.0,1344467,UBRO,Ubrogepant,140.41,ng/mL,140.41,140.41,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:53:00,15.0,1 h,1.0,Period 3 Dose,2018-04-06T09:53:00
3110-103-002,PC,3110-103-002.103001066,30.0,1344470,UBRO,Ubrogepant,183.35,ng/mL,183.35,183.35,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:23:00,15.0,1.5 h,1.5,Period 3 Dose,2018-04-06T09:53:00
3110-103-002,PC,3110-103-002.103001066,31.0,1344474,UBRO,Ubrogepant,241.08,ng/mL,241.08,241.08,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:53:00,15.0,2 h,2.0,Period 3 Dose,2018-04-06T09:53:00
3110-103-002,PC,3110-103-002.103001066,32.0,1344475,UBRO,Ubrogepant,205.89,ng/mL,205.89,205.89,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T12:53:00,15.0,3 h,3.0,Period 3 Dose,2018-04-06T09:53:00
3110-103-002,PC,3110-103-002.103001066,33.0,1344476,UBRO,Ubrogepant,141.02,ng/mL,141.02,141.02,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T13:53:00,15.0,4 h,4.0,Period 3 Dose,2018-04-06T09:53:00
3110-103-002,PC,3110-103-002.103001066,34.0,1344481,UBRO,Ubrogepant,95.30,ng/mL,95.30,95.3,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T14:53:00,15.0,5 h,5.0,Period 3 Dose,2018-04-06T09:53:00
3110-103-002,PC,3110-103-002.103001066,35.0,1344482,UBRO,Ubrogepant,75.84,ng/mL,75.84,75.84,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T15:53:00,15.0,6 h,6.0,Period 3 Dose,2018-04-06T09:53:00
3110-103-002,PC,3110-103-002.103001066,36.0,1344483,UBRO,Ubrogepant,41.71,ng/mL,41.71,41.71,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T17:53:00,15.0,8 h,8.0,Period 3 Dose,2018-04-06T09:53:00
3110-103-002,PC,3110-103-002.103001066,37.0,1344486,UBRO,Ubrogepant,18.43,ng/mL,18.43,18.43,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T21:53:00,15.0,12 h,12.0,Period 3 Dose,2018-04-06T09:53:00
3110-103-002,PC,3110-103-002.103001066,38.0,1344489,UBRO,Ubrogepant,10.88,ng/mL,10.88,10.88,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T23:53:00,15.0,14 h,14.0,Period 3 Dose,2018-04-06T09:53:00
3110-103-002,PC,3110-103-002.103001066,39.0,1344495,UBRO,Ubrogepant,4.19,ng/mL,4.19,4.19,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,26.0,Period 3 Day 16,TREATMENT,2018-04-07T09:53:00,16.0,24 h,24.0,Period 3 Dose,2018-04-06T09:53:00
3110-103-002,PC,3110-103-002.103001067,1.0,1344151,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T09:24:00,1.0,Predose,0.0,Period 1 Dose,2018-03-23T09:54:00
3110-103-002,PC,3110-103-002.103001067,2.0,1344153,UBRO,Ubrogepant,101.38,ng/mL,101.38,101.38,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:24:00,1.0,0.5 h,0.5,Period 1 Dose,2018-03-23T09:54:00
3110-103-002,PC,3110-103-002.103001067,3.0,1344156,UBRO,Ubrogepant,610.07,ng/mL,610.07,610.07,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:54:00,1.0,1 h,1.0,Period 1 Dose,2018-03-23T09:54:00
3110-103-002,PC,3110-103-002.103001067,4.0,1344159,UBRO,Ubrogepant,467.39,ng/mL,467.39,467.39,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:24:00,1.0,1.5 h,1.5,Period 1 Dose,2018-03-23T09:54:00
3110-103-002,PC,3110-103-002.103001067,5.0,1344163,UBRO,Ubrogepant,373.27,ng/mL,373.27,373.27,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:54:00,1.0,2 h,2.0,Period 1 Dose,2018-03-23T09:54:00
3110-103-002,PC,3110-103-002.103001067,6.0,1344164,UBRO,Ubrogepant,261.28,ng/mL,261.28,261.28,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T12:54:00,1.0,3 h,3.0,Period 1 Dose,2018-03-23T09:54:00
3110-103-002,PC,3110-103-002.103001067,7.0,1344165,UBRO,Ubrogepant,223.22,ng/mL,223.22,223.22,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T13:54:00,1.0,4 h,4.0,Period 1 Dose,2018-03-23T09:54:00
3110-103-002,PC,3110-103-002.103001067,8.0,1344170,UBRO,Ubrogepant,186.32,ng/mL,186.32,186.32,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T14:54:00,1.0,5 h,5.0,Period 1 Dose,2018-03-23T09:54:00
3110-103-002,PC,3110-103-002.103001067,9.0,1344171,UBRO,Ubrogepant,121.92,ng/mL,121.92,121.92,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T15:54:00,1.0,6 h,6.0,Period 1 Dose,2018-03-23T09:54:00
3110-103-002,PC,3110-103-002.103001067,10.0,1344172,UBRO,Ubrogepant,79.76,ng/mL,79.76,79.76,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T17:54:00,1.0,8 h,8.0,Period 1 Dose,2018-03-23T09:54:00
3110-103-002,PC,3110-103-002.103001067,11.0,1344175,UBRO,Ubrogepant,26.44,ng/mL,26.44,26.44,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T21:54:00,1.0,12 h,12.0,Period 1 Dose,2018-03-23T09:54:00
3110-103-002,PC,3110-103-002.103001067,12.0,1344178,UBRO,Ubrogepant,15.23,ng/mL,15.23,15.23,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T23:54:00,1.0,14 h,14.0,Period 1 Dose,2018-03-23T09:54:00
3110-103-002,PC,3110-103-002.103001067,13.0,1344184,UBRO,Ubrogepant,3.46,ng/mL,3.46,3.46,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-03-24T09:54:00,2.0,24 h,24.0,Period 1 Dose,2018-03-23T09:54:00
3110-103-002,PC,3110-103-002.103001067,14.0,1344209,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T09:24:00,8.0,Predose,0.0,Period 2 Dose,2018-03-30T09:54:00
3110-103-002,PC,3110-103-002.103001067,15.0,1344211,UBRO,Ubrogepant,138.21,ng/mL,138.21,138.21,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:24:00,8.0,0.5 h,0.5,Period 2 Dose,2018-03-30T09:54:00
3110-103-002,PC,3110-103-002.103001067,16.0,1344214,UBRO,Ubrogepant,450.25,ng/mL,450.25,450.25,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:54:00,8.0,1 h,1.0,Period 2 Dose,2018-03-30T09:54:00
3110-103-002,PC,3110-103-002.103001067,17.0,1344217,UBRO,Ubrogepant,422.35,ng/mL,422.35,422.35,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:24:00,8.0,1.5 h,1.5,Period 2 Dose,2018-03-30T09:54:00
3110-103-002,PC,3110-103-002.103001067,18.0,1344221,UBRO,Ubrogepant,333.35,ng/mL,333.35,333.35,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:54:00,8.0,2 h,2.0,Period 2 Dose,2018-03-30T09:54:00
3110-103-002,PC,3110-103-002.103001067,19.0,1344222,UBRO,Ubrogepant,235.05,ng/mL,235.05,235.05,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T12:54:00,8.0,3 h,3.0,Period 2 Dose,2018-03-30T09:54:00
3110-103-002,PC,3110-103-002.103001067,20.0,1344223,UBRO,Ubrogepant,196.79,ng/mL,196.79,196.79,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T13:54:00,8.0,4 h,4.0,Period 2 Dose,2018-03-30T09:54:00
3110-103-002,PC,3110-103-002.103001067,21.0,1344228,UBRO,Ubrogepant,134.97,ng/mL,134.97,134.97,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T14:54:00,8.0,5 h,5.0,Period 2 Dose,2018-03-30T09:54:00
3110-103-002,PC,3110-103-002.103001067,22.0,1344229,UBRO,Ubrogepant,108.34,ng/mL,108.34,108.34,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T15:54:00,8.0,6 h,6.0,Period 2 Dose,2018-03-30T09:54:00
3110-103-002,PC,3110-103-002.103001067,23.0,1344230,UBRO,Ubrogepant,59.70,ng/mL,59.70,59.7,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T17:54:00,8.0,8 h,8.0,Period 2 Dose,2018-03-30T09:54:00
3110-103-002,PC,3110-103-002.103001067,24.0,1344233,UBRO,Ubrogepant,20.87,ng/mL,20.87,20.87,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T21:54:00,8.0,12 h,12.0,Period 2 Dose,2018-03-30T09:54:00
3110-103-002,PC,3110-103-002.103001067,25.0,1344236,UBRO,Ubrogepant,10.39,ng/mL,10.39,10.39,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T23:54:00,8.0,14 h,14.0,Period 2 Dose,2018-03-30T09:54:00
3110-103-002,PC,3110-103-002.103001067,26.0,1344242,UBRO,Ubrogepant,2.57,ng/mL,2.57,2.57,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-03-31T09:54:00,9.0,24 h,24.0,Period 2 Dose,2018-03-30T09:54:00
3110-103-002,PC,3110-103-002.103001067,27.0,1344267,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T09:24:00,15.0,Predose,0.0,Period 3 Dose,2018-04-06T09:54:00
3110-103-002,PC,3110-103-002.103001067,28.0,1344269,UBRO,Ubrogepant,154.14,ng/mL,154.14,154.14,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:24:00,15.0,0.5 h,0.5,Period 3 Dose,2018-04-06T09:54:00
3110-103-002,PC,3110-103-002.103001067,29.0,1344272,UBRO,Ubrogepant,371.60,ng/mL,371.60,371.6,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:54:00,15.0,1 h,1.0,Period 3 Dose,2018-04-06T09:54:00
3110-103-002,PC,3110-103-002.103001067,30.0,1344275,UBRO,Ubrogepant,287.71,ng/mL,287.71,287.71,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:24:00,15.0,1.5 h,1.5,Period 3 Dose,2018-04-06T09:54:00
3110-103-002,PC,3110-103-002.103001067,31.0,1344279,UBRO,Ubrogepant,241.31,ng/mL,241.31,241.31,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:54:00,15.0,2 h,2.0,Period 3 Dose,2018-04-06T09:54:00
3110-103-002,PC,3110-103-002.103001067,32.0,1344280,UBRO,Ubrogepant,181.10,ng/mL,181.10,181.1,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T12:54:00,15.0,3 h,3.0,Period 3 Dose,2018-04-06T09:54:00
3110-103-002,PC,3110-103-002.103001067,33.0,1344281,UBRO,Ubrogepant,153.54,ng/mL,153.54,153.54,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T13:54:00,15.0,4 h,4.0,Period 3 Dose,2018-04-06T09:54:00
3110-103-002,PC,3110-103-002.103001067,34.0,1344286,UBRO,Ubrogepant,105.88,ng/mL,105.88,105.88,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T14:54:00,15.0,5 h,5.0,Period 3 Dose,2018-04-06T09:54:00
3110-103-002,PC,3110-103-002.103001067,35.0,1344287,UBRO,Ubrogepant,76.22,ng/mL,76.22,76.22,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T15:54:00,15.0,6 h,6.0,Period 3 Dose,2018-04-06T09:54:00
3110-103-002,PC,3110-103-002.103001067,36.0,1344288,UBRO,Ubrogepant,50.89,ng/mL,50.89,50.89,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T17:54:00,15.0,8 h,8.0,Period 3 Dose,2018-04-06T09:54:00
3110-103-002,PC,3110-103-002.103001067,37.0,1344291,UBRO,Ubrogepant,18.15,ng/mL,18.15,18.15,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T21:54:00,15.0,12 h,12.0,Period 3 Dose,2018-04-06T09:54:00
3110-103-002,PC,3110-103-002.103001067,38.0,1344294,UBRO,Ubrogepant,11.44,ng/mL,11.44,11.44,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T23:54:00,15.0,14 h,14.0,Period 3 Dose,2018-04-06T09:54:00
3110-103-002,PC,3110-103-002.103001067,39.0,1344300,UBRO,Ubrogepant,2.65,ng/mL,2.65,2.65,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,26.0,Period 3 Day 16,TREATMENT,2018-04-07T09:54:00,16.0,24 h,24.0,Period 3 Dose,2018-04-06T09:54:00
3110-103-002,PC,3110-103-002.103001074,1.0,1346794,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T09:42:00,1.0,Predose,0.0,Period 1 Dose,2018-03-23T10:12:00
3110-103-002,PC,3110-103-002.103001074,2.0,1346796,UBRO,Ubrogepant,111.16,ng/mL,111.16,111.16,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:42:00,1.0,0.5 h,0.5,Period 1 Dose,2018-03-23T10:12:00
3110-103-002,PC,3110-103-002.103001074,3.0,1346799,UBRO,Ubrogepant,342.36,ng/mL,342.36,342.36,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:12:00,1.0,1 h,1.0,Period 1 Dose,2018-03-23T10:12:00
3110-103-002,PC,3110-103-002.103001074,4.0,1346802,UBRO,Ubrogepant,265.08,ng/mL,265.08,265.08,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:42:00,1.0,1.5 h,1.5,Period 1 Dose,2018-03-23T10:12:00
3110-103-002,PC,3110-103-002.103001074,5.0,1346806,UBRO,Ubrogepant,232.33,ng/mL,232.33,232.33,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T12:12:00,1.0,2 h,2.0,Period 1 Dose,2018-03-23T10:12:00
3110-103-002,PC,3110-103-002.103001074,6.0,1346807,UBRO,Ubrogepant,149.72,ng/mL,149.72,149.72,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T13:12:00,1.0,3 h,3.0,Period 1 Dose,2018-03-23T10:12:00
3110-103-002,PC,3110-103-002.103001074,7.0,1346808,UBRO,Ubrogepant,118.67,ng/mL,118.67,118.67,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T14:14:40,1.0,4 h,4.0,Period 1 Dose,2018-03-23T10:12:00
3110-103-002,PC,3110-103-002.103001074,8.0,1346813,UBRO,Ubrogepant,88.83,ng/mL,88.83,88.83,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T15:12:00,1.0,5 h,5.0,Period 1 Dose,2018-03-23T10:12:00
3110-103-002,PC,3110-103-002.103001074,9.0,1346814,UBRO,Ubrogepant,64.86,ng/mL,64.86,64.86,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T16:12:00,1.0,6 h,6.0,Period 1 Dose,2018-03-23T10:12:00
3110-103-002,PC,3110-103-002.103001074,10.0,1346815,UBRO,Ubrogepant,32.11,ng/mL,32.11,32.11,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T18:12:00,1.0,8 h,8.0,Period 1 Dose,2018-03-23T10:12:00
3110-103-002,PC,3110-103-002.103001074,11.0,1346818,UBRO,Ubrogepant,12.94,ng/mL,12.94,12.94,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T22:12:00,1.0,12 h,12.0,Period 1 Dose,2018-03-23T10:12:00
3110-103-002,PC,3110-103-002.103001074,12.0,1346821,UBRO,Ubrogepant,8.52,ng/mL,8.52,8.52,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-24T00:12:00,2.0,14 h,14.0,Period 1 Dose,2018-03-23T10:12:00
3110-103-002,PC,3110-103-002.103001074,13.0,1346827,UBRO,Ubrogepant,1.62,ng/mL,1.62,1.62,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-03-24T10:12:00,2.0,24 h,24.0,Period 1 Dose,2018-03-23T10:12:00
3110-103-002,PC,3110-103-002.103001074,14.0,1346852,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T09:42:00,8.0,Predose,0.0,Period 2 Dose,2018-03-30T10:12:00
3110-103-002,PC,3110-103-002.103001074,15.0,1346854,UBRO,Ubrogepant,101.90,ng/mL,101.90,101.9,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:42:00,8.0,0.5 h,0.5,Period 2 Dose,2018-03-30T10:12:00
3110-103-002,PC,3110-103-002.103001074,16.0,1346857,UBRO,Ubrogepant,265.61,ng/mL,265.61,265.61,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:12:00,8.0,1 h,1.0,Period 2 Dose,2018-03-30T10:12:00
3110-103-002,PC,3110-103-002.103001074,17.0,1346860,UBRO,Ubrogepant,221.26,ng/mL,221.26,221.26,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:42:00,8.0,1.5 h,1.5,Period 2 Dose,2018-03-30T10:12:00
3110-103-002,PC,3110-103-002.103001074,18.0,1346864,UBRO,Ubrogepant,251.46,ng/mL,251.46,251.46,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T12:12:00,8.0,2 h,2.0,Period 2 Dose,2018-03-30T10:12:00
3110-103-002,PC,3110-103-002.103001074,19.0,1346865,UBRO,Ubrogepant,205.29,ng/mL,205.29,205.29,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T13:12:00,8.0,3 h,3.0,Period 2 Dose,2018-03-30T10:12:00
3110-103-002,PC,3110-103-002.103001074,20.0,1346866,UBRO,Ubrogepant,185.27,ng/mL,185.27,185.27,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T14:12:00,8.0,4 h,4.0,Period 2 Dose,2018-03-30T10:12:00
3110-103-002,PC,3110-103-002.103001074,21.0,1346871,UBRO,Ubrogepant,138.43,ng/mL,138.43,138.43,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T15:12:00,8.0,5 h,5.0,Period 2 Dose,2018-03-30T10:12:00
3110-103-002,PC,3110-103-002.103001074,22.0,1346872,UBRO,Ubrogepant,104.76,ng/mL,104.76,104.76,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T16:12:00,8.0,6 h,6.0,Period 2 Dose,2018-03-30T10:12:00
3110-103-002,PC,3110-103-002.103001074,23.0,1346873,UBRO,Ubrogepant,76.58,ng/mL,76.58,76.58,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T18:14:46,8.0,8 h,8.0,Period 2 Dose,2018-03-30T10:12:00
3110-103-002,PC,3110-103-002.103001074,24.0,1346876,UBRO,Ubrogepant,28.71,ng/mL,28.71,28.71,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T22:12:00,8.0,12 h,12.0,Period 2 Dose,2018-03-30T10:12:00
3110-103-002,PC,3110-103-002.103001074,25.0,1346879,UBRO,Ubrogepant,19.22,ng/mL,19.22,19.22,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-31T00:12:00,9.0,14 h,14.0,Period 2 Dose,2018-03-30T10:12:00
3110-103-002,PC,3110-103-002.103001074,26.0,1346885,UBRO,Ubrogepant,3.11,ng/mL,3.11,3.11,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-03-31T10:12:00,9.0,24 h,24.0,Period 2 Dose,2018-03-30T10:12:00
3110-103-002,PC,3110-103-002.103001074,27.0,1346910,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T09:42:00,15.0,Predose,0.0,Period 3 Dose,2018-04-06T10:12:00
3110-103-002,PC,3110-103-002.103001074,28.0,1346912,UBRO,Ubrogepant,65.08,ng/mL,65.08,65.08,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:42:00,15.0,0.5 h,0.5,Period 3 Dose,2018-04-06T10:12:00
3110-103-002,PC,3110-103-002.103001074,29.0,1346915,UBRO,Ubrogepant,349.21,ng/mL,349.21,349.21,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:12:00,15.0,1 h,1.0,Period 3 Dose,2018-04-06T10:12:00
3110-103-002,PC,3110-103-002.103001074,30.0,1346918,UBRO,Ubrogepant,268.15,ng/mL,268.15,268.15,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:42:00,15.0,1.5 h,1.5,Period 3 Dose,2018-04-06T10:12:00
3110-103-002,PC,3110-103-002.103001074,31.0,1346922,UBRO,Ubrogepant,268.87,ng/mL,268.87,268.87,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T12:12:00,15.0,2 h,2.0,Period 3 Dose,2018-04-06T10:12:00
3110-103-002,PC,3110-103-002.103001074,32.0,1346923,UBRO,Ubrogepant,213.03,ng/mL,213.03,213.03,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T13:12:00,15.0,3 h,3.0,Period 3 Dose,2018-04-06T10:12:00
3110-103-002,PC,3110-103-002.103001074,33.0,1346924,UBRO,Ubrogepant,181.73,ng/mL,181.73,181.73,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T14:12:00,15.0,4 h,4.0,Period 3 Dose,2018-04-06T10:12:00
3110-103-002,PC,3110-103-002.103001074,34.0,1346929,UBRO,Ubrogepant,125.94,ng/mL,125.94,125.94,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T15:12:00,15.0,5 h,5.0,Period 3 Dose,2018-04-06T10:12:00
3110-103-002,PC,3110-103-002.103001074,35.0,1346930,UBRO,Ubrogepant,100.86,ng/mL,100.86,100.86,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T16:12:00,15.0,6 h,6.0,Period 3 Dose,2018-04-06T10:12:00
3110-103-002,PC,3110-103-002.103001074,36.0,1346931,UBRO,Ubrogepant,56.33,ng/mL,56.33,56.33,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T18:12:00,15.0,8 h,8.0,Period 3 Dose,2018-04-06T10:12:00
3110-103-002,PC,3110-103-002.103001074,37.0,1346934,UBRO,Ubrogepant,19.80,ng/mL,19.80,19.8,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T22:12:00,15.0,12 h,12.0,Period 3 Dose,2018-04-06T10:12:00
3110-103-002,PC,3110-103-002.103001074,38.0,1346937,UBRO,Ubrogepant,13.50,ng/mL,13.50,13.5,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-07T00:12:00,16.0,14 h,14.0,Period 3 Dose,2018-04-06T10:12:00
3110-103-002,PC,3110-103-002.103001074,39.0,1346943,UBRO,Ubrogepant,2.87,ng/mL,2.87,2.87,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,26.0,Period 3 Day 16,TREATMENT,2018-04-07T10:12:00,16.0,24 h,24.0,Period 3 Dose,2018-04-06T10:12:00
3110-103-002,PC,3110-103-002.103001079,1.0,1343956,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T09:25:00,1.0,Predose,0.0,Period 1 Dose,2018-03-23T09:55:00
3110-103-002,PC,3110-103-002.103001079,2.0,1343958,UBRO,Ubrogepant,61.11,ng/mL,61.11,61.11,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:25:00,1.0,0.5 h,0.5,Period 1 Dose,2018-03-23T09:55:00
3110-103-002,PC,3110-103-002.103001079,3.0,1343961,UBRO,Ubrogepant,153.72,ng/mL,153.72,153.72,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:55:00,1.0,1 h,1.0,Period 1 Dose,2018-03-23T09:55:00
3110-103-002,PC,3110-103-002.103001079,4.0,1343964,UBRO,Ubrogepant,184.25,ng/mL,184.25,184.25,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:25:00,1.0,1.5 h,1.5,Period 1 Dose,2018-03-23T09:55:00
3110-103-002,PC,3110-103-002.103001079,5.0,1343968,UBRO,Ubrogepant,321.19,ng/mL,321.19,321.19,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:55:00,1.0,2 h,2.0,Period 1 Dose,2018-03-23T09:55:00
3110-103-002,PC,3110-103-002.103001079,6.0,1343969,UBRO,Ubrogepant,213.46,ng/mL,213.46,213.46,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T12:55:00,1.0,3 h,3.0,Period 1 Dose,2018-03-23T09:55:00
3110-103-002,PC,3110-103-002.103001079,7.0,1343970,UBRO,Ubrogepant,189.92,ng/mL,189.92,189.92,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T13:55:00,1.0,4 h,4.0,Period 1 Dose,2018-03-23T09:55:00
3110-103-002,PC,3110-103-002.103001079,8.0,1343975,UBRO,Ubrogepant,151.93,ng/mL,151.93,151.93,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T14:55:00,1.0,5 h,5.0,Period 1 Dose,2018-03-23T09:55:00
3110-103-002,PC,3110-103-002.103001079,9.0,1343976,UBRO,Ubrogepant,107.71,ng/mL,107.71,107.71,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T15:55:00,1.0,6 h,6.0,Period 1 Dose,2018-03-23T09:55:00
3110-103-002,PC,3110-103-002.103001079,10.0,1343977,UBRO,Ubrogepant,51.66,ng/mL,51.66,51.66,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T17:55:00,1.0,8 h,8.0,Period 1 Dose,2018-03-23T09:55:00
3110-103-002,PC,3110-103-002.103001079,11.0,1343980,UBRO,Ubrogepant,20.96,ng/mL,20.96,20.96,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T21:55:00,1.0,12 h,12.0,Period 1 Dose,2018-03-23T09:55:00
3110-103-002,PC,3110-103-002.103001079,12.0,1343983,UBRO,Ubrogepant,13.74,ng/mL,13.74,13.74,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T23:57:10,1.0,14 h,14.0,Period 1 Dose,2018-03-23T09:55:00
3110-103-002,PC,3110-103-002.103001079,13.0,1343989,UBRO,Ubrogepant,4.37,ng/mL,4.37,4.37,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-03-24T09:55:00,2.0,24 h,24.0,Period 1 Dose,2018-03-23T09:55:00
3110-103-002,PC,3110-103-002.103001079,14.0,1344014,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T09:25:00,8.0,Predose,0.0,Period 2 Dose,2018-03-30T09:55:58
3110-103-002,PC,3110-103-002.103001079,15.0,1344016,UBRO,Ubrogepant,105.69,ng/mL,105.69,105.69,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:25:00,8.0,0.5 h,0.5,Period 2 Dose,2018-03-30T09:55:58
3110-103-002,PC,3110-103-002.103001079,16.0,1344019,UBRO,Ubrogepant,220.78,ng/mL,220.78,220.78,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:55:00,8.0,1 h,1.0,Period 2 Dose,2018-03-30T09:55:58
3110-103-002,PC,3110-103-002.103001079,17.0,1344022,UBRO,Ubrogepant,341.70,ng/mL,341.70,341.7,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:25:00,8.0,1.5 h,1.5,Period 2 Dose,2018-03-30T09:55:58
3110-103-002,PC,3110-103-002.103001079,18.0,1344026,UBRO,Ubrogepant,354.40,ng/mL,354.40,354.4,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:55:00,8.0,2 h,2.0,Period 2 Dose,2018-03-30T09:55:58
3110-103-002,PC,3110-103-002.103001079,19.0,1344027,UBRO,Ubrogepant,211.57,ng/mL,211.57,211.57,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T12:55:00,8.0,3 h,3.0,Period 2 Dose,2018-03-30T09:55:58
3110-103-002,PC,3110-103-002.103001079,20.0,1344028,UBRO,Ubrogepant,154.64,ng/mL,154.64,154.64,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T13:55:00,8.0,4 h,4.0,Period 2 Dose,2018-03-30T09:55:58
3110-103-002,PC,3110-103-002.103001079,21.0,1344033,UBRO,Ubrogepant,129.92,ng/mL,129.92,129.92,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T14:55:00,8.0,5 h,5.0,Period 2 Dose,2018-03-30T09:55:58
3110-103-002,PC,3110-103-002.103001079,22.0,1344034,UBRO,Ubrogepant,84.47,ng/mL,84.47,84.47,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T15:55:00,8.0,6 h,6.0,Period 2 Dose,2018-03-30T09:55:58
3110-103-002,PC,3110-103-002.103001079,23.0,1344035,UBRO,Ubrogepant,50.03,ng/mL,50.03,50.03,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T17:55:00,8.0,8 h,8.0,Period 2 Dose,2018-03-30T09:55:58
3110-103-002,PC,3110-103-002.103001079,24.0,1344038,UBRO,Ubrogepant,20.87,ng/mL,20.87,20.87,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T21:55:00,8.0,12 h,12.0,Period 2 Dose,2018-03-30T09:55:58
3110-103-002,PC,3110-103-002.103001079,25.0,1344041,UBRO,Ubrogepant,15.52,ng/mL,15.52,15.52,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T23:55:00,8.0,14 h,14.0,Period 2 Dose,2018-03-30T09:55:58
3110-103-002,PC,3110-103-002.103001079,26.0,1344047,UBRO,Ubrogepant,4.68,ng/mL,4.68,4.68,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-03-31T09:55:00,9.0,24 h,24.0,Period 2 Dose,2018-03-30T09:55:58
3110-103-002,PC,3110-103-002.103001079,27.0,1344072,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T09:25:00,15.0,Predose,0.0,Period 3 Dose,2018-04-06T09:55:00
3110-103-002,PC,3110-103-002.103001079,28.0,1344074,UBRO,Ubrogepant,149.98,ng/mL,149.98,149.98,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:25:00,15.0,0.5 h,0.5,Period 3 Dose,2018-04-06T09:55:00
3110-103-002,PC,3110-103-002.103001079,29.0,1344077,UBRO,Ubrogepant,450.54,ng/mL,450.54,450.54,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:55:00,15.0,1 h,1.0,Period 3 Dose,2018-04-06T09:55:00
3110-103-002,PC,3110-103-002.103001079,30.0,1344080,UBRO,Ubrogepant,306.42,ng/mL,306.42,306.42,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:25:00,15.0,1.5 h,1.5,Period 3 Dose,2018-04-06T09:55:00
3110-103-002,PC,3110-103-002.103001079,31.0,1344084,UBRO,Ubrogepant,443.24,ng/mL,443.24,443.24,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:55:00,15.0,2 h,2.0,Period 3 Dose,2018-04-06T09:55:00
3110-103-002,PC,3110-103-002.103001079,32.0,1344085,UBRO,Ubrogepant,253.81,ng/mL,253.81,253.81,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T12:55:00,15.0,3 h,3.0,Period 3 Dose,2018-04-06T09:55:00
3110-103-002,PC,3110-103-002.103001079,33.0,1344086,UBRO,Ubrogepant,196.88,ng/mL,196.88,196.88,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T13:55:00,15.0,4 h,4.0,Period 3 Dose,2018-04-06T09:55:00
3110-103-002,PC,3110-103-002.103001079,34.0,1344091,UBRO,Ubrogepant,160.73,ng/mL,160.73,160.73,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T14:55:00,15.0,5 h,5.0,Period 3 Dose,2018-04-06T09:55:00
3110-103-002,PC,3110-103-002.103001079,35.0,1344092,UBRO,Ubrogepant,110.51,ng/mL,110.51,110.51,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T15:55:00,15.0,6 h,6.0,Period 3 Dose,2018-04-06T09:55:00
3110-103-002,PC,3110-103-002.103001079,36.0,1344093,UBRO,Ubrogepant,81.15,ng/mL,81.15,81.15,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T17:55:00,15.0,8 h,8.0,Period 3 Dose,2018-04-06T09:55:00
3110-103-002,PC,3110-103-002.103001079,37.0,1344096,UBRO,Ubrogepant,27.50,ng/mL,27.50,27.5,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T21:55:00,15.0,12 h,12.0,Period 3 Dose,2018-04-06T09:55:00
3110-103-002,PC,3110-103-002.103001079,38.0,1344099,UBRO,Ubrogepant,15.65,ng/mL,15.65,15.65,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T23:55:00,15.0,14 h,14.0,Period 3 Dose,2018-04-06T09:55:00
3110-103-002,PC,3110-103-002.103001079,39.0,1344105,UBRO,Ubrogepant,4.11,ng/mL,4.11,4.11,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,26.0,Period 3 Day 16,TREATMENT,2018-04-07T09:55:00,16.0,24 h,24.0,Period 3 Dose,2018-04-06T09:55:00
3110-103-002,PC,3110-103-002.103001089,1.0,1346989,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T09:43:00,1.0,Predose,0.0,Period 1 Dose,2018-03-23T10:13:00
3110-103-002,PC,3110-103-002.103001089,2.0,1346991,UBRO,Ubrogepant,94.79,ng/mL,94.79,94.79,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:43:00,1.0,0.5 h,0.5,Period 1 Dose,2018-03-23T10:13:00
3110-103-002,PC,3110-103-002.103001089,3.0,1346994,UBRO,Ubrogepant,213.40,ng/mL,213.40,213.4,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:13:00,1.0,1 h,1.0,Period 1 Dose,2018-03-23T10:13:00
3110-103-002,PC,3110-103-002.103001089,4.0,1346997,UBRO,Ubrogepant,275.50,ng/mL,275.50,275.5,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:43:00,1.0,1.5 h,1.5,Period 1 Dose,2018-03-23T10:13:00
3110-103-002,PC,3110-103-002.103001089,5.0,1347001,UBRO,Ubrogepant,408.09,ng/mL,408.09,408.09,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T12:13:00,1.0,2 h,2.0,Period 1 Dose,2018-03-23T10:13:00
3110-103-002,PC,3110-103-002.103001089,6.0,1347002,UBRO,Ubrogepant,266.63,ng/mL,266.63,266.63,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T13:13:00,1.0,3 h,3.0,Period 1 Dose,2018-03-23T10:13:00
3110-103-002,PC,3110-103-002.103001089,7.0,1347003,UBRO,Ubrogepant,181.59,ng/mL,181.59,181.59,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T14:13:00,1.0,4 h,4.0,Period 1 Dose,2018-03-23T10:13:00
3110-103-002,PC,3110-103-002.103001089,8.0,1347008,UBRO,Ubrogepant,149.82,ng/mL,149.82,149.82,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T15:13:00,1.0,5 h,5.0,Period 1 Dose,2018-03-23T10:13:00
3110-103-002,PC,3110-103-002.103001089,9.0,1347009,UBRO,Ubrogepant,112.65,ng/mL,112.65,112.65,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T16:13:00,1.0,6 h,6.0,Period 1 Dose,2018-03-23T10:13:00
3110-103-002,PC,3110-103-002.103001089,10.0,1347010,UBRO,Ubrogepant,62.70,ng/mL,62.70,62.7,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T18:13:00,1.0,8 h,8.0,Period 1 Dose,2018-03-23T10:13:00
3110-103-002,PC,3110-103-002.103001089,11.0,1347013,UBRO,Ubrogepant,24.43,ng/mL,24.43,24.43,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T22:13:00,1.0,12 h,12.0,Period 1 Dose,2018-03-23T10:13:00
3110-103-002,PC,3110-103-002.103001089,12.0,1347016,UBRO,Ubrogepant,16.49,ng/mL,16.49,16.49,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-24T00:13:00,2.0,14 h,14.0,Period 1 Dose,2018-03-23T10:13:00
3110-103-002,PC,3110-103-002.103001089,13.0,1347022,UBRO,Ubrogepant,3.12,ng/mL,3.12,3.12,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-03-24T10:13:00,2.0,24 h,24.0,Period 1 Dose,2018-03-23T10:13:00
3110-103-002,PC,3110-103-002.103001089,14.0,1347047,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T09:43:00,8.0,Predose,0.0,Period 2 Dose,2018-03-30T10:13:00
3110-103-002,PC,3110-103-002.103001089,15.0,1347049,UBRO,Ubrogepant,49.53,ng/mL,49.53,49.53,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:43:00,8.0,0.5 h,0.5,Period 2 Dose,2018-03-30T10:13:00
3110-103-002,PC,3110-103-002.103001089,16.0,1347052,UBRO,Ubrogepant,230.46,ng/mL,230.46,230.46,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:13:00,8.0,1 h,1.0,Period 2 Dose,2018-03-30T10:13:00
3110-103-002,PC,3110-103-002.103001089,17.0,1347055,UBRO,Ubrogepant,308.57,ng/mL,308.57,308.57,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:43:00,8.0,1.5 h,1.5,Period 2 Dose,2018-03-30T10:13:00
3110-103-002,PC,3110-103-002.103001089,18.0,1347059,UBRO,Ubrogepant,276.93,ng/mL,276.93,276.93,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T12:13:00,8.0,2 h,2.0,Period 2 Dose,2018-03-30T10:13:00
3110-103-002,PC,3110-103-002.103001089,19.0,1347060,UBRO,Ubrogepant,194.56,ng/mL,194.56,194.56,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T13:13:00,8.0,3 h,3.0,Period 2 Dose,2018-03-30T10:13:00
3110-103-002,PC,3110-103-002.103001089,20.0,1347061,UBRO,Ubrogepant,162.34,ng/mL,162.34,162.34,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T14:13:00,8.0,4 h,4.0,Period 2 Dose,2018-03-30T10:13:00
3110-103-002,PC,3110-103-002.103001089,21.0,1347066,UBRO,Ubrogepant,110.52,ng/mL,110.52,110.52,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T15:13:00,8.0,5 h,5.0,Period 2 Dose,2018-03-30T10:13:00
3110-103-002,PC,3110-103-002.103001089,22.0,1347067,UBRO,Ubrogepant,79.64,ng/mL,79.64,79.64,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T16:14:20,8.0,6 h,6.0,Period 2 Dose,2018-03-30T10:13:00
3110-103-002,PC,3110-103-002.103001089,23.0,1347068,UBRO,Ubrogepant,50.04,ng/mL,50.04,50.04,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T18:13:00,8.0,8 h,8.0,Period 2 Dose,2018-03-30T10:13:00
3110-103-002,PC,3110-103-002.103001089,24.0,1347071,UBRO,Ubrogepant,17.30,ng/mL,17.30,17.3,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T22:13:00,8.0,12 h,12.0,Period 2 Dose,2018-03-30T10:13:00
3110-103-002,PC,3110-103-002.103001089,25.0,1347074,UBRO,Ubrogepant,10.96,ng/mL,10.96,10.96,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-31T00:13:00,9.0,14 h,14.0,Period 2 Dose,2018-03-30T10:13:00
3110-103-002,PC,3110-103-002.103001089,26.0,1347080,UBRO,Ubrogepant,2.70,ng/mL,2.70,2.7,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-03-31T10:13:00,9.0,24 h,24.0,Period 2 Dose,2018-03-30T10:13:00
3110-103-002,PC,3110-103-002.103001089,27.0,1347105,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T09:43:00,15.0,Predose,0.0,Period 3 Dose,2018-04-06T10:13:00
3110-103-002,PC,3110-103-002.103001089,28.0,1347107,UBRO,Ubrogepant,50.48,ng/mL,50.48,50.48,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:43:00,15.0,0.5 h,0.5,Period 3 Dose,2018-04-06T10:13:00
3110-103-002,PC,3110-103-002.103001089,29.0,1347110,UBRO,Ubrogepant,184.37,ng/mL,184.37,184.37,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:13:00,15.0,1 h,1.0,Period 3 Dose,2018-04-06T10:13:00
3110-103-002,PC,3110-103-002.103001089,30.0,1347113,UBRO,Ubrogepant,274.59,ng/mL,274.59,274.59,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:43:00,15.0,1.5 h,1.5,Period 3 Dose,2018-04-06T10:13:00
3110-103-002,PC,3110-103-002.103001089,31.0,1347117,UBRO,Ubrogepant,376.28,ng/mL,376.28,376.28,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T12:13:00,15.0,2 h,2.0,Period 3 Dose,2018-04-06T10:13:00
3110-103-002,PC,3110-103-002.103001089,32.0,1347118,UBRO,Ubrogepant,309.17,ng/mL,309.17,309.17,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T13:13:00,15.0,3 h,3.0,Period 3 Dose,2018-04-06T10:13:00
3110-103-002,PC,3110-103-002.103001089,33.0,1347119,UBRO,Ubrogepant,232.89,ng/mL,232.89,232.89,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T14:13:00,15.0,4 h,4.0,Period 3 Dose,2018-04-06T10:13:00
3110-103-002,PC,3110-103-002.103001089,34.0,1347124,UBRO,Ubrogepant,173.08,ng/mL,173.08,173.08,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T15:13:00,15.0,5 h,5.0,Period 3 Dose,2018-04-06T10:13:00
3110-103-002,PC,3110-103-002.103001089,35.0,1347125,UBRO,Ubrogepant,113.56,ng/mL,113.56,113.56,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T16:13:00,15.0,6 h,6.0,Period 3 Dose,2018-04-06T10:13:00
3110-103-002,PC,3110-103-002.103001089,36.0,1347126,UBRO,Ubrogepant,70.97,ng/mL,70.97,70.97,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T18:13:00,15.0,8 h,8.0,Period 3 Dose,2018-04-06T10:13:00
3110-103-002,PC,3110-103-002.103001089,37.0,1347129,UBRO,Ubrogepant,26.33,ng/mL,26.33,26.33,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T22:13:00,15.0,12 h,12.0,Period 3 Dose,2018-04-06T10:13:00
3110-103-002,PC,3110-103-002.103001089,38.0,1347132,UBRO,Ubrogepant,15.06,ng/mL,15.06,15.06,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-07T00:13:00,16.0,14 h,14.0,Period 3 Dose,2018-04-06T10:13:00
3110-103-002,PC,3110-103-002.103001089,39.0,1347138,UBRO,Ubrogepant,3.04,ng/mL,3.04,3.04,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,26.0,Period 3 Day 16,TREATMENT,2018-04-07T10:13:00,16.0,24 h,24.0,Period 3 Dose,2018-04-06T10:13:00
3110-103-002,PC,3110-103-002.103001092,1.0,1346467,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T09:15:00,1.0,Predose,0.0,Period 1 Dose,2018-03-23T09:45:00
3110-103-002,PC,3110-103-002.103001092,2.0,1346473,UBRO,Ubrogepant,80.60,ng/mL,80.60,80.6,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:15:00,1.0,0.5 h,0.5,Period 1 Dose,2018-03-23T09:45:00
3110-103-002,PC,3110-103-002.103001092,3.0,1346480,UBRO,Ubrogepant,182.21,ng/mL,182.21,182.21,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:46:02,1.0,1 h,1.0,Period 1 Dose,2018-03-23T09:45:00
3110-103-002,PC,3110-103-002.103001092,4.0,1346489,UBRO,Ubrogepant,134.66,ng/mL,134.66,134.66,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:15:00,1.0,1.5 h,1.5,Period 1 Dose,2018-03-23T09:45:00
3110-103-002,PC,3110-103-002.103001092,5.0,1346499,UBRO,Ubrogepant,134.36,ng/mL,134.36,134.36,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:45:00,1.0,2 h,2.0,Period 1 Dose,2018-03-23T09:45:00
3110-103-002,PC,3110-103-002.103001092,6.0,1346501,UBRO,Ubrogepant,108.05,ng/mL,108.05,108.05,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T12:45:00,1.0,3 h,3.0,Period 1 Dose,2018-03-23T09:45:00
3110-103-002,PC,3110-103-002.103001092,7.0,1346502,UBRO,Ubrogepant,82.91,ng/mL,82.91,82.91,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T13:45:00,1.0,4 h,4.0,Period 1 Dose,2018-03-23T09:45:00
3110-103-002,PC,3110-103-002.103001092,8.0,1346507,UBRO,Ubrogepant,64.28,ng/mL,64.28,64.28,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T14:45:00,1.0,5 h,5.0,Period 1 Dose,2018-03-23T09:45:00
3110-103-002,PC,3110-103-002.103001092,9.0,1346508,UBRO,Ubrogepant,43.81,ng/mL,43.81,43.81,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T15:45:00,1.0,6 h,6.0,Period 1 Dose,2018-03-23T09:45:00
3110-103-002,PC,3110-103-002.103001092,10.0,1346510,UBRO,Ubrogepant,31.65,ng/mL,31.65,31.65,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T17:45:00,1.0,8 h,8.0,Period 1 Dose,2018-03-23T09:45:00
3110-103-002,PC,3110-103-002.103001092,11.0,1346515,UBRO,Ubrogepant,13.28,ng/mL,13.28,13.28,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T21:45:00,1.0,12 h,12.0,Period 1 Dose,2018-03-23T09:45:00
3110-103-002,PC,3110-103-002.103001092,12.0,1346518,UBRO,Ubrogepant,9.08,ng/mL,9.08,9.08,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T23:45:00,1.0,14 h,14.0,Period 1 Dose,2018-03-23T09:45:00
3110-103-002,PC,3110-103-002.103001092,13.0,1346524,UBRO,Ubrogepant,2.41,ng/mL,2.41,2.41,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-03-24T09:45:00,2.0,24 h,24.0,Period 1 Dose,2018-03-23T09:45:00
3110-103-002,PC,3110-103-002.103001092,14.0,1346549,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T09:15:00,8.0,Predose,0.0,Period 2 Dose,2018-03-30T09:45:00
3110-103-002,PC,3110-103-002.103001092,15.0,1346551,UBRO,Ubrogepant,91.93,ng/mL,91.93,91.93,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:16:20,8.0,0.5 h,0.5,Period 2 Dose,2018-03-30T09:45:00
3110-103-002,PC,3110-103-002.103001092,16.0,1346554,UBRO,Ubrogepant,136.54,ng/mL,136.54,136.54,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:45:00,8.0,1 h,1.0,Period 2 Dose,2018-03-30T09:45:00
3110-103-002,PC,3110-103-002.103001092,17.0,1346557,UBRO,Ubrogepant,149.89,ng/mL,149.89,149.89,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:15:00,8.0,1.5 h,1.5,Period 2 Dose,2018-03-30T09:45:00
3110-103-002,PC,3110-103-002.103001092,18.0,1346561,UBRO,Ubrogepant,142.85,ng/mL,142.85,142.85,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:45:00,8.0,2 h,2.0,Period 2 Dose,2018-03-30T09:45:00
3110-103-002,PC,3110-103-002.103001092,19.0,1346562,UBRO,Ubrogepant,91.75,ng/mL,91.75,91.75,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T12:46:21,8.0,3 h,3.0,Period 2 Dose,2018-03-30T09:45:00
3110-103-002,PC,3110-103-002.103001092,20.0,1346563,UBRO,Ubrogepant,90.75,ng/mL,90.75,90.75,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T13:45:00,8.0,4 h,4.0,Period 2 Dose,2018-03-30T09:45:00
3110-103-002,PC,3110-103-002.103001092,21.0,1346568,UBRO,Ubrogepant,77.12,ng/mL,77.12,77.12,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T14:45:00,8.0,5 h,5.0,Period 2 Dose,2018-03-30T09:45:00
3110-103-002,PC,3110-103-002.103001092,22.0,1346569,UBRO,Ubrogepant,62.09,ng/mL,62.09,62.09,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T15:45:00,8.0,6 h,6.0,Period 2 Dose,2018-03-30T09:45:00
3110-103-002,PC,3110-103-002.103001092,23.0,1346570,UBRO,Ubrogepant,29.52,ng/mL,29.52,29.52,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T17:45:00,8.0,8 h,8.0,Period 2 Dose,2018-03-30T09:45:00
3110-103-002,PC,3110-103-002.103001092,24.0,1346573,UBRO,Ubrogepant,12.34,ng/mL,12.34,12.34,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T21:45:00,8.0,12 h,12.0,Period 2 Dose,2018-03-30T09:45:00
3110-103-002,PC,3110-103-002.103001092,25.0,1346576,UBRO,Ubrogepant,8.41,ng/mL,8.41,8.41,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T23:45:00,8.0,14 h,14.0,Period 2 Dose,2018-03-30T09:45:00
3110-103-002,PC,3110-103-002.103001092,26.0,1346582,UBRO,Ubrogepant,2.58,ng/mL,2.58,2.58,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-03-31T09:45:00,9.0,24 h,24.0,Period 2 Dose,2018-03-30T09:45:00
3110-103-002,PC,3110-103-002.103001092,27.0,1346607,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T09:15:00,15.0,Predose,0.0,Period 3 Dose,2018-04-06T09:45:00
3110-103-002,PC,3110-103-002.103001092,28.0,1346609,UBRO,Ubrogepant,11.08,ng/mL,11.08,11.08,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:15:00,15.0,0.5 h,0.5,Period 3 Dose,2018-04-06T09:45:00
3110-103-002,PC,3110-103-002.103001092,29.0,1346612,UBRO,Ubrogepant,21.41,ng/mL,21.41,21.41,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:45:00,15.0,1 h,1.0,Period 3 Dose,2018-04-06T09:45:00
3110-103-002,PC,3110-103-002.103001092,30.0,1346615,UBRO,Ubrogepant,45.28,ng/mL,45.28,45.28,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:15:00,15.0,1.5 h,1.5,Period 3 Dose,2018-04-06T09:45:00
3110-103-002,PC,3110-103-002.103001092,31.0,1346619,UBRO,Ubrogepant,51.02,ng/mL,51.02,51.02,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:45:00,15.0,2 h,2.0,Period 3 Dose,2018-04-06T09:45:00
3110-103-002,PC,3110-103-002.103001092,32.0,1346620,UBRO,Ubrogepant,216.47,ng/mL,216.47,216.47,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T12:45:00,15.0,3 h,3.0,Period 3 Dose,2018-04-06T09:45:00
3110-103-002,PC,3110-103-002.103001092,33.0,1346621,UBRO,Ubrogepant,139.77,ng/mL,139.77,139.77,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T13:45:00,15.0,4 h,4.0,Period 3 Dose,2018-04-06T09:45:00
3110-103-002,PC,3110-103-002.103001092,34.0,1346626,UBRO,Ubrogepant,98.13,ng/mL,98.13,98.13,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T14:45:00,15.0,5 h,5.0,Period 3 Dose,2018-04-06T09:45:00
3110-103-002,PC,3110-103-002.103001092,35.0,1346627,UBRO,Ubrogepant,62.38,ng/mL,62.38,62.38,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T15:45:00,15.0,6 h,6.0,Period 3 Dose,2018-04-06T09:45:00
3110-103-002,PC,3110-103-002.103001092,36.0,1346628,UBRO,Ubrogepant,43.46,ng/mL,43.46,43.46,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T17:45:00,15.0,8 h,8.0,Period 3 Dose,2018-04-06T09:45:00
3110-103-002,PC,3110-103-002.103001092,37.0,1346631,UBRO,Ubrogepant,17.83,ng/mL,17.83,17.83,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T21:45:00,15.0,12 h,12.0,Period 3 Dose,2018-04-06T09:45:00
3110-103-002,PC,3110-103-002.103001092,38.0,1346634,UBRO,Ubrogepant,12.25,ng/mL,12.25,12.25,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T23:45:00,15.0,14 h,14.0,Period 3 Dose,2018-04-06T09:45:00
3110-103-002,PC,3110-103-002.103001092,39.0,1346640,UBRO,Ubrogepant,2.47,ng/mL,2.47,2.47,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,26.0,Period 3 Day 16,TREATMENT,2018-04-07T09:46:02,16.0,24 h,24.0,Period 3 Dose,2018-04-06T09:45:00
3110-103-002,PC,3110-103-002.103001096,1.0,1342981,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T09:29:00,1.0,Predose,0.0,Period 1 Dose,2018-03-23T09:59:00
3110-103-002,PC,3110-103-002.103001096,2.0,1342983,UBRO,Ubrogepant,278.11,ng/mL,278.11,278.11,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:29:00,1.0,0.5 h,0.5,Period 1 Dose,2018-03-23T09:59:00
3110-103-002,PC,3110-103-002.103001096,3.0,1342986,UBRO,Ubrogepant,613.87,ng/mL,613.87,613.87,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:59:00,1.0,1 h,1.0,Period 1 Dose,2018-03-23T09:59:00
3110-103-002,PC,3110-103-002.103001096,4.0,1342989,UBRO,Ubrogepant,470.34,ng/mL,470.34,470.34,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:30:02,1.0,1.5 h,1.5,Period 1 Dose,2018-03-23T09:59:00
3110-103-002,PC,3110-103-002.103001096,5.0,1342993,UBRO,Ubrogepant,306.07,ng/mL,306.07,306.07,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:59:00,1.0,2 h,2.0,Period 1 Dose,2018-03-23T09:59:00
3110-103-002,PC,3110-103-002.103001096,6.0,1342994,UBRO,Ubrogepant,237.18,ng/mL,237.18,237.18,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T12:59:00,1.0,3 h,3.0,Period 1 Dose,2018-03-23T09:59:00
3110-103-002,PC,3110-103-002.103001096,7.0,1342995,UBRO,Ubrogepant,165.70,ng/mL,165.70,165.7,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T13:59:00,1.0,4 h,4.0,Period 1 Dose,2018-03-23T09:59:00
3110-103-002,PC,3110-103-002.103001096,8.0,1343000,UBRO,Ubrogepant,143.63,ng/mL,143.63,143.63,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T14:59:00,1.0,5 h,5.0,Period 1 Dose,2018-03-23T09:59:00
3110-103-002,PC,3110-103-002.103001096,9.0,1343001,UBRO,Ubrogepant,90.33,ng/mL,90.33,90.33,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T15:59:00,1.0,6 h,6.0,Period 1 Dose,2018-03-23T09:59:00
3110-103-002,PC,3110-103-002.103001096,10.0,1343002,UBRO,Ubrogepant,60.23,ng/mL,60.23,60.23,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T17:59:00,1.0,8 h,8.0,Period 1 Dose,2018-03-23T09:59:00
3110-103-002,PC,3110-103-002.103001096,11.0,1343005,UBRO,Ubrogepant,23.71,ng/mL,23.71,23.71,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T21:59:00,1.0,12 h,12.0,Period 1 Dose,2018-03-23T09:59:00
3110-103-002,PC,3110-103-002.103001096,12.0,1343008,UBRO,Ubrogepant,16.83,ng/mL,16.83,16.83,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T23:59:00,1.0,14 h,14.0,Period 1 Dose,2018-03-23T09:59:00
3110-103-002,PC,3110-103-002.103001096,13.0,1343014,UBRO,Ubrogepant,3.90,ng/mL,3.90,3.9,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-03-24T09:59:00,2.0,24 h,24.0,Period 1 Dose,2018-03-23T09:59:00
3110-103-002,PC,3110-103-002.103001096,14.0,1343039,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T09:29:00,8.0,Predose,0.0,Period 2 Dose,2018-03-30T09:59:00
3110-103-002,PC,3110-103-002.103001096,15.0,1343041,UBRO,Ubrogepant,187.48,ng/mL,187.48,187.48,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:29:00,8.0,0.5 h,0.5,Period 2 Dose,2018-03-30T09:59:00
3110-103-002,PC,3110-103-002.103001096,16.0,1343044,UBRO,Ubrogepant,580.63,ng/mL,580.63,580.63,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:59:00,8.0,1 h,1.0,Period 2 Dose,2018-03-30T09:59:00
3110-103-002,PC,3110-103-002.103001096,17.0,1343047,UBRO,Ubrogepant,393.20,ng/mL,393.20,393.2,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:29:00,8.0,1.5 h,1.5,Period 2 Dose,2018-03-30T09:59:00
3110-103-002,PC,3110-103-002.103001096,18.0,1343051,UBRO,Ubrogepant,279.71,ng/mL,279.71,279.71,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:59:00,8.0,2 h,2.0,Period 2 Dose,2018-03-30T09:59:00
3110-103-002,PC,3110-103-002.103001096,19.0,1343052,UBRO,Ubrogepant,174.52,ng/mL,174.52,174.52,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T12:59:00,8.0,3 h,3.0,Period 2 Dose,2018-03-30T09:59:00
3110-103-002,PC,3110-103-002.103001096,20.0,1343053,UBRO,Ubrogepant,131.10,ng/mL,131.10,131.1,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T13:59:00,8.0,4 h,4.0,Period 2 Dose,2018-03-30T09:59:00
3110-103-002,PC,3110-103-002.103001096,21.0,1343058,UBRO,Ubrogepant,113.04,ng/mL,113.04,113.04,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T14:59:00,8.0,5 h,5.0,Period 2 Dose,2018-03-30T09:59:00
3110-103-002,PC,3110-103-002.103001096,22.0,1343059,UBRO,Ubrogepant,78.18,ng/mL,78.18,78.18,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T15:59:00,8.0,6 h,6.0,Period 2 Dose,2018-03-30T09:59:00
3110-103-002,PC,3110-103-002.103001096,23.0,1343060,UBRO,Ubrogepant,51.32,ng/mL,51.32,51.32,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T17:59:00,8.0,8 h,8.0,Period 2 Dose,2018-03-30T09:59:00
3110-103-002,PC,3110-103-002.103001096,24.0,1343063,UBRO,Ubrogepant,18.81,ng/mL,18.81,18.81,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T21:59:00,8.0,12 h,12.0,Period 2 Dose,2018-03-30T09:59:00
3110-103-002,PC,3110-103-002.103001096,25.0,1343066,UBRO,Ubrogepant,14.07,ng/mL,14.07,14.07,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T23:59:00,8.0,14 h,14.0,Period 2 Dose,2018-03-30T09:59:00
3110-103-002,PC,3110-103-002.103001096,26.0,1343072,UBRO,Ubrogepant,2.40,ng/mL,2.40,2.4,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-03-31T09:59:00,9.0,24 h,24.0,Period 2 Dose,2018-03-30T09:59:00
3110-103-002,PC,3110-103-002.103001096,27.0,1343097,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T09:29:00,15.0,Predose,0.0,Period 3 Dose,2018-04-06T09:59:00
3110-103-002,PC,3110-103-002.103001096,28.0,1343099,UBRO,Ubrogepant,138.99,ng/mL,138.99,138.99,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:29:00,15.0,0.5 h,0.5,Period 3 Dose,2018-04-06T09:59:00
3110-103-002,PC,3110-103-002.103001096,29.0,1343102,UBRO,Ubrogepant,555.95,ng/mL,555.95,555.95,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:59:00,15.0,1 h,1.0,Period 3 Dose,2018-04-06T09:59:00
3110-103-002,PC,3110-103-002.103001096,30.0,1343105,UBRO,Ubrogepant,340.72,ng/mL,340.72,340.72,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:29:00,15.0,1.5 h,1.5,Period 3 Dose,2018-04-06T09:59:00
3110-103-002,PC,3110-103-002.103001096,31.0,1343109,UBRO,Ubrogepant,293.06,ng/mL,293.06,293.06,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:59:00,15.0,2 h,2.0,Period 3 Dose,2018-04-06T09:59:00
3110-103-002,PC,3110-103-002.103001096,32.0,1343110,UBRO,Ubrogepant,171.98,ng/mL,171.98,171.98,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T12:59:00,15.0,3 h,3.0,Period 3 Dose,2018-04-06T09:59:00
3110-103-002,PC,3110-103-002.103001096,33.0,1343111,UBRO,Ubrogepant,143.51,ng/mL,143.51,143.51,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T13:59:00,15.0,4 h,4.0,Period 3 Dose,2018-04-06T09:59:00
3110-103-002,PC,3110-103-002.103001096,34.0,1343116,UBRO,Ubrogepant,118.52,ng/mL,118.52,118.52,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T14:59:00,15.0,5 h,5.0,Period 3 Dose,2018-04-06T09:59:00
3110-103-002,PC,3110-103-002.103001096,35.0,1343117,UBRO,Ubrogepant,82.82,ng/mL,82.82,82.82,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T15:59:00,15.0,6 h,6.0,Period 3 Dose,2018-04-06T09:59:00
3110-103-002,PC,3110-103-002.103001096,36.0,1343118,UBRO,Ubrogepant,65.46,ng/mL,65.46,65.46,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T17:59:00,15.0,8 h,8.0,Period 3 Dose,2018-04-06T09:59:00
3110-103-002,PC,3110-103-002.103001096,37.0,1343121,UBRO,Ubrogepant,22.74,ng/mL,22.74,22.74,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T21:59:00,15.0,12 h,12.0,Period 3 Dose,2018-04-06T09:59:00
3110-103-002,PC,3110-103-002.103001096,38.0,1343124,UBRO,Ubrogepant,13.95,ng/mL,13.95,13.95,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T23:59:00,15.0,14 h,14.0,Period 3 Dose,2018-04-06T09:59:00
3110-103-002,PC,3110-103-002.103001096,39.0,1343130,UBRO,Ubrogepant,3.19,ng/mL,3.19,3.19,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,26.0,Period 3 Day 16,TREATMENT,2018-04-07T09:59:00,16.0,24 h,24.0,Period 3 Dose,2018-04-06T09:59:00
3110-103-002,PC,3110-103-002.103001098,1.0,1342396,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T09:32:00,1.0,Predose,0.0,Period 1 Dose,2018-03-23T10:02:00
3110-103-002,PC,3110-103-002.103001098,2.0,1342398,UBRO,Ubrogepant,92.79,ng/mL,92.79,92.79,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:32:00,1.0,0.5 h,0.5,Period 1 Dose,2018-03-23T10:02:00
3110-103-002,PC,3110-103-002.103001098,3.0,1342401,UBRO,Ubrogepant,428.26,ng/mL,428.26,428.26,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:02:00,1.0,1 h,1.0,Period 1 Dose,2018-03-23T10:02:00
3110-103-002,PC,3110-103-002.103001098,4.0,1342404,UBRO,Ubrogepant,536.45,ng/mL,536.45,536.45,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:32:00,1.0,1.5 h,1.5,Period 1 Dose,2018-03-23T10:02:00
3110-103-002,PC,3110-103-002.103001098,5.0,1342408,UBRO,Ubrogepant,399.66,ng/mL,399.66,399.66,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T12:02:00,1.0,2 h,2.0,Period 1 Dose,2018-03-23T10:02:00
3110-103-002,PC,3110-103-002.103001098,6.0,1342409,UBRO,Ubrogepant,297.51,ng/mL,297.51,297.51,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T13:02:00,1.0,3 h,3.0,Period 1 Dose,2018-03-23T10:02:00
3110-103-002,PC,3110-103-002.103001098,7.0,1342410,UBRO,Ubrogepant,238.64,ng/mL,238.64,238.64,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T14:02:00,1.0,4 h,4.0,Period 1 Dose,2018-03-23T10:02:00
3110-103-002,PC,3110-103-002.103001098,8.0,1342415,UBRO,Ubrogepant,157.65,ng/mL,157.65,157.65,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T15:02:00,1.0,5 h,5.0,Period 1 Dose,2018-03-23T10:02:00
3110-103-002,PC,3110-103-002.103001098,9.0,1342416,UBRO,Ubrogepant,109.96,ng/mL,109.96,109.96,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T16:02:00,1.0,6 h,6.0,Period 1 Dose,2018-03-23T10:02:00
3110-103-002,PC,3110-103-002.103001098,10.0,1342417,UBRO,Ubrogepant,54.44,ng/mL,54.44,54.44,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T18:04:06,1.0,8 h,8.0,Period 1 Dose,2018-03-23T10:02:00
3110-103-002,PC,3110-103-002.103001098,11.0,1342420,UBRO,Ubrogepant,20.52,ng/mL,20.52,20.52,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T22:02:00,1.0,12 h,12.0,Period 1 Dose,2018-03-23T10:02:00
3110-103-002,PC,3110-103-002.103001098,12.0,1342423,UBRO,Ubrogepant,13.33,ng/mL,13.33,13.33,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-24T00:02:00,2.0,14 h,14.0,Period 1 Dose,2018-03-23T10:02:00
3110-103-002,PC,3110-103-002.103001098,13.0,1342429,UBRO,Ubrogepant,3.87,ng/mL,3.87,3.87,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-03-24T10:02:00,2.0,24 h,24.0,Period 1 Dose,2018-03-23T10:02:00
3110-103-002,PC,3110-103-002.103001098,14.0,1342454,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T09:32:00,8.0,Predose,0.0,Period 2 Dose,2018-03-30T10:02:00
3110-103-002,PC,3110-103-002.103001098,15.0,1342456,UBRO,Ubrogepant,7.87,ng/mL,7.87,7.87,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:32:00,8.0,0.5 h,0.5,Period 2 Dose,2018-03-30T10:02:00
3110-103-002,PC,3110-103-002.103001098,16.0,1342459,UBRO,Ubrogepant,20.29,ng/mL,20.29,20.29,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:02:00,8.0,1 h,1.0,Period 2 Dose,2018-03-30T10:02:00
3110-103-002,PC,3110-103-002.103001098,17.0,1342462,UBRO,Ubrogepant,89.96,ng/mL,89.96,89.96,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:32:00,8.0,1.5 h,1.5,Period 2 Dose,2018-03-30T10:02:00
3110-103-002,PC,3110-103-002.103001098,18.0,1342466,UBRO,Ubrogepant,195.82,ng/mL,195.82,195.82,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T12:02:00,8.0,2 h,2.0,Period 2 Dose,2018-03-30T10:02:00
3110-103-002,PC,3110-103-002.103001098,19.0,1342467,UBRO,Ubrogepant,177.57,ng/mL,177.57,177.57,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T13:02:00,8.0,3 h,3.0,Period 2 Dose,2018-03-30T10:02:00
3110-103-002,PC,3110-103-002.103001098,20.0,1342468,UBRO,Ubrogepant,274.84,ng/mL,274.84,274.84,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T14:02:00,8.0,4 h,4.0,Period 2 Dose,2018-03-30T10:02:00
3110-103-002,PC,3110-103-002.103001098,21.0,1342473,UBRO,Ubrogepant,279.44,ng/mL,279.44,279.44,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T15:02:00,8.0,5 h,5.0,Period 2 Dose,2018-03-30T10:02:00
3110-103-002,PC,3110-103-002.103001098,22.0,1342474,UBRO,Ubrogepant,219.53,ng/mL,219.53,219.53,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T16:02:00,8.0,6 h,6.0,Period 2 Dose,2018-03-30T10:02:00
3110-103-002,PC,3110-103-002.103001098,23.0,1342475,UBRO,Ubrogepant,130.84,ng/mL,130.84,130.84,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T18:02:00,8.0,8 h,8.0,Period 2 Dose,2018-03-30T10:02:00
3110-103-002,PC,3110-103-002.103001098,24.0,1342478,UBRO,Ubrogepant,30.46,ng/mL,30.46,30.46,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T22:02:00,8.0,12 h,12.0,Period 2 Dose,2018-03-30T10:02:00
3110-103-002,PC,3110-103-002.103001098,25.0,1342481,UBRO,Ubrogepant,24.38,ng/mL,24.38,24.38,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-31T00:02:00,9.0,14 h,14.0,Period 2 Dose,2018-03-30T10:02:00
3110-103-002,PC,3110-103-002.103001098,26.0,1342487,UBRO,Ubrogepant,6.15,ng/mL,6.15,6.15,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-03-31T10:02:00,9.0,24 h,24.0,Period 2 Dose,2018-03-30T10:02:00
3110-103-002,PC,3110-103-002.103001098,27.0,1342512,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T09:32:00,15.0,Predose,0.0,Period 3 Dose,2018-04-06T10:02:00
3110-103-002,PC,3110-103-002.103001098,28.0,1342514,UBRO,Ubrogepant,20.55,ng/mL,20.55,20.55,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:32:00,15.0,0.5 h,0.5,Period 3 Dose,2018-04-06T10:02:00
3110-103-002,PC,3110-103-002.103001098,29.0,1342517,UBRO,Ubrogepant,163.52,ng/mL,163.52,163.52,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:02:00,15.0,1 h,1.0,Period 3 Dose,2018-04-06T10:02:00
3110-103-002,PC,3110-103-002.103001098,30.0,1342520,UBRO,Ubrogepant,196.49,ng/mL,196.49,196.49,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:32:00,15.0,1.5 h,1.5,Period 3 Dose,2018-04-06T10:02:00
3110-103-002,PC,3110-103-002.103001098,31.0,1342524,UBRO,Ubrogepant,240.88,ng/mL,240.88,240.88,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T12:02:00,15.0,2 h,2.0,Period 3 Dose,2018-04-06T10:02:00
3110-103-002,PC,3110-103-002.103001098,32.0,1342525,UBRO,Ubrogepant,313.69,ng/mL,313.69,313.69,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T13:02:00,15.0,3 h,3.0,Period 3 Dose,2018-04-06T10:02:00
3110-103-002,PC,3110-103-002.103001098,33.0,1342526,UBRO,Ubrogepant,260.29,ng/mL,260.29,260.29,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T14:02:00,15.0,4 h,4.0,Period 3 Dose,2018-04-06T10:02:00
3110-103-002,PC,3110-103-002.103001098,34.0,1342531,UBRO,Ubrogepant,202.08,ng/mL,202.08,202.08,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T15:02:00,15.0,5 h,5.0,Period 3 Dose,2018-04-06T10:02:00
3110-103-002,PC,3110-103-002.103001098,35.0,1342532,UBRO,Ubrogepant,152.33,ng/mL,152.33,152.33,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T16:02:00,15.0,6 h,6.0,Period 3 Dose,2018-04-06T10:02:00
3110-103-002,PC,3110-103-002.103001098,36.0,1342533,UBRO,Ubrogepant,74.05,ng/mL,74.05,74.05,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T18:02:00,15.0,8 h,8.0,Period 3 Dose,2018-04-06T10:02:00
3110-103-002,PC,3110-103-002.103001098,37.0,1342536,UBRO,Ubrogepant,27.54,ng/mL,27.54,27.54,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T22:02:00,15.0,12 h,12.0,Period 3 Dose,2018-04-06T10:02:00
3110-103-002,PC,3110-103-002.103001098,38.0,1342539,UBRO,Ubrogepant,20.00,ng/mL,20.00,20.0,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-07T00:02:00,16.0,14 h,14.0,Period 3 Dose,2018-04-06T10:02:00
3110-103-002,PC,3110-103-002.103001098,39.0,1342545,UBRO,Ubrogepant,5.08,ng/mL,5.08,5.08,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,26.0,Period 3 Day 16,TREATMENT,2018-04-07T10:02:00,16.0,24 h,24.0,Period 3 Dose,2018-04-06T10:02:00
3110-103-002,PC,3110-103-002.103001105,1.0,1343552,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T09:27:00,1.0,Predose,0.0,Period 1 Dose,2018-03-23T09:57:00
3110-103-002,PC,3110-103-002.103001105,2.0,1343560,UBRO,Ubrogepant,180.57,ng/mL,180.57,180.57,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:27:00,1.0,0.5 h,0.5,Period 1 Dose,2018-03-23T09:57:00
3110-103-002,PC,3110-103-002.103001105,3.0,1343564,UBRO,Ubrogepant,606.16,ng/mL,606.16,606.16,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:57:00,1.0,1 h,1.0,Period 1 Dose,2018-03-23T09:57:00
3110-103-002,PC,3110-103-002.103001105,4.0,1343571,UBRO,Ubrogepant,499.19,ng/mL,499.19,499.19,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:27:00,1.0,1.5 h,1.5,Period 1 Dose,2018-03-23T09:57:00
3110-103-002,PC,3110-103-002.103001105,5.0,1343575,UBRO,Ubrogepant,532.76,ng/mL,532.76,532.76,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:57:00,1.0,2 h,2.0,Period 1 Dose,2018-03-23T09:57:00
3110-103-002,PC,3110-103-002.103001105,6.0,1343576,UBRO,Ubrogepant,388.56,ng/mL,388.56,388.56,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T12:57:00,1.0,3 h,3.0,Period 1 Dose,2018-03-23T09:57:00
3110-103-002,PC,3110-103-002.103001105,7.0,1343579,UBRO,Ubrogepant,298.09,ng/mL,298.09,298.09,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T13:57:00,1.0,4 h,4.0,Period 1 Dose,2018-03-23T09:57:00
3110-103-002,PC,3110-103-002.103001105,8.0,1343585,UBRO,Ubrogepant,220.34,ng/mL,220.34,220.34,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T14:57:00,1.0,5 h,5.0,Period 1 Dose,2018-03-23T09:57:00
3110-103-002,PC,3110-103-002.103001105,9.0,1343586,UBRO,Ubrogepant,169.87,ng/mL,169.87,169.87,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T15:57:00,1.0,6 h,6.0,Period 1 Dose,2018-03-23T09:57:00
3110-103-002,PC,3110-103-002.103001105,10.0,1343587,UBRO,Ubrogepant,102.97,ng/mL,102.97,102.97,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T17:57:00,1.0,8 h,8.0,Period 1 Dose,2018-03-23T09:57:00
3110-103-002,PC,3110-103-002.103001105,11.0,1343590,UBRO,Ubrogepant,35.62,ng/mL,35.62,35.62,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T21:57:00,1.0,12 h,12.0,Period 1 Dose,2018-03-23T09:57:00
3110-103-002,PC,3110-103-002.103001105,12.0,1343593,UBRO,Ubrogepant,24.08,ng/mL,24.08,24.08,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T23:57:00,1.0,14 h,14.0,Period 1 Dose,2018-03-23T09:57:00
3110-103-002,PC,3110-103-002.103001105,13.0,1343599,UBRO,Ubrogepant,5.01,ng/mL,5.01,5.01,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-03-24T09:57:00,2.0,24 h,24.0,Period 1 Dose,2018-03-23T09:57:00
3110-103-002,PC,3110-103-002.103001105,14.0,1343624,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T09:27:00,8.0,Predose,0.0,Period 2 Dose,2018-03-30T09:57:00
3110-103-002,PC,3110-103-002.103001105,15.0,1343626,UBRO,Ubrogepant,15.59,ng/mL,15.59,15.59,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:27:00,8.0,0.5 h,0.5,Period 2 Dose,2018-03-30T09:57:00
3110-103-002,PC,3110-103-002.103001105,16.0,1343629,UBRO,Ubrogepant,176.47,ng/mL,176.47,176.47,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:57:00,8.0,1 h,1.0,Period 2 Dose,2018-03-30T09:57:00
3110-103-002,PC,3110-103-002.103001105,17.0,1343632,UBRO,Ubrogepant,263.25,ng/mL,263.25,263.25,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:27:00,8.0,1.5 h,1.5,Period 2 Dose,2018-03-30T09:57:00
3110-103-002,PC,3110-103-002.103001105,18.0,1343636,UBRO,Ubrogepant,437.07,ng/mL,437.07,437.07,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:59:38,8.0,2 h,2.0,Period 2 Dose,2018-03-30T09:57:00
3110-103-002,PC,3110-103-002.103001105,19.0,1343637,UBRO,Ubrogepant,407.54,ng/mL,407.54,407.54,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T12:57:00,8.0,3 h,3.0,Period 2 Dose,2018-03-30T09:57:00
3110-103-002,PC,3110-103-002.103001105,20.0,1343638,UBRO,Ubrogepant,300.88,ng/mL,300.88,300.88,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T13:57:00,8.0,4 h,4.0,Period 2 Dose,2018-03-30T09:57:00
3110-103-002,PC,3110-103-002.103001105,21.0,1343643,UBRO,Ubrogepant,215.66,ng/mL,215.66,215.66,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T14:57:00,8.0,5 h,5.0,Period 2 Dose,2018-03-30T09:57:00
3110-103-002,PC,3110-103-002.103001105,22.0,1343644,UBRO,Ubrogepant,170.71,ng/mL,170.71,170.71,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T15:57:00,8.0,6 h,6.0,Period 2 Dose,2018-03-30T09:57:00
3110-103-002,PC,3110-103-002.103001105,23.0,1343645,UBRO,Ubrogepant,106.85,ng/mL,106.85,106.85,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T17:57:00,8.0,8 h,8.0,Period 2 Dose,2018-03-30T09:57:00
3110-103-002,PC,3110-103-002.103001105,24.0,1343648,UBRO,Ubrogepant,37.08,ng/mL,37.08,37.08,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T21:57:00,8.0,12 h,12.0,Period 2 Dose,2018-03-30T09:57:00
3110-103-002,PC,3110-103-002.103001105,25.0,1343651,UBRO,Ubrogepant,22.85,ng/mL,22.85,22.85,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T23:57:00,8.0,14 h,14.0,Period 2 Dose,2018-03-30T09:57:00
3110-103-002,PC,3110-103-002.103001105,26.0,1343657,UBRO,Ubrogepant,5.49,ng/mL,5.49,5.49,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-03-31T09:57:00,9.0,24 h,24.0,Period 2 Dose,2018-03-30T09:57:00
3110-103-002,PC,3110-103-002.103001107,1.0,1340056,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T09:08:00,1.0,Predose,0.0,Period 1 Dose,2018-03-23T09:38:00
3110-103-002,PC,3110-103-002.103001107,2.0,1340058,UBRO,Ubrogepant,15.91,ng/mL,15.91,15.91,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:08:00,1.0,0.5 h,0.5,Period 1 Dose,2018-03-23T09:38:00
3110-103-002,PC,3110-103-002.103001107,3.0,1340061,UBRO,Ubrogepant,205.13,ng/mL,205.13,205.13,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:38:00,1.0,1 h,1.0,Period 1 Dose,2018-03-23T09:38:00
3110-103-002,PC,3110-103-002.103001107,4.0,1340064,UBRO,Ubrogepant,229.79,ng/mL,229.79,229.79,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:08:00,1.0,1.5 h,1.5,Period 1 Dose,2018-03-23T09:38:00
3110-103-002,PC,3110-103-002.103001107,5.0,1340068,UBRO,Ubrogepant,248.16,ng/mL,248.16,248.16,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:38:00,1.0,2 h,2.0,Period 1 Dose,2018-03-23T09:38:00
3110-103-002,PC,3110-103-002.103001107,6.0,1340069,UBRO,Ubrogepant,166.57,ng/mL,166.57,166.57,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T12:38:00,1.0,3 h,3.0,Period 1 Dose,2018-03-23T09:38:00
3110-103-002,PC,3110-103-002.103001107,7.0,1340070,UBRO,Ubrogepant,136.69,ng/mL,136.69,136.69,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T13:38:00,1.0,4 h,4.0,Period 1 Dose,2018-03-23T09:38:00
3110-103-002,PC,3110-103-002.103001107,8.0,1340075,UBRO,Ubrogepant,109.36,ng/mL,109.36,109.36,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T14:38:00,1.0,5 h,5.0,Period 1 Dose,2018-03-23T09:38:00
3110-103-002,PC,3110-103-002.103001107,9.0,1340076,UBRO,Ubrogepant,75.00,ng/mL,75.00,75.0,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T15:38:00,1.0,6 h,6.0,Period 1 Dose,2018-03-23T09:38:00
3110-103-002,PC,3110-103-002.103001107,10.0,1340077,UBRO,Ubrogepant,46.07,ng/mL,46.07,46.07,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T17:38:00,1.0,8 h,8.0,Period 1 Dose,2018-03-23T09:38:00
3110-103-002,PC,3110-103-002.103001107,11.0,1340080,UBRO,Ubrogepant,18.10,ng/mL,18.10,18.1,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T21:38:00,1.0,12 h,12.0,Period 1 Dose,2018-03-23T09:38:00
3110-103-002,PC,3110-103-002.103001107,12.0,1340083,UBRO,Ubrogepant,11.94,ng/mL,11.94,11.94,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T23:38:00,1.0,14 h,14.0,Period 1 Dose,2018-03-23T09:38:00
3110-103-002,PC,3110-103-002.103001107,13.0,1340089,UBRO,Ubrogepant,3.39,ng/mL,3.39,3.39,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-03-24T09:38:00,2.0,24 h,24.0,Period 1 Dose,2018-03-23T09:38:00
3110-103-002,PC,3110-103-002.103001107,14.0,1340114,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T09:08:00,8.0,Predose,0.0,Period 2 Dose,2018-03-30T09:38:00
3110-103-002,PC,3110-103-002.103001107,15.0,1340116,UBRO,Ubrogepant,43.31,ng/mL,43.31,43.31,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:08:00,8.0,0.5 h,0.5,Period 2 Dose,2018-03-30T09:38:00
3110-103-002,PC,3110-103-002.103001107,16.0,1340119,UBRO,Ubrogepant,275.81,ng/mL,275.81,275.81,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:38:00,8.0,1 h,1.0,Period 2 Dose,2018-03-30T09:38:00
3110-103-002,PC,3110-103-002.103001107,17.0,1340122,UBRO,Ubrogepant,220.69,ng/mL,220.69,220.69,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:08:00,8.0,1.5 h,1.5,Period 2 Dose,2018-03-30T09:38:00
3110-103-002,PC,3110-103-002.103001107,18.0,1340126,UBRO,Ubrogepant,247.14,ng/mL,247.14,247.14,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:38:00,8.0,2 h,2.0,Period 2 Dose,2018-03-30T09:38:00
3110-103-002,PC,3110-103-002.103001107,19.0,1340127,UBRO,Ubrogepant,161.58,ng/mL,161.58,161.58,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T12:38:00,8.0,3 h,3.0,Period 2 Dose,2018-03-30T09:38:00
3110-103-002,PC,3110-103-002.103001107,20.0,1340128,UBRO,Ubrogepant,117.95,ng/mL,117.95,117.95,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T13:38:00,8.0,4 h,4.0,Period 2 Dose,2018-03-30T09:38:00
3110-103-002,PC,3110-103-002.103001107,21.0,1340133,UBRO,Ubrogepant,88.40,ng/mL,88.40,88.4,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T14:38:00,8.0,5 h,5.0,Period 2 Dose,2018-03-30T09:38:00
3110-103-002,PC,3110-103-002.103001107,22.0,1340134,UBRO,Ubrogepant,70.80,ng/mL,70.80,70.8,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T15:38:00,8.0,6 h,6.0,Period 2 Dose,2018-03-30T09:38:00
3110-103-002,PC,3110-103-002.103001107,23.0,1340135,UBRO,Ubrogepant,40.92,ng/mL,40.92,40.92,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T17:38:00,8.0,8 h,8.0,Period 2 Dose,2018-03-30T09:38:00
3110-103-002,PC,3110-103-002.103001107,24.0,1340138,UBRO,Ubrogepant,16.13,ng/mL,16.13,16.13,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T21:38:00,8.0,12 h,12.0,Period 2 Dose,2018-03-30T09:38:00
3110-103-002,PC,3110-103-002.103001107,25.0,1340141,UBRO,Ubrogepant,9.56,ng/mL,9.56,9.56,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T23:38:00,8.0,14 h,14.0,Period 2 Dose,2018-03-30T09:38:00
3110-103-002,PC,3110-103-002.103001107,26.0,1340147,UBRO,Ubrogepant,2.27,ng/mL,2.27,2.27,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-03-31T09:38:00,9.0,24 h,24.0,Period 2 Dose,2018-03-30T09:38:00
3110-103-002,PC,3110-103-002.103001107,27.0,1340172,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T09:08:00,15.0,Predose,0.0,Period 3 Dose,2018-04-06T09:38:00
3110-103-002,PC,3110-103-002.103001107,28.0,1340174,UBRO,Ubrogepant,10.73,ng/mL,10.73,10.73,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:08:00,15.0,0.5 h,0.5,Period 3 Dose,2018-04-06T09:38:00
3110-103-002,PC,3110-103-002.103001107,29.0,1340177,UBRO,Ubrogepant,49.83,ng/mL,49.83,49.83,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:38:00,15.0,1 h,1.0,Period 3 Dose,2018-04-06T09:38:00
3110-103-002,PC,3110-103-002.103001107,30.0,1340180,UBRO,Ubrogepant,91.92,ng/mL,91.92,91.92,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:08:00,15.0,1.5 h,1.5,Period 3 Dose,2018-04-06T09:38:00
3110-103-002,PC,3110-103-002.103001107,31.0,1340184,UBRO,Ubrogepant,192.83,ng/mL,192.83,192.83,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:38:00,15.0,2 h,2.0,Period 3 Dose,2018-04-06T09:38:00
3110-103-002,PC,3110-103-002.103001107,32.0,1340185,UBRO,Ubrogepant,202.26,ng/mL,202.26,202.26,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T12:38:00,15.0,3 h,3.0,Period 3 Dose,2018-04-06T09:38:00
3110-103-002,PC,3110-103-002.103001107,33.0,1340186,UBRO,Ubrogepant,218.70,ng/mL,218.70,218.7,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T13:38:00,15.0,4 h,4.0,Period 3 Dose,2018-04-06T09:38:00
3110-103-002,PC,3110-103-002.103001107,34.0,1340191,UBRO,Ubrogepant,169.04,ng/mL,169.04,169.04,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T14:38:00,15.0,5 h,5.0,Period 3 Dose,2018-04-06T09:38:00
3110-103-002,PC,3110-103-002.103001107,35.0,1340192,UBRO,Ubrogepant,127.62,ng/mL,127.62,127.62,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T15:38:00,15.0,6 h,6.0,Period 3 Dose,2018-04-06T09:38:00
3110-103-002,PC,3110-103-002.103001107,36.0,1340193,UBRO,Ubrogepant,60.56,ng/mL,60.56,60.56,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T17:38:00,15.0,8 h,8.0,Period 3 Dose,2018-04-06T09:38:00
3110-103-002,PC,3110-103-002.103001107,37.0,1340196,UBRO,Ubrogepant,27.92,ng/mL,27.92,27.92,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T21:38:00,15.0,12 h,12.0,Period 3 Dose,2018-04-06T09:38:00
3110-103-002,PC,3110-103-002.103001107,38.0,1340199,UBRO,Ubrogepant,18.06,ng/mL,18.06,18.06,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T23:38:00,15.0,14 h,14.0,Period 3 Dose,2018-04-06T09:38:00
3110-103-002,PC,3110-103-002.103001107,39.0,1340205,UBRO,Ubrogepant,2.63,ng/mL,2.63,2.63,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,26.0,Period 3 Day 16,TREATMENT,2018-04-07T09:38:00,16.0,24 h,24.0,Period 3 Dose,2018-04-06T09:38:00
3110-103-002,PC,3110-103-002.103001111,1.0,1340446,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T09:40:00,1.0,Predose,0.0,Period 1 Dose,2018-03-23T10:10:00
3110-103-002,PC,3110-103-002.103001111,2.0,1340448,UBRO,Ubrogepant,214.96,ng/mL,214.96,214.96,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:40:00,1.0,0.5 h,0.5,Period 1 Dose,2018-03-23T10:10:00
3110-103-002,PC,3110-103-002.103001111,3.0,1340451,UBRO,Ubrogepant,497.23,ng/mL,497.23,497.23,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:10:00,1.0,1 h,1.0,Period 1 Dose,2018-03-23T10:10:00
3110-103-002,PC,3110-103-002.103001111,4.0,1340454,UBRO,Ubrogepant,307.66,ng/mL,307.66,307.66,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:40:10,1.0,1.5 h,1.5,Period 1 Dose,2018-03-23T10:10:00
3110-103-002,PC,3110-103-002.103001111,5.0,1340458,UBRO,Ubrogepant,214.33,ng/mL,214.33,214.33,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T12:10:00,1.0,2 h,2.0,Period 1 Dose,2018-03-23T10:10:00
3110-103-002,PC,3110-103-002.103001111,6.0,1340459,UBRO,Ubrogepant,129.97,ng/mL,129.97,129.97,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T13:11:13,1.0,3 h,3.0,Period 1 Dose,2018-03-23T10:10:00
3110-103-002,PC,3110-103-002.103001111,7.0,1340460,UBRO,Ubrogepant,105.82,ng/mL,105.82,105.82,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T14:10:00,1.0,4 h,4.0,Period 1 Dose,2018-03-23T10:10:00
3110-103-002,PC,3110-103-002.103001111,8.0,1340465,UBRO,Ubrogepant,75.11,ng/mL,75.11,75.11,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T15:10:00,1.0,5 h,5.0,Period 1 Dose,2018-03-23T10:10:00
3110-103-002,PC,3110-103-002.103001111,9.0,1340466,UBRO,Ubrogepant,57.32,ng/mL,57.32,57.32,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T16:10:00,1.0,6 h,6.0,Period 1 Dose,2018-03-23T10:10:00
3110-103-002,PC,3110-103-002.103001111,10.0,1340467,UBRO,Ubrogepant,31.52,ng/mL,31.52,31.52,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T18:10:00,1.0,8 h,8.0,Period 1 Dose,2018-03-23T10:10:00
3110-103-002,PC,3110-103-002.103001111,11.0,1340470,UBRO,Ubrogepant,13.29,ng/mL,13.29,13.29,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T22:10:00,1.0,12 h,12.0,Period 1 Dose,2018-03-23T10:10:00
3110-103-002,PC,3110-103-002.103001111,12.0,1340473,UBRO,Ubrogepant,8.24,ng/mL,8.24,8.24,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-24T00:10:00,2.0,14 h,14.0,Period 1 Dose,2018-03-23T10:10:00
3110-103-002,PC,3110-103-002.103001111,13.0,1340479,UBRO,Ubrogepant,2.30,ng/mL,2.30,2.3,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-03-24T10:10:00,2.0,24 h,24.0,Period 1 Dose,2018-03-23T10:10:00
3110-103-002,PC,3110-103-002.103001111,14.0,1340504,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T09:40:00,8.0,Predose,0.0,Period 2 Dose,2018-03-30T10:10:00
3110-103-002,PC,3110-103-002.103001111,15.0,1340506,UBRO,Ubrogepant,169.55,ng/mL,169.55,169.55,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:40:00,8.0,0.5 h,0.5,Period 2 Dose,2018-03-30T10:10:00
3110-103-002,PC,3110-103-002.103001111,16.0,1340509,UBRO,Ubrogepant,394.81,ng/mL,394.81,394.81,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:10:00,8.0,1 h,1.0,Period 2 Dose,2018-03-30T10:10:00
3110-103-002,PC,3110-103-002.103001111,17.0,1340512,UBRO,Ubrogepant,289.00,ng/mL,289.00,289.0,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:40:00,8.0,1.5 h,1.5,Period 2 Dose,2018-03-30T10:10:00
3110-103-002,PC,3110-103-002.103001111,18.0,1340516,UBRO,Ubrogepant,215.34,ng/mL,215.34,215.34,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T12:10:00,8.0,2 h,2.0,Period 2 Dose,2018-03-30T10:10:00
3110-103-002,PC,3110-103-002.103001111,19.0,1340517,UBRO,Ubrogepant,144.50,ng/mL,144.50,144.5,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T13:10:00,8.0,3 h,3.0,Period 2 Dose,2018-03-30T10:10:00
3110-103-002,PC,3110-103-002.103001111,20.0,1340518,UBRO,Ubrogepant,97.69,ng/mL,97.69,97.69,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T14:10:00,8.0,4 h,4.0,Period 2 Dose,2018-03-30T10:10:00
3110-103-002,PC,3110-103-002.103001111,21.0,1340523,UBRO,Ubrogepant,80.72,ng/mL,80.72,80.72,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T15:10:00,8.0,5 h,5.0,Period 2 Dose,2018-03-30T10:10:00
3110-103-002,PC,3110-103-002.103001111,22.0,1340524,UBRO,Ubrogepant,65.45,ng/mL,65.45,65.45,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T16:10:00,8.0,6 h,6.0,Period 2 Dose,2018-03-30T10:10:00
3110-103-002,PC,3110-103-002.103001111,23.0,1340525,UBRO,Ubrogepant,42.78,ng/mL,42.78,42.78,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T18:10:00,8.0,8 h,8.0,Period 2 Dose,2018-03-30T10:10:00
3110-103-002,PC,3110-103-002.103001111,24.0,1340528,UBRO,Ubrogepant,20.38,ng/mL,20.38,20.38,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T22:10:00,8.0,12 h,12.0,Period 2 Dose,2018-03-30T10:10:00
3110-103-002,PC,3110-103-002.103001111,25.0,1340531,UBRO,Ubrogepant,15.07,ng/mL,15.07,15.07,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-31T00:10:00,9.0,14 h,14.0,Period 2 Dose,2018-03-30T10:10:00
3110-103-002,PC,3110-103-002.103001111,26.0,1340537,UBRO,Ubrogepant,4.06,ng/mL,4.06,4.06,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-03-31T10:10:00,9.0,24 h,24.0,Period 2 Dose,2018-03-30T10:10:00
3110-103-002,PC,3110-103-002.103001111,27.0,1340562,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-13T09:40:00,22.0,Predose,0.0,Period 3 Dose,2018-04-13T10:10:00
3110-103-002,PC,3110-103-002.103001111,28.0,1340564,UBRO,Ubrogepant,126.42,ng/mL,126.42,126.42,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-13T10:40:00,22.0,0.5 h,0.5,Period 3 Dose,2018-04-13T10:10:00
3110-103-002,PC,3110-103-002.103001111,29.0,1340567,UBRO,Ubrogepant,354.26,ng/mL,354.26,354.26,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-13T11:10:00,22.0,1 h,1.0,Period 3 Dose,2018-04-13T10:10:00
3110-103-002,PC,3110-103-002.103001111,30.0,1340570,UBRO,Ubrogepant,304.95,ng/mL,304.95,304.95,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-13T11:40:00,22.0,1.5 h,1.5,Period 3 Dose,2018-04-13T10:10:00
3110-103-002,PC,3110-103-002.103001111,31.0,1340574,UBRO,Ubrogepant,290.82,ng/mL,290.82,290.82,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-13T12:10:00,22.0,2 h,2.0,Period 3 Dose,2018-04-13T10:10:00
3110-103-002,PC,3110-103-002.103001111,32.0,1340575,UBRO,Ubrogepant,170.20,ng/mL,170.20,170.2,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-13T13:10:00,22.0,3 h,3.0,Period 3 Dose,2018-04-13T10:10:00
3110-103-002,PC,3110-103-002.103001111,33.0,1340576,UBRO,Ubrogepant,126.05,ng/mL,126.05,126.05,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-13T14:10:00,22.0,4 h,4.0,Period 3 Dose,2018-04-13T10:10:00
3110-103-002,PC,3110-103-002.103001111,34.0,1340581,UBRO,Ubrogepant,91.71,ng/mL,91.71,91.71,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-13T15:10:00,22.0,5 h,5.0,Period 3 Dose,2018-04-13T10:10:00
3110-103-002,PC,3110-103-002.103001111,35.0,1340582,UBRO,Ubrogepant,74.75,ng/mL,74.75,74.75,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-13T16:10:00,22.0,6 h,6.0,Period 3 Dose,2018-04-13T10:10:00
3110-103-002,PC,3110-103-002.103001111,36.0,1340583,UBRO,Ubrogepant,42.06,ng/mL,42.06,42.06,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-13T18:10:00,22.0,8 h,8.0,Period 3 Dose,2018-04-13T10:10:00
3110-103-002,PC,3110-103-002.103001111,37.0,1340586,UBRO,Ubrogepant,14.92,ng/mL,14.92,14.92,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-13T22:10:00,22.0,12 h,12.0,Period 3 Dose,2018-04-13T10:10:00
3110-103-002,PC,3110-103-002.103001111,38.0,1340589,UBRO,Ubrogepant,9.53,ng/mL,9.53,9.53,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-14T00:10:00,23.0,14 h,14.0,Period 3 Dose,2018-04-13T10:10:00
3110-103-002,PC,3110-103-002.103001111,39.0,1340595,UBRO,Ubrogepant,2.45,ng/mL,2.45,2.45,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,26.0,Period 3 Day 16,TREATMENT,2018-04-14T10:10:00,23.0,24 h,24.0,Period 3 Dose,2018-04-13T10:10:00
3110-103-002,PC,3110-103-002.103001114,1.0,1341421,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T09:09:00,1.0,Predose,0.0,Period 1 Dose,2018-03-23T09:39:00
3110-103-002,PC,3110-103-002.103001114,2.0,1341423,UBRO,Ubrogepant,194.10,ng/mL,194.10,194.1,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:09:00,1.0,0.5 h,0.5,Period 1 Dose,2018-03-23T09:39:00
3110-103-002,PC,3110-103-002.103001114,3.0,1341426,UBRO,Ubrogepant,257.23,ng/mL,257.23,257.23,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:39:00,1.0,1 h,1.0,Period 1 Dose,2018-03-23T09:39:00
3110-103-002,PC,3110-103-002.103001114,4.0,1341429,UBRO,Ubrogepant,170.42,ng/mL,170.42,170.42,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:09:00,1.0,1.5 h,1.5,Period 1 Dose,2018-03-23T09:39:00
3110-103-002,PC,3110-103-002.103001114,5.0,1341433,UBRO,Ubrogepant,140.73,ng/mL,140.73,140.73,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:41:39,1.0,2 h,2.0,Period 1 Dose,2018-03-23T09:39:00
3110-103-002,PC,3110-103-002.103001114,6.0,1341434,UBRO,Ubrogepant,103.12,ng/mL,103.12,103.12,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T12:39:00,1.0,3 h,3.0,Period 1 Dose,2018-03-23T09:39:00
3110-103-002,PC,3110-103-002.103001114,7.0,1341435,UBRO,Ubrogepant,76.17,ng/mL,76.17,76.17,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T13:39:00,1.0,4 h,4.0,Period 1 Dose,2018-03-23T09:39:00
3110-103-002,PC,3110-103-002.103001114,8.0,1341440,UBRO,Ubrogepant,61.90,ng/mL,61.90,61.9,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T14:39:00,1.0,5 h,5.0,Period 1 Dose,2018-03-23T09:39:00
3110-103-002,PC,3110-103-002.103001114,9.0,1341441,UBRO,Ubrogepant,43.60,ng/mL,43.60,43.6,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T15:40:28,1.0,6 h,6.0,Period 1 Dose,2018-03-23T09:39:00
3110-103-002,PC,3110-103-002.103001114,10.0,1341442,UBRO,Ubrogepant,26.61,ng/mL,26.61,26.61,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T17:43:03,1.0,8 h,8.0,Period 1 Dose,2018-03-23T09:39:00
3110-103-002,PC,3110-103-002.103001114,11.0,1341445,UBRO,Ubrogepant,10.00,ng/mL,10.00,10.0,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T21:40:16,1.0,12 h,12.0,Period 1 Dose,2018-03-23T09:39:00
3110-103-002,PC,3110-103-002.103001114,12.0,1341448,UBRO,Ubrogepant,6.71,ng/mL,6.71,6.71,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T23:39:00,1.0,14 h,14.0,Period 1 Dose,2018-03-23T09:39:00
3110-103-002,PC,3110-103-002.103001114,13.0,1341454,UBRO,Ubrogepant,1.36,ng/mL,1.36,1.36,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-03-24T09:39:00,2.0,24 h,24.0,Period 1 Dose,2018-03-23T09:39:00
3110-103-002,PC,3110-103-002.103001114,14.0,1341479,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T09:09:00,8.0,Predose,0.0,Period 2 Dose,2018-03-30T09:39:00
3110-103-002,PC,3110-103-002.103001114,15.0,1341481,UBRO,Ubrogepant,118.52,ng/mL,118.52,118.52,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:09:00,8.0,0.5 h,0.5,Period 2 Dose,2018-03-30T09:39:00
3110-103-002,PC,3110-103-002.103001114,16.0,1341484,UBRO,Ubrogepant,282.42,ng/mL,282.42,282.42,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:39:00,8.0,1 h,1.0,Period 2 Dose,2018-03-30T09:39:00
3110-103-002,PC,3110-103-002.103001114,17.0,1341487,UBRO,Ubrogepant,222.41,ng/mL,222.41,222.41,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:09:00,8.0,1.5 h,1.5,Period 2 Dose,2018-03-30T09:39:00
3110-103-002,PC,3110-103-002.103001114,18.0,1341491,UBRO,Ubrogepant,194.51,ng/mL,194.51,194.51,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:39:00,8.0,2 h,2.0,Period 2 Dose,2018-03-30T09:39:00
3110-103-002,PC,3110-103-002.103001114,19.0,1341492,UBRO,Ubrogepant,174.25,ng/mL,174.25,174.25,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T12:39:00,8.0,3 h,3.0,Period 2 Dose,2018-03-30T09:39:00
3110-103-002,PC,3110-103-002.103001114,20.0,1341493,UBRO,Ubrogepant,115.57,ng/mL,115.57,115.57,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T13:39:00,8.0,4 h,4.0,Period 2 Dose,2018-03-30T09:39:00
3110-103-002,PC,3110-103-002.103001114,21.0,1341498,UBRO,Ubrogepant,69.14,ng/mL,69.14,69.14,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T14:39:00,8.0,5 h,5.0,Period 2 Dose,2018-03-30T09:39:00
3110-103-002,PC,3110-103-002.103001114,22.0,1341499,UBRO,Ubrogepant,55.31,ng/mL,55.31,55.31,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T15:39:00,8.0,6 h,6.0,Period 2 Dose,2018-03-30T09:39:00
3110-103-002,PC,3110-103-002.103001114,23.0,1341500,UBRO,Ubrogepant,31.54,ng/mL,31.54,31.54,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T17:39:00,8.0,8 h,8.0,Period 2 Dose,2018-03-30T09:39:00
3110-103-002,PC,3110-103-002.103001114,24.0,1341503,UBRO,Ubrogepant,12.25,ng/mL,12.25,12.25,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T21:39:00,8.0,12 h,12.0,Period 2 Dose,2018-03-30T09:39:00
3110-103-002,PC,3110-103-002.103001114,25.0,1341506,UBRO,Ubrogepant,5.98,ng/mL,5.98,5.98,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T23:39:00,8.0,14 h,14.0,Period 2 Dose,2018-03-30T09:39:00
3110-103-002,PC,3110-103-002.103001114,26.0,1341512,UBRO,Ubrogepant,1.02,ng/mL,1.02,1.02,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-03-31T09:39:00,9.0,24 h,24.0,Period 2 Dose,2018-03-30T09:39:00
3110-103-002,PC,3110-103-002.103001114,27.0,1341537,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T09:09:00,15.0,Predose,0.0,Period 3 Dose,2018-04-06T09:39:00
3110-103-002,PC,3110-103-002.103001114,28.0,1341539,UBRO,Ubrogepant,24.59,ng/mL,24.59,24.59,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:09:00,15.0,0.5 h,0.5,Period 3 Dose,2018-04-06T09:39:00
3110-103-002,PC,3110-103-002.103001114,29.0,1341542,UBRO,Ubrogepant,81.41,ng/mL,81.41,81.41,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:39:00,15.0,1 h,1.0,Period 3 Dose,2018-04-06T09:39:00
3110-103-002,PC,3110-103-002.103001114,30.0,1341545,UBRO,Ubrogepant,161.51,ng/mL,161.51,161.51,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:09:00,15.0,1.5 h,1.5,Period 3 Dose,2018-04-06T09:39:00
3110-103-002,PC,3110-103-002.103001114,31.0,1341549,UBRO,Ubrogepant,158.53,ng/mL,158.53,158.53,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:39:00,15.0,2 h,2.0,Period 3 Dose,2018-04-06T09:39:00
3110-103-002,PC,3110-103-002.103001114,32.0,1341550,UBRO,Ubrogepant,210.45,ng/mL,210.45,210.45,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T12:39:00,15.0,3 h,3.0,Period 3 Dose,2018-04-06T09:39:00
3110-103-002,PC,3110-103-002.103001114,33.0,1341551,UBRO,Ubrogepant,144.54,ng/mL,144.54,144.54,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T13:39:00,15.0,4 h,4.0,Period 3 Dose,2018-04-06T09:39:00
3110-103-002,PC,3110-103-002.103001114,34.0,1341556,UBRO,Ubrogepant,86.11,ng/mL,86.11,86.11,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T14:40:10,15.0,5 h,5.0,Period 3 Dose,2018-04-06T09:39:00
3110-103-002,PC,3110-103-002.103001114,35.0,1341557,UBRO,Ubrogepant,56.29,ng/mL,56.29,56.29,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T15:39:00,15.0,6 h,6.0,Period 3 Dose,2018-04-06T09:39:00
3110-103-002,PC,3110-103-002.103001114,36.0,1341558,UBRO,Ubrogepant,32.53,ng/mL,32.53,32.53,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T17:39:00,15.0,8 h,8.0,Period 3 Dose,2018-04-06T09:39:00
3110-103-002,PC,3110-103-002.103001114,37.0,1341561,UBRO,Ubrogepant,10.79,ng/mL,10.79,10.79,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T21:39:00,15.0,12 h,12.0,Period 3 Dose,2018-04-06T09:39:00
3110-103-002,PC,3110-103-002.103001114,38.0,1341564,UBRO,Ubrogepant,7.14,ng/mL,7.14,7.14,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T23:39:00,15.0,14 h,14.0,Period 3 Dose,2018-04-06T09:39:00
3110-103-002,PC,3110-103-002.103001114,39.0,1341570,UBRO,Ubrogepant,1.71,ng/mL,1.71,1.71,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,26.0,Period 3 Day 16,TREATMENT,2018-04-07T09:42:31,16.0,24 h,24.0,Period 3 Dose,2018-04-06T09:39:00
3110-103-002,PC,3110-103-002.103001129,1.0,1341616,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T09:35:00,1.0,Predose,0.0,Period 1 Dose,2018-03-23T10:05:00
3110-103-002,PC,3110-103-002.103001129,2.0,1341618,UBRO,Ubrogepant,61.72,ng/mL,61.72,61.72,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:35:00,1.0,0.5 h,0.5,Period 1 Dose,2018-03-23T10:05:00
3110-103-002,PC,3110-103-002.103001129,3.0,1341621,UBRO,Ubrogepant,219.33,ng/mL,219.33,219.33,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:05:00,1.0,1 h,1.0,Period 1 Dose,2018-03-23T10:05:00
3110-103-002,PC,3110-103-002.103001129,4.0,1341624,UBRO,Ubrogepant,266.99,ng/mL,266.99,266.99,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:35:00,1.0,1.5 h,1.5,Period 1 Dose,2018-03-23T10:05:00
3110-103-002,PC,3110-103-002.103001129,5.0,1341628,UBRO,Ubrogepant,222.94,ng/mL,222.94,222.94,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T12:05:00,1.0,2 h,2.0,Period 1 Dose,2018-03-23T10:05:00
3110-103-002,PC,3110-103-002.103001129,6.0,1341629,UBRO,Ubrogepant,154.47,ng/mL,154.47,154.47,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T13:05:00,1.0,3 h,3.0,Period 1 Dose,2018-03-23T10:05:00
3110-103-002,PC,3110-103-002.103001129,7.0,1341630,UBRO,Ubrogepant,126.15,ng/mL,126.15,126.15,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T14:05:00,1.0,4 h,4.0,Period 1 Dose,2018-03-23T10:05:00
3110-103-002,PC,3110-103-002.103001129,8.0,1341635,UBRO,Ubrogepant,79.92,ng/mL,79.92,79.92,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T15:05:00,1.0,5 h,5.0,Period 1 Dose,2018-03-23T10:05:00
3110-103-002,PC,3110-103-002.103001129,9.0,1341636,UBRO,Ubrogepant,61.33,ng/mL,61.33,61.33,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T16:05:00,1.0,6 h,6.0,Period 1 Dose,2018-03-23T10:05:00
3110-103-002,PC,3110-103-002.103001129,10.0,1341637,UBRO,Ubrogepant,29.24,ng/mL,29.24,29.24,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T18:05:00,1.0,8 h,8.0,Period 1 Dose,2018-03-23T10:05:00
3110-103-002,PC,3110-103-002.103001129,11.0,1341640,UBRO,Ubrogepant,7.34,ng/mL,7.34,7.34,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T22:05:00,1.0,12 h,12.0,Period 1 Dose,2018-03-23T10:05:00
3110-103-002,PC,3110-103-002.103001129,12.0,1341643,UBRO,Ubrogepant,4.16,ng/mL,4.16,4.16,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-24T00:05:00,2.0,14 h,14.0,Period 1 Dose,2018-03-23T10:05:00
3110-103-002,PC,3110-103-002.103001129,13.0,1341649,UBRO,Ubrogepant,1.44,ng/mL,1.44,1.44,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-03-24T10:05:00,2.0,24 h,24.0,Period 1 Dose,2018-03-23T10:05:00
3110-103-002,PC,3110-103-002.103001129,14.0,1341674,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T09:35:00,8.0,Predose,0.0,Period 2 Dose,2018-03-30T10:05:00
3110-103-002,PC,3110-103-002.103001129,15.0,1341676,UBRO,Ubrogepant,177.93,ng/mL,177.93,177.93,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:35:00,8.0,0.5 h,0.5,Period 2 Dose,2018-03-30T10:05:00
3110-103-002,PC,3110-103-002.103001129,16.0,1341679,UBRO,Ubrogepant,387.62,ng/mL,387.62,387.62,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:05:00,8.0,1 h,1.0,Period 2 Dose,2018-03-30T10:05:00
3110-103-002,PC,3110-103-002.103001129,17.0,1341682,UBRO,Ubrogepant,294.31,ng/mL,294.31,294.31,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:35:00,8.0,1.5 h,1.5,Period 2 Dose,2018-03-30T10:05:00
3110-103-002,PC,3110-103-002.103001129,18.0,1341686,UBRO,Ubrogepant,286.66,ng/mL,286.66,286.66,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T12:05:00,8.0,2 h,2.0,Period 2 Dose,2018-03-30T10:05:00
3110-103-002,PC,3110-103-002.103001129,19.0,1341687,UBRO,Ubrogepant,187.50,ng/mL,187.50,187.5,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T13:05:00,8.0,3 h,3.0,Period 2 Dose,2018-03-30T10:05:00
3110-103-002,PC,3110-103-002.103001129,20.0,1341688,UBRO,Ubrogepant,122.95,ng/mL,122.95,122.95,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T14:05:00,8.0,4 h,4.0,Period 2 Dose,2018-03-30T10:05:00
3110-103-002,PC,3110-103-002.103001129,21.0,1341693,UBRO,Ubrogepant,89.32,ng/mL,89.32,89.32,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T15:05:00,8.0,5 h,5.0,Period 2 Dose,2018-03-30T10:05:00
3110-103-002,PC,3110-103-002.103001129,22.0,1341694,UBRO,Ubrogepant,64.32,ng/mL,64.32,64.32,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T16:05:00,8.0,6 h,6.0,Period 2 Dose,2018-03-30T10:05:00
3110-103-002,PC,3110-103-002.103001129,23.0,1341695,UBRO,Ubrogepant,38.26,ng/mL,38.26,38.26,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T18:05:00,8.0,8 h,8.0,Period 2 Dose,2018-03-30T10:05:00
3110-103-002,PC,3110-103-002.103001129,24.0,1341698,UBRO,Ubrogepant,9.85,ng/mL,9.85,9.85,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T22:05:00,8.0,12 h,12.0,Period 2 Dose,2018-03-30T10:05:00
3110-103-002,PC,3110-103-002.103001129,25.0,1341701,UBRO,Ubrogepant,5.81,ng/mL,5.81,5.81,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-31T00:05:00,9.0,14 h,14.0,Period 2 Dose,2018-03-30T10:05:00
3110-103-002,PC,3110-103-002.103001129,26.0,1341707,UBRO,Ubrogepant,1.75,ng/mL,1.75,1.75,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-03-31T10:05:00,9.0,24 h,24.0,Period 2 Dose,2018-03-30T10:05:00
3110-103-002,PC,3110-103-002.103001129,27.0,1341732,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T09:35:00,15.0,Predose,0.0,Period 3 Dose,2018-04-06T10:05:00
3110-103-002,PC,3110-103-002.103001129,28.0,1341734,UBRO,Ubrogepant,149.56,ng/mL,149.56,149.56,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:35:00,15.0,0.5 h,0.5,Period 3 Dose,2018-04-06T10:05:00
3110-103-002,PC,3110-103-002.103001129,29.0,1341737,UBRO,Ubrogepant,326.46,ng/mL,326.46,326.46,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:05:00,15.0,1 h,1.0,Period 3 Dose,2018-04-06T10:05:00
3110-103-002,PC,3110-103-002.103001129,30.0,1341740,UBRO,Ubrogepant,294.46,ng/mL,294.46,294.46,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:35:00,15.0,1.5 h,1.5,Period 3 Dose,2018-04-06T10:05:00
3110-103-002,PC,3110-103-002.103001129,31.0,1341744,UBRO,Ubrogepant,225.22,ng/mL,225.22,225.22,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T12:05:00,15.0,2 h,2.0,Period 3 Dose,2018-04-06T10:05:00
3110-103-002,PC,3110-103-002.103001129,32.0,1341745,UBRO,Ubrogepant,148.10,ng/mL,148.10,148.1,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T13:05:00,15.0,3 h,3.0,Period 3 Dose,2018-04-06T10:05:00
3110-103-002,PC,3110-103-002.103001129,33.0,1341746,UBRO,Ubrogepant,104.15,ng/mL,104.15,104.15,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T14:05:00,15.0,4 h,4.0,Period 3 Dose,2018-04-06T10:05:00
3110-103-002,PC,3110-103-002.103001129,34.0,1341751,UBRO,Ubrogepant,86.49,ng/mL,86.49,86.49,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T15:05:00,15.0,5 h,5.0,Period 3 Dose,2018-04-06T10:05:00
3110-103-002,PC,3110-103-002.103001129,35.0,1341752,UBRO,Ubrogepant,63.63,ng/mL,63.63,63.63,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T16:05:00,15.0,6 h,6.0,Period 3 Dose,2018-04-06T10:05:00
3110-103-002,PC,3110-103-002.103001129,36.0,1341753,UBRO,Ubrogepant,33.96,ng/mL,33.96,33.96,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T18:05:00,15.0,8 h,8.0,Period 3 Dose,2018-04-06T10:05:00
3110-103-002,PC,3110-103-002.103001129,37.0,1341756,UBRO,Ubrogepant,10.00,ng/mL,10.00,10.0,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T22:05:00,15.0,12 h,12.0,Period 3 Dose,2018-04-06T10:05:00
3110-103-002,PC,3110-103-002.103001129,38.0,1341759,UBRO,Ubrogepant,4.65,ng/mL,4.65,4.65,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-07T00:05:00,16.0,14 h,14.0,Period 3 Dose,2018-04-06T10:05:00
3110-103-002,PC,3110-103-002.103001129,39.0,1341765,UBRO,Ubrogepant,1.65,ng/mL,1.65,1.65,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,26.0,Period 3 Day 16,TREATMENT,2018-04-07T10:05:00,16.0,24 h,24.0,Period 3 Dose,2018-04-06T10:05:00
3110-103-002,PC,3110-103-002.103001136,1.0,1346098,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T09:16:00,1.0,Predose,0.0,Period 1 Dose,2018-03-23T09:46:00
3110-103-002,PC,3110-103-002.103001136,2.0,1346102,UBRO,Ubrogepant,152.32,ng/mL,152.32,152.32,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:16:00,1.0,0.5 h,0.5,Period 1 Dose,2018-03-23T09:46:00
3110-103-002,PC,3110-103-002.103001136,3.0,1346106,UBRO,Ubrogepant,468.96,ng/mL,468.96,468.96,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:46:00,1.0,1 h,1.0,Period 1 Dose,2018-03-23T09:46:00
3110-103-002,PC,3110-103-002.103001136,4.0,1346109,UBRO,Ubrogepant,411.90,ng/mL,411.90,411.9,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:16:00,1.0,1.5 h,1.5,Period 1 Dose,2018-03-23T09:46:00
3110-103-002,PC,3110-103-002.103001136,5.0,1346113,UBRO,Ubrogepant,410.37,ng/mL,410.37,410.37,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:46:00,1.0,2 h,2.0,Period 1 Dose,2018-03-23T09:46:00
3110-103-002,PC,3110-103-002.103001136,6.0,1346114,UBRO,Ubrogepant,242.17,ng/mL,242.17,242.17,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T12:46:00,1.0,3 h,3.0,Period 1 Dose,2018-03-23T09:46:00
3110-103-002,PC,3110-103-002.103001136,7.0,1346115,UBRO,Ubrogepant,174.10,ng/mL,174.10,174.1,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T13:46:00,1.0,4 h,4.0,Period 1 Dose,2018-03-23T09:46:00
3110-103-002,PC,3110-103-002.103001136,8.0,1346120,UBRO,Ubrogepant,132.79,ng/mL,132.79,132.79,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T14:46:00,1.0,5 h,5.0,Period 1 Dose,2018-03-23T09:46:00
3110-103-002,PC,3110-103-002.103001136,9.0,1346121,UBRO,Ubrogepant,96.53,ng/mL,96.53,96.53,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T15:46:00,1.0,6 h,6.0,Period 1 Dose,2018-03-23T09:46:00
3110-103-002,PC,3110-103-002.103001136,10.0,1346122,UBRO,Ubrogepant,62.00,ng/mL,62.00,62.0,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T17:46:00,1.0,8 h,8.0,Period 1 Dose,2018-03-23T09:46:00
3110-103-002,PC,3110-103-002.103001136,11.0,1346125,UBRO,Ubrogepant,17.05,ng/mL,17.05,17.05,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T21:46:00,1.0,12 h,12.0,Period 1 Dose,2018-03-23T09:46:00
3110-103-002,PC,3110-103-002.103001136,12.0,1346128,UBRO,Ubrogepant,10.67,ng/mL,10.67,10.67,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T23:46:00,1.0,14 h,14.0,Period 1 Dose,2018-03-23T09:46:00
3110-103-002,PC,3110-103-002.103001136,13.0,1346134,UBRO,Ubrogepant,2.55,ng/mL,2.55,2.55,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-03-24T09:46:00,2.0,24 h,24.0,Period 1 Dose,2018-03-23T09:46:00
3110-103-002,PC,3110-103-002.103001136,14.0,1346159,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T09:16:00,8.0,Predose,0.0,Period 2 Dose,2018-03-30T09:46:00
3110-103-002,PC,3110-103-002.103001136,15.0,1346161,UBRO,Ubrogepant,70.34,ng/mL,70.34,70.34,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:16:00,8.0,0.5 h,0.5,Period 2 Dose,2018-03-30T09:46:00
3110-103-002,PC,3110-103-002.103001136,16.0,1346164,UBRO,Ubrogepant,341.91,ng/mL,341.91,341.91,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:46:00,8.0,1 h,1.0,Period 2 Dose,2018-03-30T09:46:00
3110-103-002,PC,3110-103-002.103001136,17.0,1346167,UBRO,Ubrogepant,313.37,ng/mL,313.37,313.37,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:16:00,8.0,1.5 h,1.5,Period 2 Dose,2018-03-30T09:46:00
3110-103-002,PC,3110-103-002.103001136,18.0,1346171,UBRO,Ubrogepant,265.26,ng/mL,265.26,265.26,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:46:00,8.0,2 h,2.0,Period 2 Dose,2018-03-30T09:46:00
3110-103-002,PC,3110-103-002.103001136,19.0,1346172,UBRO,Ubrogepant,216.59,ng/mL,216.59,216.59,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T12:46:00,8.0,3 h,3.0,Period 2 Dose,2018-03-30T09:46:00
3110-103-002,PC,3110-103-002.103001136,20.0,1346173,UBRO,Ubrogepant,185.92,ng/mL,185.92,185.92,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T13:46:00,8.0,4 h,4.0,Period 2 Dose,2018-03-30T09:46:00
3110-103-002,PC,3110-103-002.103001136,21.0,1346178,UBRO,Ubrogepant,118.75,ng/mL,118.75,118.75,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T14:46:00,8.0,5 h,5.0,Period 2 Dose,2018-03-30T09:46:00
3110-103-002,PC,3110-103-002.103001136,22.0,1346179,UBRO,Ubrogepant,87.50,ng/mL,87.50,87.5,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T15:46:00,8.0,6 h,6.0,Period 2 Dose,2018-03-30T09:46:00
3110-103-002,PC,3110-103-002.103001136,23.0,1346180,UBRO,Ubrogepant,57.10,ng/mL,57.10,57.1,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T17:46:00,8.0,8 h,8.0,Period 2 Dose,2018-03-30T09:46:00
3110-103-002,PC,3110-103-002.103001136,24.0,1346183,UBRO,Ubrogepant,16.52,ng/mL,16.52,16.52,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T21:46:00,8.0,12 h,12.0,Period 2 Dose,2018-03-30T09:46:00
3110-103-002,PC,3110-103-002.103001136,25.0,1346186,UBRO,Ubrogepant,10.80,ng/mL,10.80,10.8,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T23:46:00,8.0,14 h,14.0,Period 2 Dose,2018-03-30T09:46:00
3110-103-002,PC,3110-103-002.103001136,26.0,1346192,UBRO,Ubrogepant,2.10,ng/mL,2.10,2.1,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-03-31T09:46:00,9.0,24 h,24.0,Period 2 Dose,2018-03-30T09:46:00
3110-103-002,PC,3110-103-002.103001136,27.0,1346217,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T09:16:00,15.0,Predose,0.0,Period 3 Dose,2018-04-06T09:46:00
3110-103-002,PC,3110-103-002.103001136,28.0,1346219,UBRO,Ubrogepant,200.29,ng/mL,200.29,200.29,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:16:00,15.0,0.5 h,0.5,Period 3 Dose,2018-04-06T09:46:00
3110-103-002,PC,3110-103-002.103001136,29.0,1346222,UBRO,Ubrogepant,673.91,ng/mL,673.91,673.91,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:46:00,15.0,1 h,1.0,Period 3 Dose,2018-04-06T09:46:00
3110-103-002,PC,3110-103-002.103001136,30.0,1346225,UBRO,Ubrogepant,415.47,ng/mL,415.47,415.47,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:16:00,15.0,1.5 h,1.5,Period 3 Dose,2018-04-06T09:46:00
3110-103-002,PC,3110-103-002.103001136,31.0,1346229,UBRO,Ubrogepant,343.77,ng/mL,343.77,343.77,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:46:00,15.0,2 h,2.0,Period 3 Dose,2018-04-06T09:46:00
3110-103-002,PC,3110-103-002.103001136,32.0,1346230,UBRO,Ubrogepant,274.23,ng/mL,274.23,274.23,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T12:46:00,15.0,3 h,3.0,Period 3 Dose,2018-04-06T09:46:00
3110-103-002,PC,3110-103-002.103001136,33.0,1346231,UBRO,Ubrogepant,223.28,ng/mL,223.28,223.28,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T13:46:00,15.0,4 h,4.0,Period 3 Dose,2018-04-06T09:46:00
3110-103-002,PC,3110-103-002.103001136,34.0,1346236,UBRO,Ubrogepant,156.91,ng/mL,156.91,156.91,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T14:46:00,15.0,5 h,5.0,Period 3 Dose,2018-04-06T09:46:00
3110-103-002,PC,3110-103-002.103001136,35.0,1346237,UBRO,Ubrogepant,112.67,ng/mL,112.67,112.67,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T15:46:00,15.0,6 h,6.0,Period 3 Dose,2018-04-06T09:46:00
3110-103-002,PC,3110-103-002.103001136,36.0,1346238,UBRO,Ubrogepant,75.34,ng/mL,75.34,75.34,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T17:46:00,15.0,8 h,8.0,Period 3 Dose,2018-04-06T09:46:00
3110-103-002,PC,3110-103-002.103001136,37.0,1346241,UBRO,Ubrogepant,20.45,ng/mL,20.45,20.45,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T21:46:00,15.0,12 h,12.0,Period 3 Dose,2018-04-06T09:46:00
3110-103-002,PC,3110-103-002.103001136,38.0,1346244,UBRO,Ubrogepant,12.36,ng/mL,12.36,12.36,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T23:46:00,15.0,14 h,14.0,Period 3 Dose,2018-04-06T09:46:00
3110-103-002,PC,3110-103-002.103001136,39.0,1346250,UBRO,Ubrogepant,2.69,ng/mL,2.69,2.69,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,26.0,Period 3 Day 16,TREATMENT,2018-04-07T09:46:00,16.0,24 h,24.0,Period 3 Dose,2018-04-06T09:46:00
3110-103-002,PC,3110-103-002.103001141,1.0,1342006,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T09:10:00,1.0,Predose,0.0,Period 1 Dose,2018-03-23T09:40:00
3110-103-002,PC,3110-103-002.103001141,2.0,1342008,UBRO,Ubrogepant,46.92,ng/mL,46.92,46.92,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:10:00,1.0,0.5 h,0.5,Period 1 Dose,2018-03-23T09:40:00
3110-103-002,PC,3110-103-002.103001141,3.0,1342011,UBRO,Ubrogepant,232.50,ng/mL,232.50,232.5,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:40:00,1.0,1 h,1.0,Period 1 Dose,2018-03-23T09:40:00
3110-103-002,PC,3110-103-002.103001141,4.0,1342014,UBRO,Ubrogepant,212.84,ng/mL,212.84,212.84,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:10:00,1.0,1.5 h,1.5,Period 1 Dose,2018-03-23T09:40:00
3110-103-002,PC,3110-103-002.103001141,5.0,1342018,UBRO,Ubrogepant,208.72,ng/mL,208.72,208.72,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:40:00,1.0,2 h,2.0,Period 1 Dose,2018-03-23T09:40:00
3110-103-002,PC,3110-103-002.103001141,6.0,1342019,UBRO,Ubrogepant,132.49,ng/mL,132.49,132.49,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T12:40:00,1.0,3 h,3.0,Period 1 Dose,2018-03-23T09:40:00
3110-103-002,PC,3110-103-002.103001141,7.0,1342020,UBRO,Ubrogepant,147.75,ng/mL,147.75,147.75,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T13:40:00,1.0,4 h,4.0,Period 1 Dose,2018-03-23T09:40:00
3110-103-002,PC,3110-103-002.103001141,8.0,1342025,UBRO,Ubrogepant,114.56,ng/mL,114.56,114.56,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T14:40:00,1.0,5 h,5.0,Period 1 Dose,2018-03-23T09:40:00
3110-103-002,PC,3110-103-002.103001141,9.0,1342026,UBRO,Ubrogepant,76.69,ng/mL,76.69,76.69,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T15:40:00,1.0,6 h,6.0,Period 1 Dose,2018-03-23T09:40:00
3110-103-002,PC,3110-103-002.103001141,10.0,1342027,UBRO,Ubrogepant,41.11,ng/mL,41.11,41.11,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T17:40:00,1.0,8 h,8.0,Period 1 Dose,2018-03-23T09:40:00
3110-103-002,PC,3110-103-002.103001141,11.0,1342030,UBRO,Ubrogepant,18.03,ng/mL,18.03,18.03,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T21:40:00,1.0,12 h,12.0,Period 1 Dose,2018-03-23T09:40:00
3110-103-002,PC,3110-103-002.103001141,12.0,1342033,UBRO,Ubrogepant,11.44,ng/mL,11.44,11.44,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T23:40:00,1.0,14 h,14.0,Period 1 Dose,2018-03-23T09:40:00
3110-103-002,PC,3110-103-002.103001141,13.0,1342039,UBRO,Ubrogepant,3.90,ng/mL,3.90,3.9,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-03-24T09:40:00,2.0,24 h,24.0,Period 1 Dose,2018-03-23T09:40:00
3110-103-002,PC,3110-103-002.103001141,14.0,1342064,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T09:10:00,8.0,Predose,0.0,Period 2 Dose,2018-03-30T09:40:00
3110-103-002,PC,3110-103-002.103001141,15.0,1342066,UBRO,Ubrogepant,19.12,ng/mL,19.12,19.12,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:10:00,8.0,0.5 h,0.5,Period 2 Dose,2018-03-30T09:40:00
3110-103-002,PC,3110-103-002.103001141,16.0,1342069,UBRO,Ubrogepant,121.54,ng/mL,121.54,121.54,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:40:00,8.0,1 h,1.0,Period 2 Dose,2018-03-30T09:40:00
3110-103-002,PC,3110-103-002.103001141,17.0,1342072,UBRO,Ubrogepant,138.80,ng/mL,138.80,138.8,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:10:00,8.0,1.5 h,1.5,Period 2 Dose,2018-03-30T09:40:00
3110-103-002,PC,3110-103-002.103001141,18.0,1342076,UBRO,Ubrogepant,113.85,ng/mL,113.85,113.85,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:40:00,8.0,2 h,2.0,Period 2 Dose,2018-03-30T09:40:00
3110-103-002,PC,3110-103-002.103001141,19.0,1342077,UBRO,Ubrogepant,104.56,ng/mL,104.56,104.56,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T12:40:00,8.0,3 h,3.0,Period 2 Dose,2018-03-30T09:40:00
3110-103-002,PC,3110-103-002.103001141,20.0,1342078,UBRO,Ubrogepant,93.70,ng/mL,93.70,93.7,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T13:40:00,8.0,4 h,4.0,Period 2 Dose,2018-03-30T09:40:00
3110-103-002,PC,3110-103-002.103001141,21.0,1342083,UBRO,Ubrogepant,81.24,ng/mL,81.24,81.24,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T14:40:00,8.0,5 h,5.0,Period 2 Dose,2018-03-30T09:40:00
3110-103-002,PC,3110-103-002.103001141,22.0,1342084,UBRO,Ubrogepant,53.17,ng/mL,53.17,53.17,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T15:40:00,8.0,6 h,6.0,Period 2 Dose,2018-03-30T09:40:00
3110-103-002,PC,3110-103-002.103001141,23.0,1342085,UBRO,Ubrogepant,33.16,ng/mL,33.16,33.16,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T17:40:00,8.0,8 h,8.0,Period 2 Dose,2018-03-30T09:40:00
3110-103-002,PC,3110-103-002.103001141,24.0,1342088,UBRO,Ubrogepant,12.64,ng/mL,12.64,12.64,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T21:40:00,8.0,12 h,12.0,Period 2 Dose,2018-03-30T09:40:00
3110-103-002,PC,3110-103-002.103001141,25.0,1342091,UBRO,Ubrogepant,8.42,ng/mL,8.42,8.42,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T23:40:00,8.0,14 h,14.0,Period 2 Dose,2018-03-30T09:40:00
3110-103-002,PC,3110-103-002.103001141,26.0,1342097,UBRO,Ubrogepant,3.89,ng/mL,3.89,3.89,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-03-31T09:40:00,9.0,24 h,24.0,Period 2 Dose,2018-03-30T09:40:00
3110-103-002,PC,3110-103-002.103001141,27.0,1342122,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T09:10:00,15.0,Predose,0.0,Period 3 Dose,2018-04-06T09:40:00
3110-103-002,PC,3110-103-002.103001141,28.0,1342124,UBRO,Ubrogepant,35.29,ng/mL,35.29,35.29,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:10:00,15.0,0.5 h,0.5,Period 3 Dose,2018-04-06T09:40:00
3110-103-002,PC,3110-103-002.103001141,29.0,1342127,UBRO,Ubrogepant,146.41,ng/mL,146.41,146.41,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:40:00,15.0,1 h,1.0,Period 3 Dose,2018-04-06T09:40:00
3110-103-002,PC,3110-103-002.103001141,30.0,1342130,UBRO,Ubrogepant,192.84,ng/mL,192.84,192.84,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:10:00,15.0,1.5 h,1.5,Period 3 Dose,2018-04-06T09:40:00
3110-103-002,PC,3110-103-002.103001141,31.0,1342134,UBRO,Ubrogepant,195.97,ng/mL,195.97,195.97,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:40:00,15.0,2 h,2.0,Period 3 Dose,2018-04-06T09:40:00
3110-103-002,PC,3110-103-002.103001141,32.0,1342135,UBRO,Ubrogepant,159.12,ng/mL,159.12,159.12,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T12:40:00,15.0,3 h,3.0,Period 3 Dose,2018-04-06T09:40:00
3110-103-002,PC,3110-103-002.103001141,33.0,1342136,UBRO,Ubrogepant,119.78,ng/mL,119.78,119.78,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T13:40:00,15.0,4 h,4.0,Period 3 Dose,2018-04-06T09:40:00
3110-103-002,PC,3110-103-002.103001141,34.0,1342141,UBRO,Ubrogepant,95.05,ng/mL,95.05,95.05,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T14:40:00,15.0,5 h,5.0,Period 3 Dose,2018-04-06T09:40:00
3110-103-002,PC,3110-103-002.103001141,35.0,1342142,UBRO,Ubrogepant,68.74,ng/mL,68.74,68.74,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T15:40:00,15.0,6 h,6.0,Period 3 Dose,2018-04-06T09:40:00
3110-103-002,PC,3110-103-002.103001141,36.0,1342143,UBRO,Ubrogepant,34.94,ng/mL,34.94,34.94,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T17:40:00,15.0,8 h,8.0,Period 3 Dose,2018-04-06T09:40:00
3110-103-002,PC,3110-103-002.103001141,37.0,1342146,UBRO,Ubrogepant,14.03,ng/mL,14.03,14.03,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T21:40:00,15.0,12 h,12.0,Period 3 Dose,2018-04-06T09:40:00
3110-103-002,PC,3110-103-002.103001141,38.0,1342149,UBRO,Ubrogepant,8.77,ng/mL,8.77,8.77,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T23:40:00,15.0,14 h,14.0,Period 3 Dose,2018-04-06T09:40:00
3110-103-002,PC,3110-103-002.103001141,39.0,1342155,UBRO,Ubrogepant,3.21,ng/mL,3.21,3.21,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,26.0,Period 3 Day 16,TREATMENT,2018-04-07T09:40:00,16.0,24 h,24.0,Period 3 Dose,2018-04-06T09:40:00
3110-103-002,PC,3110-103-002.103001149,1.0,1342591,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T09:31:00,1.0,Predose,0.0,Period 1 Dose,2018-03-23T10:01:00
3110-103-002,PC,3110-103-002.103001149,2.0,1342593,UBRO,Ubrogepant,366.19,ng/mL,366.19,366.19,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:31:00,1.0,0.5 h,0.5,Period 1 Dose,2018-03-23T10:01:00
3110-103-002,PC,3110-103-002.103001149,3.0,1342596,UBRO,Ubrogepant,657.94,ng/mL,657.94,657.94,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:01:00,1.0,1 h,1.0,Period 1 Dose,2018-03-23T10:01:00
3110-103-002,PC,3110-103-002.103001149,4.0,1342599,UBRO,Ubrogepant,416.16,ng/mL,416.16,416.16,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:31:00,1.0,1.5 h,1.5,Period 1 Dose,2018-03-23T10:01:00
3110-103-002,PC,3110-103-002.103001149,5.0,1342603,UBRO,Ubrogepant,330.05,ng/mL,330.05,330.05,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T12:01:00,1.0,2 h,2.0,Period 1 Dose,2018-03-23T10:01:00
3110-103-002,PC,3110-103-002.103001149,6.0,1342604,UBRO,Ubrogepant,233.47,ng/mL,233.47,233.47,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T13:01:00,1.0,3 h,3.0,Period 1 Dose,2018-03-23T10:01:00
3110-103-002,PC,3110-103-002.103001149,7.0,1342605,UBRO,Ubrogepant,146.37,ng/mL,146.37,146.37,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T14:01:00,1.0,4 h,4.0,Period 1 Dose,2018-03-23T10:01:00
3110-103-002,PC,3110-103-002.103001149,8.0,1342610,UBRO,Ubrogepant,127.74,ng/mL,127.74,127.74,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T15:01:00,1.0,5 h,5.0,Period 1 Dose,2018-03-23T10:01:00
3110-103-002,PC,3110-103-002.103001149,9.0,1342611,UBRO,Ubrogepant,99.03,ng/mL,99.03,99.03,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T16:01:00,1.0,6 h,6.0,Period 1 Dose,2018-03-23T10:01:00
3110-103-002,PC,3110-103-002.103001149,10.0,1342612,UBRO,Ubrogepant,56.79,ng/mL,56.79,56.79,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T18:01:00,1.0,8 h,8.0,Period 1 Dose,2018-03-23T10:01:00
3110-103-002,PC,3110-103-002.103001149,11.0,1342615,UBRO,Ubrogepant,17.94,ng/mL,17.94,17.94,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T22:01:00,1.0,12 h,12.0,Period 1 Dose,2018-03-23T10:01:00
3110-103-002,PC,3110-103-002.103001149,12.0,1342618,UBRO,Ubrogepant,11.23,ng/mL,11.23,11.23,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-24T00:01:00,2.0,14 h,14.0,Period 1 Dose,2018-03-23T10:01:00
3110-103-002,PC,3110-103-002.103001149,13.0,1342624,UBRO,Ubrogepant,1.80,ng/mL,1.80,1.8,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-03-24T10:01:00,2.0,24 h,24.0,Period 1 Dose,2018-03-23T10:01:00
3110-103-002,PC,3110-103-002.103001149,14.0,1342649,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T09:31:00,8.0,Predose,0.0,Period 2 Dose,2018-03-30T10:01:00
3110-103-002,PC,3110-103-002.103001149,15.0,1342651,UBRO,Ubrogepant,123.59,ng/mL,123.59,123.59,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:31:00,8.0,0.5 h,0.5,Period 2 Dose,2018-03-30T10:01:00
3110-103-002,PC,3110-103-002.103001149,16.0,1342654,UBRO,Ubrogepant,293.13,ng/mL,293.13,293.13,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:01:00,8.0,1 h,1.0,Period 2 Dose,2018-03-30T10:01:00
3110-103-002,PC,3110-103-002.103001149,17.0,1342657,UBRO,Ubrogepant,553.93,ng/mL,553.93,553.93,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:31:00,8.0,1.5 h,1.5,Period 2 Dose,2018-03-30T10:01:00
3110-103-002,PC,3110-103-002.103001149,18.0,1342661,UBRO,Ubrogepant,429.91,ng/mL,429.91,429.91,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T12:01:00,8.0,2 h,2.0,Period 2 Dose,2018-03-30T10:01:00
3110-103-002,PC,3110-103-002.103001149,19.0,1342662,UBRO,Ubrogepant,275.10,ng/mL,275.10,275.1,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T13:01:00,8.0,3 h,3.0,Period 2 Dose,2018-03-30T10:01:00
3110-103-002,PC,3110-103-002.103001149,20.0,1342663,UBRO,Ubrogepant,205.78,ng/mL,205.78,205.78,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T14:01:00,8.0,4 h,4.0,Period 2 Dose,2018-03-30T10:01:00
3110-103-002,PC,3110-103-002.103001149,21.0,1342668,UBRO,Ubrogepant,139.31,ng/mL,139.31,139.31,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T15:01:00,8.0,5 h,5.0,Period 2 Dose,2018-03-30T10:01:00
3110-103-002,PC,3110-103-002.103001149,22.0,1342669,UBRO,Ubrogepant,116.86,ng/mL,116.86,116.86,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T16:01:00,8.0,6 h,6.0,Period 2 Dose,2018-03-30T10:01:00
3110-103-002,PC,3110-103-002.103001149,23.0,1342670,UBRO,Ubrogepant,59.40,ng/mL,59.40,59.4,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T18:01:00,8.0,8 h,8.0,Period 2 Dose,2018-03-30T10:01:00
3110-103-002,PC,3110-103-002.103001149,24.0,1342673,UBRO,Ubrogepant,22.54,ng/mL,22.54,22.54,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T22:01:00,8.0,12 h,12.0,Period 2 Dose,2018-03-30T10:01:00
3110-103-002,PC,3110-103-002.103001149,25.0,1342676,UBRO,Ubrogepant,12.42,ng/mL,12.42,12.42,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-31T00:01:00,9.0,14 h,14.0,Period 2 Dose,2018-03-30T10:01:00
3110-103-002,PC,3110-103-002.103001149,26.0,1342682,UBRO,Ubrogepant,2.67,ng/mL,2.67,2.67,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-03-31T10:01:00,9.0,24 h,24.0,Period 2 Dose,2018-03-30T10:01:00
3110-103-002,PC,3110-103-002.103001149,27.0,1342707,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T09:31:00,15.0,Predose,0.0,Period 3 Dose,2018-04-06T10:01:00
3110-103-002,PC,3110-103-002.103001149,28.0,1342709,UBRO,Ubrogepant,436.08,ng/mL,436.08,436.08,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:31:00,15.0,0.5 h,0.5,Period 3 Dose,2018-04-06T10:01:00
3110-103-002,PC,3110-103-002.103001149,29.0,1342712,UBRO,Ubrogepant,436.62,ng/mL,436.62,436.62,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:01:00,15.0,1 h,1.0,Period 3 Dose,2018-04-06T10:01:00
3110-103-002,PC,3110-103-002.103001149,30.0,1342715,UBRO,Ubrogepant,405.87,ng/mL,405.87,405.87,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:31:00,15.0,1.5 h,1.5,Period 3 Dose,2018-04-06T10:01:00
3110-103-002,PC,3110-103-002.103001149,31.0,1342719,UBRO,Ubrogepant,329.96,ng/mL,329.96,329.96,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T12:01:00,15.0,2 h,2.0,Period 3 Dose,2018-04-06T10:01:00
3110-103-002,PC,3110-103-002.103001149,32.0,1342720,UBRO,Ubrogepant,219.49,ng/mL,219.49,219.49,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T13:01:00,15.0,3 h,3.0,Period 3 Dose,2018-04-06T10:01:00
3110-103-002,PC,3110-103-002.103001149,33.0,1342721,UBRO,Ubrogepant,174.70,ng/mL,174.70,174.7,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T14:01:00,15.0,4 h,4.0,Period 3 Dose,2018-04-06T10:01:00
3110-103-002,PC,3110-103-002.103001149,34.0,1342726,UBRO,Ubrogepant,110.91,ng/mL,110.91,110.91,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T15:01:00,15.0,5 h,5.0,Period 3 Dose,2018-04-06T10:01:00
3110-103-002,PC,3110-103-002.103001149,35.0,1342727,UBRO,Ubrogepant,89.37,ng/mL,89.37,89.37,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T16:01:00,15.0,6 h,6.0,Period 3 Dose,2018-04-06T10:01:00
3110-103-002,PC,3110-103-002.103001149,36.0,1342728,UBRO,Ubrogepant,51.12,ng/mL,51.12,51.12,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T18:01:00,15.0,8 h,8.0,Period 3 Dose,2018-04-06T10:01:00
3110-103-002,PC,3110-103-002.103001149,37.0,1342731,UBRO,Ubrogepant,15.48,ng/mL,15.48,15.48,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T22:01:00,15.0,12 h,12.0,Period 3 Dose,2018-04-06T10:01:00
3110-103-002,PC,3110-103-002.103001149,38.0,1342734,UBRO,Ubrogepant,11.07,ng/mL,11.07,11.07,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-07T00:01:00,16.0,14 h,14.0,Period 3 Dose,2018-04-06T10:01:00
3110-103-002,PC,3110-103-002.103001149,39.0,1342740,UBRO,Ubrogepant,2.24,ng/mL,2.24,2.24,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,26.0,Period 3 Day 16,TREATMENT,2018-04-07T10:01:00,16.0,24 h,24.0,Period 3 Dose,2018-04-06T10:01:00
3110-103-002,PC,3110-103-002.103001150,1.0,1340251,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T09:41:00,1.0,Predose,0.0,Period 1 Dose,2018-03-23T10:11:00
3110-103-002,PC,3110-103-002.103001150,2.0,1340253,UBRO,Ubrogepant,91.25,ng/mL,91.25,91.25,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:41:00,1.0,0.5 h,0.5,Period 1 Dose,2018-03-23T10:11:00
3110-103-002,PC,3110-103-002.103001150,3.0,1340256,UBRO,Ubrogepant,497.51,ng/mL,497.51,497.51,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:11:00,1.0,1 h,1.0,Period 1 Dose,2018-03-23T10:11:00
3110-103-002,PC,3110-103-002.103001150,4.0,1340259,UBRO,Ubrogepant,410.19,ng/mL,410.19,410.19,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:41:00,1.0,1.5 h,1.5,Period 1 Dose,2018-03-23T10:11:00
3110-103-002,PC,3110-103-002.103001150,5.0,1340263,UBRO,Ubrogepant,318.33,ng/mL,318.33,318.33,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T12:11:00,1.0,2 h,2.0,Period 1 Dose,2018-03-23T10:11:00
3110-103-002,PC,3110-103-002.103001150,6.0,1340264,UBRO,Ubrogepant,212.31,ng/mL,212.31,212.31,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T13:11:00,1.0,3 h,3.0,Period 1 Dose,2018-03-23T10:11:00
3110-103-002,PC,3110-103-002.103001150,7.0,1340265,UBRO,Ubrogepant,135.26,ng/mL,135.26,135.26,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T14:11:00,1.0,4 h,4.0,Period 1 Dose,2018-03-23T10:11:00
3110-103-002,PC,3110-103-002.103001150,8.0,1340270,UBRO,Ubrogepant,101.26,ng/mL,101.26,101.26,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T15:11:00,1.0,5 h,5.0,Period 1 Dose,2018-03-23T10:11:00
3110-103-002,PC,3110-103-002.103001150,9.0,1340271,UBRO,Ubrogepant,66.47,ng/mL,66.47,66.47,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T16:11:00,1.0,6 h,6.0,Period 1 Dose,2018-03-23T10:11:00
3110-103-002,PC,3110-103-002.103001150,10.0,1340272,UBRO,Ubrogepant,36.86,ng/mL,36.86,36.86,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T18:11:00,1.0,8 h,8.0,Period 1 Dose,2018-03-23T10:11:00
3110-103-002,PC,3110-103-002.103001150,11.0,1340275,UBRO,Ubrogepant,13.12,ng/mL,13.12,13.12,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T22:11:00,1.0,12 h,12.0,Period 1 Dose,2018-03-23T10:11:00
3110-103-002,PC,3110-103-002.103001150,12.0,1340278,UBRO,Ubrogepant,8.74,ng/mL,8.74,8.74,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-24T00:11:00,2.0,14 h,14.0,Period 1 Dose,2018-03-23T10:11:00
3110-103-002,PC,3110-103-002.103001150,13.0,1340284,UBRO,Ubrogepant,2.85,ng/mL,2.85,2.85,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-03-24T10:11:00,2.0,24 h,24.0,Period 1 Dose,2018-03-23T10:11:00
3110-103-002,PC,3110-103-002.103001150,14.0,1340309,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T09:41:00,8.0,Predose,0.0,Period 2 Dose,2018-03-30T10:11:00
3110-103-002,PC,3110-103-002.103001150,15.0,1340311,UBRO,Ubrogepant,45.04,ng/mL,45.04,45.04,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:41:00,8.0,0.5 h,0.5,Period 2 Dose,2018-03-30T10:11:00
3110-103-002,PC,3110-103-002.103001150,16.0,1340314,UBRO,Ubrogepant,454.93,ng/mL,454.93,454.93,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:11:00,8.0,1 h,1.0,Period 2 Dose,2018-03-30T10:11:00
3110-103-002,PC,3110-103-002.103001150,17.0,1340317,UBRO,Ubrogepant,377.50,ng/mL,377.50,377.5,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:41:00,8.0,1.5 h,1.5,Period 2 Dose,2018-03-30T10:11:00
3110-103-002,PC,3110-103-002.103001150,18.0,1340321,UBRO,Ubrogepant,293.67,ng/mL,293.67,293.67,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T12:11:48,8.0,2 h,2.0,Period 2 Dose,2018-03-30T10:11:00
3110-103-002,PC,3110-103-002.103001150,19.0,1340322,UBRO,Ubrogepant,299.33,ng/mL,299.33,299.33,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T13:11:00,8.0,3 h,3.0,Period 2 Dose,2018-03-30T10:11:00
3110-103-002,PC,3110-103-002.103001150,20.0,1340323,UBRO,Ubrogepant,179.23,ng/mL,179.23,179.23,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T14:11:00,8.0,4 h,4.0,Period 2 Dose,2018-03-30T10:11:00
3110-103-002,PC,3110-103-002.103001150,21.0,1340328,UBRO,Ubrogepant,104.66,ng/mL,104.66,104.66,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T15:11:00,8.0,5 h,5.0,Period 2 Dose,2018-03-30T10:11:00
3110-103-002,PC,3110-103-002.103001150,22.0,1340329,UBRO,Ubrogepant,95.74,ng/mL,95.74,95.74,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T16:11:00,8.0,6 h,6.0,Period 2 Dose,2018-03-30T10:11:00
3110-103-002,PC,3110-103-002.103001150,23.0,1340330,UBRO,Ubrogepant,37.70,ng/mL,37.70,37.7,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T18:11:00,8.0,8 h,8.0,Period 2 Dose,2018-03-30T10:11:00
3110-103-002,PC,3110-103-002.103001150,24.0,1340333,UBRO,Ubrogepant,13.28,ng/mL,13.28,13.28,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T22:11:00,8.0,12 h,12.0,Period 2 Dose,2018-03-30T10:11:00
3110-103-002,PC,3110-103-002.103001150,25.0,1340336,UBRO,Ubrogepant,7.95,ng/mL,7.95,7.95,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-31T00:11:00,9.0,14 h,14.0,Period 2 Dose,2018-03-30T10:11:00
3110-103-002,PC,3110-103-002.103001150,26.0,1340342,UBRO,Ubrogepant,4.39,ng/mL,4.39,4.39,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-03-31T10:11:00,9.0,24 h,24.0,Period 2 Dose,2018-03-30T10:11:00
3110-103-002,PC,3110-103-002.103001150,27.0,1340367,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T09:41:00,15.0,Predose,0.0,Period 3 Dose,2018-04-06T10:11:00
3110-103-002,PC,3110-103-002.103001150,28.0,1340369,UBRO,Ubrogepant,38.67,ng/mL,38.67,38.67,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:41:00,15.0,0.5 h,0.5,Period 3 Dose,2018-04-06T10:11:00
3110-103-002,PC,3110-103-002.103001150,29.0,1340372,UBRO,Ubrogepant,289.21,ng/mL,289.21,289.21,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:11:00,15.0,1 h,1.0,Period 3 Dose,2018-04-06T10:11:00
3110-103-002,PC,3110-103-002.103001150,30.0,1340375,UBRO,Ubrogepant,237.31,ng/mL,237.31,237.31,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:41:00,15.0,1.5 h,1.5,Period 3 Dose,2018-04-06T10:11:00
3110-103-002,PC,3110-103-002.103001150,31.0,1340379,UBRO,Ubrogepant,309.33,ng/mL,309.33,309.33,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T12:11:00,15.0,2 h,2.0,Period 3 Dose,2018-04-06T10:11:00
3110-103-002,PC,3110-103-002.103001150,32.0,1340380,UBRO,Ubrogepant,215.46,ng/mL,215.46,215.46,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T13:11:00,15.0,3 h,3.0,Period 3 Dose,2018-04-06T10:11:00
3110-103-002,PC,3110-103-002.103001150,33.0,1340381,UBRO,Ubrogepant,165.64,ng/mL,165.64,165.64,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T14:11:00,15.0,4 h,4.0,Period 3 Dose,2018-04-06T10:11:00
3110-103-002,PC,3110-103-002.103001150,34.0,1340386,UBRO,Ubrogepant,129.32,ng/mL,129.32,129.32,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T15:11:00,15.0,5 h,5.0,Period 3 Dose,2018-04-06T10:11:00
3110-103-002,PC,3110-103-002.103001150,35.0,1340387,UBRO,Ubrogepant,85.26,ng/mL,85.26,85.26,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T16:11:00,15.0,6 h,6.0,Period 3 Dose,2018-04-06T10:11:00
3110-103-002,PC,3110-103-002.103001150,36.0,1340388,UBRO,Ubrogepant,53.89,ng/mL,53.89,53.89,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T18:11:00,15.0,8 h,8.0,Period 3 Dose,2018-04-06T10:11:00
3110-103-002,PC,3110-103-002.103001150,37.0,1340391,UBRO,Ubrogepant,11.87,ng/mL,11.87,11.87,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T22:11:00,15.0,12 h,12.0,Period 3 Dose,2018-04-06T10:11:00
3110-103-002,PC,3110-103-002.103001150,38.0,1340394,UBRO,Ubrogepant,5.62,ng/mL,5.62,5.62,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-07T00:11:00,16.0,14 h,14.0,Period 3 Dose,2018-04-06T10:11:00
3110-103-002,PC,3110-103-002.103001150,39.0,1340400,UBRO,Ubrogepant,2.63,ng/mL,2.63,2.63,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,26.0,Period 3 Day 16,TREATMENT,2018-04-07T10:11:00,16.0,24 h,24.0,Period 3 Dose,2018-04-06T10:11:00
3110-103-002,PC,3110-103-002.103001155,1.0,1341811,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T09:34:00,1.0,Predose,0.0,Period 1 Dose,2018-03-23T10:04:00
3110-103-002,PC,3110-103-002.103001155,2.0,1341813,UBRO,Ubrogepant,93.49,ng/mL,93.49,93.49,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:34:00,1.0,0.5 h,0.5,Period 1 Dose,2018-03-23T10:04:00
3110-103-002,PC,3110-103-002.103001155,3.0,1341816,UBRO,Ubrogepant,252.68,ng/mL,252.68,252.68,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:04:00,1.0,1 h,1.0,Period 1 Dose,2018-03-23T10:04:00
3110-103-002,PC,3110-103-002.103001155,4.0,1341819,UBRO,Ubrogepant,365.56,ng/mL,365.56,365.56,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:34:00,1.0,1.5 h,1.5,Period 1 Dose,2018-03-23T10:04:00
3110-103-002,PC,3110-103-002.103001155,5.0,1341823,UBRO,Ubrogepant,425.93,ng/mL,425.93,425.93,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T12:04:00,1.0,2 h,2.0,Period 1 Dose,2018-03-23T10:04:00
3110-103-002,PC,3110-103-002.103001155,6.0,1341824,UBRO,Ubrogepant,264.72,ng/mL,264.72,264.72,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T13:04:00,1.0,3 h,3.0,Period 1 Dose,2018-03-23T10:04:00
3110-103-002,PC,3110-103-002.103001155,7.0,1341825,UBRO,Ubrogepant,177.80,ng/mL,177.80,177.8,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T14:04:00,1.0,4 h,4.0,Period 1 Dose,2018-03-23T10:04:00
3110-103-002,PC,3110-103-002.103001155,8.0,1341830,UBRO,Ubrogepant,111.98,ng/mL,111.98,111.98,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T15:05:28,1.0,5 h,5.0,Period 1 Dose,2018-03-23T10:04:00
3110-103-002,PC,3110-103-002.103001155,9.0,1341831,UBRO,Ubrogepant,74.98,ng/mL,74.98,74.98,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T16:04:00,1.0,6 h,6.0,Period 1 Dose,2018-03-23T10:04:00
3110-103-002,PC,3110-103-002.103001155,10.0,1341832,UBRO,Ubrogepant,32.60,ng/mL,32.60,32.6,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T18:07:13,1.0,8 h,8.0,Period 1 Dose,2018-03-23T10:04:00
3110-103-002,PC,3110-103-002.103001155,11.0,1341835,UBRO,Ubrogepant,8.51,ng/mL,8.51,8.51,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T22:04:00,1.0,12 h,12.0,Period 1 Dose,2018-03-23T10:04:00
3110-103-002,PC,3110-103-002.103001155,12.0,1341838,UBRO,Ubrogepant,5.87,ng/mL,5.87,5.87,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-24T00:04:00,2.0,14 h,14.0,Period 1 Dose,2018-03-23T10:04:00
3110-103-002,PC,3110-103-002.103001155,13.0,1341844,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-03-24T10:04:00,2.0,24 h,24.0,Period 1 Dose,2018-03-23T10:04:00
3110-103-002,PC,3110-103-002.103001155,14.0,1341869,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T09:34:00,8.0,Predose,0.0,Period 2 Dose,2018-03-30T10:04:00
3110-103-002,PC,3110-103-002.103001155,15.0,1341871,UBRO,Ubrogepant,15.58,ng/mL,15.58,15.58,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:34:00,8.0,0.5 h,0.5,Period 2 Dose,2018-03-30T10:04:00
3110-103-002,PC,3110-103-002.103001155,16.0,1341874,UBRO,Ubrogepant,118.77,ng/mL,118.77,118.77,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:04:00,8.0,1 h,1.0,Period 2 Dose,2018-03-30T10:04:00
3110-103-002,PC,3110-103-002.103001155,17.0,1341877,UBRO,Ubrogepant,191.27,ng/mL,191.27,191.27,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:40:38,8.0,1.5 h,1.5,Period 2 Dose,2018-03-30T10:04:00
3110-103-002,PC,3110-103-002.103001155,18.0,1341881,UBRO,Ubrogepant,250.32,ng/mL,250.32,250.32,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T12:04:00,8.0,2 h,2.0,Period 2 Dose,2018-03-30T10:04:00
3110-103-002,PC,3110-103-002.103001155,19.0,1341882,UBRO,Ubrogepant,193.02,ng/mL,193.02,193.02,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T13:04:00,8.0,3 h,3.0,Period 2 Dose,2018-03-30T10:04:00
3110-103-002,PC,3110-103-002.103001155,20.0,1341883,UBRO,Ubrogepant,173.90,ng/mL,173.90,173.9,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T14:05:06,8.0,4 h,4.0,Period 2 Dose,2018-03-30T10:04:00
3110-103-002,PC,3110-103-002.103001155,21.0,1341888,UBRO,Ubrogepant,194.49,ng/mL,194.49,194.49,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T15:04:00,8.0,5 h,5.0,Period 2 Dose,2018-03-30T10:04:00
3110-103-002,PC,3110-103-002.103001155,22.0,1341889,UBRO,Ubrogepant,124.46,ng/mL,124.46,124.46,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T16:04:00,8.0,6 h,6.0,Period 2 Dose,2018-03-30T10:04:00
3110-103-002,PC,3110-103-002.103001155,23.0,1341890,UBRO,Ubrogepant,65.44,ng/mL,65.44,65.44,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T18:04:00,8.0,8 h,8.0,Period 2 Dose,2018-03-30T10:04:00
3110-103-002,PC,3110-103-002.103001155,24.0,1341893,UBRO,Ubrogepant,13.13,ng/mL,13.13,13.13,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T22:04:00,8.0,12 h,12.0,Period 2 Dose,2018-03-30T10:04:00
3110-103-002,PC,3110-103-002.103001155,25.0,1341896,UBRO,Ubrogepant,7.38,ng/mL,7.38,7.38,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-31T00:05:45,9.0,14 h,14.0,Period 2 Dose,2018-03-30T10:04:00
3110-103-002,PC,3110-103-002.103001155,26.0,1341902,UBRO,Ubrogepant,1.69,ng/mL,1.69,1.69,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-03-31T10:04:00,9.0,24 h,24.0,Period 2 Dose,2018-03-30T10:04:00
3110-103-002,PC,3110-103-002.103001155,27.0,1341927,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T09:34:00,15.0,Predose,0.0,Period 3 Dose,2018-04-06T10:04:00
3110-103-002,PC,3110-103-002.103001155,28.0,1341929,UBRO,Ubrogepant,64.92,ng/mL,64.92,64.92,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:34:00,15.0,0.5 h,0.5,Period 3 Dose,2018-04-06T10:04:00
3110-103-002,PC,3110-103-002.103001155,29.0,1341932,UBRO,Ubrogepant,268.00,ng/mL,268.00,268.0,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:04:00,15.0,1 h,1.0,Period 3 Dose,2018-04-06T10:04:00
3110-103-002,PC,3110-103-002.103001155,30.0,1341935,UBRO,Ubrogepant,454.35,ng/mL,454.35,454.35,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:34:00,15.0,1.5 h,1.5,Period 3 Dose,2018-04-06T10:04:00
3110-103-002,PC,3110-103-002.103001155,31.0,1341939,UBRO,Ubrogepant,480.19,ng/mL,480.19,480.19,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T12:04:00,15.0,2 h,2.0,Period 3 Dose,2018-04-06T10:04:00
3110-103-002,PC,3110-103-002.103001155,32.0,1341940,UBRO,Ubrogepant,240.77,ng/mL,240.77,240.77,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T13:04:00,15.0,3 h,3.0,Period 3 Dose,2018-04-06T10:04:00
3110-103-002,PC,3110-103-002.103001155,33.0,1341941,UBRO,Ubrogepant,182.43,ng/mL,182.43,182.43,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T14:04:00,15.0,4 h,4.0,Period 3 Dose,2018-04-06T10:04:00
3110-103-002,PC,3110-103-002.103001155,34.0,1341946,UBRO,Ubrogepant,105.77,ng/mL,105.77,105.77,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T15:06:20,15.0,5 h,5.0,Period 3 Dose,2018-04-06T10:04:00
3110-103-002,PC,3110-103-002.103001155,35.0,1341947,UBRO,Ubrogepant,77.73,ng/mL,77.73,77.73,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T16:04:00,15.0,6 h,6.0,Period 3 Dose,2018-04-06T10:04:00
3110-103-002,PC,3110-103-002.103001155,36.0,1341948,UBRO,Ubrogepant,34.38,ng/mL,34.38,34.38,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T18:04:00,15.0,8 h,8.0,Period 3 Dose,2018-04-06T10:04:00
3110-103-002,PC,3110-103-002.103001155,37.0,1341951,UBRO,Ubrogepant,10.21,ng/mL,10.21,10.21,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T22:04:00,15.0,12 h,12.0,Period 3 Dose,2018-04-06T10:04:00
3110-103-002,PC,3110-103-002.103001155,38.0,1341954,UBRO,Ubrogepant,5.62,ng/mL,5.62,5.62,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-07T00:04:00,16.0,14 h,14.0,Period 3 Dose,2018-04-06T10:04:00
3110-103-002,PC,3110-103-002.103001155,39.0,1341960,UBRO,Ubrogepant,1.05,ng/mL,1.05,1.05,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,26.0,Period 3 Day 16,TREATMENT,2018-04-07T10:04:00,16.0,24 h,24.0,Period 3 Dose,2018-04-06T10:04:00
3110-103-002,PC,3110-103-002.103001156,1.0,1343176,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T09:28:00,1.0,Predose,0.0,Period 1 Dose,2018-03-23T09:58:00
3110-103-002,PC,3110-103-002.103001156,2.0,1343178,UBRO,Ubrogepant,20.49,ng/mL,20.49,20.49,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:28:00,1.0,0.5 h,0.5,Period 1 Dose,2018-03-23T09:58:00
3110-103-002,PC,3110-103-002.103001156,3.0,1343181,UBRO,Ubrogepant,118.43,ng/mL,118.43,118.43,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:58:00,1.0,1 h,1.0,Period 1 Dose,2018-03-23T09:58:00
3110-103-002,PC,3110-103-002.103001156,4.0,1343184,UBRO,Ubrogepant,99.06,ng/mL,99.06,99.06,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:28:00,1.0,1.5 h,1.5,Period 1 Dose,2018-03-23T09:58:00
3110-103-002,PC,3110-103-002.103001156,5.0,1343188,UBRO,Ubrogepant,240.20,ng/mL,240.20,240.2,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:58:00,1.0,2 h,2.0,Period 1 Dose,2018-03-23T09:58:00
3110-103-002,PC,3110-103-002.103001156,6.0,1343189,UBRO,Ubrogepant,234.78,ng/mL,234.78,234.78,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T12:58:00,1.0,3 h,3.0,Period 1 Dose,2018-03-23T09:58:00
3110-103-002,PC,3110-103-002.103001156,7.0,1343190,UBRO,Ubrogepant,140.64,ng/mL,140.64,140.64,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T13:58:00,1.0,4 h,4.0,Period 1 Dose,2018-03-23T09:58:00
3110-103-002,PC,3110-103-002.103001156,8.0,1343195,UBRO,Ubrogepant,100.53,ng/mL,100.53,100.53,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T14:58:00,1.0,5 h,5.0,Period 1 Dose,2018-03-23T09:58:00
3110-103-002,PC,3110-103-002.103001156,9.0,1343196,UBRO,Ubrogepant,75.56,ng/mL,75.56,75.56,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T15:58:00,1.0,6 h,6.0,Period 1 Dose,2018-03-23T09:58:00
3110-103-002,PC,3110-103-002.103001156,10.0,1343197,UBRO,Ubrogepant,46.51,ng/mL,46.51,46.51,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T17:58:00,1.0,8 h,8.0,Period 1 Dose,2018-03-23T09:58:00
3110-103-002,PC,3110-103-002.103001156,11.0,1343200,UBRO,Ubrogepant,19.21,ng/mL,19.21,19.21,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T21:58:00,1.0,12 h,12.0,Period 1 Dose,2018-03-23T09:58:00
3110-103-002,PC,3110-103-002.103001156,12.0,1343203,UBRO,Ubrogepant,12.53,ng/mL,12.53,12.53,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T23:58:00,1.0,14 h,14.0,Period 1 Dose,2018-03-23T09:58:00
3110-103-002,PC,3110-103-002.103001156,13.0,1343209,UBRO,Ubrogepant,5.25,ng/mL,5.25,5.25,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-03-24T09:58:00,2.0,24 h,24.0,Period 1 Dose,2018-03-23T09:58:00
3110-103-002,PC,3110-103-002.103001193,1.0,1342201,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T09:33:00,1.0,Predose,0.0,Period 1 Dose,2018-03-23T10:03:00
3110-103-002,PC,3110-103-002.103001193,2.0,1342203,UBRO,Ubrogepant,153.82,ng/mL,153.82,153.82,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:33:00,1.0,0.5 h,0.5,Period 1 Dose,2018-03-23T10:03:00
3110-103-002,PC,3110-103-002.103001193,3.0,1342206,UBRO,Ubrogepant,482.13,ng/mL,482.13,482.13,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:03:00,1.0,1 h,1.0,Period 1 Dose,2018-03-23T10:03:00
3110-103-002,PC,3110-103-002.103001193,4.0,1342209,UBRO,Ubrogepant,490.38,ng/mL,490.38,490.38,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:33:00,1.0,1.5 h,1.5,Period 1 Dose,2018-03-23T10:03:00
3110-103-002,PC,3110-103-002.103001193,5.0,1342213,UBRO,Ubrogepant,439.76,ng/mL,439.76,439.76,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T12:03:00,1.0,2 h,2.0,Period 1 Dose,2018-03-23T10:03:00
3110-103-002,PC,3110-103-002.103001193,6.0,1342214,UBRO,Ubrogepant,334.83,ng/mL,334.83,334.83,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T13:03:00,1.0,3 h,3.0,Period 1 Dose,2018-03-23T10:03:00
3110-103-002,PC,3110-103-002.103001193,7.0,1342215,UBRO,Ubrogepant,247.52,ng/mL,247.52,247.52,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T14:03:00,1.0,4 h,4.0,Period 1 Dose,2018-03-23T10:03:00
3110-103-002,PC,3110-103-002.103001193,8.0,1342220,UBRO,Ubrogepant,169.99,ng/mL,169.99,169.99,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T15:03:00,1.0,5 h,5.0,Period 1 Dose,2018-03-23T10:03:00
3110-103-002,PC,3110-103-002.103001193,9.0,1342221,UBRO,Ubrogepant,119.59,ng/mL,119.59,119.59,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T16:03:00,1.0,6 h,6.0,Period 1 Dose,2018-03-23T10:03:00
3110-103-002,PC,3110-103-002.103001193,10.0,1342222,UBRO,Ubrogepant,67.79,ng/mL,67.79,67.79,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T18:03:00,1.0,8 h,8.0,Period 1 Dose,2018-03-23T10:03:00
3110-103-002,PC,3110-103-002.103001193,11.0,1342225,UBRO,Ubrogepant,16.32,ng/mL,16.32,16.32,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T22:03:00,1.0,12 h,12.0,Period 1 Dose,2018-03-23T10:03:00
3110-103-002,PC,3110-103-002.103001193,12.0,1342228,UBRO,Ubrogepant,12.98,ng/mL,12.98,12.98,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-24T00:03:00,2.0,14 h,14.0,Period 1 Dose,2018-03-23T10:03:00
3110-103-002,PC,3110-103-002.103001193,13.0,1342234,UBRO,Ubrogepant,3.17,ng/mL,3.17,3.17,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-03-24T10:03:00,2.0,24 h,24.0,Period 1 Dose,2018-03-23T10:03:00
3110-103-002,PC,3110-103-002.103001193,14.0,1342259,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T09:33:00,8.0,Predose,0.0,Period 2 Dose,2018-03-30T10:03:00
3110-103-002,PC,3110-103-002.103001193,15.0,1342261,UBRO,Ubrogepant,42.18,ng/mL,42.18,42.18,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:33:00,8.0,0.5 h,0.5,Period 2 Dose,2018-03-30T10:03:00
3110-103-002,PC,3110-103-002.103001193,16.0,1342264,UBRO,Ubrogepant,161.76,ng/mL,161.76,161.76,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:03:00,8.0,1 h,1.0,Period 2 Dose,2018-03-30T10:03:00
3110-103-002,PC,3110-103-002.103001193,17.0,1342267,UBRO,Ubrogepant,245.15,ng/mL,245.15,245.15,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:33:00,8.0,1.5 h,1.5,Period 2 Dose,2018-03-30T10:03:00
3110-103-002,PC,3110-103-002.103001193,18.0,1342271,UBRO,Ubrogepant,599.78,ng/mL,599.78,599.78,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T12:03:00,8.0,2 h,2.0,Period 2 Dose,2018-03-30T10:03:00
3110-103-002,PC,3110-103-002.103001193,19.0,1342272,UBRO,Ubrogepant,527.94,ng/mL,527.94,527.94,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T13:03:00,8.0,3 h,3.0,Period 2 Dose,2018-03-30T10:03:00
3110-103-002,PC,3110-103-002.103001193,20.0,1342273,UBRO,Ubrogepant,418.58,ng/mL,418.58,418.58,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T14:03:00,8.0,4 h,4.0,Period 2 Dose,2018-03-30T10:03:00
3110-103-002,PC,3110-103-002.103001193,21.0,1342278,UBRO,Ubrogepant,276.86,ng/mL,276.86,276.86,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T15:03:00,8.0,5 h,5.0,Period 2 Dose,2018-03-30T10:03:00
3110-103-002,PC,3110-103-002.103001193,22.0,1342279,UBRO,Ubrogepant,231.18,ng/mL,231.18,231.18,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T16:03:00,8.0,6 h,6.0,Period 2 Dose,2018-03-30T10:03:00
3110-103-002,PC,3110-103-002.103001193,23.0,1342280,UBRO,Ubrogepant,119.21,ng/mL,119.21,119.21,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T18:03:00,8.0,8 h,8.0,Period 2 Dose,2018-03-30T10:03:00
3110-103-002,PC,3110-103-002.103001193,24.0,1342283,UBRO,Ubrogepant,41.98,ng/mL,41.98,41.98,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T22:03:00,8.0,12 h,12.0,Period 2 Dose,2018-03-30T10:03:00
3110-103-002,PC,3110-103-002.103001193,25.0,1342286,UBRO,Ubrogepant,17.09,ng/mL,17.09,17.09,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-31T00:03:00,9.0,14 h,14.0,Period 2 Dose,2018-03-30T10:03:00
3110-103-002,PC,3110-103-002.103001193,26.0,1342292,UBRO,Ubrogepant,5.80,ng/mL,5.80,5.8,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-03-31T10:04:08,9.0,24 h,24.0,Period 2 Dose,2018-03-30T10:03:00
3110-103-002,PC,3110-103-002.103001193,27.0,1342317,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T09:33:00,15.0,Predose,0.0,Period 3 Dose,2018-04-06T10:03:00
3110-103-002,PC,3110-103-002.103001193,28.0,1342319,UBRO,Ubrogepant,125.94,ng/mL,125.94,125.94,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:33:00,15.0,0.5 h,0.5,Period 3 Dose,2018-04-06T10:03:00
3110-103-002,PC,3110-103-002.103001193,29.0,1342322,UBRO,Ubrogepant,408.77,ng/mL,408.77,408.77,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:03:00,15.0,1 h,1.0,Period 3 Dose,2018-04-06T10:03:00
3110-103-002,PC,3110-103-002.103001193,30.0,1342325,UBRO,Ubrogepant,374.00,ng/mL,374.00,374.0,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:33:00,15.0,1.5 h,1.5,Period 3 Dose,2018-04-06T10:03:00
3110-103-002,PC,3110-103-002.103001193,31.0,1342329,UBRO,Ubrogepant,559.32,ng/mL,559.32,559.32,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T12:03:00,15.0,2 h,2.0,Period 3 Dose,2018-04-06T10:03:00
3110-103-002,PC,3110-103-002.103001193,32.0,1342330,UBRO,Ubrogepant,402.77,ng/mL,402.77,402.77,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T13:03:00,15.0,3 h,3.0,Period 3 Dose,2018-04-06T10:03:00
3110-103-002,PC,3110-103-002.103001193,33.0,1342331,UBRO,Ubrogepant,274.66,ng/mL,274.66,274.66,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T14:03:00,15.0,4 h,4.0,Period 3 Dose,2018-04-06T10:03:00
3110-103-002,PC,3110-103-002.103001193,34.0,1342336,UBRO,Ubrogepant,206.83,ng/mL,206.83,206.83,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T15:03:00,15.0,5 h,5.0,Period 3 Dose,2018-04-06T10:03:00
3110-103-002,PC,3110-103-002.103001193,35.0,1342337,UBRO,Ubrogepant,142.04,ng/mL,142.04,142.04,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T16:03:00,15.0,6 h,6.0,Period 3 Dose,2018-04-06T10:03:00
3110-103-002,PC,3110-103-002.103001193,36.0,1342338,UBRO,Ubrogepant,82.98,ng/mL,82.98,82.98,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T18:03:00,15.0,8 h,8.0,Period 3 Dose,2018-04-06T10:03:00
3110-103-002,PC,3110-103-002.103001193,37.0,1342341,UBRO,Ubrogepant,27.59,ng/mL,27.59,27.59,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T22:03:00,15.0,12 h,12.0,Period 3 Dose,2018-04-06T10:03:00
3110-103-002,PC,3110-103-002.103001193,38.0,1342344,UBRO,Ubrogepant,17.33,ng/mL,17.33,17.33,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-07T00:03:00,16.0,14 h,14.0,Period 3 Dose,2018-04-06T10:03:00
3110-103-002,PC,3110-103-002.103001193,39.0,1342350,UBRO,Ubrogepant,3.83,ng/mL,3.83,3.83,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,26.0,Period 3 Day 16,TREATMENT,2018-04-07T10:03:00,16.0,24 h,24.0,Period 3 Dose,2018-04-06T10:03:00
3110-103-002,PC,3110-103-002.103001201,1.0,1338496,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T09:00:00,1.0,Predose,0.0,Period 1 Dose,2018-03-23T09:30:00
3110-103-002,PC,3110-103-002.103001201,2.0,1338498,UBRO,Ubrogepant,5.20,ng/mL,5.20,5.2,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:00:00,1.0,0.5 h,0.5,Period 1 Dose,2018-03-23T09:30:00
3110-103-002,PC,3110-103-002.103001201,3.0,1338501,UBRO,Ubrogepant,101.35,ng/mL,101.35,101.35,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:30:00,1.0,1 h,1.0,Period 1 Dose,2018-03-23T09:30:00
3110-103-002,PC,3110-103-002.103001201,4.0,1338504,UBRO,Ubrogepant,191.01,ng/mL,191.01,191.01,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:00:00,1.0,1.5 h,1.5,Period 1 Dose,2018-03-23T09:30:00
3110-103-002,PC,3110-103-002.103001201,5.0,1338508,UBRO,Ubrogepant,269.48,ng/mL,269.48,269.48,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:30:00,1.0,2 h,2.0,Period 1 Dose,2018-03-23T09:30:00
3110-103-002,PC,3110-103-002.103001201,6.0,1338509,UBRO,Ubrogepant,210.39,ng/mL,210.39,210.39,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T12:30:00,1.0,3 h,3.0,Period 1 Dose,2018-03-23T09:30:00
3110-103-002,PC,3110-103-002.103001201,7.0,1338510,UBRO,Ubrogepant,131.78,ng/mL,131.78,131.78,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T13:30:00,1.0,4 h,4.0,Period 1 Dose,2018-03-23T09:30:00
3110-103-002,PC,3110-103-002.103001201,8.0,1338515,UBRO,Ubrogepant,85.88,ng/mL,85.88,85.88,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T14:30:00,1.0,5 h,5.0,Period 1 Dose,2018-03-23T09:30:00
3110-103-002,PC,3110-103-002.103001201,9.0,1338516,UBRO,Ubrogepant,61.58,ng/mL,61.58,61.58,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T15:30:00,1.0,6 h,6.0,Period 1 Dose,2018-03-23T09:30:00
3110-103-002,PC,3110-103-002.103001201,10.0,1338517,UBRO,Ubrogepant,33.82,ng/mL,33.82,33.82,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T17:30:00,1.0,8 h,8.0,Period 1 Dose,2018-03-23T09:30:00
3110-103-002,PC,3110-103-002.103001201,11.0,1338520,UBRO,Ubrogepant,12.47,ng/mL,12.47,12.47,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T21:30:00,1.0,12 h,12.0,Period 1 Dose,2018-03-23T09:30:00
3110-103-002,PC,3110-103-002.103001201,12.0,1338523,UBRO,Ubrogepant,8.34,ng/mL,8.34,8.34,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T23:30:00,1.0,14 h,14.0,Period 1 Dose,2018-03-23T09:30:00
3110-103-002,PC,3110-103-002.103001201,13.0,1338529,UBRO,Ubrogepant,5.66,ng/mL,5.66,5.66,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-03-24T09:30:00,2.0,24 h,24.0,Period 1 Dose,2018-03-23T09:30:00
3110-103-002,PC,3110-103-002.103001201,14.0,1338554,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T09:00:00,8.0,Predose,0.0,Period 2 Dose,2018-03-30T09:30:00
3110-103-002,PC,3110-103-002.103001201,15.0,1338556,UBRO,Ubrogepant,20.39,ng/mL,20.39,20.39,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:00:00,8.0,0.5 h,0.5,Period 2 Dose,2018-03-30T09:30:00
3110-103-002,PC,3110-103-002.103001201,16.0,1338559,UBRO,Ubrogepant,117.63,ng/mL,117.63,117.63,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:30:00,8.0,1 h,1.0,Period 2 Dose,2018-03-30T09:30:00
3110-103-002,PC,3110-103-002.103001201,17.0,1338562,UBRO,Ubrogepant,133.76,ng/mL,133.76,133.76,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:00:00,8.0,1.5 h,1.5,Period 2 Dose,2018-03-30T09:30:00
3110-103-002,PC,3110-103-002.103001201,18.0,1338566,UBRO,Ubrogepant,192.72,ng/mL,192.72,192.72,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:30:00,8.0,2 h,2.0,Period 2 Dose,2018-03-30T09:30:00
3110-103-002,PC,3110-103-002.103001201,19.0,1338567,UBRO,Ubrogepant,196.32,ng/mL,196.32,196.32,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T12:30:00,8.0,3 h,3.0,Period 2 Dose,2018-03-30T09:30:00
3110-103-002,PC,3110-103-002.103001201,20.0,1338568,UBRO,Ubrogepant,146.02,ng/mL,146.02,146.02,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T13:30:00,8.0,4 h,4.0,Period 2 Dose,2018-03-30T09:30:00
3110-103-002,PC,3110-103-002.103001201,21.0,1338573,UBRO,Ubrogepant,98.00,ng/mL,98.00,98.0,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T14:30:00,8.0,5 h,5.0,Period 2 Dose,2018-03-30T09:30:00
3110-103-002,PC,3110-103-002.103001201,22.0,1338574,UBRO,Ubrogepant,70.68,ng/mL,70.68,70.68,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T15:30:00,8.0,6 h,6.0,Period 2 Dose,2018-03-30T09:30:00
3110-103-002,PC,3110-103-002.103001201,23.0,1338575,UBRO,Ubrogepant,39.49,ng/mL,39.49,39.49,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T17:30:00,8.0,8 h,8.0,Period 2 Dose,2018-03-30T09:30:00
3110-103-002,PC,3110-103-002.103001201,24.0,1338578,UBRO,Ubrogepant,12.86,ng/mL,12.86,12.86,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T21:30:00,8.0,12 h,12.0,Period 2 Dose,2018-03-30T09:30:00
3110-103-002,PC,3110-103-002.103001201,25.0,1338581,UBRO,Ubrogepant,9.18,ng/mL,9.18,9.18,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T23:30:00,8.0,14 h,14.0,Period 2 Dose,2018-03-30T09:30:00
3110-103-002,PC,3110-103-002.103001201,26.0,1338587,UBRO,Ubrogepant,3.95,ng/mL,3.95,3.95,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-03-31T09:30:00,9.0,24 h,24.0,Period 2 Dose,2018-03-30T09:30:00
3110-103-002,PC,3110-103-002.103001201,27.0,1338612,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T09:00:00,15.0,Predose,0.0,Period 3 Dose,2018-04-06T09:30:00
3110-103-002,PC,3110-103-002.103001201,28.0,1338614,UBRO,Ubrogepant,10.30,ng/mL,10.30,10.3,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:00:00,15.0,0.5 h,0.5,Period 3 Dose,2018-04-06T09:30:00
3110-103-002,PC,3110-103-002.103001201,29.0,1338617,UBRO,Ubrogepant,12.26,ng/mL,12.26,12.26,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:30:00,15.0,1 h,1.0,Period 3 Dose,2018-04-06T09:30:00
3110-103-002,PC,3110-103-002.103001201,30.0,1338620,UBRO,Ubrogepant,21.83,ng/mL,21.83,21.83,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:00:00,15.0,1.5 h,1.5,Period 3 Dose,2018-04-06T09:30:00
3110-103-002,PC,3110-103-002.103001201,31.0,1338624,UBRO,Ubrogepant,49.62,ng/mL,49.62,49.62,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:30:00,15.0,2 h,2.0,Period 3 Dose,2018-04-06T09:30:00
3110-103-002,PC,3110-103-002.103001201,32.0,1338625,UBRO,Ubrogepant,48.44,ng/mL,48.44,48.44,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T12:30:00,15.0,3 h,3.0,Period 3 Dose,2018-04-06T09:30:00
3110-103-002,PC,3110-103-002.103001201,33.0,1338626,UBRO,Ubrogepant,38.65,ng/mL,38.65,38.65,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T13:30:00,15.0,4 h,4.0,Period 3 Dose,2018-04-06T09:30:00
3110-103-002,PC,3110-103-002.103001201,34.0,1338631,UBRO,Ubrogepant,39.10,ng/mL,39.10,39.1,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T14:30:00,15.0,5 h,5.0,Period 3 Dose,2018-04-06T09:30:00
3110-103-002,PC,3110-103-002.103001201,35.0,1338632,UBRO,Ubrogepant,29.57,ng/mL,29.57,29.57,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T15:30:00,15.0,6 h,6.0,Period 3 Dose,2018-04-06T09:30:00
3110-103-002,PC,3110-103-002.103001201,36.0,1338633,UBRO,Ubrogepant,19.33,ng/mL,19.33,19.33,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T17:30:00,15.0,8 h,8.0,Period 3 Dose,2018-04-06T09:30:00
3110-103-002,PC,3110-103-002.103001201,37.0,1338636,UBRO,Ubrogepant,8.96,ng/mL,8.96,8.96,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T21:30:00,15.0,12 h,12.0,Period 3 Dose,2018-04-06T09:30:00
3110-103-002,PC,3110-103-002.103001201,38.0,1338639,UBRO,Ubrogepant,7.23,ng/mL,7.23,7.23,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T23:30:00,15.0,14 h,14.0,Period 3 Dose,2018-04-06T09:30:00
3110-103-002,PC,3110-103-002.103001201,39.0,1338645,UBRO,Ubrogepant,5.74,ng/mL,5.74,5.74,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,26.0,Period 3 Day 16,TREATMENT,2018-04-07T09:30:00,16.0,24 h,24.0,Period 3 Dose,2018-04-06T09:30:00
3110-103-002,PC,3110-103-002.103001211,1.0,1338691,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T09:01:00,1.0,Predose,0.0,Period 1 Dose,2018-03-23T09:31:00
3110-103-002,PC,3110-103-002.103001211,2.0,1338693,UBRO,Ubrogepant,133.70,ng/mL,133.70,133.7,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:01:00,1.0,0.5 h,0.5,Period 1 Dose,2018-03-23T09:31:00
3110-103-002,PC,3110-103-002.103001211,3.0,1338696,UBRO,Ubrogepant,332.67,ng/mL,332.67,332.67,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T10:31:00,1.0,1 h,1.0,Period 1 Dose,2018-03-23T09:31:00
3110-103-002,PC,3110-103-002.103001211,4.0,1338699,UBRO,Ubrogepant,236.97,ng/mL,236.97,236.97,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:01:00,1.0,1.5 h,1.5,Period 1 Dose,2018-03-23T09:31:00
3110-103-002,PC,3110-103-002.103001211,5.0,1338703,UBRO,Ubrogepant,234.27,ng/mL,234.27,234.27,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T11:31:00,1.0,2 h,2.0,Period 1 Dose,2018-03-23T09:31:00
3110-103-002,PC,3110-103-002.103001211,6.0,1338704,UBRO,Ubrogepant,176.23,ng/mL,176.23,176.23,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T12:31:00,1.0,3 h,3.0,Period 1 Dose,2018-03-23T09:31:00
3110-103-002,PC,3110-103-002.103001211,7.0,1338705,UBRO,Ubrogepant,151.09,ng/mL,151.09,151.09,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T13:31:00,1.0,4 h,4.0,Period 1 Dose,2018-03-23T09:31:00
3110-103-002,PC,3110-103-002.103001211,8.0,1338710,UBRO,Ubrogepant,107.03,ng/mL,107.03,107.03,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T14:31:00,1.0,5 h,5.0,Period 1 Dose,2018-03-23T09:31:00
3110-103-002,PC,3110-103-002.103001211,9.0,1338711,UBRO,Ubrogepant,81.20,ng/mL,81.20,81.2,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T15:31:00,1.0,6 h,6.0,Period 1 Dose,2018-03-23T09:31:00
3110-103-002,PC,3110-103-002.103001211,10.0,1338712,UBRO,Ubrogepant,54.05,ng/mL,54.05,54.05,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T17:31:00,1.0,8 h,8.0,Period 1 Dose,2018-03-23T09:31:00
3110-103-002,PC,3110-103-002.103001211,11.0,1338715,UBRO,Ubrogepant,18.41,ng/mL,18.41,18.41,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T21:31:00,1.0,12 h,12.0,Period 1 Dose,2018-03-23T09:31:00
3110-103-002,PC,3110-103-002.103001211,12.0,1338718,UBRO,Ubrogepant,12.39,ng/mL,12.39,12.39,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-03-23T23:31:00,1.0,14 h,14.0,Period 1 Dose,2018-03-23T09:31:00
3110-103-002,PC,3110-103-002.103001211,13.0,1338724,UBRO,Ubrogepant,3.03,ng/mL,3.03,3.03,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-03-24T09:31:00,2.0,24 h,24.0,Period 1 Dose,2018-03-23T09:31:00
3110-103-002,PC,3110-103-002.103001211,14.0,1338749,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T09:01:00,8.0,Predose,0.0,Period 2 Dose,2018-03-30T09:31:00
3110-103-002,PC,3110-103-002.103001211,15.0,1338751,UBRO,Ubrogepant,50.70,ng/mL,50.70,50.7,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:01:00,8.0,0.5 h,0.5,Period 2 Dose,2018-03-30T09:31:00
3110-103-002,PC,3110-103-002.103001211,16.0,1338754,UBRO,Ubrogepant,94.24,ng/mL,94.24,94.24,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T10:31:00,8.0,1 h,1.0,Period 2 Dose,2018-03-30T09:31:00
3110-103-002,PC,3110-103-002.103001211,17.0,1338757,UBRO,Ubrogepant,140.24,ng/mL,140.24,140.24,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:01:00,8.0,1.5 h,1.5,Period 2 Dose,2018-03-30T09:31:00
3110-103-002,PC,3110-103-002.103001211,18.0,1338761,UBRO,Ubrogepant,281.57,ng/mL,281.57,281.57,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T11:31:00,8.0,2 h,2.0,Period 2 Dose,2018-03-30T09:31:00
3110-103-002,PC,3110-103-002.103001211,19.0,1338762,UBRO,Ubrogepant,158.74,ng/mL,158.74,158.74,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T12:31:00,8.0,3 h,3.0,Period 2 Dose,2018-03-30T09:31:00
3110-103-002,PC,3110-103-002.103001211,20.0,1338763,UBRO,Ubrogepant,150.97,ng/mL,150.97,150.97,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T13:31:00,8.0,4 h,4.0,Period 2 Dose,2018-03-30T09:31:00
3110-103-002,PC,3110-103-002.103001211,21.0,1338768,UBRO,Ubrogepant,146.71,ng/mL,146.71,146.71,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T14:31:00,8.0,5 h,5.0,Period 2 Dose,2018-03-30T09:31:00
3110-103-002,PC,3110-103-002.103001211,22.0,1338769,UBRO,Ubrogepant,101.23,ng/mL,101.23,101.23,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T15:31:00,8.0,6 h,6.0,Period 2 Dose,2018-03-30T09:31:00
3110-103-002,PC,3110-103-002.103001211,23.0,1338770,UBRO,Ubrogepant,54.69,ng/mL,54.69,54.69,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T17:31:00,8.0,8 h,8.0,Period 2 Dose,2018-03-30T09:31:00
3110-103-002,PC,3110-103-002.103001211,24.0,1338773,UBRO,Ubrogepant,19.41,ng/mL,19.41,19.41,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T21:31:00,8.0,12 h,12.0,Period 2 Dose,2018-03-30T09:31:00
3110-103-002,PC,3110-103-002.103001211,25.0,1338776,UBRO,Ubrogepant,12.42,ng/mL,12.42,12.42,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-03-30T23:31:00,8.0,14 h,14.0,Period 2 Dose,2018-03-30T09:31:00
3110-103-002,PC,3110-103-002.103001211,26.0,1338782,UBRO,Ubrogepant,3.05,ng/mL,3.05,3.05,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-03-31T09:31:00,9.0,24 h,24.0,Period 2 Dose,2018-03-30T09:31:00
3110-103-002,PC,3110-103-002.103001211,27.0,1338807,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T09:01:00,15.0,Predose,0.0,Period 3 Dose,2018-04-06T09:31:00
3110-103-002,PC,3110-103-002.103001211,28.0,1338809,UBRO,Ubrogepant,221.83,ng/mL,221.83,221.83,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:01:00,15.0,0.5 h,0.5,Period 3 Dose,2018-04-06T09:31:00
3110-103-002,PC,3110-103-002.103001211,29.0,1338812,UBRO,Ubrogepant,366.95,ng/mL,366.95,366.95,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T10:31:00,15.0,1 h,1.0,Period 3 Dose,2018-04-06T09:31:00
3110-103-002,PC,3110-103-002.103001211,30.0,1338815,UBRO,Ubrogepant,232.50,ng/mL,232.50,232.5,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:01:00,15.0,1.5 h,1.5,Period 3 Dose,2018-04-06T09:31:00
3110-103-002,PC,3110-103-002.103001211,31.0,1338819,UBRO,Ubrogepant,219.59,ng/mL,219.59,219.59,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T11:31:00,15.0,2 h,2.0,Period 3 Dose,2018-04-06T09:31:00
3110-103-002,PC,3110-103-002.103001211,32.0,1338820,UBRO,Ubrogepant,194.84,ng/mL,194.84,194.84,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T12:31:00,15.0,3 h,3.0,Period 3 Dose,2018-04-06T09:31:00
3110-103-002,PC,3110-103-002.103001211,33.0,1338821,UBRO,Ubrogepant,154.34,ng/mL,154.34,154.34,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T13:31:00,15.0,4 h,4.0,Period 3 Dose,2018-04-06T09:31:00
3110-103-002,PC,3110-103-002.103001211,34.0,1338826,UBRO,Ubrogepant,103.70,ng/mL,103.70,103.7,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T14:31:00,15.0,5 h,5.0,Period 3 Dose,2018-04-06T09:31:00
3110-103-002,PC,3110-103-002.103001211,35.0,1338827,UBRO,Ubrogepant,80.71,ng/mL,80.71,80.71,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T15:31:00,15.0,6 h,6.0,Period 3 Dose,2018-04-06T09:31:00
3110-103-002,PC,3110-103-002.103001211,36.0,1338828,UBRO,Ubrogepant,45.83,ng/mL,45.83,45.83,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T17:31:00,15.0,8 h,8.0,Period 3 Dose,2018-04-06T09:31:00
3110-103-002,PC,3110-103-002.103001211,37.0,1338831,UBRO,Ubrogepant,16.74,ng/mL,16.74,16.74,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T21:31:00,15.0,12 h,12.0,Period 3 Dose,2018-04-06T09:31:00
3110-103-002,PC,3110-103-002.103001211,38.0,1338834,UBRO,Ubrogepant,11.17,ng/mL,11.17,11.17,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-04-06T23:31:00,15.0,14 h,14.0,Period 3 Dose,2018-04-06T09:31:00
3110-103-002,PC,3110-103-002.103001211,39.0,1338840,UBRO,Ubrogepant,2.23,ng/mL,2.23,2.23,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,26.0,Period 3 Day 16,TREATMENT,2018-04-07T09:31:00,16.0,24 h,24.0,Period 3 Dose,2018-04-06T09:31:00
3110-103-002,PC,3110-103-002.103001218,1.0,1369681,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T07:39:00,1.0,Predose,0.0,Period 1 Dose,2018-04-18T08:18:00
3110-103-002,PC,3110-103-002.103001218,2.0,1369683,UBRO,Ubrogepant,252.04,ng/mL,252.04,252.04,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T08:48:00,1.0,0.5 h,0.5,Period 1 Dose,2018-04-18T08:18:00
3110-103-002,PC,3110-103-002.103001218,3.0,1369686,UBRO,Ubrogepant,315.13,ng/mL,315.13,315.13,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T09:18:00,1.0,1 h,1.0,Period 1 Dose,2018-04-18T08:18:00
3110-103-002,PC,3110-103-002.103001218,4.0,1369689,UBRO,Ubrogepant,303.14,ng/mL,303.14,303.14,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T09:48:00,1.0,1.5 h,1.5,Period 1 Dose,2018-04-18T08:18:00
3110-103-002,PC,3110-103-002.103001218,5.0,1369693,UBRO,Ubrogepant,252.37,ng/mL,252.37,252.37,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T10:18:00,1.0,2 h,2.0,Period 1 Dose,2018-04-18T08:18:00
3110-103-002,PC,3110-103-002.103001218,6.0,1369694,UBRO,Ubrogepant,123.75,ng/mL,123.75,123.75,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T11:18:00,1.0,3 h,3.0,Period 1 Dose,2018-04-18T08:18:00
3110-103-002,PC,3110-103-002.103001218,7.0,1369695,UBRO,Ubrogepant,96.65,ng/mL,96.65,96.65,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T12:18:00,1.0,4 h,4.0,Period 1 Dose,2018-04-18T08:18:00
3110-103-002,PC,3110-103-002.103001218,8.0,1369700,UBRO,Ubrogepant,62.88,ng/mL,62.88,62.88,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T13:18:00,1.0,5 h,5.0,Period 1 Dose,2018-04-18T08:18:00
3110-103-002,PC,3110-103-002.103001218,9.0,1369701,UBRO,Ubrogepant,46.90,ng/mL,46.90,46.9,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T14:18:00,1.0,6 h,6.0,Period 1 Dose,2018-04-18T08:18:00
3110-103-002,PC,3110-103-002.103001218,10.0,1369702,UBRO,Ubrogepant,25.84,ng/mL,25.84,25.84,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T16:18:00,1.0,8 h,8.0,Period 1 Dose,2018-04-18T08:18:00
3110-103-002,PC,3110-103-002.103001218,11.0,1369705,UBRO,Ubrogepant,10.16,ng/mL,10.16,10.16,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T20:18:00,1.0,12 h,12.0,Period 1 Dose,2018-04-18T08:18:00
3110-103-002,PC,3110-103-002.103001218,12.0,1369708,UBRO,Ubrogepant,8.02,ng/mL,8.02,8.02,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T22:18:00,1.0,14 h,14.0,Period 1 Dose,2018-04-18T08:18:00
3110-103-002,PC,3110-103-002.103001218,13.0,1369714,UBRO,Ubrogepant,4.45,ng/mL,4.45,4.45,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-04-19T08:18:00,2.0,24 h,24.0,Period 1 Dose,2018-04-18T08:18:00
3110-103-002,PC,3110-103-002.103001218,14.0,1369739,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T07:40:00,8.0,Predose,0.0,Period 2 Dose,2018-04-25T08:18:00
3110-103-002,PC,3110-103-002.103001218,15.0,1369741,UBRO,Ubrogepant,224.51,ng/mL,224.51,224.51,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T08:48:00,8.0,0.5 h,0.5,Period 2 Dose,2018-04-25T08:18:00
3110-103-002,PC,3110-103-002.103001218,16.0,1369744,UBRO,Ubrogepant,313.52,ng/mL,313.52,313.52,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T09:18:00,8.0,1 h,1.0,Period 2 Dose,2018-04-25T08:18:00
3110-103-002,PC,3110-103-002.103001218,17.0,1369747,UBRO,Ubrogepant,228.77,ng/mL,228.77,228.77,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T09:48:00,8.0,1.5 h,1.5,Period 2 Dose,2018-04-25T08:18:00
3110-103-002,PC,3110-103-002.103001218,18.0,1369751,UBRO,Ubrogepant,185.11,ng/mL,185.11,185.11,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T10:18:00,8.0,2 h,2.0,Period 2 Dose,2018-04-25T08:18:00
3110-103-002,PC,3110-103-002.103001218,19.0,1369752,UBRO,Ubrogepant,122.76,ng/mL,122.76,122.76,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T11:18:00,8.0,3 h,3.0,Period 2 Dose,2018-04-25T08:18:00
3110-103-002,PC,3110-103-002.103001218,20.0,1369753,UBRO,Ubrogepant,86.42,ng/mL,86.42,86.42,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T12:18:00,8.0,4 h,4.0,Period 2 Dose,2018-04-25T08:18:00
3110-103-002,PC,3110-103-002.103001218,21.0,1369758,UBRO,Ubrogepant,62.16,ng/mL,62.16,62.16,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T13:18:00,8.0,5 h,5.0,Period 2 Dose,2018-04-25T08:18:00
3110-103-002,PC,3110-103-002.103001218,22.0,1369759,UBRO,Ubrogepant,45.39,ng/mL,45.39,45.39,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T14:18:00,8.0,6 h,6.0,Period 2 Dose,2018-04-25T08:18:00
3110-103-002,PC,3110-103-002.103001218,23.0,1369760,UBRO,Ubrogepant,22.49,ng/mL,22.49,22.49,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T16:18:00,8.0,8 h,8.0,Period 2 Dose,2018-04-25T08:18:00
3110-103-002,PC,3110-103-002.103001218,24.0,1369763,UBRO,Ubrogepant,7.91,ng/mL,7.91,7.91,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T20:18:00,8.0,12 h,12.0,Period 2 Dose,2018-04-25T08:18:00
3110-103-002,PC,3110-103-002.103001218,25.0,1369766,UBRO,Ubrogepant,5.34,ng/mL,5.34,5.34,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T22:18:00,8.0,14 h,14.0,Period 2 Dose,2018-04-25T08:18:00
3110-103-002,PC,3110-103-002.103001218,26.0,1369772,UBRO,Ubrogepant,2.31,ng/mL,2.31,2.31,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-04-26T08:18:00,9.0,24 h,24.0,Period 2 Dose,2018-04-25T08:18:00
3110-103-002,PC,3110-103-002.103001218,27.0,1369797,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T07:48:00,15.0,Predose,0.0,Period 3 Dose,2018-05-02T08:18:00
3110-103-002,PC,3110-103-002.103001218,28.0,1369799,UBRO,Ubrogepant,127.89,ng/mL,127.89,127.89,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T08:48:00,15.0,0.5 h,0.5,Period 3 Dose,2018-05-02T08:18:00
3110-103-002,PC,3110-103-002.103001218,29.0,1369802,UBRO,Ubrogepant,378.47,ng/mL,378.47,378.47,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T09:18:00,15.0,1 h,1.0,Period 3 Dose,2018-05-02T08:18:00
3110-103-002,PC,3110-103-002.103001218,30.0,1369805,UBRO,Ubrogepant,253.73,ng/mL,253.73,253.73,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T09:48:00,15.0,1.5 h,1.5,Period 3 Dose,2018-05-02T08:18:00
3110-103-002,PC,3110-103-002.103001218,31.0,1369809,UBRO,Ubrogepant,227.04,ng/mL,227.04,227.04,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T10:18:00,15.0,2 h,2.0,Period 3 Dose,2018-05-02T08:18:00
3110-103-002,PC,3110-103-002.103001218,32.0,1369810,UBRO,Ubrogepant,124.79,ng/mL,124.79,124.79,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T11:18:00,15.0,3 h,3.0,Period 3 Dose,2018-05-02T08:18:00
3110-103-002,PC,3110-103-002.103001218,33.0,1369811,UBRO,Ubrogepant,68.91,ng/mL,68.91,68.91,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T12:18:00,15.0,4 h,4.0,Period 3 Dose,2018-05-02T08:18:00
3110-103-002,PC,3110-103-002.103001218,34.0,1369816,UBRO,Ubrogepant,53.81,ng/mL,53.81,53.81,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T13:18:00,15.0,5 h,5.0,Period 3 Dose,2018-05-02T08:18:00
3110-103-002,PC,3110-103-002.103001218,35.0,1369817,UBRO,Ubrogepant,42.41,ng/mL,42.41,42.41,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T14:18:00,15.0,6 h,6.0,Period 3 Dose,2018-05-02T08:18:00
3110-103-002,PC,3110-103-002.103001218,36.0,1369818,UBRO,Ubrogepant,26.22,ng/mL,26.22,26.22,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T16:18:00,15.0,8 h,8.0,Period 3 Dose,2018-05-02T08:18:00
3110-103-002,PC,3110-103-002.103001218,37.0,1369821,UBRO,Ubrogepant,7.32,ng/mL,7.32,7.32,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T20:18:00,15.0,12 h,12.0,Period 3 Dose,2018-05-02T08:18:00
3110-103-002,PC,3110-103-002.103001218,38.0,1369824,UBRO,Ubrogepant,4.60,ng/mL,4.60,4.6,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T22:18:00,15.0,14 h,14.0,Period 3 Dose,2018-05-02T08:18:00
3110-103-002,PC,3110-103-002.103001218,39.0,1369830,UBRO,Ubrogepant,1.40,ng/mL,1.40,1.4,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,26.0,Period 3 Day 16,TREATMENT,2018-05-03T08:18:00,16.0,24 h,24.0,Period 3 Dose,2018-05-02T08:18:00
3110-103-002,PC,3110-103-002.103001220,1.0,1369876,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T07:40:00,1.0,Predose,0.0,Period 1 Dose,2018-04-18T08:20:00
3110-103-002,PC,3110-103-002.103001220,2.0,1369878,UBRO,Ubrogepant,347.23,ng/mL,347.23,347.23,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T08:50:54,1.0,0.5 h,0.5,Period 1 Dose,2018-04-18T08:20:00
3110-103-002,PC,3110-103-002.103001220,3.0,1369881,UBRO,Ubrogepant,505.13,ng/mL,505.13,505.13,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T09:20:00,1.0,1 h,1.0,Period 1 Dose,2018-04-18T08:20:00
3110-103-002,PC,3110-103-002.103001220,4.0,1369884,UBRO,Ubrogepant,285.70,ng/mL,285.70,285.7,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T09:50:00,1.0,1.5 h,1.5,Period 1 Dose,2018-04-18T08:20:00
3110-103-002,PC,3110-103-002.103001220,5.0,1369888,UBRO,Ubrogepant,236.92,ng/mL,236.92,236.92,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T10:20:00,1.0,2 h,2.0,Period 1 Dose,2018-04-18T08:20:00
3110-103-002,PC,3110-103-002.103001220,6.0,1369889,UBRO,Ubrogepant,184.90,ng/mL,184.90,184.9,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T11:20:00,1.0,3 h,3.0,Period 1 Dose,2018-04-18T08:20:00
3110-103-002,PC,3110-103-002.103001220,7.0,1369890,UBRO,Ubrogepant,153.97,ng/mL,153.97,153.97,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T12:20:00,1.0,4 h,4.0,Period 1 Dose,2018-04-18T08:20:00
3110-103-002,PC,3110-103-002.103001220,8.0,1369895,UBRO,Ubrogepant,95.99,ng/mL,95.99,95.99,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T13:20:00,1.0,5 h,5.0,Period 1 Dose,2018-04-18T08:20:00
3110-103-002,PC,3110-103-002.103001220,9.0,1369896,UBRO,Ubrogepant,93.78,ng/mL,93.78,93.78,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T14:20:00,1.0,6 h,6.0,Period 1 Dose,2018-04-18T08:20:00
3110-103-002,PC,3110-103-002.103001220,10.0,1369897,UBRO,Ubrogepant,48.40,ng/mL,48.40,48.4,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T16:20:00,1.0,8 h,8.0,Period 1 Dose,2018-04-18T08:20:00
3110-103-002,PC,3110-103-002.103001220,11.0,1369900,UBRO,Ubrogepant,17.75,ng/mL,17.75,17.75,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T20:20:00,1.0,12 h,12.0,Period 1 Dose,2018-04-18T08:20:00
3110-103-002,PC,3110-103-002.103001220,12.0,1369903,UBRO,Ubrogepant,11.06,ng/mL,11.06,11.06,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T22:20:00,1.0,14 h,14.0,Period 1 Dose,2018-04-18T08:20:00
3110-103-002,PC,3110-103-002.103001220,13.0,1369909,UBRO,Ubrogepant,2.92,ng/mL,2.92,2.92,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-04-19T08:20:00,2.0,24 h,24.0,Period 1 Dose,2018-04-18T08:20:00
3110-103-002,PC,3110-103-002.103001220,14.0,1369934,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T07:42:00,8.0,Predose,0.0,Period 2 Dose,2018-04-25T08:20:00
3110-103-002,PC,3110-103-002.103001220,15.0,1369936,UBRO,Ubrogepant,60.86,ng/mL,60.86,60.86,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T08:50:00,8.0,0.5 h,0.5,Period 2 Dose,2018-04-25T08:20:00
3110-103-002,PC,3110-103-002.103001220,16.0,1369939,UBRO,Ubrogepant,199.17,ng/mL,199.17,199.17,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T09:20:00,8.0,1 h,1.0,Period 2 Dose,2018-04-25T08:20:00
3110-103-002,PC,3110-103-002.103001220,17.0,1369942,UBRO,Ubrogepant,162.14,ng/mL,162.14,162.14,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T09:50:00,8.0,1.5 h,1.5,Period 2 Dose,2018-04-25T08:20:00
3110-103-002,PC,3110-103-002.103001220,18.0,1369946,UBRO,Ubrogepant,317.38,ng/mL,317.38,317.38,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T10:20:00,8.0,2 h,2.0,Period 2 Dose,2018-04-25T08:20:00
3110-103-002,PC,3110-103-002.103001220,19.0,1369947,UBRO,Ubrogepant,247.91,ng/mL,247.91,247.91,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T11:20:03,8.0,3 h,3.0,Period 2 Dose,2018-04-25T08:20:00
3110-103-002,PC,3110-103-002.103001220,20.0,1369948,UBRO,Ubrogepant,177.59,ng/mL,177.59,177.59,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T12:20:00,8.0,4 h,4.0,Period 2 Dose,2018-04-25T08:20:00
3110-103-002,PC,3110-103-002.103001220,21.0,1369953,UBRO,Ubrogepant,135.86,ng/mL,135.86,135.86,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T13:20:00,8.0,5 h,5.0,Period 2 Dose,2018-04-25T08:20:00
3110-103-002,PC,3110-103-002.103001220,22.0,1369954,UBRO,Ubrogepant,106.62,ng/mL,106.62,106.62,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T14:20:00,8.0,6 h,6.0,Period 2 Dose,2018-04-25T08:20:00
3110-103-002,PC,3110-103-002.103001220,23.0,1369955,UBRO,Ubrogepant,64.31,ng/mL,64.31,64.31,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T16:20:00,8.0,8 h,8.0,Period 2 Dose,2018-04-25T08:20:00
3110-103-002,PC,3110-103-002.103001220,24.0,1369958,UBRO,Ubrogepant,20.62,ng/mL,20.62,20.62,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T20:20:00,8.0,12 h,12.0,Period 2 Dose,2018-04-25T08:20:00
3110-103-002,PC,3110-103-002.103001220,25.0,1369961,UBRO,Ubrogepant,11.00,ng/mL,11.00,11.0,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T22:20:00,8.0,14 h,14.0,Period 2 Dose,2018-04-25T08:20:00
3110-103-002,PC,3110-103-002.103001220,26.0,1369967,UBRO,Ubrogepant,3.16,ng/mL,3.16,3.16,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-04-26T08:20:00,9.0,24 h,24.0,Period 2 Dose,2018-04-25T08:20:00
3110-103-002,PC,3110-103-002.103001220,27.0,1369992,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T07:50:00,15.0,Predose,0.0,Period 3 Dose,2018-05-02T08:20:00
3110-103-002,PC,3110-103-002.103001220,28.0,1369994,UBRO,Ubrogepant,53.33,ng/mL,53.33,53.33,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T08:50:00,15.0,0.5 h,0.5,Period 3 Dose,2018-05-02T08:20:00
3110-103-002,PC,3110-103-002.103001220,29.0,1369997,UBRO,Ubrogepant,227.74,ng/mL,227.74,227.74,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T09:20:00,15.0,1 h,1.0,Period 3 Dose,2018-05-02T08:20:00
3110-103-002,PC,3110-103-002.103001220,30.0,1370000,UBRO,Ubrogepant,235.42,ng/mL,235.42,235.42,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T09:50:00,15.0,1.5 h,1.5,Period 3 Dose,2018-05-02T08:20:00
3110-103-002,PC,3110-103-002.103001220,31.0,1370004,UBRO,Ubrogepant,371.46,ng/mL,371.46,371.46,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T10:20:00,15.0,2 h,2.0,Period 3 Dose,2018-05-02T08:20:00
3110-103-002,PC,3110-103-002.103001220,32.0,1370005,UBRO,Ubrogepant,229.49,ng/mL,229.49,229.49,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T11:20:00,15.0,3 h,3.0,Period 3 Dose,2018-05-02T08:20:00
3110-103-002,PC,3110-103-002.103001220,33.0,1370006,UBRO,Ubrogepant,156.95,ng/mL,156.95,156.95,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T12:20:00,15.0,4 h,4.0,Period 3 Dose,2018-05-02T08:20:00
3110-103-002,PC,3110-103-002.103001220,34.0,1370011,UBRO,Ubrogepant,116.06,ng/mL,116.06,116.06,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T13:20:00,15.0,5 h,5.0,Period 3 Dose,2018-05-02T08:20:00
3110-103-002,PC,3110-103-002.103001220,35.0,1370012,UBRO,Ubrogepant,91.59,ng/mL,91.59,91.59,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T14:20:00,15.0,6 h,6.0,Period 3 Dose,2018-05-02T08:20:00
3110-103-002,PC,3110-103-002.103001220,36.0,1370013,UBRO,Ubrogepant,39.43,ng/mL,39.43,39.43,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T16:20:00,15.0,8 h,8.0,Period 3 Dose,2018-05-02T08:20:00
3110-103-002,PC,3110-103-002.103001220,37.0,1370016,UBRO,Ubrogepant,16.33,ng/mL,16.33,16.33,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T20:20:00,15.0,12 h,12.0,Period 3 Dose,2018-05-02T08:20:00
3110-103-002,PC,3110-103-002.103001220,38.0,1370019,UBRO,Ubrogepant,9.16,ng/mL,9.16,9.16,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T22:20:00,15.0,14 h,14.0,Period 3 Dose,2018-05-02T08:20:00
3110-103-002,PC,3110-103-002.103001220,39.0,1370025,UBRO,Ubrogepant,2.62,ng/mL,2.62,2.62,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,26.0,Period 3 Day 16,TREATMENT,2018-05-03T08:20:00,16.0,24 h,24.0,Period 3 Dose,2018-05-02T08:20:00
3110-103-002,PC,3110-103-002.103001222,1.0,1370266,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T07:44:00,1.0,Predose,0.0,Period 1 Dose,2018-04-18T08:24:00
3110-103-002,PC,3110-103-002.103001222,2.0,1370268,UBRO,Ubrogepant,55.72,ng/mL,55.72,55.72,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T08:54:00,1.0,0.5 h,0.5,Period 1 Dose,2018-04-18T08:24:00
3110-103-002,PC,3110-103-002.103001222,3.0,1370271,UBRO,Ubrogepant,124.09,ng/mL,124.09,124.09,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T09:24:00,1.0,1 h,1.0,Period 1 Dose,2018-04-18T08:24:00
3110-103-002,PC,3110-103-002.103001222,4.0,1370274,UBRO,Ubrogepant,279.76,ng/mL,279.76,279.76,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T09:54:00,1.0,1.5 h,1.5,Period 1 Dose,2018-04-18T08:24:00
3110-103-002,PC,3110-103-002.103001222,5.0,1370278,UBRO,Ubrogepant,224.60,ng/mL,224.60,224.6,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T10:24:00,1.0,2 h,2.0,Period 1 Dose,2018-04-18T08:24:00
3110-103-002,PC,3110-103-002.103001222,6.0,1370279,UBRO,Ubrogepant,181.78,ng/mL,181.78,181.78,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T11:24:00,1.0,3 h,3.0,Period 1 Dose,2018-04-18T08:24:00
3110-103-002,PC,3110-103-002.103001222,7.0,1370280,UBRO,Ubrogepant,119.32,ng/mL,119.32,119.32,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T12:24:00,1.0,4 h,4.0,Period 1 Dose,2018-04-18T08:24:00
3110-103-002,PC,3110-103-002.103001222,8.0,1370285,UBRO,Ubrogepant,84.54,ng/mL,84.54,84.54,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T13:24:00,1.0,5 h,5.0,Period 1 Dose,2018-04-18T08:24:00
3110-103-002,PC,3110-103-002.103001222,9.0,1370286,UBRO,Ubrogepant,61.45,ng/mL,61.45,61.45,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T14:24:00,1.0,6 h,6.0,Period 1 Dose,2018-04-18T08:24:00
3110-103-002,PC,3110-103-002.103001222,10.0,1370287,UBRO,Ubrogepant,40.53,ng/mL,40.53,40.53,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T16:24:00,1.0,8 h,8.0,Period 1 Dose,2018-04-18T08:24:00
3110-103-002,PC,3110-103-002.103001222,11.0,1370290,UBRO,Ubrogepant,15.95,ng/mL,15.95,15.95,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T20:24:00,1.0,12 h,12.0,Period 1 Dose,2018-04-18T08:24:00
3110-103-002,PC,3110-103-002.103001222,12.0,1370293,UBRO,Ubrogepant,10.69,ng/mL,10.69,10.69,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T22:24:00,1.0,14 h,14.0,Period 1 Dose,2018-04-18T08:24:00
3110-103-002,PC,3110-103-002.103001222,13.0,1370299,UBRO,Ubrogepant,2.30,ng/mL,2.30,2.3,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-04-19T08:24:00,2.0,24 h,24.0,Period 1 Dose,2018-04-18T08:24:00
3110-103-002,PC,3110-103-002.103001222,14.0,1370324,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T07:46:00,8.0,Predose,0.0,Period 2 Dose,2018-04-25T08:24:00
3110-103-002,PC,3110-103-002.103001222,15.0,1370326,UBRO,Ubrogepant,169.67,ng/mL,169.67,169.67,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T08:54:00,8.0,0.5 h,0.5,Period 2 Dose,2018-04-25T08:24:00
3110-103-002,PC,3110-103-002.103001222,16.0,1370329,UBRO,Ubrogepant,216.50,ng/mL,216.50,216.5,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T09:24:00,8.0,1 h,1.0,Period 2 Dose,2018-04-25T08:24:00
3110-103-002,PC,3110-103-002.103001222,17.0,1370332,UBRO,Ubrogepant,202.24,ng/mL,202.24,202.24,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T09:54:00,8.0,1.5 h,1.5,Period 2 Dose,2018-04-25T08:24:00
3110-103-002,PC,3110-103-002.103001222,18.0,1370336,UBRO,Ubrogepant,155.15,ng/mL,155.15,155.15,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T10:24:00,8.0,2 h,2.0,Period 2 Dose,2018-04-25T08:24:00
3110-103-002,PC,3110-103-002.103001222,19.0,1370337,UBRO,Ubrogepant,97.58,ng/mL,97.58,97.58,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T11:24:00,8.0,3 h,3.0,Period 2 Dose,2018-04-25T08:24:00
3110-103-002,PC,3110-103-002.103001222,20.0,1370338,UBRO,Ubrogepant,71.19,ng/mL,71.19,71.19,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T12:24:00,8.0,4 h,4.0,Period 2 Dose,2018-04-25T08:24:00
3110-103-002,PC,3110-103-002.103001222,21.0,1370343,UBRO,Ubrogepant,54.75,ng/mL,54.75,54.75,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T13:24:00,8.0,5 h,5.0,Period 2 Dose,2018-04-25T08:24:00
3110-103-002,PC,3110-103-002.103001222,22.0,1370344,UBRO,Ubrogepant,36.65,ng/mL,36.65,36.65,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T14:24:00,8.0,6 h,6.0,Period 2 Dose,2018-04-25T08:24:00
3110-103-002,PC,3110-103-002.103001222,23.0,1370345,UBRO,Ubrogepant,26.32,ng/mL,26.32,26.32,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T16:24:00,8.0,8 h,8.0,Period 2 Dose,2018-04-25T08:24:00
3110-103-002,PC,3110-103-002.103001222,24.0,1370348,UBRO,Ubrogepant,12.12,ng/mL,12.12,12.12,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T20:24:00,8.0,12 h,12.0,Period 2 Dose,2018-04-25T08:24:00
3110-103-002,PC,3110-103-002.103001222,25.0,1370351,UBRO,Ubrogepant,7.92,ng/mL,7.92,7.92,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T22:24:00,8.0,14 h,14.0,Period 2 Dose,2018-04-25T08:24:00
3110-103-002,PC,3110-103-002.103001222,26.0,1370357,UBRO,Ubrogepant,2.49,ng/mL,2.49,2.49,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-04-26T08:24:00,9.0,24 h,24.0,Period 2 Dose,2018-04-25T08:24:00
3110-103-002,PC,3110-103-002.103001222,27.0,1370382,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T07:54:00,15.0,Predose,0.0,Period 3 Dose,2018-05-02T08:24:00
3110-103-002,PC,3110-103-002.103001222,28.0,1370384,UBRO,Ubrogepant,105.22,ng/mL,105.22,105.22,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T08:54:00,15.0,0.5 h,0.5,Period 3 Dose,2018-05-02T08:24:00
3110-103-002,PC,3110-103-002.103001222,29.0,1370387,UBRO,Ubrogepant,162.47,ng/mL,162.47,162.47,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T09:24:00,15.0,1 h,1.0,Period 3 Dose,2018-05-02T08:24:00
3110-103-002,PC,3110-103-002.103001222,30.0,1370390,UBRO,Ubrogepant,171.55,ng/mL,171.55,171.55,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T09:54:00,15.0,1.5 h,1.5,Period 3 Dose,2018-05-02T08:24:00
3110-103-002,PC,3110-103-002.103001222,31.0,1370394,UBRO,Ubrogepant,327.39,ng/mL,327.39,327.39,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T10:24:00,15.0,2 h,2.0,Period 3 Dose,2018-05-02T08:24:00
3110-103-002,PC,3110-103-002.103001222,32.0,1370395,UBRO,Ubrogepant,174.63,ng/mL,174.63,174.63,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T11:24:00,15.0,3 h,3.0,Period 3 Dose,2018-05-02T08:24:00
3110-103-002,PC,3110-103-002.103001222,33.0,1370396,UBRO,Ubrogepant,116.89,ng/mL,116.89,116.89,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T12:24:00,15.0,4 h,4.0,Period 3 Dose,2018-05-02T08:24:00
3110-103-002,PC,3110-103-002.103001222,34.0,1370401,UBRO,Ubrogepant,72.76,ng/mL,72.76,72.76,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T13:24:00,15.0,5 h,5.0,Period 3 Dose,2018-05-02T08:24:00
3110-103-002,PC,3110-103-002.103001222,35.0,1370402,UBRO,Ubrogepant,58.47,ng/mL,58.47,58.47,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T14:24:00,15.0,6 h,6.0,Period 3 Dose,2018-05-02T08:24:00
3110-103-002,PC,3110-103-002.103001222,36.0,1370403,UBRO,Ubrogepant,33.08,ng/mL,33.08,33.08,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T16:24:00,15.0,8 h,8.0,Period 3 Dose,2018-05-02T08:24:00
3110-103-002,PC,3110-103-002.103001222,37.0,1370406,UBRO,Ubrogepant,13.67,ng/mL,13.67,13.67,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T20:24:00,15.0,12 h,12.0,Period 3 Dose,2018-05-02T08:24:00
3110-103-002,PC,3110-103-002.103001222,38.0,1370409,UBRO,Ubrogepant,8.41,ng/mL,8.41,8.41,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T22:24:00,15.0,14 h,14.0,Period 3 Dose,2018-05-02T08:24:00
3110-103-002,PC,3110-103-002.103001222,39.0,1370415,UBRO,Ubrogepant,1.96,ng/mL,1.96,1.96,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,26.0,Period 3 Day 16,TREATMENT,2018-05-03T08:24:00,16.0,24 h,24.0,Period 3 Dose,2018-05-02T08:24:00
3110-103-002,PC,3110-103-002.103001225,1.0,1370656,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T07:26:04,1.0,Predose,0.0,Period 1 Dose,2018-04-18T08:02:00
3110-103-002,PC,3110-103-002.103001225,2.0,1370658,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T08:32:00,1.0,0.5 h,0.5,Period 1 Dose,2018-04-18T08:02:00
3110-103-002,PC,3110-103-002.103001225,3.0,1370661,UBRO,Ubrogepant,69.17,ng/mL,69.17,69.17,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T09:02:00,1.0,1 h,1.0,Period 1 Dose,2018-04-18T08:02:00
3110-103-002,PC,3110-103-002.103001225,4.0,1370664,UBRO,Ubrogepant,138.38,ng/mL,138.38,138.38,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T09:32:00,1.0,1.5 h,1.5,Period 1 Dose,2018-04-18T08:02:00
3110-103-002,PC,3110-103-002.103001225,5.0,1370668,UBRO,Ubrogepant,208.29,ng/mL,208.29,208.29,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T10:02:00,1.0,2 h,2.0,Period 1 Dose,2018-04-18T08:02:00
3110-103-002,PC,3110-103-002.103001225,6.0,1370669,UBRO,Ubrogepant,310.92,ng/mL,310.92,310.92,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T11:02:00,1.0,3 h,3.0,Period 1 Dose,2018-04-18T08:02:00
3110-103-002,PC,3110-103-002.103001225,7.0,1378629,UBRO,Ubrogepant,166.34,ng/mL,166.34,166.34,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T12:02:00,1.0,4 h,4.0,Period 1 Dose,2018-04-18T08:02:00
3110-103-002,PC,3110-103-002.103001225,8.0,1378634,UBRO,Ubrogepant,113.37,ng/mL,113.37,113.37,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T13:02:00,1.0,5 h,5.0,Period 1 Dose,2018-04-18T08:02:00
3110-103-002,PC,3110-103-002.103001225,9.0,1378635,UBRO,Ubrogepant,85.38,ng/mL,85.38,85.38,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T14:02:00,1.0,6 h,6.0,Period 1 Dose,2018-04-18T08:02:00
3110-103-002,PC,3110-103-002.103001225,10.0,1378636,UBRO,Ubrogepant,46.90,ng/mL,46.90,46.9,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T16:02:00,1.0,8 h,8.0,Period 1 Dose,2018-04-18T08:02:00
3110-103-002,PC,3110-103-002.103001225,11.0,1378639,UBRO,Ubrogepant,18.88,ng/mL,18.88,18.88,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T20:02:00,1.0,12 h,12.0,Period 1 Dose,2018-04-18T08:02:00
3110-103-002,PC,3110-103-002.103001225,12.0,1378642,UBRO,Ubrogepant,10.52,ng/mL,10.52,10.52,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T22:02:00,1.0,14 h,14.0,Period 1 Dose,2018-04-18T08:02:00
3110-103-002,PC,3110-103-002.103001225,13.0,1378648,UBRO,Ubrogepant,2.55,ng/mL,2.55,2.55,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-04-19T08:02:00,2.0,24 h,24.0,Period 1 Dose,2018-04-18T08:02:00
3110-103-002,PC,3110-103-002.103001225,14.0,1378673,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T07:22:00,8.0,Predose,0.0,Period 2 Dose,2018-04-25T08:02:00
3110-103-002,PC,3110-103-002.103001225,15.0,1378677,UBRO,Ubrogepant,97.08,ng/mL,97.08,97.08,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T08:32:00,8.0,0.5 h,0.5,Period 2 Dose,2018-04-25T08:02:00
3110-103-002,PC,3110-103-002.103001225,16.0,1378680,UBRO,Ubrogepant,342.37,ng/mL,342.37,342.37,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T09:02:00,8.0,1 h,1.0,Period 2 Dose,2018-04-25T08:02:00
3110-103-002,PC,3110-103-002.103001225,17.0,1378683,UBRO,Ubrogepant,239.36,ng/mL,239.36,239.36,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T09:32:00,8.0,1.5 h,1.5,Period 2 Dose,2018-04-25T08:02:00
3110-103-002,PC,3110-103-002.103001225,18.0,1378687,UBRO,Ubrogepant,181.64,ng/mL,181.64,181.64,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T10:02:00,8.0,2 h,2.0,Period 2 Dose,2018-04-25T08:02:00
3110-103-002,PC,3110-103-002.103001225,19.0,1378688,UBRO,Ubrogepant,122.10,ng/mL,122.10,122.1,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T11:02:00,8.0,3 h,3.0,Period 2 Dose,2018-04-25T08:02:00
3110-103-002,PC,3110-103-002.103001225,20.0,1378689,UBRO,Ubrogepant,96.97,ng/mL,96.97,96.97,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T12:02:00,8.0,4 h,4.0,Period 2 Dose,2018-04-25T08:02:00
3110-103-002,PC,3110-103-002.103001225,21.0,1378694,UBRO,Ubrogepant,72.98,ng/mL,72.98,72.98,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T13:02:00,8.0,5 h,5.0,Period 2 Dose,2018-04-25T08:02:00
3110-103-002,PC,3110-103-002.103001225,22.0,1378695,UBRO,Ubrogepant,60.80,ng/mL,60.80,60.8,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T14:02:00,8.0,6 h,6.0,Period 2 Dose,2018-04-25T08:02:00
3110-103-002,PC,3110-103-002.103001225,23.0,1378696,UBRO,Ubrogepant,41.40,ng/mL,41.40,41.4,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T16:02:00,8.0,8 h,8.0,Period 2 Dose,2018-04-25T08:02:00
3110-103-002,PC,3110-103-002.103001225,24.0,1378699,UBRO,Ubrogepant,14.12,ng/mL,14.12,14.12,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T20:02:00,8.0,12 h,12.0,Period 2 Dose,2018-04-25T08:02:00
3110-103-002,PC,3110-103-002.103001225,25.0,1378702,UBRO,Ubrogepant,8.38,ng/mL,8.38,8.38,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T22:02:00,8.0,14 h,14.0,Period 2 Dose,2018-04-25T08:02:00
3110-103-002,PC,3110-103-002.103001225,26.0,1378708,UBRO,Ubrogepant,2.05,ng/mL,2.05,2.05,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-04-26T08:02:00,9.0,24 h,24.0,Period 2 Dose,2018-04-25T08:02:00
3110-103-002,PC,3110-103-002.103001233,1.0,1370851,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T07:27:04,1.0,Predose,0.0,Period 1 Dose,2018-04-18T08:04:00
3110-103-002,PC,3110-103-002.103001233,2.0,1370853,UBRO,Ubrogepant,379.40,ng/mL,379.40,379.4,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T08:34:00,1.0,0.5 h,0.5,Period 1 Dose,2018-04-18T08:04:00
3110-103-002,PC,3110-103-002.103001233,3.0,1370856,UBRO,Ubrogepant,269.32,ng/mL,269.32,269.32,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T09:04:00,1.0,1 h,1.0,Period 1 Dose,2018-04-18T08:04:00
3110-103-002,PC,3110-103-002.103001233,4.0,1370859,UBRO,Ubrogepant,317.05,ng/mL,317.05,317.05,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T09:34:00,1.0,1.5 h,1.5,Period 1 Dose,2018-04-18T08:04:00
3110-103-002,PC,3110-103-002.103001233,5.0,1370863,UBRO,Ubrogepant,409.04,ng/mL,409.04,409.04,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T10:04:00,1.0,2 h,2.0,Period 1 Dose,2018-04-18T08:04:00
3110-103-002,PC,3110-103-002.103001233,6.0,1370864,UBRO,Ubrogepant,255.11,ng/mL,255.11,255.11,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T11:04:00,1.0,3 h,3.0,Period 1 Dose,2018-04-18T08:04:00
3110-103-002,PC,3110-103-002.103001233,7.0,1378772,UBRO,Ubrogepant,179.49,ng/mL,179.49,179.49,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T12:04:00,1.0,4 h,4.0,Period 1 Dose,2018-04-18T08:04:00
3110-103-002,PC,3110-103-002.103001233,8.0,1378777,UBRO,Ubrogepant,126.61,ng/mL,126.61,126.61,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T13:04:00,1.0,5 h,5.0,Period 1 Dose,2018-04-18T08:04:00
3110-103-002,PC,3110-103-002.103001233,9.0,1378778,UBRO,Ubrogepant,84.48,ng/mL,84.48,84.48,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T14:04:00,1.0,6 h,6.0,Period 1 Dose,2018-04-18T08:04:00
3110-103-002,PC,3110-103-002.103001233,10.0,1378779,UBRO,Ubrogepant,54.23,ng/mL,54.23,54.23,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T16:04:00,1.0,8 h,8.0,Period 1 Dose,2018-04-18T08:04:00
3110-103-002,PC,3110-103-002.103001233,11.0,1378782,UBRO,Ubrogepant,17.22,ng/mL,17.22,17.22,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T20:04:00,1.0,12 h,12.0,Period 1 Dose,2018-04-18T08:04:00
3110-103-002,PC,3110-103-002.103001233,12.0,1378785,UBRO,Ubrogepant,9.96,ng/mL,9.96,9.96,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T22:04:00,1.0,14 h,14.0,Period 1 Dose,2018-04-18T08:04:00
3110-103-002,PC,3110-103-002.103001233,13.0,1378791,UBRO,Ubrogepant,4.49,ng/mL,4.49,4.49,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-04-19T08:04:00,2.0,24 h,24.0,Period 1 Dose,2018-04-18T08:04:00
3110-103-002,PC,3110-103-002.103001233,14.0,1378816,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T07:24:00,8.0,Predose,0.0,Period 2 Dose,2018-04-25T08:04:00
3110-103-002,PC,3110-103-002.103001233,15.0,1378820,UBRO,Ubrogepant,726.53,ng/mL,726.53,726.53,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T08:34:00,8.0,0.5 h,0.5,Period 2 Dose,2018-04-25T08:04:00
3110-103-002,PC,3110-103-002.103001233,16.0,1378823,UBRO,Ubrogepant,542.10,ng/mL,542.10,542.1,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T09:04:00,8.0,1 h,1.0,Period 2 Dose,2018-04-25T08:04:00
3110-103-002,PC,3110-103-002.103001233,17.0,1378826,UBRO,Ubrogepant,304.93,ng/mL,304.93,304.93,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T09:34:00,8.0,1.5 h,1.5,Period 2 Dose,2018-04-25T08:04:00
3110-103-002,PC,3110-103-002.103001233,18.0,1378830,UBRO,Ubrogepant,265.65,ng/mL,265.65,265.65,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T10:04:00,8.0,2 h,2.0,Period 2 Dose,2018-04-25T08:04:00
3110-103-002,PC,3110-103-002.103001233,19.0,1378831,UBRO,Ubrogepant,207.57,ng/mL,207.57,207.57,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T11:04:00,8.0,3 h,3.0,Period 2 Dose,2018-04-25T08:04:00
3110-103-002,PC,3110-103-002.103001233,20.0,1378832,UBRO,Ubrogepant,140.04,ng/mL,140.04,140.04,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T12:04:00,8.0,4 h,4.0,Period 2 Dose,2018-04-25T08:04:00
3110-103-002,PC,3110-103-002.103001233,21.0,1378837,UBRO,Ubrogepant,101.54,ng/mL,101.54,101.54,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T13:04:00,8.0,5 h,5.0,Period 2 Dose,2018-04-25T08:04:00
3110-103-002,PC,3110-103-002.103001233,22.0,1378838,UBRO,Ubrogepant,72.10,ng/mL,72.10,72.1,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T14:04:00,8.0,6 h,6.0,Period 2 Dose,2018-04-25T08:04:00
3110-103-002,PC,3110-103-002.103001233,23.0,1378839,UBRO,Ubrogepant,42.13,ng/mL,42.13,42.13,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T16:04:00,8.0,8 h,8.0,Period 2 Dose,2018-04-25T08:04:00
3110-103-002,PC,3110-103-002.103001233,24.0,1378842,UBRO,Ubrogepant,13.71,ng/mL,13.71,13.71,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T20:04:00,8.0,12 h,12.0,Period 2 Dose,2018-04-25T08:04:00
3110-103-002,PC,3110-103-002.103001233,25.0,1378845,UBRO,Ubrogepant,9.10,ng/mL,9.10,9.1,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T22:04:00,8.0,14 h,14.0,Period 2 Dose,2018-04-25T08:04:00
3110-103-002,PC,3110-103-002.103001233,26.0,1378851,UBRO,Ubrogepant,2.25,ng/mL,2.25,2.25,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-04-26T08:04:00,9.0,24 h,24.0,Period 2 Dose,2018-04-25T08:04:00
3110-103-002,PC,3110-103-002.103001234,1.0,1371241,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T07:30:20,1.0,Predose,0.0,Period 1 Dose,2018-04-18T08:08:00
3110-103-002,PC,3110-103-002.103001234,2.0,1371243,UBRO,Ubrogepant,221.64,ng/mL,221.64,221.64,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T08:38:00,1.0,0.5 h,0.5,Period 1 Dose,2018-04-18T08:08:00
3110-103-002,PC,3110-103-002.103001234,3.0,1371246,UBRO,Ubrogepant,270.99,ng/mL,270.99,270.99,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T09:08:00,1.0,1 h,1.0,Period 1 Dose,2018-04-18T08:08:00
3110-103-002,PC,3110-103-002.103001234,4.0,1371249,UBRO,Ubrogepant,200.54,ng/mL,200.54,200.54,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T09:39:29,1.0,1.5 h,1.5,Period 1 Dose,2018-04-18T08:08:00
3110-103-002,PC,3110-103-002.103001234,5.0,1371253,UBRO,Ubrogepant,202.32,ng/mL,202.32,202.32,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T10:10:27,1.0,2 h,2.0,Period 1 Dose,2018-04-18T08:08:00
3110-103-002,PC,3110-103-002.103001234,6.0,1371254,UBRO,Ubrogepant,126.25,ng/mL,126.25,126.25,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T11:08:00,1.0,3 h,3.0,Period 1 Dose,2018-04-18T08:08:00
3110-103-002,PC,3110-103-002.103001234,7.0,1379058,UBRO,Ubrogepant,91.65,ng/mL,91.65,91.65,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T12:08:00,1.0,4 h,4.0,Period 1 Dose,2018-04-18T08:08:00
3110-103-002,PC,3110-103-002.103001234,8.0,1379063,UBRO,Ubrogepant,81.01,ng/mL,81.01,81.01,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T13:08:00,1.0,5 h,5.0,Period 1 Dose,2018-04-18T08:08:00
3110-103-002,PC,3110-103-002.103001234,9.0,1379064,UBRO,Ubrogepant,67.64,ng/mL,67.64,67.64,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T14:08:00,1.0,6 h,6.0,Period 1 Dose,2018-04-18T08:08:00
3110-103-002,PC,3110-103-002.103001234,10.0,1379065,UBRO,Ubrogepant,42.52,ng/mL,42.52,42.52,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T16:08:00,1.0,8 h,8.0,Period 1 Dose,2018-04-18T08:08:00
3110-103-002,PC,3110-103-002.103001234,11.0,1379068,UBRO,Ubrogepant,10.59,ng/mL,10.59,10.59,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T20:08:00,1.0,12 h,12.0,Period 1 Dose,2018-04-18T08:08:00
3110-103-002,PC,3110-103-002.103001234,12.0,1379071,UBRO,Ubrogepant,11.89,ng/mL,11.89,11.89,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T22:08:00,1.0,14 h,14.0,Period 1 Dose,2018-04-18T08:08:00
3110-103-002,PC,3110-103-002.103001234,13.0,1379077,UBRO,Ubrogepant,3.89,ng/mL,3.89,3.89,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-04-19T08:08:00,2.0,24 h,24.0,Period 1 Dose,2018-04-18T08:08:00
3110-103-002,PC,3110-103-002.103001241,1.0,1371826,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T07:34:00,1.0,Predose,0.0,Period 1 Dose,2018-04-18T08:14:00
3110-103-002,PC,3110-103-002.103001241,2.0,1371828,UBRO,Ubrogepant,255.87,ng/mL,255.87,255.87,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T08:44:00,1.0,0.5 h,0.5,Period 1 Dose,2018-04-18T08:14:00
3110-103-002,PC,3110-103-002.103001241,3.0,1371831,UBRO,Ubrogepant,317.62,ng/mL,317.62,317.62,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T09:14:00,1.0,1 h,1.0,Period 1 Dose,2018-04-18T08:14:00
3110-103-002,PC,3110-103-002.103001241,4.0,1371834,UBRO,Ubrogepant,186.82,ng/mL,186.82,186.82,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T09:44:00,1.0,1.5 h,1.5,Period 1 Dose,2018-04-18T08:14:00
3110-103-002,PC,3110-103-002.103001241,5.0,1371838,UBRO,Ubrogepant,164.36,ng/mL,164.36,164.36,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T10:14:00,1.0,2 h,2.0,Period 1 Dose,2018-04-18T08:14:00
3110-103-002,PC,3110-103-002.103001241,6.0,1371839,UBRO,Ubrogepant,107.36,ng/mL,107.36,107.36,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T11:14:00,1.0,3 h,3.0,Period 1 Dose,2018-04-18T08:14:00
3110-103-002,PC,3110-103-002.103001241,7.0,1379487,UBRO,Ubrogepant,84.14,ng/mL,84.14,84.14,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T12:14:00,1.0,4 h,4.0,Period 1 Dose,2018-04-18T08:14:00
3110-103-002,PC,3110-103-002.103001241,8.0,1379492,UBRO,Ubrogepant,72.42,ng/mL,72.42,72.42,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T13:18:25,1.0,5 h,5.0,Period 1 Dose,2018-04-18T08:14:00
3110-103-002,PC,3110-103-002.103001241,9.0,1379493,UBRO,Ubrogepant,57.02,ng/mL,57.02,57.02,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T14:14:00,1.0,6 h,6.0,Period 1 Dose,2018-04-18T08:14:00
3110-103-002,PC,3110-103-002.103001241,10.0,1379494,UBRO,Ubrogepant,31.82,ng/mL,31.82,31.82,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T16:15:32,1.0,8 h,8.0,Period 1 Dose,2018-04-18T08:14:00
3110-103-002,PC,3110-103-002.103001241,11.0,1379497,UBRO,Ubrogepant,19.29,ng/mL,19.29,19.29,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T20:18:05,1.0,12 h,12.0,Period 1 Dose,2018-04-18T08:14:00
3110-103-002,PC,3110-103-002.103001241,12.0,1379500,UBRO,Ubrogepant,7.50,ng/mL,7.50,7.5,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T22:14:00,1.0,14 h,14.0,Period 1 Dose,2018-04-18T08:14:00
3110-103-002,PC,3110-103-002.103001241,13.0,1379506,UBRO,Ubrogepant,1.49,ng/mL,1.49,1.49,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-04-19T08:15:10,2.0,24 h,24.0,Period 1 Dose,2018-04-18T08:14:00
3110-103-002,PC,3110-103-002.103001241,14.0,1379531,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T07:34:00,8.0,Predose,0.0,Period 2 Dose,2018-04-25T08:14:00
3110-103-002,PC,3110-103-002.103001241,15.0,1379535,UBRO,Ubrogepant,1.03,ng/mL,1.03,1.03,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T08:44:00,8.0,0.5 h,0.5,Period 2 Dose,2018-04-25T08:14:00
3110-103-002,PC,3110-103-002.103001241,16.0,1379538,UBRO,Ubrogepant,17.82,ng/mL,17.82,17.82,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T09:14:00,8.0,1 h,1.0,Period 2 Dose,2018-04-25T08:14:00
3110-103-002,PC,3110-103-002.103001241,17.0,1379541,UBRO,Ubrogepant,39.43,ng/mL,39.43,39.43,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T09:44:00,8.0,1.5 h,1.5,Period 2 Dose,2018-04-25T08:14:00
3110-103-002,PC,3110-103-002.103001241,18.0,1379545,UBRO,Ubrogepant,54.99,ng/mL,54.99,54.99,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T10:14:00,8.0,2 h,2.0,Period 2 Dose,2018-04-25T08:14:00
3110-103-002,PC,3110-103-002.103001241,19.0,1379546,UBRO,Ubrogepant,87.37,ng/mL,87.37,87.37,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T11:16:21,8.0,3 h,3.0,Period 2 Dose,2018-04-25T08:14:00
3110-103-002,PC,3110-103-002.103001241,20.0,1379547,UBRO,Ubrogepant,227.78,ng/mL,227.78,227.78,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T12:14:00,8.0,4 h,4.0,Period 2 Dose,2018-04-25T08:14:00
3110-103-002,PC,3110-103-002.103001241,21.0,1379552,UBRO,Ubrogepant,193.64,ng/mL,193.64,193.64,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T13:16:55,8.0,5 h,5.0,Period 2 Dose,2018-04-25T08:14:00
3110-103-002,PC,3110-103-002.103001241,22.0,1379553,UBRO,Ubrogepant,127.85,ng/mL,127.85,127.85,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T14:14:00,8.0,6 h,6.0,Period 2 Dose,2018-04-25T08:14:00
3110-103-002,PC,3110-103-002.103001241,23.0,1379554,UBRO,Ubrogepant,72.86,ng/mL,72.86,72.86,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T16:14:00,8.0,8 h,8.0,Period 2 Dose,2018-04-25T08:14:00
3110-103-002,PC,3110-103-002.103001241,24.0,1379557,UBRO,Ubrogepant,24.26,ng/mL,24.26,24.26,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T20:14:00,8.0,12 h,12.0,Period 2 Dose,2018-04-25T08:14:00
3110-103-002,PC,3110-103-002.103001241,25.0,1379560,UBRO,Ubrogepant,16.13,ng/mL,16.13,16.13,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T22:14:00,8.0,14 h,14.0,Period 2 Dose,2018-04-25T08:14:00
3110-103-002,PC,3110-103-002.103001241,26.0,1379566,UBRO,Ubrogepant,3.47,ng/mL,3.47,3.47,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-04-26T08:14:00,9.0,24 h,24.0,Period 2 Dose,2018-04-25T08:14:00
3110-103-002,PC,3110-103-002.103001248,1.0,1371046,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T07:29:47,1.0,Predose,0.0,Period 1 Dose,2018-04-18T08:06:00
3110-103-002,PC,3110-103-002.103001248,2.0,1371048,UBRO,Ubrogepant,12.13,ng/mL,12.13,12.13,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T08:36:00,1.0,0.5 h,0.5,Period 1 Dose,2018-04-18T08:06:00
3110-103-002,PC,3110-103-002.103001248,3.0,1371051,UBRO,Ubrogepant,38.92,ng/mL,38.92,38.92,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T09:06:00,1.0,1 h,1.0,Period 1 Dose,2018-04-18T08:06:00
3110-103-002,PC,3110-103-002.103001248,4.0,1371054,UBRO,Ubrogepant,74.53,ng/mL,74.53,74.53,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T09:36:00,1.0,1.5 h,1.5,Period 1 Dose,2018-04-18T08:06:00
3110-103-002,PC,3110-103-002.103001248,5.0,1371058,UBRO,Ubrogepant,95.82,ng/mL,95.82,95.82,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T10:06:00,1.0,2 h,2.0,Period 1 Dose,2018-04-18T08:06:00
3110-103-002,PC,3110-103-002.103001248,6.0,1371059,UBRO,Ubrogepant,118.27,ng/mL,118.27,118.27,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T11:06:00,1.0,3 h,3.0,Period 1 Dose,2018-04-18T08:06:00
3110-103-002,PC,3110-103-002.103001248,7.0,1378915,UBRO,Ubrogepant,272.51,ng/mL,272.51,272.51,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T12:06:00,1.0,4 h,4.0,Period 1 Dose,2018-04-18T08:06:00
3110-103-002,PC,3110-103-002.103001248,8.0,1378920,UBRO,Ubrogepant,183.98,ng/mL,183.98,183.98,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T13:06:00,1.0,5 h,5.0,Period 1 Dose,2018-04-18T08:06:00
3110-103-002,PC,3110-103-002.103001248,9.0,1378921,UBRO,Ubrogepant,113.89,ng/mL,113.89,113.89,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T14:06:00,1.0,6 h,6.0,Period 1 Dose,2018-04-18T08:06:00
3110-103-002,PC,3110-103-002.103001248,10.0,1378922,UBRO,Ubrogepant,64.79,ng/mL,64.79,64.79,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T16:06:00,1.0,8 h,8.0,Period 1 Dose,2018-04-18T08:06:00
3110-103-002,PC,3110-103-002.103001248,11.0,1378925,UBRO,Ubrogepant,20.37,ng/mL,20.37,20.37,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T20:06:00,1.0,12 h,12.0,Period 1 Dose,2018-04-18T08:06:00
3110-103-002,PC,3110-103-002.103001248,12.0,1378928,UBRO,Ubrogepant,12.28,ng/mL,12.28,12.28,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T22:06:00,1.0,14 h,14.0,Period 1 Dose,2018-04-18T08:06:00
3110-103-002,PC,3110-103-002.103001248,13.0,1378934,UBRO,Ubrogepant,2.97,ng/mL,2.97,2.97,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-04-19T08:06:00,2.0,24 h,24.0,Period 1 Dose,2018-04-18T08:06:00
3110-103-002,PC,3110-103-002.103001248,14.0,1378959,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T07:26:00,8.0,Predose,0.0,Period 2 Dose,2018-04-25T08:06:00
3110-103-002,PC,3110-103-002.103001248,15.0,1378963,UBRO,Ubrogepant,82.77,ng/mL,82.77,82.77,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T08:36:00,8.0,0.5 h,0.5,Period 2 Dose,2018-04-25T08:06:00
3110-103-002,PC,3110-103-002.103001248,16.0,1378966,UBRO,Ubrogepant,335.85,ng/mL,335.85,335.85,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T09:06:00,8.0,1 h,1.0,Period 2 Dose,2018-04-25T08:06:00
3110-103-002,PC,3110-103-002.103001248,17.0,1378969,UBRO,Ubrogepant,276.62,ng/mL,276.62,276.62,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T09:36:00,8.0,1.5 h,1.5,Period 2 Dose,2018-04-25T08:06:00
3110-103-002,PC,3110-103-002.103001248,18.0,1378973,UBRO,Ubrogepant,257.21,ng/mL,257.21,257.21,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T10:06:00,8.0,2 h,2.0,Period 2 Dose,2018-04-25T08:06:00
3110-103-002,PC,3110-103-002.103001248,19.0,1378974,UBRO,Ubrogepant,138.08,ng/mL,138.08,138.08,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T11:06:00,8.0,3 h,3.0,Period 2 Dose,2018-04-25T08:06:00
3110-103-002,PC,3110-103-002.103001248,20.0,1378975,UBRO,Ubrogepant,97.01,ng/mL,97.01,97.01,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T12:06:00,8.0,4 h,4.0,Period 2 Dose,2018-04-25T08:06:00
3110-103-002,PC,3110-103-002.103001248,21.0,1378980,UBRO,Ubrogepant,76.34,ng/mL,76.34,76.34,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T13:06:00,8.0,5 h,5.0,Period 2 Dose,2018-04-25T08:06:00
3110-103-002,PC,3110-103-002.103001248,22.0,1378981,UBRO,Ubrogepant,57.84,ng/mL,57.84,57.84,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T14:06:00,8.0,6 h,6.0,Period 2 Dose,2018-04-25T08:06:00
3110-103-002,PC,3110-103-002.103001248,23.0,1378982,UBRO,Ubrogepant,33.81,ng/mL,33.81,33.81,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T16:06:00,8.0,8 h,8.0,Period 2 Dose,2018-04-25T08:06:00
3110-103-002,PC,3110-103-002.103001248,24.0,1378985,UBRO,Ubrogepant,10.86,ng/mL,10.86,10.86,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T20:06:00,8.0,12 h,12.0,Period 2 Dose,2018-04-25T08:06:00
3110-103-002,PC,3110-103-002.103001248,25.0,1378988,UBRO,Ubrogepant,6.98,ng/mL,6.98,6.98,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T22:06:00,8.0,14 h,14.0,Period 2 Dose,2018-04-25T08:06:00
3110-103-002,PC,3110-103-002.103001248,26.0,1378994,UBRO,Ubrogepant,1.84,ng/mL,1.84,1.84,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-04-26T08:06:00,9.0,24 h,24.0,Period 2 Dose,2018-04-25T08:06:00
3110-103-002,PC,3110-103-002.103001279,1.0,1371436,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T07:30:50,1.0,Predose,0.0,Period 1 Dose,2018-04-18T08:10:00
3110-103-002,PC,3110-103-002.103001279,2.0,1371438,UBRO,Ubrogepant,13.75,ng/mL,13.75,13.75,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T08:40:00,1.0,0.5 h,0.5,Period 1 Dose,2018-04-18T08:10:00
3110-103-002,PC,3110-103-002.103001279,3.0,1371441,UBRO,Ubrogepant,23.04,ng/mL,23.04,23.04,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T09:10:00,1.0,1 h,1.0,Period 1 Dose,2018-04-18T08:10:00
3110-103-002,PC,3110-103-002.103001279,4.0,1371444,UBRO,Ubrogepant,33.09,ng/mL,33.09,33.09,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T09:40:00,1.0,1.5 h,1.5,Period 1 Dose,2018-04-18T08:10:00
3110-103-002,PC,3110-103-002.103001279,5.0,1371448,UBRO,Ubrogepant,77.81,ng/mL,77.81,77.81,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T10:10:00,1.0,2 h,2.0,Period 1 Dose,2018-04-18T08:10:00
3110-103-002,PC,3110-103-002.103001279,6.0,1371449,UBRO,Ubrogepant,186.08,ng/mL,186.08,186.08,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T11:10:00,1.0,3 h,3.0,Period 1 Dose,2018-04-18T08:10:00
3110-103-002,PC,3110-103-002.103001279,7.0,1379201,UBRO,Ubrogepant,203.22,ng/mL,203.22,203.22,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T12:10:00,1.0,4 h,4.0,Period 1 Dose,2018-04-18T08:10:00
3110-103-002,PC,3110-103-002.103001279,8.0,1379206,UBRO,Ubrogepant,175.90,ng/mL,175.90,175.9,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T13:10:00,1.0,5 h,5.0,Period 1 Dose,2018-04-18T08:10:00
3110-103-002,PC,3110-103-002.103001279,9.0,1379207,UBRO,Ubrogepant,135.24,ng/mL,135.24,135.24,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T14:10:00,1.0,6 h,6.0,Period 1 Dose,2018-04-18T08:10:00
3110-103-002,PC,3110-103-002.103001279,10.0,1379208,UBRO,Ubrogepant,74.50,ng/mL,74.50,74.5,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T16:10:00,1.0,8 h,8.0,Period 1 Dose,2018-04-18T08:10:00
3110-103-002,PC,3110-103-002.103001279,11.0,1379211,UBRO,Ubrogepant,25.05,ng/mL,25.05,25.05,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T20:10:00,1.0,12 h,12.0,Period 1 Dose,2018-04-18T08:10:00
3110-103-002,PC,3110-103-002.103001279,12.0,1379214,UBRO,Ubrogepant,13.48,ng/mL,13.48,13.48,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T22:10:00,1.0,14 h,14.0,Period 1 Dose,2018-04-18T08:10:00
3110-103-002,PC,3110-103-002.103001279,13.0,1379220,UBRO,Ubrogepant,2.39,ng/mL,2.39,2.39,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-04-19T08:10:00,2.0,24 h,24.0,Period 1 Dose,2018-04-18T08:10:00
3110-103-002,PC,3110-103-002.103001279,14.0,1379245,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T07:30:00,8.0,Predose,0.0,Period 2 Dose,2018-04-25T08:10:00
3110-103-002,PC,3110-103-002.103001279,15.0,1379249,UBRO,Ubrogepant,103.35,ng/mL,103.35,103.35,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T08:40:00,8.0,0.5 h,0.5,Period 2 Dose,2018-04-25T08:10:00
3110-103-002,PC,3110-103-002.103001279,16.0,1379252,UBRO,Ubrogepant,474.03,ng/mL,474.03,474.03,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T09:10:00,8.0,1 h,1.0,Period 2 Dose,2018-04-25T08:10:00
3110-103-002,PC,3110-103-002.103001279,17.0,1379255,UBRO,Ubrogepant,356.44,ng/mL,356.44,356.44,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T09:40:00,8.0,1.5 h,1.5,Period 2 Dose,2018-04-25T08:10:00
3110-103-002,PC,3110-103-002.103001279,18.0,1379259,UBRO,Ubrogepant,291.62,ng/mL,291.62,291.62,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T10:10:00,8.0,2 h,2.0,Period 2 Dose,2018-04-25T08:10:00
3110-103-002,PC,3110-103-002.103001279,19.0,1379260,UBRO,Ubrogepant,198.75,ng/mL,198.75,198.75,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T11:10:00,8.0,3 h,3.0,Period 2 Dose,2018-04-25T08:10:00
3110-103-002,PC,3110-103-002.103001279,20.0,1379261,UBRO,Ubrogepant,150.79,ng/mL,150.79,150.79,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T12:10:00,8.0,4 h,4.0,Period 2 Dose,2018-04-25T08:10:00
3110-103-002,PC,3110-103-002.103001279,21.0,1379266,UBRO,Ubrogepant,111.90,ng/mL,111.90,111.9,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T13:10:00,8.0,5 h,5.0,Period 2 Dose,2018-04-25T08:10:00
3110-103-002,PC,3110-103-002.103001279,22.0,1379267,UBRO,Ubrogepant,72.87,ng/mL,72.87,72.87,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T14:10:00,8.0,6 h,6.0,Period 2 Dose,2018-04-25T08:10:00
3110-103-002,PC,3110-103-002.103001279,23.0,1379268,UBRO,Ubrogepant,44.22,ng/mL,44.22,44.22,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T16:10:00,8.0,8 h,8.0,Period 2 Dose,2018-04-25T08:10:00
3110-103-002,PC,3110-103-002.103001279,24.0,1379271,UBRO,Ubrogepant,11.44,ng/mL,11.44,11.44,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T20:10:00,8.0,12 h,12.0,Period 2 Dose,2018-04-25T08:10:00
3110-103-002,PC,3110-103-002.103001279,25.0,1379274,UBRO,Ubrogepant,6.68,ng/mL,6.68,6.68,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T22:10:00,8.0,14 h,14.0,Period 2 Dose,2018-04-25T08:10:00
3110-103-002,PC,3110-103-002.103001279,26.0,1379280,UBRO,Ubrogepant,2.15,ng/mL,2.15,2.15,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-04-26T08:10:00,9.0,24 h,24.0,Period 2 Dose,2018-04-25T08:10:00
3110-103-002,PC,3110-103-002.103001284,1.0,1370461,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T07:25:17,1.0,Predose,0.0,Period 1 Dose,2018-04-18T08:00:00
3110-103-002,PC,3110-103-002.103001284,2.0,1370463,UBRO,Ubrogepant,34.22,ng/mL,34.22,34.22,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T08:30:00,1.0,0.5 h,0.5,Period 1 Dose,2018-04-18T08:00:00
3110-103-002,PC,3110-103-002.103001284,3.0,1370466,UBRO,Ubrogepant,209.98,ng/mL,209.98,209.98,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T09:00:00,1.0,1 h,1.0,Period 1 Dose,2018-04-18T08:00:00
3110-103-002,PC,3110-103-002.103001284,4.0,1370469,UBRO,Ubrogepant,390.60,ng/mL,390.60,390.6,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T09:30:00,1.0,1.5 h,1.5,Period 1 Dose,2018-04-18T08:00:00
3110-103-002,PC,3110-103-002.103001284,5.0,1370473,UBRO,Ubrogepant,376.56,ng/mL,376.56,376.56,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T10:00:00,1.0,2 h,2.0,Period 1 Dose,2018-04-18T08:00:00
3110-103-002,PC,3110-103-002.103001284,6.0,1370474,UBRO,Ubrogepant,386.36,ng/mL,386.36,386.36,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T11:00:00,1.0,3 h,3.0,Period 1 Dose,2018-04-18T08:00:00
3110-103-002,PC,3110-103-002.103001284,7.0,1378486,UBRO,Ubrogepant,202.42,ng/mL,202.42,202.42,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T12:00:00,1.0,4 h,4.0,Period 1 Dose,2018-04-18T08:00:00
3110-103-002,PC,3110-103-002.103001284,8.0,1378491,UBRO,Ubrogepant,226.85,ng/mL,226.85,226.85,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T13:00:00,1.0,5 h,5.0,Period 1 Dose,2018-04-18T08:00:00
3110-103-002,PC,3110-103-002.103001284,9.0,1378492,UBRO,Ubrogepant,157.93,ng/mL,157.93,157.93,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T14:00:00,1.0,6 h,6.0,Period 1 Dose,2018-04-18T08:00:00
3110-103-002,PC,3110-103-002.103001284,10.0,1378493,UBRO,Ubrogepant,64.42,ng/mL,64.42,64.42,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T16:00:00,1.0,8 h,8.0,Period 1 Dose,2018-04-18T08:00:00
3110-103-002,PC,3110-103-002.103001284,11.0,1378496,UBRO,Ubrogepant,30.38,ng/mL,30.38,30.38,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T20:00:00,1.0,12 h,12.0,Period 1 Dose,2018-04-18T08:00:00
3110-103-002,PC,3110-103-002.103001284,12.0,1378499,UBRO,Ubrogepant,13.65,ng/mL,13.65,13.65,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T22:00:00,1.0,14 h,14.0,Period 1 Dose,2018-04-18T08:00:00
3110-103-002,PC,3110-103-002.103001284,13.0,1378505,UBRO,Ubrogepant,7.43,ng/mL,7.43,7.43,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-04-19T08:00:00,2.0,24 h,24.0,Period 1 Dose,2018-04-18T08:00:00
3110-103-002,PC,3110-103-002.103001284,14.0,1378530,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T07:20:00,8.0,Predose,0.0,Period 2 Dose,2018-04-25T08:00:00
3110-103-002,PC,3110-103-002.103001284,15.0,1378534,UBRO,Ubrogepant,4.21,ng/mL,4.21,4.21,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T08:30:00,8.0,0.5 h,0.5,Period 2 Dose,2018-04-25T08:00:00
3110-103-002,PC,3110-103-002.103001284,16.0,1378537,UBRO,Ubrogepant,43.47,ng/mL,43.47,43.47,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T09:00:00,8.0,1 h,1.0,Period 2 Dose,2018-04-25T08:00:00
3110-103-002,PC,3110-103-002.103001284,17.0,1378540,UBRO,Ubrogepant,205.87,ng/mL,205.87,205.87,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T09:30:00,8.0,1.5 h,1.5,Period 2 Dose,2018-04-25T08:00:00
3110-103-002,PC,3110-103-002.103001284,18.0,1378544,UBRO,Ubrogepant,217.44,ng/mL,217.44,217.44,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T10:00:00,8.0,2 h,2.0,Period 2 Dose,2018-04-25T08:00:00
3110-103-002,PC,3110-103-002.103001284,19.0,1378545,UBRO,Ubrogepant,195.04,ng/mL,195.04,195.04,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T11:00:00,8.0,3 h,3.0,Period 2 Dose,2018-04-25T08:00:00
3110-103-002,PC,3110-103-002.103001284,20.0,1378546,UBRO,Ubrogepant,229.18,ng/mL,229.18,229.18,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T12:00:00,8.0,4 h,4.0,Period 2 Dose,2018-04-25T08:00:00
3110-103-002,PC,3110-103-002.103001284,21.0,1378551,UBRO,Ubrogepant,155.96,ng/mL,155.96,155.96,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T13:01:19,8.0,5 h,5.0,Period 2 Dose,2018-04-25T08:00:00
3110-103-002,PC,3110-103-002.103001284,22.0,1378552,UBRO,Ubrogepant,151.25,ng/mL,151.25,151.25,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T14:00:00,8.0,6 h,6.0,Period 2 Dose,2018-04-25T08:00:00
3110-103-002,PC,3110-103-002.103001284,23.0,1378553,UBRO,Ubrogepant,119.74,ng/mL,119.74,119.74,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T16:00:00,8.0,8 h,8.0,Period 2 Dose,2018-04-25T08:00:00
3110-103-002,PC,3110-103-002.103001284,24.0,1378556,UBRO,Ubrogepant,42.40,ng/mL,42.40,42.4,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T20:00:00,8.0,12 h,12.0,Period 2 Dose,2018-04-25T08:00:00
3110-103-002,PC,3110-103-002.103001284,25.0,1378559,UBRO,Ubrogepant,29.11,ng/mL,29.11,29.11,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T22:00:00,8.0,14 h,14.0,Period 2 Dose,2018-04-25T08:00:00
3110-103-002,PC,3110-103-002.103001284,26.0,1378565,UBRO,Ubrogepant,9.37,ng/mL,9.37,9.37,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-04-26T08:00:00,9.0,24 h,24.0,Period 2 Dose,2018-04-25T08:00:00
3110-103-002,PC,3110-103-002.103001288,1.0,1369486,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T07:36:00,1.0,Predose,0.0,Period 1 Dose,2018-04-18T08:16:00
3110-103-002,PC,3110-103-002.103001288,2.0,1369488,UBRO,Ubrogepant,134.67,ng/mL,134.67,134.67,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T08:46:00,1.0,0.5 h,0.5,Period 1 Dose,2018-04-18T08:16:00
3110-103-002,PC,3110-103-002.103001288,3.0,1369491,UBRO,Ubrogepant,264.60,ng/mL,264.60,264.6,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T09:16:00,1.0,1 h,1.0,Period 1 Dose,2018-04-18T08:16:00
3110-103-002,PC,3110-103-002.103001288,4.0,1369494,UBRO,Ubrogepant,190.85,ng/mL,190.85,190.85,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T09:46:00,1.0,1.5 h,1.5,Period 1 Dose,2018-04-18T08:16:00
3110-103-002,PC,3110-103-002.103001288,5.0,1369498,UBRO,Ubrogepant,174.02,ng/mL,174.02,174.02,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T10:16:00,1.0,2 h,2.0,Period 1 Dose,2018-04-18T08:16:00
3110-103-002,PC,3110-103-002.103001288,6.0,1369499,UBRO,Ubrogepant,108.78,ng/mL,108.78,108.78,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T11:16:00,1.0,3 h,3.0,Period 1 Dose,2018-04-18T08:16:00
3110-103-002,PC,3110-103-002.103001288,7.0,1369500,UBRO,Ubrogepant,72.86,ng/mL,72.86,72.86,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T12:16:00,1.0,4 h,4.0,Period 1 Dose,2018-04-18T08:16:00
3110-103-002,PC,3110-103-002.103001288,8.0,1369505,UBRO,Ubrogepant,54.92,ng/mL,54.92,54.92,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T13:16:00,1.0,5 h,5.0,Period 1 Dose,2018-04-18T08:16:00
3110-103-002,PC,3110-103-002.103001288,9.0,1369506,UBRO,Ubrogepant,38.62,ng/mL,38.62,38.62,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T14:16:00,1.0,6 h,6.0,Period 1 Dose,2018-04-18T08:16:00
3110-103-002,PC,3110-103-002.103001288,10.0,1369507,UBRO,Ubrogepant,26.90,ng/mL,26.90,26.9,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T16:16:00,1.0,8 h,8.0,Period 1 Dose,2018-04-18T08:16:00
3110-103-002,PC,3110-103-002.103001288,11.0,1369510,UBRO,Ubrogepant,14.63,ng/mL,14.63,14.63,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T20:17:16,1.0,12 h,12.0,Period 1 Dose,2018-04-18T08:16:00
3110-103-002,PC,3110-103-002.103001288,12.0,1369513,UBRO,Ubrogepant,8.70,ng/mL,8.70,8.7,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T22:16:00,1.0,14 h,14.0,Period 1 Dose,2018-04-18T08:16:00
3110-103-002,PC,3110-103-002.103001288,13.0,1369519,UBRO,Ubrogepant,5.30,ng/mL,5.30,5.3,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-04-19T08:17:16,2.0,24 h,24.0,Period 1 Dose,2018-04-18T08:16:00
3110-103-002,PC,3110-103-002.103001288,14.0,1369544,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T07:39:20,8.0,Predose,0.0,Period 2 Dose,2018-04-25T08:16:00
3110-103-002,PC,3110-103-002.103001288,15.0,1369546,UBRO,Ubrogepant,201.80,ng/mL,201.80,201.8,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T08:46:00,8.0,0.5 h,0.5,Period 2 Dose,2018-04-25T08:16:00
3110-103-002,PC,3110-103-002.103001288,16.0,1369549,UBRO,Ubrogepant,441.23,ng/mL,441.23,441.23,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T09:16:00,8.0,1 h,1.0,Period 2 Dose,2018-04-25T08:16:00
3110-103-002,PC,3110-103-002.103001288,17.0,1369552,UBRO,Ubrogepant,357.75,ng/mL,357.75,357.75,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T09:46:00,8.0,1.5 h,1.5,Period 2 Dose,2018-04-25T08:16:00
3110-103-002,PC,3110-103-002.103001288,18.0,1369556,UBRO,Ubrogepant,300.06,ng/mL,300.06,300.06,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T10:16:00,8.0,2 h,2.0,Period 2 Dose,2018-04-25T08:16:00
3110-103-002,PC,3110-103-002.103001288,19.0,1369557,UBRO,Ubrogepant,177.11,ng/mL,177.11,177.11,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T11:16:00,8.0,3 h,3.0,Period 2 Dose,2018-04-25T08:16:00
3110-103-002,PC,3110-103-002.103001288,20.0,1369558,UBRO,Ubrogepant,115.53,ng/mL,115.53,115.53,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T12:16:00,8.0,4 h,4.0,Period 2 Dose,2018-04-25T08:16:00
3110-103-002,PC,3110-103-002.103001288,21.0,1369563,UBRO,Ubrogepant,93.41,ng/mL,93.41,93.41,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T13:16:49,8.0,5 h,5.0,Period 2 Dose,2018-04-25T08:16:00
3110-103-002,PC,3110-103-002.103001288,22.0,1369564,UBRO,Ubrogepant,64.07,ng/mL,64.07,64.07,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T14:16:00,8.0,6 h,6.0,Period 2 Dose,2018-04-25T08:16:00
3110-103-002,PC,3110-103-002.103001288,23.0,1369565,UBRO,Ubrogepant,45.33,ng/mL,45.33,45.33,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T16:16:00,8.0,8 h,8.0,Period 2 Dose,2018-04-25T08:16:00
3110-103-002,PC,3110-103-002.103001288,24.0,1369568,UBRO,Ubrogepant,19.50,ng/mL,19.50,19.5,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T20:16:00,8.0,12 h,12.0,Period 2 Dose,2018-04-25T08:16:00
3110-103-002,PC,3110-103-002.103001288,25.0,1369571,UBRO,Ubrogepant,14.23,ng/mL,14.23,14.23,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T22:16:00,8.0,14 h,14.0,Period 2 Dose,2018-04-25T08:16:00
3110-103-002,PC,3110-103-002.103001288,26.0,1369577,UBRO,Ubrogepant,4.93,ng/mL,4.93,4.93,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-04-26T08:16:00,9.0,24 h,24.0,Period 2 Dose,2018-04-25T08:16:00
3110-103-002,PC,3110-103-002.103001288,27.0,1369602,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T07:46:00,15.0,Predose,0.0,Period 3 Dose,2018-05-02T08:16:00
3110-103-002,PC,3110-103-002.103001288,28.0,1369604,UBRO,Ubrogepant,388.41,ng/mL,388.41,388.41,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T08:49:13,15.0,0.5 h,0.5,Period 3 Dose,2018-05-02T08:16:00
3110-103-002,PC,3110-103-002.103001288,29.0,1369607,UBRO,Ubrogepant,474.83,ng/mL,474.83,474.83,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T09:16:00,15.0,1 h,1.0,Period 3 Dose,2018-05-02T08:16:00
3110-103-002,PC,3110-103-002.103001288,30.0,1369610,UBRO,Ubrogepant,434.17,ng/mL,434.17,434.17,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T09:47:24,15.0,1.5 h,1.5,Period 3 Dose,2018-05-02T08:16:00
3110-103-002,PC,3110-103-002.103001288,31.0,1369614,UBRO,Ubrogepant,428.84,ng/mL,428.84,428.84,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T10:16:00,15.0,2 h,2.0,Period 3 Dose,2018-05-02T08:16:00
3110-103-002,PC,3110-103-002.103001288,32.0,1369615,UBRO,Ubrogepant,354.56,ng/mL,354.56,354.56,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T11:16:00,15.0,3 h,3.0,Period 3 Dose,2018-05-02T08:16:00
3110-103-002,PC,3110-103-002.103001288,33.0,1369616,UBRO,Ubrogepant,234.37,ng/mL,234.37,234.37,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T12:16:00,15.0,4 h,4.0,Period 3 Dose,2018-05-02T08:16:00
3110-103-002,PC,3110-103-002.103001288,34.0,1369621,UBRO,Ubrogepant,162.71,ng/mL,162.71,162.71,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T13:16:00,15.0,5 h,5.0,Period 3 Dose,2018-05-02T08:16:00
3110-103-002,PC,3110-103-002.103001288,35.0,1369622,UBRO,Ubrogepant,96.74,ng/mL,96.74,96.74,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T14:16:00,15.0,6 h,6.0,Period 3 Dose,2018-05-02T08:16:00
3110-103-002,PC,3110-103-002.103001288,36.0,1369623,UBRO,Ubrogepant,61.49,ng/mL,61.49,61.49,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T16:16:00,15.0,8 h,8.0,Period 3 Dose,2018-05-02T08:16:00
3110-103-002,PC,3110-103-002.103001288,37.0,1369626,UBRO,Ubrogepant,20.90,ng/mL,20.90,20.9,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T20:16:00,15.0,12 h,12.0,Period 3 Dose,2018-05-02T08:16:00
3110-103-002,PC,3110-103-002.103001288,38.0,1369629,UBRO,Ubrogepant,14.27,ng/mL,14.27,14.27,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T22:16:00,15.0,14 h,14.0,Period 3 Dose,2018-05-02T08:16:00
3110-103-002,PC,3110-103-002.103001288,39.0,1369635,UBRO,Ubrogepant,2.73,ng/mL,2.73,2.73,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,26.0,Period 3 Day 16,TREATMENT,2018-05-03T08:17:05,16.0,24 h,24.0,Period 3 Dose,2018-05-02T08:16:00
3110-103-002,PC,3110-103-002.103001290,1.0,1370071,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T07:42:00,1.0,Predose,0.0,Period 1 Dose,2018-04-18T08:22:00
3110-103-002,PC,3110-103-002.103001290,2.0,1370073,UBRO,Ubrogepant,50.87,ng/mL,50.87,50.87,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T08:52:00,1.0,0.5 h,0.5,Period 1 Dose,2018-04-18T08:22:00
3110-103-002,PC,3110-103-002.103001290,3.0,1370076,UBRO,Ubrogepant,147.33,ng/mL,147.33,147.33,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T09:22:00,1.0,1 h,1.0,Period 1 Dose,2018-04-18T08:22:00
3110-103-002,PC,3110-103-002.103001290,4.0,1370079,UBRO,Ubrogepant,125.00,ng/mL,125.00,125.0,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T09:52:00,1.0,1.5 h,1.5,Period 1 Dose,2018-04-18T08:22:00
3110-103-002,PC,3110-103-002.103001290,5.0,1370083,UBRO,Ubrogepant,270.63,ng/mL,270.63,270.63,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T10:22:00,1.0,2 h,2.0,Period 1 Dose,2018-04-18T08:22:00
3110-103-002,PC,3110-103-002.103001290,6.0,1370084,UBRO,Ubrogepant,173.75,ng/mL,173.75,173.75,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T11:22:00,1.0,3 h,3.0,Period 1 Dose,2018-04-18T08:22:00
3110-103-002,PC,3110-103-002.103001290,7.0,1370085,UBRO,Ubrogepant,114.78,ng/mL,114.78,114.78,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T12:22:00,1.0,4 h,4.0,Period 1 Dose,2018-04-18T08:22:00
3110-103-002,PC,3110-103-002.103001290,8.0,1370090,UBRO,Ubrogepant,80.64,ng/mL,80.64,80.64,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T13:22:00,1.0,5 h,5.0,Period 1 Dose,2018-04-18T08:22:00
3110-103-002,PC,3110-103-002.103001290,9.0,1370091,UBRO,Ubrogepant,68.03,ng/mL,68.03,68.03,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T14:22:00,1.0,6 h,6.0,Period 1 Dose,2018-04-18T08:22:00
3110-103-002,PC,3110-103-002.103001290,10.0,1370092,UBRO,Ubrogepant,32.30,ng/mL,32.30,32.3,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T16:22:00,1.0,8 h,8.0,Period 1 Dose,2018-04-18T08:22:00
3110-103-002,PC,3110-103-002.103001290,11.0,1370095,UBRO,Ubrogepant,15.38,ng/mL,15.38,15.38,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T20:22:00,1.0,12 h,12.0,Period 1 Dose,2018-04-18T08:22:00
3110-103-002,PC,3110-103-002.103001290,12.0,1370098,UBRO,Ubrogepant,8.24,ng/mL,8.24,8.24,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T22:22:00,1.0,14 h,14.0,Period 1 Dose,2018-04-18T08:22:00
3110-103-002,PC,3110-103-002.103001290,13.0,1370104,UBRO,Ubrogepant,1.98,ng/mL,1.98,1.98,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-04-19T08:22:00,2.0,24 h,24.0,Period 1 Dose,2018-04-18T08:22:00
3110-103-002,PC,3110-103-002.103001290,14.0,1370129,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T07:44:00,8.0,Predose,0.0,Period 2 Dose,2018-04-25T08:22:00
3110-103-002,PC,3110-103-002.103001290,15.0,1370131,UBRO,Ubrogepant,6.47,ng/mL,6.47,6.47,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T08:52:00,8.0,0.5 h,0.5,Period 2 Dose,2018-04-25T08:22:00
3110-103-002,PC,3110-103-002.103001290,16.0,1370134,UBRO,Ubrogepant,50.86,ng/mL,50.86,50.86,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T09:22:00,8.0,1 h,1.0,Period 2 Dose,2018-04-25T08:22:00
3110-103-002,PC,3110-103-002.103001290,17.0,1370137,UBRO,Ubrogepant,64.84,ng/mL,64.84,64.84,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T09:52:00,8.0,1.5 h,1.5,Period 2 Dose,2018-04-25T08:22:00
3110-103-002,PC,3110-103-002.103001290,18.0,1370141,UBRO,Ubrogepant,104.88,ng/mL,104.88,104.88,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T10:22:00,8.0,2 h,2.0,Period 2 Dose,2018-04-25T08:22:00
3110-103-002,PC,3110-103-002.103001290,19.0,1370142,UBRO,Ubrogepant,143.50,ng/mL,143.50,143.5,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T11:22:00,8.0,3 h,3.0,Period 2 Dose,2018-04-25T08:22:00
3110-103-002,PC,3110-103-002.103001290,20.0,1370143,UBRO,Ubrogepant,234.64,ng/mL,234.64,234.64,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T12:22:00,8.0,4 h,4.0,Period 2 Dose,2018-04-25T08:22:00
3110-103-002,PC,3110-103-002.103001290,21.0,1370148,UBRO,Ubrogepant,161.08,ng/mL,161.08,161.08,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T13:22:00,8.0,5 h,5.0,Period 2 Dose,2018-04-25T08:22:00
3110-103-002,PC,3110-103-002.103001290,22.0,1370149,UBRO,Ubrogepant,89.92,ng/mL,89.92,89.92,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T14:22:00,8.0,6 h,6.0,Period 2 Dose,2018-04-25T08:22:00
3110-103-002,PC,3110-103-002.103001290,23.0,1370150,UBRO,Ubrogepant,56.17,ng/mL,56.17,56.17,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T16:22:00,8.0,8 h,8.0,Period 2 Dose,2018-04-25T08:22:00
3110-103-002,PC,3110-103-002.103001290,24.0,1370153,UBRO,Ubrogepant,20.08,ng/mL,20.08,20.08,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T20:22:00,8.0,12 h,12.0,Period 2 Dose,2018-04-25T08:22:00
3110-103-002,PC,3110-103-002.103001290,25.0,1370156,UBRO,Ubrogepant,12.72,ng/mL,12.72,12.72,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T22:22:00,8.0,14 h,14.0,Period 2 Dose,2018-04-25T08:22:00
3110-103-002,PC,3110-103-002.103001290,26.0,1370162,UBRO,Ubrogepant,2.38,ng/mL,2.38,2.38,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-04-26T08:22:00,9.0,24 h,24.0,Period 2 Dose,2018-04-25T08:22:00
3110-103-002,PC,3110-103-002.103001290,27.0,1370187,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T07:52:00,15.0,Predose,0.0,Period 3 Dose,2018-05-02T08:22:00
3110-103-002,PC,3110-103-002.103001290,28.0,1370189,UBRO,Ubrogepant,9.61,ng/mL,9.61,9.61,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T08:52:00,15.0,0.5 h,0.5,Period 3 Dose,2018-05-02T08:22:00
3110-103-002,PC,3110-103-002.103001290,29.0,1370192,UBRO,Ubrogepant,104.01,ng/mL,104.01,104.01,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T09:22:00,15.0,1 h,1.0,Period 3 Dose,2018-05-02T08:22:00
3110-103-002,PC,3110-103-002.103001290,30.0,1370195,UBRO,Ubrogepant,136.28,ng/mL,136.28,136.28,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T09:52:00,15.0,1.5 h,1.5,Period 3 Dose,2018-05-02T08:22:00
3110-103-002,PC,3110-103-002.103001290,31.0,1370199,UBRO,Ubrogepant,170.87,ng/mL,170.87,170.87,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T10:22:00,15.0,2 h,2.0,Period 3 Dose,2018-05-02T08:22:00
3110-103-002,PC,3110-103-002.103001290,32.0,1370200,UBRO,Ubrogepant,118.86,ng/mL,118.86,118.86,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T11:22:00,15.0,3 h,3.0,Period 3 Dose,2018-05-02T08:22:00
3110-103-002,PC,3110-103-002.103001290,33.0,1370201,UBRO,Ubrogepant,88.33,ng/mL,88.33,88.33,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T12:22:00,15.0,4 h,4.0,Period 3 Dose,2018-05-02T08:22:00
3110-103-002,PC,3110-103-002.103001290,34.0,1370206,UBRO,Ubrogepant,67.99,ng/mL,67.99,67.99,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T13:22:00,15.0,5 h,5.0,Period 3 Dose,2018-05-02T08:22:00
3110-103-002,PC,3110-103-002.103001290,35.0,1370207,UBRO,Ubrogepant,43.99,ng/mL,43.99,43.99,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T14:22:00,15.0,6 h,6.0,Period 3 Dose,2018-05-02T08:22:00
3110-103-002,PC,3110-103-002.103001290,36.0,1370208,UBRO,Ubrogepant,30.77,ng/mL,30.77,30.77,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T16:22:00,15.0,8 h,8.0,Period 3 Dose,2018-05-02T08:22:00
3110-103-002,PC,3110-103-002.103001290,37.0,1370211,UBRO,Ubrogepant,12.51,ng/mL,12.51,12.51,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T20:22:00,15.0,12 h,12.0,Period 3 Dose,2018-05-02T08:22:00
3110-103-002,PC,3110-103-002.103001290,38.0,1370214,UBRO,Ubrogepant,8.98,ng/mL,8.98,8.98,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,25.0,Period 3 Day 15,TREATMENT,2018-05-02T22:22:00,15.0,14 h,14.0,Period 3 Dose,2018-05-02T08:22:00
3110-103-002,PC,3110-103-002.103001290,39.0,1370220,UBRO,Ubrogepant,2.57,ng/mL,2.57,2.57,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,26.0,Period 3 Day 16,TREATMENT,2018-05-03T08:22:00,16.0,24 h,24.0,Period 3 Dose,2018-05-02T08:22:00
3110-103-002,PC,3110-103-002.103001303,1.0,1371631,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T07:32:17,1.0,Predose,0.0,Period 1 Dose,2018-04-18T08:12:00
3110-103-002,PC,3110-103-002.103001303,2.0,1371633,UBRO,Ubrogepant,1.20,ng/mL,1.20,1.2,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T08:42:00,1.0,0.5 h,0.5,Period 1 Dose,2018-04-18T08:12:00
3110-103-002,PC,3110-103-002.103001303,3.0,1371636,UBRO,Ubrogepant,18.60,ng/mL,18.60,18.6,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T09:12:00,1.0,1 h,1.0,Period 1 Dose,2018-04-18T08:12:00
3110-103-002,PC,3110-103-002.103001303,4.0,1371639,UBRO,Ubrogepant,87.22,ng/mL,87.22,87.22,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T09:42:00,1.0,1.5 h,1.5,Period 1 Dose,2018-04-18T08:12:00
3110-103-002,PC,3110-103-002.103001303,5.0,1371643,UBRO,Ubrogepant,153.21,ng/mL,153.21,153.21,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T10:12:00,1.0,2 h,2.0,Period 1 Dose,2018-04-18T08:12:00
3110-103-002,PC,3110-103-002.103001303,6.0,1371644,UBRO,Ubrogepant,154.93,ng/mL,154.93,154.93,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T11:12:00,1.0,3 h,3.0,Period 1 Dose,2018-04-18T08:12:00
3110-103-002,PC,3110-103-002.103001303,7.0,1379344,UBRO,Ubrogepant,171.82,ng/mL,171.82,171.82,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T12:12:00,1.0,4 h,4.0,Period 1 Dose,2018-04-18T08:12:00
3110-103-002,PC,3110-103-002.103001303,8.0,1379349,UBRO,Ubrogepant,114.47,ng/mL,114.47,114.47,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T13:12:00,1.0,5 h,5.0,Period 1 Dose,2018-04-18T08:12:00
3110-103-002,PC,3110-103-002.103001303,9.0,1379350,UBRO,Ubrogepant,63.61,ng/mL,63.61,63.61,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T14:12:00,1.0,6 h,6.0,Period 1 Dose,2018-04-18T08:12:00
3110-103-002,PC,3110-103-002.103001303,10.0,1379351,UBRO,Ubrogepant,34.78,ng/mL,34.78,34.78,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T16:12:00,1.0,8 h,8.0,Period 1 Dose,2018-04-18T08:12:00
3110-103-002,PC,3110-103-002.103001303,11.0,1379354,UBRO,Ubrogepant,8.40,ng/mL,8.40,8.4,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T20:12:00,1.0,12 h,12.0,Period 1 Dose,2018-04-18T08:12:00
3110-103-002,PC,3110-103-002.103001303,12.0,1379357,UBRO,Ubrogepant,4.36,ng/mL,4.36,4.36,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-18T22:12:00,1.0,14 h,14.0,Period 1 Dose,2018-04-18T08:12:00
3110-103-002,PC,3110-103-002.103001303,13.0,1379363,UBRO,Ubrogepant,1.32,ng/mL,1.32,1.32,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-04-19T08:12:00,2.0,24 h,24.0,Period 1 Dose,2018-04-18T08:12:00
3110-103-002,PC,3110-103-002.103001303,14.0,1379388,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T07:32:00,8.0,Predose,0.0,Period 2 Dose,2018-04-25T08:12:00
3110-103-002,PC,3110-103-002.103001303,15.0,1379392,UBRO,Ubrogepant,88.24,ng/mL,88.24,88.24,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T08:42:00,8.0,0.5 h,0.5,Period 2 Dose,2018-04-25T08:12:00
3110-103-002,PC,3110-103-002.103001303,16.0,1379395,UBRO,Ubrogepant,272.93,ng/mL,272.93,272.93,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T09:12:00,8.0,1 h,1.0,Period 2 Dose,2018-04-25T08:12:00
3110-103-002,PC,3110-103-002.103001303,17.0,1379398,UBRO,Ubrogepant,161.10,ng/mL,161.10,161.1,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T09:42:00,8.0,1.5 h,1.5,Period 2 Dose,2018-04-25T08:12:00
3110-103-002,PC,3110-103-002.103001303,18.0,1379402,UBRO,Ubrogepant,172.34,ng/mL,172.34,172.34,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T10:12:00,8.0,2 h,2.0,Period 2 Dose,2018-04-25T08:12:00
3110-103-002,PC,3110-103-002.103001303,19.0,1379403,UBRO,Ubrogepant,120.68,ng/mL,120.68,120.68,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T11:12:00,8.0,3 h,3.0,Period 2 Dose,2018-04-25T08:12:00
3110-103-002,PC,3110-103-002.103001303,20.0,1379404,UBRO,Ubrogepant,97.21,ng/mL,97.21,97.21,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T12:12:00,8.0,4 h,4.0,Period 2 Dose,2018-04-25T08:12:00
3110-103-002,PC,3110-103-002.103001303,21.0,1379409,UBRO,Ubrogepant,63.92,ng/mL,63.92,63.92,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T13:12:00,8.0,5 h,5.0,Period 2 Dose,2018-04-25T08:12:00
3110-103-002,PC,3110-103-002.103001303,22.0,1379410,UBRO,Ubrogepant,52.95,ng/mL,52.95,52.95,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T14:12:00,8.0,6 h,6.0,Period 2 Dose,2018-04-25T08:12:00
3110-103-002,PC,3110-103-002.103001303,23.0,1379411,UBRO,Ubrogepant,35.61,ng/mL,35.61,35.61,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T16:12:00,8.0,8 h,8.0,Period 2 Dose,2018-04-25T08:12:00
3110-103-002,PC,3110-103-002.103001303,24.0,1379414,UBRO,Ubrogepant,8.38,ng/mL,8.38,8.38,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T20:12:00,8.0,12 h,12.0,Period 2 Dose,2018-04-25T08:12:00
3110-103-002,PC,3110-103-002.103001303,25.0,1379417,UBRO,Ubrogepant,5.63,ng/mL,5.63,5.63,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-04-25T22:12:00,8.0,14 h,14.0,Period 2 Dose,2018-04-25T08:12:00
3110-103-002,PC,3110-103-002.103001303,26.0,1379423,UBRO,Ubrogepant,1.26,ng/mL,1.26,1.26,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-04-26T08:12:00,9.0,24 h,24.0,Period 2 Dose,2018-04-25T08:12:00
3110-103-002,PC,3110-103-002.103001305,1.0,1387973,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T07:30:00,1.0,Predose,0.0,Period 1 Dose,2018-04-27T08:10:00
3110-103-002,PC,3110-103-002.103001305,2.0,1387977,UBRO,Ubrogepant,14.46,ng/mL,14.46,14.46,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T08:40:00,1.0,0.5 h,0.5,Period 1 Dose,2018-04-27T08:10:00
3110-103-002,PC,3110-103-002.103001305,3.0,1387980,UBRO,Ubrogepant,63.12,ng/mL,63.12,63.12,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T09:10:00,1.0,1 h,1.0,Period 1 Dose,2018-04-27T08:10:00
3110-103-002,PC,3110-103-002.103001305,4.0,1387983,UBRO,Ubrogepant,60.71,ng/mL,60.71,60.71,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T09:40:00,1.0,1.5 h,1.5,Period 1 Dose,2018-04-27T08:10:00
3110-103-002,PC,3110-103-002.103001305,5.0,1387987,UBRO,Ubrogepant,217.18,ng/mL,217.18,217.18,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T10:10:00,1.0,2 h,2.0,Period 1 Dose,2018-04-27T08:10:00
3110-103-002,PC,3110-103-002.103001305,6.0,1387988,UBRO,Ubrogepant,254.67,ng/mL,254.67,254.67,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T11:10:00,1.0,3 h,3.0,Period 1 Dose,2018-04-27T08:10:00
3110-103-002,PC,3110-103-002.103001305,7.0,1387989,UBRO,Ubrogepant,157.50,ng/mL,157.50,157.5,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T12:10:00,1.0,4 h,4.0,Period 1 Dose,2018-04-27T08:10:00
3110-103-002,PC,3110-103-002.103001305,8.0,1387994,UBRO,Ubrogepant,121.03,ng/mL,121.03,121.03,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T13:10:00,1.0,5 h,5.0,Period 1 Dose,2018-04-27T08:10:00
3110-103-002,PC,3110-103-002.103001305,9.0,1387995,UBRO,Ubrogepant,86.65,ng/mL,86.65,86.65,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T14:10:00,1.0,6 h,6.0,Period 1 Dose,2018-04-27T08:10:00
3110-103-002,PC,3110-103-002.103001305,10.0,1387996,UBRO,Ubrogepant,56.17,ng/mL,56.17,56.17,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T16:10:00,1.0,8 h,8.0,Period 1 Dose,2018-04-27T08:10:00
3110-103-002,PC,3110-103-002.103001305,11.0,1387999,UBRO,Ubrogepant,24.05,ng/mL,24.05,24.05,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T20:10:00,1.0,12 h,12.0,Period 1 Dose,2018-04-27T08:10:00
3110-103-002,PC,3110-103-002.103001305,12.0,1388002,UBRO,Ubrogepant,18.08,ng/mL,18.08,18.08,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T22:10:00,1.0,14 h,14.0,Period 1 Dose,2018-04-27T08:10:00
3110-103-002,PC,3110-103-002.103001305,13.0,1388008,UBRO,Ubrogepant,5.09,ng/mL,5.09,5.09,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-04-28T08:10:00,2.0,24 h,24.0,Period 1 Dose,2018-04-27T08:10:00
3110-103-002,PC,3110-103-002.103001305,14.0,1388033,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-11T07:30:00,15.0,Predose,0.0,Period 2 Dose,2018-05-11T08:10:00
3110-103-002,PC,3110-103-002.103001305,15.0,1388037,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-11T08:40:00,15.0,0.5 h,0.5,Period 2 Dose,2018-05-11T08:10:00
3110-103-002,PC,3110-103-002.103001305,16.0,1388040,UBRO,Ubrogepant,31.85,ng/mL,31.85,31.85,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-11T09:10:00,15.0,1 h,1.0,Period 2 Dose,2018-05-11T08:10:00
3110-103-002,PC,3110-103-002.103001305,17.0,1388043,UBRO,Ubrogepant,104.55,ng/mL,104.55,104.55,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-11T09:40:00,15.0,1.5 h,1.5,Period 2 Dose,2018-05-11T08:10:00
3110-103-002,PC,3110-103-002.103001305,18.0,1388047,UBRO,Ubrogepant,144.46,ng/mL,144.46,144.46,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-11T10:10:00,15.0,2 h,2.0,Period 2 Dose,2018-05-11T08:10:00
3110-103-002,PC,3110-103-002.103001305,19.0,1388048,UBRO,Ubrogepant,164.90,ng/mL,164.90,164.9,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-11T11:10:00,15.0,3 h,3.0,Period 2 Dose,2018-05-11T08:10:00
3110-103-002,PC,3110-103-002.103001305,20.0,1388049,UBRO,Ubrogepant,119.84,ng/mL,119.84,119.84,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-11T12:10:00,15.0,4 h,4.0,Period 2 Dose,2018-05-11T08:10:00
3110-103-002,PC,3110-103-002.103001305,21.0,1388054,UBRO,Ubrogepant,143.34,ng/mL,143.34,143.34,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-11T13:10:00,15.0,5 h,5.0,Period 2 Dose,2018-05-11T08:10:00
3110-103-002,PC,3110-103-002.103001305,22.0,1388055,UBRO,Ubrogepant,112.96,ng/mL,112.96,112.96,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-11T14:10:00,15.0,6 h,6.0,Period 2 Dose,2018-05-11T08:10:00
3110-103-002,PC,3110-103-002.103001305,23.0,1388056,UBRO,Ubrogepant,79.49,ng/mL,79.49,79.49,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-11T16:10:00,15.0,8 h,8.0,Period 2 Dose,2018-05-11T08:10:00
3110-103-002,PC,3110-103-002.103001305,24.0,1388059,UBRO,Ubrogepant,24.94,ng/mL,24.94,24.94,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-11T20:10:00,15.0,12 h,12.0,Period 2 Dose,2018-05-11T08:10:00
3110-103-002,PC,3110-103-002.103001305,25.0,1388062,UBRO,Ubrogepant,17.10,ng/mL,17.10,17.1,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-11T22:10:00,15.0,14 h,14.0,Period 2 Dose,2018-05-11T08:10:00
3110-103-002,PC,3110-103-002.103001305,26.0,1388068,UBRO,Ubrogepant,4.42,ng/mL,4.42,4.42,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-05-12T08:10:00,16.0,24 h,24.0,Period 2 Dose,2018-05-11T08:10:00
3110-103-002,PC,3110-103-002.103001306,1.0,1387258,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T07:20:00,1.0,Predose,0.0,Period 1 Dose,2018-04-27T08:00:00
3110-103-002,PC,3110-103-002.103001306,2.0,1387262,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T08:30:00,1.0,0.5 h,0.5,Period 1 Dose,2018-04-27T08:00:00
3110-103-002,PC,3110-103-002.103001306,3.0,1387265,UBRO,Ubrogepant,37.64,ng/mL,37.64,37.64,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T09:00:00,1.0,1 h,1.0,Period 1 Dose,2018-04-27T08:00:00
3110-103-002,PC,3110-103-002.103001306,4.0,1387268,UBRO,Ubrogepant,137.79,ng/mL,137.79,137.79,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T09:30:00,1.0,1.5 h,1.5,Period 1 Dose,2018-04-27T08:00:00
3110-103-002,PC,3110-103-002.103001306,5.0,1387272,UBRO,Ubrogepant,238.30,ng/mL,238.30,238.3,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T10:00:00,1.0,2 h,2.0,Period 1 Dose,2018-04-27T08:00:00
3110-103-002,PC,3110-103-002.103001306,6.0,1387273,UBRO,Ubrogepant,134.70,ng/mL,134.70,134.7,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T11:00:00,1.0,3 h,3.0,Period 1 Dose,2018-04-27T08:00:00
3110-103-002,PC,3110-103-002.103001306,7.0,1387274,UBRO,Ubrogepant,134.00,ng/mL,134.00,134.0,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T12:00:00,1.0,4 h,4.0,Period 1 Dose,2018-04-27T08:00:00
3110-103-002,PC,3110-103-002.103001306,8.0,1387279,UBRO,Ubrogepant,120.36,ng/mL,120.36,120.36,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T13:00:00,1.0,5 h,5.0,Period 1 Dose,2018-04-27T08:00:00
3110-103-002,PC,3110-103-002.103001306,9.0,1387280,UBRO,Ubrogepant,146.54,ng/mL,146.54,146.54,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T14:00:00,1.0,6 h,6.0,Period 1 Dose,2018-04-27T08:00:00
3110-103-002,PC,3110-103-002.103001306,10.0,1387281,UBRO,Ubrogepant,77.39,ng/mL,77.39,77.39,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T16:00:00,1.0,8 h,8.0,Period 1 Dose,2018-04-27T08:00:00
3110-103-002,PC,3110-103-002.103001306,11.0,1387284,UBRO,Ubrogepant,28.47,ng/mL,28.47,28.47,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T20:00:00,1.0,12 h,12.0,Period 1 Dose,2018-04-27T08:00:00
3110-103-002,PC,3110-103-002.103001306,12.0,1387287,UBRO,Ubrogepant,18.63,ng/mL,18.63,18.63,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T22:00:00,1.0,14 h,14.0,Period 1 Dose,2018-04-27T08:00:00
3110-103-002,PC,3110-103-002.103001306,13.0,1387293,UBRO,Ubrogepant,4.42,ng/mL,4.42,4.42,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-04-28T08:00:00,2.0,24 h,24.0,Period 1 Dose,2018-04-27T08:00:00
3110-103-002,PC,3110-103-002.103001306,14.0,1387318,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T07:20:00,8.0,Predose,0.0,Period 2 Dose,2018-05-04T08:00:00
3110-103-002,PC,3110-103-002.103001306,15.0,1387322,UBRO,Ubrogepant,10.97,ng/mL,10.97,10.97,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T08:30:00,8.0,0.5 h,0.5,Period 2 Dose,2018-05-04T08:00:00
3110-103-002,PC,3110-103-002.103001306,16.0,1387325,UBRO,Ubrogepant,162.98,ng/mL,162.98,162.98,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T09:00:00,8.0,1 h,1.0,Period 2 Dose,2018-05-04T08:00:00
3110-103-002,PC,3110-103-002.103001306,17.0,1387328,UBRO,Ubrogepant,308.36,ng/mL,308.36,308.36,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T09:30:00,8.0,1.5 h,1.5,Period 2 Dose,2018-05-04T08:00:00
3110-103-002,PC,3110-103-002.103001306,18.0,1387332,UBRO,Ubrogepant,415.56,ng/mL,415.56,415.56,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T10:00:00,8.0,2 h,2.0,Period 2 Dose,2018-05-04T08:00:00
3110-103-002,PC,3110-103-002.103001306,19.0,1387333,UBRO,Ubrogepant,298.47,ng/mL,298.47,298.47,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T11:00:00,8.0,3 h,3.0,Period 2 Dose,2018-05-04T08:00:00
3110-103-002,PC,3110-103-002.103001306,20.0,1387334,UBRO,Ubrogepant,213.07,ng/mL,213.07,213.07,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T12:00:00,8.0,4 h,4.0,Period 2 Dose,2018-05-04T08:00:00
3110-103-002,PC,3110-103-002.103001306,21.0,1387339,UBRO,Ubrogepant,137.76,ng/mL,137.76,137.76,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T13:00:00,8.0,5 h,5.0,Period 2 Dose,2018-05-04T08:00:00
3110-103-002,PC,3110-103-002.103001306,22.0,1387340,UBRO,Ubrogepant,106.68,ng/mL,106.68,106.68,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T14:00:00,8.0,6 h,6.0,Period 2 Dose,2018-05-04T08:00:00
3110-103-002,PC,3110-103-002.103001306,23.0,1387341,UBRO,Ubrogepant,56.74,ng/mL,56.74,56.74,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T16:00:00,8.0,8 h,8.0,Period 2 Dose,2018-05-04T08:00:00
3110-103-002,PC,3110-103-002.103001306,24.0,1387344,UBRO,Ubrogepant,18.22,ng/mL,18.22,18.22,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T20:00:00,8.0,12 h,12.0,Period 2 Dose,2018-05-04T08:00:00
3110-103-002,PC,3110-103-002.103001306,25.0,1387347,UBRO,Ubrogepant,10.98,ng/mL,10.98,10.98,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T22:00:00,8.0,14 h,14.0,Period 2 Dose,2018-05-04T08:00:00
3110-103-002,PC,3110-103-002.103001306,26.0,1387353,UBRO,Ubrogepant,1.98,ng/mL,1.98,1.98,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-05-05T08:00:00,9.0,24 h,24.0,Period 2 Dose,2018-05-04T08:00:00
3110-103-002,PC,3110-103-002.103001325,1.0,1387401,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T07:22:00,1.0,Predose,0.0,Period 1 Dose,2018-04-27T08:02:00
3110-103-002,PC,3110-103-002.103001325,2.0,1387405,UBRO,Ubrogepant,615.18,ng/mL,615.18,615.18,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T08:32:00,1.0,0.5 h,0.5,Period 1 Dose,2018-04-27T08:02:00
3110-103-002,PC,3110-103-002.103001325,3.0,1387408,UBRO,Ubrogepant,669.73,ng/mL,669.73,669.73,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T09:02:00,1.0,1 h,1.0,Period 1 Dose,2018-04-27T08:02:00
3110-103-002,PC,3110-103-002.103001325,4.0,1387411,UBRO,Ubrogepant,628.99,ng/mL,628.99,628.99,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T09:32:00,1.0,1.5 h,1.5,Period 1 Dose,2018-04-27T08:02:00
3110-103-002,PC,3110-103-002.103001325,5.0,1387415,UBRO,Ubrogepant,580.49,ng/mL,580.49,580.49,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T10:02:00,1.0,2 h,2.0,Period 1 Dose,2018-04-27T08:02:00
3110-103-002,PC,3110-103-002.103001325,6.0,1387416,UBRO,Ubrogepant,443.17,ng/mL,443.17,443.17,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T11:02:00,1.0,3 h,3.0,Period 1 Dose,2018-04-27T08:02:00
3110-103-002,PC,3110-103-002.103001325,7.0,1387417,UBRO,Ubrogepant,317.07,ng/mL,317.07,317.07,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T12:02:00,1.0,4 h,4.0,Period 1 Dose,2018-04-27T08:02:00
3110-103-002,PC,3110-103-002.103001325,8.0,1387422,UBRO,Ubrogepant,225.06,ng/mL,225.06,225.06,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T13:02:00,1.0,5 h,5.0,Period 1 Dose,2018-04-27T08:02:00
3110-103-002,PC,3110-103-002.103001325,9.0,1387423,UBRO,Ubrogepant,169.15,ng/mL,169.15,169.15,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T14:02:00,1.0,6 h,6.0,Period 1 Dose,2018-04-27T08:02:00
3110-103-002,PC,3110-103-002.103001325,10.0,1387424,UBRO,Ubrogepant,104.12,ng/mL,104.12,104.12,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T16:02:00,1.0,8 h,8.0,Period 1 Dose,2018-04-27T08:02:00
3110-103-002,PC,3110-103-002.103001325,11.0,1387427,UBRO,Ubrogepant,44.44,ng/mL,44.44,44.44,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T20:02:00,1.0,12 h,12.0,Period 1 Dose,2018-04-27T08:02:00
3110-103-002,PC,3110-103-002.103001325,12.0,1387430,UBRO,Ubrogepant,28.52,ng/mL,28.52,28.52,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T22:02:00,1.0,14 h,14.0,Period 1 Dose,2018-04-27T08:02:00
3110-103-002,PC,3110-103-002.103001325,13.0,1387436,UBRO,Ubrogepant,8.94,ng/mL,8.94,8.94,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-04-28T08:02:00,2.0,24 h,24.0,Period 1 Dose,2018-04-27T08:02:00
3110-103-002,PC,3110-103-002.103001325,14.0,1387461,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T07:22:00,8.0,Predose,0.0,Period 2 Dose,2018-05-04T08:02:00
3110-103-002,PC,3110-103-002.103001325,15.0,1387465,UBRO,Ubrogepant,15.04,ng/mL,15.04,15.04,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T08:32:00,8.0,0.5 h,0.5,Period 2 Dose,2018-05-04T08:02:00
3110-103-002,PC,3110-103-002.103001325,16.0,1387468,UBRO,Ubrogepant,98.67,ng/mL,98.67,98.67,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T09:02:00,8.0,1 h,1.0,Period 2 Dose,2018-05-04T08:02:00
3110-103-002,PC,3110-103-002.103001325,17.0,1387471,UBRO,Ubrogepant,174.87,ng/mL,174.87,174.87,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T09:32:00,8.0,1.5 h,1.5,Period 2 Dose,2018-05-04T08:02:00
3110-103-002,PC,3110-103-002.103001325,18.0,1387475,UBRO,Ubrogepant,362.16,ng/mL,362.16,362.16,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T10:02:00,8.0,2 h,2.0,Period 2 Dose,2018-05-04T08:02:00
3110-103-002,PC,3110-103-002.103001325,19.0,1387476,UBRO,Ubrogepant,385.49,ng/mL,385.49,385.49,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T11:02:00,8.0,3 h,3.0,Period 2 Dose,2018-05-04T08:02:00
3110-103-002,PC,3110-103-002.103001325,20.0,1387477,UBRO,Ubrogepant,326.83,ng/mL,326.83,326.83,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T12:02:00,8.0,4 h,4.0,Period 2 Dose,2018-05-04T08:02:00
3110-103-002,PC,3110-103-002.103001325,21.0,1387482,UBRO,Ubrogepant,285.50,ng/mL,285.50,285.5,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T13:02:00,8.0,5 h,5.0,Period 2 Dose,2018-05-04T08:02:00
3110-103-002,PC,3110-103-002.103001325,22.0,1387483,UBRO,Ubrogepant,208.20,ng/mL,208.20,208.2,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T14:02:00,8.0,6 h,6.0,Period 2 Dose,2018-05-04T08:02:00
3110-103-002,PC,3110-103-002.103001325,23.0,1387484,UBRO,Ubrogepant,125.33,ng/mL,125.33,125.33,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T16:02:00,8.0,8 h,8.0,Period 2 Dose,2018-05-04T08:02:00
3110-103-002,PC,3110-103-002.103001325,24.0,1387487,UBRO,Ubrogepant,38.58,ng/mL,38.58,38.58,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T20:02:00,8.0,12 h,12.0,Period 2 Dose,2018-05-04T08:02:00
3110-103-002,PC,3110-103-002.103001325,25.0,1387490,UBRO,Ubrogepant,23.10,ng/mL,23.10,23.1,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T22:02:00,8.0,14 h,14.0,Period 2 Dose,2018-05-04T08:02:00
3110-103-002,PC,3110-103-002.103001325,26.0,1387496,UBRO,Ubrogepant,8.24,ng/mL,8.24,8.24,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-05-05T08:02:00,9.0,24 h,24.0,Period 2 Dose,2018-05-04T08:02:00
3110-103-002,PC,3110-103-002.103001327,1.0,1387544,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T07:24:00,1.0,Predose,0.0,Period 1 Dose,2018-04-27T08:04:00
3110-103-002,PC,3110-103-002.103001327,2.0,1387548,UBRO,Ubrogepant,40.90,ng/mL,40.90,40.9,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T08:34:00,1.0,0.5 h,0.5,Period 1 Dose,2018-04-27T08:04:00
3110-103-002,PC,3110-103-002.103001327,3.0,1387551,UBRO,Ubrogepant,186.75,ng/mL,186.75,186.75,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T09:04:00,1.0,1 h,1.0,Period 1 Dose,2018-04-27T08:04:00
3110-103-002,PC,3110-103-002.103001327,4.0,1387554,UBRO,Ubrogepant,265.16,ng/mL,265.16,265.16,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T09:34:00,1.0,1.5 h,1.5,Period 1 Dose,2018-04-27T08:04:00
3110-103-002,PC,3110-103-002.103001327,5.0,1387558,UBRO,Ubrogepant,245.72,ng/mL,245.72,245.72,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T10:04:00,1.0,2 h,2.0,Period 1 Dose,2018-04-27T08:04:00
3110-103-002,PC,3110-103-002.103001327,6.0,1387559,UBRO,Ubrogepant,154.94,ng/mL,154.94,154.94,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T11:04:00,1.0,3 h,3.0,Period 1 Dose,2018-04-27T08:04:00
3110-103-002,PC,3110-103-002.103001327,7.0,1387560,UBRO,Ubrogepant,135.27,ng/mL,135.27,135.27,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T12:04:00,1.0,4 h,4.0,Period 1 Dose,2018-04-27T08:04:00
3110-103-002,PC,3110-103-002.103001327,8.0,1387565,UBRO,Ubrogepant,126.14,ng/mL,126.14,126.14,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T13:04:00,1.0,5 h,5.0,Period 1 Dose,2018-04-27T08:04:00
3110-103-002,PC,3110-103-002.103001327,9.0,1387566,UBRO,Ubrogepant,86.17,ng/mL,86.17,86.17,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T14:04:00,1.0,6 h,6.0,Period 1 Dose,2018-04-27T08:04:00
3110-103-002,PC,3110-103-002.103001327,10.0,1387567,UBRO,Ubrogepant,49.68,ng/mL,49.68,49.68,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T16:05:35,1.0,8 h,8.0,Period 1 Dose,2018-04-27T08:04:00
3110-103-002,PC,3110-103-002.103001327,11.0,1387570,UBRO,Ubrogepant,19.08,ng/mL,19.08,19.08,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T20:04:00,1.0,12 h,12.0,Period 1 Dose,2018-04-27T08:04:00
3110-103-002,PC,3110-103-002.103001327,12.0,1387573,UBRO,Ubrogepant,10.53,ng/mL,10.53,10.53,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T22:04:00,1.0,14 h,14.0,Period 1 Dose,2018-04-27T08:04:00
3110-103-002,PC,3110-103-002.103001327,13.0,1387579,UBRO,Ubrogepant,2.64,ng/mL,2.64,2.64,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-04-28T08:04:00,2.0,24 h,24.0,Period 1 Dose,2018-04-27T08:04:00
3110-103-002,PC,3110-103-002.103001327,14.0,1387604,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T07:24:00,8.0,Predose,0.0,Period 2 Dose,2018-05-04T08:04:00
3110-103-002,PC,3110-103-002.103001327,15.0,1387608,UBRO,Ubrogepant,243.67,ng/mL,243.67,243.67,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T08:34:00,8.0,0.5 h,0.5,Period 2 Dose,2018-05-04T08:04:00
3110-103-002,PC,3110-103-002.103001327,16.0,1387611,UBRO,Ubrogepant,387.96,ng/mL,387.96,387.96,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T09:06:56,8.0,1 h,1.0,Period 2 Dose,2018-05-04T08:04:00
3110-103-002,PC,3110-103-002.103001327,17.0,1387614,UBRO,Ubrogepant,316.41,ng/mL,316.41,316.41,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T09:34:00,8.0,1.5 h,1.5,Period 2 Dose,2018-05-04T08:04:00
3110-103-002,PC,3110-103-002.103001327,18.0,1387618,UBRO,Ubrogepant,223.31,ng/mL,223.31,223.31,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T10:04:00,8.0,2 h,2.0,Period 2 Dose,2018-05-04T08:04:00
3110-103-002,PC,3110-103-002.103001327,19.0,1387619,UBRO,Ubrogepant,145.62,ng/mL,145.62,145.62,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T11:04:00,8.0,3 h,3.0,Period 2 Dose,2018-05-04T08:04:00
3110-103-002,PC,3110-103-002.103001327,20.0,1387620,UBRO,Ubrogepant,118.14,ng/mL,118.14,118.14,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T12:04:00,8.0,4 h,4.0,Period 2 Dose,2018-05-04T08:04:00
3110-103-002,PC,3110-103-002.103001327,21.0,1387625,UBRO,Ubrogepant,94.30,ng/mL,94.30,94.3,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T13:04:00,8.0,5 h,5.0,Period 2 Dose,2018-05-04T08:04:00
3110-103-002,PC,3110-103-002.103001327,22.0,1387626,UBRO,Ubrogepant,70.04,ng/mL,70.04,70.04,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T14:04:00,8.0,6 h,6.0,Period 2 Dose,2018-05-04T08:04:00
3110-103-002,PC,3110-103-002.103001327,23.0,1387627,UBRO,Ubrogepant,43.88,ng/mL,43.88,43.88,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T16:04:00,8.0,8 h,8.0,Period 2 Dose,2018-05-04T08:04:00
3110-103-002,PC,3110-103-002.103001327,24.0,1387630,UBRO,Ubrogepant,12.06,ng/mL,12.06,12.06,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T20:04:00,8.0,12 h,12.0,Period 2 Dose,2018-05-04T08:04:00
3110-103-002,PC,3110-103-002.103001327,25.0,1387633,UBRO,Ubrogepant,7.48,ng/mL,7.48,7.48,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T22:04:00,8.0,14 h,14.0,Period 2 Dose,2018-05-04T08:04:00
3110-103-002,PC,3110-103-002.103001327,26.0,1387639,UBRO,Ubrogepant,2.23,ng/mL,2.23,2.23,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-05-05T08:04:00,9.0,24 h,24.0,Period 2 Dose,2018-05-04T08:04:00
3110-103-002,PC,3110-103-002.103001328,1.0,1388116,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T07:32:00,1.0,Predose,0.0,Period 1 Dose,2018-04-27T08:12:00
3110-103-002,PC,3110-103-002.103001328,2.0,1388120,UBRO,Ubrogepant,42.02,ng/mL,42.02,42.02,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T08:42:00,1.0,0.5 h,0.5,Period 1 Dose,2018-04-27T08:12:00
3110-103-002,PC,3110-103-002.103001328,3.0,1388123,UBRO,Ubrogepant,186.96,ng/mL,186.96,186.96,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T09:12:44,1.0,1 h,1.0,Period 1 Dose,2018-04-27T08:12:00
3110-103-002,PC,3110-103-002.103001328,4.0,1388126,UBRO,Ubrogepant,225.83,ng/mL,225.83,225.83,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T09:42:00,1.0,1.5 h,1.5,Period 1 Dose,2018-04-27T08:12:00
3110-103-002,PC,3110-103-002.103001328,5.0,1388130,UBRO,Ubrogepant,289.16,ng/mL,289.16,289.16,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T10:12:00,1.0,2 h,2.0,Period 1 Dose,2018-04-27T08:12:00
3110-103-002,PC,3110-103-002.103001328,6.0,1388131,UBRO,Ubrogepant,221.51,ng/mL,221.51,221.51,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T11:12:00,1.0,3 h,3.0,Period 1 Dose,2018-04-27T08:12:00
3110-103-002,PC,3110-103-002.103001328,7.0,1388132,UBRO,Ubrogepant,140.34,ng/mL,140.34,140.34,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T12:12:00,1.0,4 h,4.0,Period 1 Dose,2018-04-27T08:12:00
3110-103-002,PC,3110-103-002.103001328,8.0,1388137,UBRO,Ubrogepant,116.54,ng/mL,116.54,116.54,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T13:12:00,1.0,5 h,5.0,Period 1 Dose,2018-04-27T08:12:00
3110-103-002,PC,3110-103-002.103001328,9.0,1388138,UBRO,Ubrogepant,97.64,ng/mL,97.64,97.64,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T14:12:00,1.0,6 h,6.0,Period 1 Dose,2018-04-27T08:12:00
3110-103-002,PC,3110-103-002.103001328,10.0,1388139,UBRO,Ubrogepant,51.33,ng/mL,51.33,51.33,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T16:12:00,1.0,8 h,8.0,Period 1 Dose,2018-04-27T08:12:00
3110-103-002,PC,3110-103-002.103001328,11.0,1388142,UBRO,Ubrogepant,19.86,ng/mL,19.86,19.86,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T20:12:00,1.0,12 h,12.0,Period 1 Dose,2018-04-27T08:12:00
3110-103-002,PC,3110-103-002.103001328,12.0,1388145,UBRO,Ubrogepant,12.72,ng/mL,12.72,12.72,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T22:12:00,1.0,14 h,14.0,Period 1 Dose,2018-04-27T08:12:00
3110-103-002,PC,3110-103-002.103001328,13.0,1388151,UBRO,Ubrogepant,3.62,ng/mL,3.62,3.62,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-04-28T08:12:00,2.0,24 h,24.0,Period 1 Dose,2018-04-27T08:12:00
3110-103-002,PC,3110-103-002.103001328,14.0,1388176,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T07:32:00,8.0,Predose,0.0,Period 2 Dose,2018-05-04T08:12:00
3110-103-002,PC,3110-103-002.103001328,15.0,1388180,UBRO,Ubrogepant,14.17,ng/mL,14.17,14.17,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T08:42:00,8.0,0.5 h,0.5,Period 2 Dose,2018-05-04T08:12:00
3110-103-002,PC,3110-103-002.103001328,16.0,1388183,UBRO,Ubrogepant,92.22,ng/mL,92.22,92.22,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T09:12:00,8.0,1 h,1.0,Period 2 Dose,2018-05-04T08:12:00
3110-103-002,PC,3110-103-002.103001328,17.0,1388186,UBRO,Ubrogepant,134.69,ng/mL,134.69,134.69,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T09:42:00,8.0,1.5 h,1.5,Period 2 Dose,2018-05-04T08:12:00
3110-103-002,PC,3110-103-002.103001328,18.0,1388190,UBRO,Ubrogepant,179.31,ng/mL,179.31,179.31,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T10:12:00,8.0,2 h,2.0,Period 2 Dose,2018-05-04T08:12:00
3110-103-002,PC,3110-103-002.103001328,19.0,1388191,UBRO,Ubrogepant,220.98,ng/mL,220.98,220.98,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T11:12:00,8.0,3 h,3.0,Period 2 Dose,2018-05-04T08:12:00
3110-103-002,PC,3110-103-002.103001328,20.0,1388192,UBRO,Ubrogepant,194.06,ng/mL,194.06,194.06,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T12:12:00,8.0,4 h,4.0,Period 2 Dose,2018-05-04T08:12:00
3110-103-002,PC,3110-103-002.103001328,21.0,1388197,UBRO,Ubrogepant,129.03,ng/mL,129.03,129.03,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T13:12:00,8.0,5 h,5.0,Period 2 Dose,2018-05-04T08:12:00
3110-103-002,PC,3110-103-002.103001328,22.0,1388198,UBRO,Ubrogepant,101.99,ng/mL,101.99,101.99,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T14:12:00,8.0,6 h,6.0,Period 2 Dose,2018-05-04T08:12:00
3110-103-002,PC,3110-103-002.103001328,23.0,1388199,UBRO,Ubrogepant,53.73,ng/mL,53.73,53.73,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T16:12:00,8.0,8 h,8.0,Period 2 Dose,2018-05-04T08:12:00
3110-103-002,PC,3110-103-002.103001328,24.0,1388202,UBRO,Ubrogepant,24.45,ng/mL,24.45,24.45,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T20:12:00,8.0,12 h,12.0,Period 2 Dose,2018-05-04T08:12:00
3110-103-002,PC,3110-103-002.103001328,25.0,1388205,UBRO,Ubrogepant,16.46,ng/mL,16.46,16.46,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T22:12:00,8.0,14 h,14.0,Period 2 Dose,2018-05-04T08:12:00
3110-103-002,PC,3110-103-002.103001328,26.0,1388211,UBRO,Ubrogepant,4.01,ng/mL,4.01,4.01,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-05-05T08:12:00,9.0,24 h,24.0,Period 2 Dose,2018-05-04T08:12:00
3110-103-002,PC,3110-103-002.103001329,1.0,1388259,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T07:34:00,1.0,Predose,0.0,Period 1 Dose,2018-04-27T08:14:00
3110-103-002,PC,3110-103-002.103001329,2.0,1388263,UBRO,Ubrogepant,75.12,ng/mL,75.12,75.12,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T08:44:00,1.0,0.5 h,0.5,Period 1 Dose,2018-04-27T08:14:00
3110-103-002,PC,3110-103-002.103001329,3.0,1388266,UBRO,Ubrogepant,371.54,ng/mL,371.54,371.54,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T09:14:00,1.0,1 h,1.0,Period 1 Dose,2018-04-27T08:14:00
3110-103-002,PC,3110-103-002.103001329,4.0,1388269,UBRO,Ubrogepant,299.44,ng/mL,299.44,299.44,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T09:44:00,1.0,1.5 h,1.5,Period 1 Dose,2018-04-27T08:14:00
3110-103-002,PC,3110-103-002.103001329,5.0,1388273,UBRO,Ubrogepant,260.44,ng/mL,260.44,260.44,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T10:14:00,1.0,2 h,2.0,Period 1 Dose,2018-04-27T08:14:00
3110-103-002,PC,3110-103-002.103001329,6.0,1388274,UBRO,Ubrogepant,184.14,ng/mL,184.14,184.14,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T11:14:00,1.0,3 h,3.0,Period 1 Dose,2018-04-27T08:14:00
3110-103-002,PC,3110-103-002.103001329,7.0,1388275,UBRO,Ubrogepant,164.33,ng/mL,164.33,164.33,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T12:14:00,1.0,4 h,4.0,Period 1 Dose,2018-04-27T08:14:00
3110-103-002,PC,3110-103-002.103001329,8.0,1388280,UBRO,Ubrogepant,96.03,ng/mL,96.03,96.03,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T13:14:00,1.0,5 h,5.0,Period 1 Dose,2018-04-27T08:14:00
3110-103-002,PC,3110-103-002.103001329,9.0,1388281,UBRO,Ubrogepant,65.93,ng/mL,65.93,65.93,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T14:14:00,1.0,6 h,6.0,Period 1 Dose,2018-04-27T08:14:00
3110-103-002,PC,3110-103-002.103001329,10.0,1388282,UBRO,Ubrogepant,40.21,ng/mL,40.21,40.21,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T16:15:16,1.0,8 h,8.0,Period 1 Dose,2018-04-27T08:14:00
3110-103-002,PC,3110-103-002.103001329,11.0,1388285,UBRO,Ubrogepant,12.89,ng/mL,12.89,12.89,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T20:14:00,1.0,12 h,12.0,Period 1 Dose,2018-04-27T08:14:00
3110-103-002,PC,3110-103-002.103001329,12.0,1388288,UBRO,Ubrogepant,7.71,ng/mL,7.71,7.71,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T22:14:00,1.0,14 h,14.0,Period 1 Dose,2018-04-27T08:14:00
3110-103-002,PC,3110-103-002.103001329,13.0,1388294,UBRO,Ubrogepant,1.92,ng/mL,1.92,1.92,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-04-28T08:14:00,2.0,24 h,24.0,Period 1 Dose,2018-04-27T08:14:00
3110-103-002,PC,3110-103-002.103001329,14.0,1388319,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T07:34:00,8.0,Predose,0.0,Period 2 Dose,2018-05-04T08:14:00
3110-103-002,PC,3110-103-002.103001329,15.0,1388323,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T08:44:00,8.0,0.5 h,0.5,Period 2 Dose,2018-05-04T08:14:00
3110-103-002,PC,3110-103-002.103001329,16.0,1388326,UBRO,Ubrogepant,1.42,ng/mL,1.42,1.42,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T09:14:00,8.0,1 h,1.0,Period 2 Dose,2018-05-04T08:14:00
3110-103-002,PC,3110-103-002.103001329,17.0,1388329,UBRO,Ubrogepant,6.08,ng/mL,6.08,6.08,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T09:44:00,8.0,1.5 h,1.5,Period 2 Dose,2018-05-04T08:14:00
3110-103-002,PC,3110-103-002.103001329,18.0,1388333,UBRO,Ubrogepant,20.39,ng/mL,20.39,20.39,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T10:14:00,8.0,2 h,2.0,Period 2 Dose,2018-05-04T08:14:00
3110-103-002,PC,3110-103-002.103001329,19.0,1388334,UBRO,Ubrogepant,130.48,ng/mL,130.48,130.48,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T11:14:00,8.0,3 h,3.0,Period 2 Dose,2018-05-04T08:14:00
3110-103-002,PC,3110-103-002.103001329,20.0,1388335,UBRO,Ubrogepant,286.23,ng/mL,286.23,286.23,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T12:14:00,8.0,4 h,4.0,Period 2 Dose,2018-05-04T08:14:00
3110-103-002,PC,3110-103-002.103001329,21.0,1388340,UBRO,Ubrogepant,242.03,ng/mL,242.03,242.03,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T13:14:00,8.0,5 h,5.0,Period 2 Dose,2018-05-04T08:14:00
3110-103-002,PC,3110-103-002.103001329,22.0,1388341,UBRO,Ubrogepant,177.78,ng/mL,177.78,177.78,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T14:14:00,8.0,6 h,6.0,Period 2 Dose,2018-05-04T08:14:00
3110-103-002,PC,3110-103-002.103001329,23.0,1388342,UBRO,Ubrogepant,101.47,ng/mL,101.47,101.47,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T16:14:00,8.0,8 h,8.0,Period 2 Dose,2018-05-04T08:14:00
3110-103-002,PC,3110-103-002.103001329,24.0,1388345,UBRO,Ubrogepant,30.29,ng/mL,30.29,30.29,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T20:14:00,8.0,12 h,12.0,Period 2 Dose,2018-05-04T08:14:00
3110-103-002,PC,3110-103-002.103001329,25.0,1388348,UBRO,Ubrogepant,16.34,ng/mL,16.34,16.34,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T22:14:00,8.0,14 h,14.0,Period 2 Dose,2018-05-04T08:14:00
3110-103-002,PC,3110-103-002.103001329,26.0,1388354,UBRO,Ubrogepant,4.51,ng/mL,4.51,4.51,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-05-05T08:14:00,9.0,24 h,24.0,Period 2 Dose,2018-05-04T08:14:00
3110-103-002,PC,3110-103-002.103001340,1.0,1388402,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T07:36:00,1.0,Predose,0.0,Period 1 Dose,2018-04-27T08:16:00
3110-103-002,PC,3110-103-002.103001340,2.0,1388406,UBRO,Ubrogepant,192.13,ng/mL,192.13,192.13,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T08:46:00,1.0,0.5 h,0.5,Period 1 Dose,2018-04-27T08:16:00
3110-103-002,PC,3110-103-002.103001340,3.0,1388409,UBRO,Ubrogepant,307.37,ng/mL,307.37,307.37,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T09:16:00,1.0,1 h,1.0,Period 1 Dose,2018-04-27T08:16:00
3110-103-002,PC,3110-103-002.103001340,4.0,1388412,UBRO,Ubrogepant,214.94,ng/mL,214.94,214.94,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T09:46:00,1.0,1.5 h,1.5,Period 1 Dose,2018-04-27T08:16:00
3110-103-002,PC,3110-103-002.103001340,5.0,1388416,UBRO,Ubrogepant,214.72,ng/mL,214.72,214.72,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T10:16:00,1.0,2 h,2.0,Period 1 Dose,2018-04-27T08:16:00
3110-103-002,PC,3110-103-002.103001340,6.0,1388417,UBRO,Ubrogepant,167.25,ng/mL,167.25,167.25,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T11:16:00,1.0,3 h,3.0,Period 1 Dose,2018-04-27T08:16:00
3110-103-002,PC,3110-103-002.103001340,7.0,1388418,UBRO,Ubrogepant,117.93,ng/mL,117.93,117.93,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T12:16:00,1.0,4 h,4.0,Period 1 Dose,2018-04-27T08:16:00
3110-103-002,PC,3110-103-002.103001340,8.0,1388423,UBRO,Ubrogepant,94.55,ng/mL,94.55,94.55,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T13:16:00,1.0,5 h,5.0,Period 1 Dose,2018-04-27T08:16:00
3110-103-002,PC,3110-103-002.103001340,9.0,1388424,UBRO,Ubrogepant,75.97,ng/mL,75.97,75.97,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T14:16:00,1.0,6 h,6.0,Period 1 Dose,2018-04-27T08:16:00
3110-103-002,PC,3110-103-002.103001340,10.0,1388425,UBRO,Ubrogepant,44.00,ng/mL,44.00,44.0,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T16:16:00,1.0,8 h,8.0,Period 1 Dose,2018-04-27T08:16:00
3110-103-002,PC,3110-103-002.103001340,11.0,1388428,UBRO,Ubrogepant,17.49,ng/mL,17.49,17.49,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T20:16:00,1.0,12 h,12.0,Period 1 Dose,2018-04-27T08:16:00
3110-103-002,PC,3110-103-002.103001340,12.0,1388431,UBRO,Ubrogepant,11.32,ng/mL,11.32,11.32,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T22:16:00,1.0,14 h,14.0,Period 1 Dose,2018-04-27T08:16:00
3110-103-002,PC,3110-103-002.103001340,13.0,1388437,UBRO,Ubrogepant,3.06,ng/mL,3.06,3.06,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-04-28T08:16:00,2.0,24 h,24.0,Period 1 Dose,2018-04-27T08:16:00
3110-103-002,PC,3110-103-002.103001340,14.0,1388462,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T07:36:00,8.0,Predose,0.0,Period 2 Dose,2018-05-04T08:16:00
3110-103-002,PC,3110-103-002.103001340,15.0,1388466,UBRO,Ubrogepant,6.38,ng/mL,6.38,6.38,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T08:46:00,8.0,0.5 h,0.5,Period 2 Dose,2018-05-04T08:16:00
3110-103-002,PC,3110-103-002.103001340,16.0,1388469,UBRO,Ubrogepant,53.47,ng/mL,53.47,53.47,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T09:16:00,8.0,1 h,1.0,Period 2 Dose,2018-05-04T08:16:00
3110-103-002,PC,3110-103-002.103001340,17.0,1388472,UBRO,Ubrogepant,107.86,ng/mL,107.86,107.86,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T09:46:00,8.0,1.5 h,1.5,Period 2 Dose,2018-05-04T08:16:00
3110-103-002,PC,3110-103-002.103001340,18.0,1388476,UBRO,Ubrogepant,166.16,ng/mL,166.16,166.16,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T10:16:00,8.0,2 h,2.0,Period 2 Dose,2018-05-04T08:16:00
3110-103-002,PC,3110-103-002.103001340,19.0,1388477,UBRO,Ubrogepant,217.48,ng/mL,217.48,217.48,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T11:16:00,8.0,3 h,3.0,Period 2 Dose,2018-05-04T08:16:00
3110-103-002,PC,3110-103-002.103001340,20.0,1388478,UBRO,Ubrogepant,208.74,ng/mL,208.74,208.74,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T12:16:00,8.0,4 h,4.0,Period 2 Dose,2018-05-04T08:16:00
3110-103-002,PC,3110-103-002.103001340,21.0,1388483,UBRO,Ubrogepant,173.19,ng/mL,173.19,173.19,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T13:16:00,8.0,5 h,5.0,Period 2 Dose,2018-05-04T08:16:00
3110-103-002,PC,3110-103-002.103001340,22.0,1388484,UBRO,Ubrogepant,137.86,ng/mL,137.86,137.86,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T14:16:00,8.0,6 h,6.0,Period 2 Dose,2018-05-04T08:16:00
3110-103-002,PC,3110-103-002.103001340,23.0,1388485,UBRO,Ubrogepant,86.80,ng/mL,86.80,86.8,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T16:16:00,8.0,8 h,8.0,Period 2 Dose,2018-05-04T08:16:00
3110-103-002,PC,3110-103-002.103001340,24.0,1388488,UBRO,Ubrogepant,30.59,ng/mL,30.59,30.59,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T20:16:00,8.0,12 h,12.0,Period 2 Dose,2018-05-04T08:16:00
3110-103-002,PC,3110-103-002.103001340,25.0,1388491,UBRO,Ubrogepant,20.33,ng/mL,20.33,20.33,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T22:16:00,8.0,14 h,14.0,Period 2 Dose,2018-05-04T08:16:00
3110-103-002,PC,3110-103-002.103001340,26.0,1388497,UBRO,Ubrogepant,3.97,ng/mL,3.97,3.97,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-05-05T08:16:00,9.0,24 h,24.0,Period 2 Dose,2018-05-04T08:16:00
3110-103-002,PC,3110-103-002.103001349,1.0,1387687,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T07:26:00,1.0,Predose,0.0,Period 1 Dose,2018-04-27T08:06:00
3110-103-002,PC,3110-103-002.103001349,2.0,1387691,UBRO,Ubrogepant,206.52,ng/mL,206.52,206.52,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T08:36:00,1.0,0.5 h,0.5,Period 1 Dose,2018-04-27T08:06:00
3110-103-002,PC,3110-103-002.103001349,3.0,1387694,UBRO,Ubrogepant,280.03,ng/mL,280.03,280.03,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T09:06:00,1.0,1 h,1.0,Period 1 Dose,2018-04-27T08:06:00
3110-103-002,PC,3110-103-002.103001349,4.0,1387697,UBRO,Ubrogepant,202.99,ng/mL,202.99,202.99,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T09:36:00,1.0,1.5 h,1.5,Period 1 Dose,2018-04-27T08:06:00
3110-103-002,PC,3110-103-002.103001349,5.0,1387701,UBRO,Ubrogepant,188.85,ng/mL,188.85,188.85,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T10:06:00,1.0,2 h,2.0,Period 1 Dose,2018-04-27T08:06:00
3110-103-002,PC,3110-103-002.103001349,6.0,1387702,UBRO,Ubrogepant,107.95,ng/mL,107.95,107.95,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T11:06:00,1.0,3 h,3.0,Period 1 Dose,2018-04-27T08:06:00
3110-103-002,PC,3110-103-002.103001349,7.0,1387703,UBRO,Ubrogepant,73.11,ng/mL,73.11,73.11,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T12:06:00,1.0,4 h,4.0,Period 1 Dose,2018-04-27T08:06:00
3110-103-002,PC,3110-103-002.103001349,8.0,1387708,UBRO,Ubrogepant,54.01,ng/mL,54.01,54.01,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T13:06:00,1.0,5 h,5.0,Period 1 Dose,2018-04-27T08:06:00
3110-103-002,PC,3110-103-002.103001349,9.0,1387709,UBRO,Ubrogepant,39.88,ng/mL,39.88,39.88,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T14:06:00,1.0,6 h,6.0,Period 1 Dose,2018-04-27T08:06:00
3110-103-002,PC,3110-103-002.103001349,10.0,1387710,UBRO,Ubrogepant,21.61,ng/mL,21.61,21.61,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T16:06:00,1.0,8 h,8.0,Period 1 Dose,2018-04-27T08:06:00
3110-103-002,PC,3110-103-002.103001349,11.0,1387713,UBRO,Ubrogepant,6.64,ng/mL,6.64,6.64,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T20:06:00,1.0,12 h,12.0,Period 1 Dose,2018-04-27T08:06:00
3110-103-002,PC,3110-103-002.103001349,12.0,1387716,UBRO,Ubrogepant,3.69,ng/mL,3.69,3.69,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T22:06:00,1.0,14 h,14.0,Period 1 Dose,2018-04-27T08:06:00
3110-103-002,PC,3110-103-002.103001349,13.0,1387722,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-04-28T08:06:00,2.0,24 h,24.0,Period 1 Dose,2018-04-27T08:06:00
3110-103-002,PC,3110-103-002.103001349,14.0,1387747,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T07:26:00,8.0,Predose,0.0,Period 2 Dose,2018-05-04T08:06:00
3110-103-002,PC,3110-103-002.103001349,15.0,1387751,UBRO,Ubrogepant,4.04,ng/mL,4.04,4.04,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T08:36:00,8.0,0.5 h,0.5,Period 2 Dose,2018-05-04T08:06:00
3110-103-002,PC,3110-103-002.103001349,16.0,1387754,UBRO,Ubrogepant,41.63,ng/mL,41.63,41.63,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T09:06:00,8.0,1 h,1.0,Period 2 Dose,2018-05-04T08:06:00
3110-103-002,PC,3110-103-002.103001349,17.0,1387757,UBRO,Ubrogepant,106.89,ng/mL,106.89,106.89,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T09:36:00,8.0,1.5 h,1.5,Period 2 Dose,2018-05-04T08:06:00
3110-103-002,PC,3110-103-002.103001349,18.0,1387761,UBRO,Ubrogepant,182.16,ng/mL,182.16,182.16,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T10:06:00,8.0,2 h,2.0,Period 2 Dose,2018-05-04T08:06:00
3110-103-002,PC,3110-103-002.103001349,19.0,1387762,UBRO,Ubrogepant,229.95,ng/mL,229.95,229.95,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T11:06:00,8.0,3 h,3.0,Period 2 Dose,2018-05-04T08:06:00
3110-103-002,PC,3110-103-002.103001349,20.0,1387763,UBRO,Ubrogepant,149.53,ng/mL,149.53,149.53,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T12:06:00,8.0,4 h,4.0,Period 2 Dose,2018-05-04T08:06:00
3110-103-002,PC,3110-103-002.103001349,21.0,1387768,UBRO,Ubrogepant,80.72,ng/mL,80.72,80.72,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T13:06:00,8.0,5 h,5.0,Period 2 Dose,2018-05-04T08:06:00
3110-103-002,PC,3110-103-002.103001349,22.0,1387769,UBRO,Ubrogepant,66.34,ng/mL,66.34,66.34,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T14:06:00,8.0,6 h,6.0,Period 2 Dose,2018-05-04T08:06:00
3110-103-002,PC,3110-103-002.103001349,23.0,1387770,UBRO,Ubrogepant,33.57,ng/mL,33.57,33.57,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T16:06:00,8.0,8 h,8.0,Period 2 Dose,2018-05-04T08:06:00
3110-103-002,PC,3110-103-002.103001349,24.0,1387773,UBRO,Ubrogepant,11.46,ng/mL,11.46,11.46,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T20:06:00,8.0,12 h,12.0,Period 2 Dose,2018-05-04T08:06:00
3110-103-002,PC,3110-103-002.103001349,25.0,1387776,UBRO,Ubrogepant,6.81,ng/mL,6.81,6.81,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T22:06:00,8.0,14 h,14.0,Period 2 Dose,2018-05-04T08:06:00
3110-103-002,PC,3110-103-002.103001349,26.0,1387782,UBRO,Ubrogepant,1.53,ng/mL,1.53,1.53,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-05-05T08:06:00,9.0,24 h,24.0,Period 2 Dose,2018-05-04T08:06:00
3110-103-002,PC,3110-103-002.103001354,1.0,1388545,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T07:38:00,1.0,Predose,0.0,Period 1 Dose,2018-04-27T08:18:00
3110-103-002,PC,3110-103-002.103001354,2.0,1388549,UBRO,Ubrogepant,6.41,ng/mL,6.41,6.41,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T08:48:00,1.0,0.5 h,0.5,Period 1 Dose,2018-04-27T08:18:00
3110-103-002,PC,3110-103-002.103001354,3.0,1388552,UBRO,Ubrogepant,32.71,ng/mL,32.71,32.71,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T09:18:00,1.0,1 h,1.0,Period 1 Dose,2018-04-27T08:18:00
3110-103-002,PC,3110-103-002.103001354,4.0,1388555,UBRO,Ubrogepant,102.58,ng/mL,102.58,102.58,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T09:48:00,1.0,1.5 h,1.5,Period 1 Dose,2018-04-27T08:18:00
3110-103-002,PC,3110-103-002.103001354,5.0,1388559,UBRO,Ubrogepant,129.92,ng/mL,129.92,129.92,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T10:18:00,1.0,2 h,2.0,Period 1 Dose,2018-04-27T08:18:00
3110-103-002,PC,3110-103-002.103001354,6.0,1388560,UBRO,Ubrogepant,271.14,ng/mL,271.14,271.14,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T11:18:00,1.0,3 h,3.0,Period 1 Dose,2018-04-27T08:18:00
3110-103-002,PC,3110-103-002.103001354,7.0,1388561,UBRO,Ubrogepant,163.90,ng/mL,163.90,163.9,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T12:18:00,1.0,4 h,4.0,Period 1 Dose,2018-04-27T08:18:00
3110-103-002,PC,3110-103-002.103001354,8.0,1388566,UBRO,Ubrogepant,116.77,ng/mL,116.77,116.77,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T13:18:00,1.0,5 h,5.0,Period 1 Dose,2018-04-27T08:18:00
3110-103-002,PC,3110-103-002.103001354,9.0,1388567,UBRO,Ubrogepant,85.83,ng/mL,85.83,85.83,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T14:18:00,1.0,6 h,6.0,Period 1 Dose,2018-04-27T08:18:00
3110-103-002,PC,3110-103-002.103001354,10.0,1388568,UBRO,Ubrogepant,51.33,ng/mL,51.33,51.33,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T16:18:00,1.0,8 h,8.0,Period 1 Dose,2018-04-27T08:18:00
3110-103-002,PC,3110-103-002.103001354,11.0,1388571,UBRO,Ubrogepant,21.03,ng/mL,21.03,21.03,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T20:18:00,1.0,12 h,12.0,Period 1 Dose,2018-04-27T08:18:00
3110-103-002,PC,3110-103-002.103001354,12.0,1388574,UBRO,Ubrogepant,15.51,ng/mL,15.51,15.51,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T22:18:00,1.0,14 h,14.0,Period 1 Dose,2018-04-27T08:18:00
3110-103-002,PC,3110-103-002.103001354,13.0,1388580,UBRO,Ubrogepant,3.33,ng/mL,3.33,3.33,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-04-28T08:18:00,2.0,24 h,24.0,Period 1 Dose,2018-04-27T08:18:00
3110-103-002,PC,3110-103-002.103001354,14.0,1388605,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T07:38:00,8.0,Predose,0.0,Period 2 Dose,2018-05-04T08:18:00
3110-103-002,PC,3110-103-002.103001354,15.0,1388609,UBRO,Ubrogepant,104.45,ng/mL,104.45,104.45,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T08:48:00,8.0,0.5 h,0.5,Period 2 Dose,2018-05-04T08:18:00
3110-103-002,PC,3110-103-002.103001354,16.0,1388612,UBRO,Ubrogepant,134.22,ng/mL,134.22,134.22,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T09:18:00,8.0,1 h,1.0,Period 2 Dose,2018-05-04T08:18:00
3110-103-002,PC,3110-103-002.103001354,17.0,1388615,UBRO,Ubrogepant,98.83,ng/mL,98.83,98.83,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T09:48:00,8.0,1.5 h,1.5,Period 2 Dose,2018-05-04T08:18:00
3110-103-002,PC,3110-103-002.103001354,18.0,1388619,UBRO,Ubrogepant,107.09,ng/mL,107.09,107.09,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T10:18:00,8.0,2 h,2.0,Period 2 Dose,2018-05-04T08:18:00
3110-103-002,PC,3110-103-002.103001354,19.0,1388620,UBRO,Ubrogepant,80.48,ng/mL,80.48,80.48,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T11:18:00,8.0,3 h,3.0,Period 2 Dose,2018-05-04T08:18:00
3110-103-002,PC,3110-103-002.103001354,20.0,1388621,UBRO,Ubrogepant,92.36,ng/mL,92.36,92.36,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T12:18:00,8.0,4 h,4.0,Period 2 Dose,2018-05-04T08:18:00
3110-103-002,PC,3110-103-002.103001354,21.0,1388626,UBRO,Ubrogepant,89.35,ng/mL,89.35,89.35,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T13:18:00,8.0,5 h,5.0,Period 2 Dose,2018-05-04T08:18:00
3110-103-002,PC,3110-103-002.103001354,22.0,1388627,UBRO,Ubrogepant,71.27,ng/mL,71.27,71.27,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T14:18:00,8.0,6 h,6.0,Period 2 Dose,2018-05-04T08:18:00
3110-103-002,PC,3110-103-002.103001354,23.0,1388628,UBRO,Ubrogepant,40.85,ng/mL,40.85,40.85,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T16:18:00,8.0,8 h,8.0,Period 2 Dose,2018-05-04T08:18:00
3110-103-002,PC,3110-103-002.103001354,24.0,1388631,UBRO,Ubrogepant,20.50,ng/mL,20.50,20.5,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T20:18:00,8.0,12 h,12.0,Period 2 Dose,2018-05-04T08:18:00
3110-103-002,PC,3110-103-002.103001354,25.0,1388634,UBRO,Ubrogepant,14.05,ng/mL,14.05,14.05,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T22:18:00,8.0,14 h,14.0,Period 2 Dose,2018-05-04T08:18:00
3110-103-002,PC,3110-103-002.103001354,26.0,1388640,UBRO,Ubrogepant,4.95,ng/mL,4.95,4.95,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-05-05T08:18:00,9.0,24 h,24.0,Period 2 Dose,2018-05-04T08:18:00
3110-103-002,PC,3110-103-002.103001358,1.0,1387830,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T07:28:00,1.0,Predose,0.0,Period 1 Dose,2018-04-27T08:08:00
3110-103-002,PC,3110-103-002.103001358,2.0,1387834,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T08:38:00,1.0,0.5 h,0.5,Period 1 Dose,2018-04-27T08:08:00
3110-103-002,PC,3110-103-002.103001358,3.0,1387837,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T09:08:00,1.0,1 h,1.0,Period 1 Dose,2018-04-27T08:08:00
3110-103-002,PC,3110-103-002.103001358,4.0,1387840,UBRO,Ubrogepant,5.84,ng/mL,5.84,5.84,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T09:38:00,1.0,1.5 h,1.5,Period 1 Dose,2018-04-27T08:08:00
3110-103-002,PC,3110-103-002.103001358,5.0,1387844,UBRO,Ubrogepant,15.24,ng/mL,15.24,15.24,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T10:08:00,1.0,2 h,2.0,Period 1 Dose,2018-04-27T08:08:00
3110-103-002,PC,3110-103-002.103001358,6.0,1387845,UBRO,Ubrogepant,217.08,ng/mL,217.08,217.08,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T11:08:00,1.0,3 h,3.0,Period 1 Dose,2018-04-27T08:08:00
3110-103-002,PC,3110-103-002.103001358,7.0,1387846,UBRO,Ubrogepant,261.45,ng/mL,261.45,261.45,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T12:08:00,1.0,4 h,4.0,Period 1 Dose,2018-04-27T08:08:00
3110-103-002,PC,3110-103-002.103001358,8.0,1387851,UBRO,Ubrogepant,255.67,ng/mL,255.67,255.67,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T13:08:00,1.0,5 h,5.0,Period 1 Dose,2018-04-27T08:08:00
3110-103-002,PC,3110-103-002.103001358,9.0,1387852,UBRO,Ubrogepant,196.34,ng/mL,196.34,196.34,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T14:08:00,1.0,6 h,6.0,Period 1 Dose,2018-04-27T08:08:00
3110-103-002,PC,3110-103-002.103001358,10.0,1387853,UBRO,Ubrogepant,124.42,ng/mL,124.42,124.42,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T16:08:00,1.0,8 h,8.0,Period 1 Dose,2018-04-27T08:08:00
3110-103-002,PC,3110-103-002.103001358,11.0,1387856,UBRO,Ubrogepant,43.43,ng/mL,43.43,43.43,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T20:08:00,1.0,12 h,12.0,Period 1 Dose,2018-04-27T08:08:00
3110-103-002,PC,3110-103-002.103001358,12.0,1387859,UBRO,Ubrogepant,27.65,ng/mL,27.65,27.65,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,1.0,Period 1 Day 1,TREATMENT,2018-04-27T22:08:00,1.0,14 h,14.0,Period 1 Dose,2018-04-27T08:08:00
3110-103-002,PC,3110-103-002.103001358,13.0,1387865,UBRO,Ubrogepant,6.52,ng/mL,6.52,6.52,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,2.0,Period 1 Day 2,TREATMENT,2018-04-28T08:08:00,2.0,24 h,24.0,Period 1 Dose,2018-04-27T08:08:00
3110-103-002,PC,3110-103-002.103001358,14.0,1387890,UBRO,Ubrogepant,BQL,ng/mL,BQL,nan,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T07:28:00,8.0,Predose,0.0,Period 2 Dose,2018-05-04T08:08:00
3110-103-002,PC,3110-103-002.103001358,15.0,1387894,UBRO,Ubrogepant,305.49,ng/mL,305.49,305.49,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T08:38:00,8.0,0.5 h,0.5,Period 2 Dose,2018-05-04T08:08:00
3110-103-002,PC,3110-103-002.103001358,16.0,1387897,UBRO,Ubrogepant,414.50,ng/mL,414.50,414.5,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T09:08:00,8.0,1 h,1.0,Period 2 Dose,2018-05-04T08:08:00
3110-103-002,PC,3110-103-002.103001358,17.0,1387900,UBRO,Ubrogepant,294.29,ng/mL,294.29,294.29,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T09:38:00,8.0,1.5 h,1.5,Period 2 Dose,2018-05-04T08:08:00
3110-103-002,PC,3110-103-002.103001358,18.0,1387904,UBRO,Ubrogepant,280.22,ng/mL,280.22,280.22,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T10:08:00,8.0,2 h,2.0,Period 2 Dose,2018-05-04T08:08:00
3110-103-002,PC,3110-103-002.103001358,19.0,1387905,UBRO,Ubrogepant,220.58,ng/mL,220.58,220.58,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T11:08:00,8.0,3 h,3.0,Period 2 Dose,2018-05-04T08:08:00
3110-103-002,PC,3110-103-002.103001358,20.0,1387906,UBRO,Ubrogepant,172.76,ng/mL,172.76,172.76,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T12:08:00,8.0,4 h,4.0,Period 2 Dose,2018-05-04T08:08:00
3110-103-002,PC,3110-103-002.103001358,21.0,1387911,UBRO,Ubrogepant,136.82,ng/mL,136.82,136.82,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T13:08:00,8.0,5 h,5.0,Period 2 Dose,2018-05-04T08:08:00
3110-103-002,PC,3110-103-002.103001358,22.0,1387912,UBRO,Ubrogepant,108.78,ng/mL,108.78,108.78,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T14:08:00,8.0,6 h,6.0,Period 2 Dose,2018-05-04T08:08:00
3110-103-002,PC,3110-103-002.103001358,23.0,1387913,UBRO,Ubrogepant,68.56,ng/mL,68.56,68.56,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T16:08:00,8.0,8 h,8.0,Period 2 Dose,2018-05-04T08:08:00
3110-103-002,PC,3110-103-002.103001358,24.0,1387916,UBRO,Ubrogepant,25.12,ng/mL,25.12,25.12,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T20:08:00,8.0,12 h,12.0,Period 2 Dose,2018-05-04T08:08:00
3110-103-002,PC,3110-103-002.103001358,25.0,1387919,UBRO,Ubrogepant,17.28,ng/mL,17.28,17.28,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,8.0,Period 2 Day 8,TREATMENT,2018-05-04T22:08:00,8.0,14 h,14.0,Period 2 Dose,2018-05-04T08:08:00
3110-103-002,PC,3110-103-002.103001358,26.0,1387925,UBRO,Ubrogepant,5.89,ng/mL,5.89,5.89,ng/mL,,,Altasciences Company Inc.,PLASMA,1.0,9.0,Period 2 Day 9,TREATMENT,2018-05-05T08:08:00,9.0,24 h,24.0,Period 2 Dose,2018-05-04T08:08:00
